2004, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, 2004

Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78: 2454-2459 (2004). *
Abal'masov DV, Pozharitskaia MM, Starosel'tseva LK, Afanas'ev VV. Study of free-radical processes and antioxidant defense parameters during hirudotherapy of patients with diseases of salivary glands. Stomatologiia (Mosk.) 83: 27-29 (2004).
Abbas AK, Lohr J, Knoechel B, Nagabhushanam V. T cell tolerance and autoimmunity. Autoimmun. Rev. 3: 471-475 (2004).
Abbas Z, Khan R, Abid S, Hamid S, Shah H, Jafri W. Is Crohn's disease in Pakistan less severe than in the West? Trop. Doct. 34: 39-41 (2004).
Abbott DW, Wilkins A, Asara JM, Cantley LC. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14: 2217-2227 (2004). *
Abbott JD, Moreland LW. Rheumatoid arthritis: developing pharmacological therapies. Expert Opin. Investig. Drugs 13: 1007-1018 (2004).
Abboud P, Zejli A, Mansour G, Birembaut P. Neonatal haemochromatosis: a rare cause of neonatal death. Eur. J. Obstet. Gynecol. Reprod. Biol. 116: 233-234 (2004).
Abdelrazeq AS, Lund JN, Leveson SH. Pouchitis-associated pyoderma gangrenosum following restorative proctocolectomy for ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 16: 1057-1058 (2004).
Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J. Hepatol. 40: 380-384 (2004). *
Abe H, Tsuboi N, Yukawa S, Tsuji S, Hayashi H, Yukawa N, Takanashi H, Tahara K, Tonozuka N, Hayashi T. Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome with crescentic glomerulonephritis and membranous nephritis. Mod. Rheumatol. 14: 174-178 (2004).
Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40: 414-423 (2004). *
Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172: 6362-6372 (2004). *
Abeyama K, Maruyama I. Inflammation and its regulatory system. Nippon Rinsho 62: 2229-2235 (2004).
Ablassmaier B, Hartmann J. A case of severe gangrenous ischemic colitis following nonsteroidal anti-inflammatory drug intake. Zentralbl. Chir. 129: 510-512 (2004).
Abraham LA, Charles JA, Holloway SA. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs. Aust. Vet. J. 82: 157-160 (2004).
Abraham NS, Fallone CA, Mayrand S, Huang J, Wieczorek P, Barkun AN. Sedation versus no sedation in the performance of diagnostic upper gastrointestinal endoscopy: a Canadian randomized controlled cost-outcome study. Am. J. Gastroenterol. 99: 1692-1699 (2004). *
Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308 (2004). *
Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann. Rheum. Dis. 63: 123-129 (2004). *
Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease. Hepatology 40: 475-483 (2004). *
Abrams SI. Role of anti-CTLA-4 therapies in the treatment of cancer. Curr. Opin. Mol. Ther. 6: 71-77 (2004).
Abreu MT. Choosing therapy on the basis of disease classifications in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 7: 169-179 (2004).
Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. 144: 421-429 (2004). *
Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129-1136 (2004). *
Abreu MT, Yang H. Is genetic testing in IBD ready for prime time? Am. J. Gastroenterol. 99: 316-318 (2004). *
Abt PL, Rapaport-Kelz R, Desai NM, Frank A, Sonnad S, Rand E, Markmann JF, Shaked A, Olthoff KM. Survival among pediatric liver transplant recipients: impact of segmental grafts. Liver Transpl. 10: 1287-1293 (2004). *
Abu-Hamda EM, Baron TH. Endoscopic management of cholangiocarcinoma. Semin. Liver Dis. 24: 165-175 (2004).
Abu-Suboh Abadia M, Casellas F, Vilaseca J, Malagelada J. Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy. Rev. Esp. Enferm. Dig. 96: 539-547 (2004).
Accomando S, Cataldo F. The global village of celiac disease. Dig. Liver Dis. 36: 492-498 (2004).
Achenbach P, Fuchtenbusch M. Modulating the autoimmune response in type 1 diabetes: a report on the 64th Scientific Sessions of the ADA, June 2004, Orlando, FL, USA. Rev. Diabet. Stud. 1: 137-140 (2004). *
Acheson DW, Luccioli S. Mucosal immune responses. Best Pract. Res. Clin. Gastroenterol. 18: 387-404 (2004).
Achkar E. Colorectal cancer screening in primary care: the long and short of it. Am. J. Gastroenterol. 99: 837-838 (2004). *
Achkar JP, Stevens T, Easley K, Brzezinski A, Seidner D, Lashner B. Indicators of clinical response to treatment with 6-mercaptopurine or azathioprine in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 10: 339-345 (2004). *
Ackerman Z, Einbinder Y, Stalnikowicz R. Recurrent postpartum exacerbation of chronic ulcerative colitis. J. Clin. Gastroenterol. 38: 914 (2004).
Actis GC, Lagget M, Rizzetto M, Fadda M, Palmo A, Pinna-Pintor M, Morino F. Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis. Minerva Med. 95: 65-70 (2004).
Actis GC, Rossetti S, Rizzetto M, Fadda M, Palmo A. Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine. Minerva Gastroenterol. Dietol. 50: 97-101 (2004).
Adachi M, Fujita Y, Murata T, Majima Y. A case of Kuttner tumor of the submandibular gland. Auris. Nasus. Larynx. 31: 309-312 (2004).
Adachi R, Shulman AI, Yamamoto K, Shimomura I, Yamada S, Mangelsdorf DJ, Makishima M. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol. Endocrinol. 18: 43-52 (2004). *
Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J. Am. Acad. Dermatol. 51: 660-662 (2004).
Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 291: 1127-1131 (2004). *
Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 39: 909-914 (2004). *
Adams LA, Lindor KD. Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought. Indian J. Gastroenterol. 23: 127-128 (2004). *
Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 99: 1316-1320 (2004). *
Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 2365-2368 (2004). *
Adams PC. Hemochromatosis. Clin. Liver Dis. 8: 735-753, vii (2004).
Adams PC. Haemochromatosis: find them or forget about them? Eur. J. Gastroenterol. Hepatol. 16: 857-858 (2004).
Adams PC, Arthur MJ, Boyer TD, DeLeve LD, Di Bisceglie AM, Hall M, Levin TR, Provenzale D, Seeff L. Screening in liver disease: report of an AASLD clinical workshop. Hepatology 39: 1204-1212 (2004). *
Adamson KA, Pearce SH, Lamb JR, Seckl JR, Howie SE. A comparative study of mRNA and protein expression of the autoimmune regulator gene (Aire) in embryonic and adult murine tissues. J. Pathol. 202: 180-187 (2004). *
Adani GL, Baccarani U, Risaliti A, Hallas J, Gaist D, Vach W, Sorensen HT. The role of age in the protection of appendicectomy against ulcerative colitis * Author's reply. Gut 53: 1719-1720 (2004). *
Ademoglu E, Erbil Y, Tam B, Barbaros U, Ilhan E, Olgac V, Mutlu-Turkoglu U. Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig. Dis. Sci. 49: 102-108 (2004). *
Adhami E. Calculating the etiology of systemic lupus erythematosus. Med. Hypotheses 62: 237-246 (2004).
Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am. J. Gastroenterol. 99: 2098-2106 (2004). *
Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564 (2004). *
Adler EM. Focus issue - tailoring the immune response. Sci. STKE 241: EG9 (2004). *
Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am. J. Clin. Nutr. 80: 245-256 (2004). *
Adorini L. Antigen-based immunointervention in human autoimmune diseases. Trends Biotechnol. 22: 547-549 (2004). *
Adrain AL, Ramberan H, Weaver GJ. Evaluation of common liver problems. J. Am. Podiatr. Med. Assoc. 94: 149-156 (2004).
Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am. J. Gastroenterol. 99: 1160-1174 (2004). *
Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment. Pharmacol. Ther. 20: 167-172 (2004). *
Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, Lachmann HJ, Karenko L, Ranki A, Bakkaloglu A, Besbas N, Topaloglu R, Hoffman HM, Hitman GA, Woo P, McDermott MF. Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun. 5: 289-293 (2004). *
Agarwal B, Kuehn S, Collins BT. Dilated pancreatic duct and common bile duct in a patient with abdominal pain and weight loss. Am. J. Gastroenterol. 99: 1623-1625 (2004). *
Agca E, Akcay A, Simsek H. Ursodeoxycholic acid and terbinafine-induced toxic hepatitis. Ann. Pharmacother. 38: 1088-1089 (2004).
Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208 (2004). *
Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann. N. Y. Acad. Sci. 1030: 434-441 (2004). *
Aggarwal BB, Takada Y, Oommen OV. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin. Investig. Drugs 13: 1327-1338 (2004).
Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, Kumar A. Nuclear transcription factor NF-kappaB: role in biology and medicine. Indian J. Exp. Biol. 42: 341-353 (2004).
Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, Gharagozlou M, Movahedi M, Atarod L, Afshar AA, Bazargan N, Hosseinpoor AR. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann. Allergy Asthma Immunol. 92: 60-64 (2004).
Agius LM. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J. Theor. Biol. 227: 219-228 (2004). *
Agnholt J, Kelsen J, Brandsborg B, Jakobsen NO, Dahlerup JF. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease - a possible target for infliximab treatment. Eur. J. Gastroenterol. Hepatol. 16: 649-655 (2004).
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325 (2004). *
Agou F, Courtois G, Chiaravalli J, Baleux F, Coic YM, Traincard F, Israel A, Veron M. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (NEMO) oligomerization. J. Biol. Chem. 279: 54248-54257 (2004). *
Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl. 10: 1166-1172 (2004). *
Aguilera-Montilla N, Perez-Blas M, Valeri AP, Lopez-Santalla M, Rodriguez-Juan C, Mencia A, Castellano G, Manzano ML, Casis B, Sanchez F, Martin-Villa JM. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand. J. Gastroenterol. 39: 1236-1242 (2004). *
Aguirre-Garcia J. Inflammatory pseudotumor of the liver. Ann. Hepatol. 3: 34 (2004). *
Aguzzi A, Sigurdson CJ. Antiprion immunotherapy: to suppress or to stimulate? Nat. Rev. Immunol. 4: 725-736 (2004). *
Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 351: 1972-1977 (2004). *
Aherrahrou Z, Axtner SB, Kaczmarek PM, Jurat A, Korff S, Doehring LC, Weichenhan D, Katus HA, Ivandic BT. A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am. J. Pathol. 164: 1379-1387 (2004). *
Ahlenstiel G, Woitas RP, Rockstroh J, Spengler U. CC-chemokine receptor 5 (CCR5) in hepatitis C - at the crossroads of the antiviral immune response? J. Antimicrob. Chemother. 53: 895-898 (2004). *
Ahluwalia A, Clodfelter KH, Waxman DJ. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol. Endocrinol. 18: 747-760 (2004). *
Ahluwalia J, Tinker A, Clapp LH, Duchen MR, Abramov AY, Pope S, Nobles M, Segal AW. The large-conductance Ca2+-activated K+ channel is essential for innate immunity. Nature 427: 853-858 (2004). *
Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Am. J. Hematol. 77: 171-176 (2004). *
Ahmad T. Phenotype-determining genes in inflammatory bowel disease. Novartis Found. Symp. 263: 17-29 (2004).
Ahmad T, Pesi Tamboli C, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126: 1533-1549 (2004). *
Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 113: 565-567 (2004). *
Ahman T. Molecular classification of IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 27. May 7-8 (2004). *
Ahmed M, Jenkins HR. Vitamin B-12 in Crohn's disease patients with small bowel surgery. Arch. Dis. Child. 89: 293 (2004). *
Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J. Hepatol. 41: 913-919 (2004). *
Ahmed S, Siddiqui AK, Chandrasekaran V. Correlation of thrombotic thrombocytopenic purpura disease activity with Von Willibrand factor-cleaving protease level in ulcerative colitis. Am. J. Med. 116: 786-787 (2004). *
Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J. Pediatr. Gastroenterol. Nutr. 38: 276-280 (2004). *
Ahn BK, Kim SC. Pyodermatitis-pyostomatitis vegetans with circulating autoantibodies to bullous pemphigoid antigen 230. J. Am. Acad. Dermatol. 50: 785-788 (2004).
Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, Oh YH, Park YM. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313: 148-155 (2004). *
Ahuja V. Crohn's disease and mycobacteria: 'the Thomson brothers' or 'back to the future'. Trop. Gastroenterol. 25: 151-155 (2004).
Ai T, Bompadre SG, Sohma Y, Wang X, Li M, Hwang TC. Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating. Pflugers Arch. 449: 88-95 (2004). *
Ai T, Bompadre SG, Wang X, Hu S, Li M, Hwang TC. Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents. Mol. Pharmacol. 65: 1415-1426 (2004). *
Ai Y, Liu SY, Yao Q. Clinical characteristics of 1241 cases of intrahepatic cholestasis of pregnancy. Zhonghua Fu Chan Ke Za Zhi 39: 217-220 (2004).
Aiello M, Chetta A, Marangio E, Zompatori M, Olivieri D. Pleural involvement in systemic disorders. Curr. Drug Targets Inflamm. Allergy 3: 441-447 (2004).
Ainsworth AP, Rafaelsen SR, Wamberg PA, Pless T, Durup J, Mortensen MB. Cost-effectiveness of endoscopic ultrasonography, magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography in patients suspected of pancreaticobiliary disease. Scand. J. Gastroenterol. 39: 579-583 (2004). *
Aisen P. Transferrin receptor 1. Int. J. Biochem. Cell. Biol. 36: 2137-2143 (2004). *
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441 (2004). *
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440 (2004). *
Ajamieh HH, Menendez S, Martinez-Sanchez G, Candelario-Jalil E, Re L, Giuliani A, Fernandez OS. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 24: 55-62 (2004). *
Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J. Endocrinol. Invest. 27: 237-245 (2004).
Akabane H, Miyagawa N, Nii H, Inami Y, Togawa M, Tanaka H, Inagaki N, Nagai H. The effect of a newly synthesized indazole compound, TAS-3-124, on experimental autoimmune disease. Biol. Pharm. Bull. 27: 1218-1223 (2004). *
Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum. Genet. 114: 503-509 (2004). *
Akahoshi M, Yoshimoto G, Nakashima H, Miyake K, Inoue Y, Tanaka Y, Tsukamoto H, Horiuchi T, Otsuka T, Harada M. MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod. Rheumatol. 14: 179-183 (2004).
Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. 76: 227-236 (2004). *
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR. Lack of association between vitamin D receptor FokI polymorphism and alopecia areata. Eur. J. Dermatol. 14: 156-158 (2004). *
Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat. Rev. Immunol. 4: 737-743 (2004). *
Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. Transplant. Proc. 36: 86-88 (2004). *
Akbiyik F, Cinar K, Demirpence E, Ozsullu T, Tunca R, Haziroglu R, Yurdaydin C, Uzunalimoglu O, Bozkaya H. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur. J. Clin. Invest. 34: 429-435 (2004).
Akbulut S, Yavuz B, Koseoglu T, Gokoz A, Saritas U. Crohn's disease with isolated esophagus and gastric involvement. Turk. J. Gastroenterol. 15: 196-200 (2004). *
Akerlund JE, Lofberg R. Pouchitis. Curr. Opin. Gastroenterol. 20: 341-344 (2004).
Akilesh S, Petkova S, Sproule TJ, Shaffer DJ, Christianson GJ, Roopenian D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest. 113: 1328-1333 (2004). *
Akin EB, Vitellas KM, Rajab A, Pelletier RP, Davies EA, Bumgardner GL, Henry ML, Ferguson RM, Elkhammas EA. Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation. J. Comput. Assist. Tomogr. 28: 613-616 (2004).
Akira S, Takeda K. Functions of Toll-like receptors: lessons from KO mice. C. R. Biol. 327: 581-589 (2004).
Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511 (2004). *
Akiyoshi H, Hatakeyama S, Pitkanen J, Mouri Y, Doucas V, Kudoh J, Tsurugaya K, Uchida D, Matsushima A, Oshikawa K, Nakayama KI, Shimizu N, Peterson P, Matsumoto M. Subcellular expression of autoimmune regulator is organized in a spatiotemporal manner. J. Biol. Chem. 279: 33984-33991 (2004). *
Akobeng A, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 1: CD003574 (2004). *
Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease Cochrane Database Syst. Rev. 1: CD003715 (2004). *
Akoume MY, Tuchweber B, Plaa GL, Yousef IM. The role of mdr2 in manganese-bilirubin induced cholestasis in mice. Toxicol. Lett. 148: 41-51 (2004). *
Aktas A, Koyuncu A, Yalcin H. Acceleration of hepatobiliary dynamics in liver transplant donors. Transplant. Proc. 36: 206-209 (2004). *
Al Jumah M, Majumdar R, Al Rajeh S, Awada A, Al Zaben A, Al Traif I, Al Jumah AR, Rehana Z. A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations. Eur. J. Neurol. 11: 121-124 (2004). *
Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, Aljebreen AM, Isnani AC, El-Badawi R. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World J. Gastroenterol. 10: 1341-1344 (2004). *
Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin. Diagn. Lab. Immunol. 11: 292-296 (2004). *
Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am. J. Hematol. 75: 225-230 (2004). *
Al-Mutawa SA, Hegab SM. Behcet's disease. Clin. Exp. Med. 4: 103-131 (2004). *
Al-Osaimi AM, Berg CL. Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Dig. Dis. Sci. 49: 438-443 (2004). *
Al-Ratrout JT, Ansari NA. Epidermolysis bullosa acquisita and Crohn's disease. Saudi Med. J. 25: 1736-1738 (2004).
Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).
Ala A, Schilsky ML. Wilson disease: pathophysiology, diagnosis, treatment, and screening. Clin. Liver Dis. 8: 787-805, viii (2004).
Ala A, Schilsky ML. Inherited metabolic liver disease. Curr. Opin. Gastroenterol. 20: 198-207 (2004).
Aladag M, Gurakar A, Jalil S, Wright H, Alamian S, Rashwan S, Sebastian A, Nour B. A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report. Transplant. Proc. 36: 203-205 (2004). *
Aladesanmi OA. Sarcoidosis: an update for the primary care physician. MedGenMed. 6: 7 (2004). *
Alam I, Nolan N, Geoghegan J. Isolated Crohn's disease of the appendix. Ir. J. Med. Sci. 173: 114 (2004).
Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology (Oxford) 43: 615-618 (2004). *
Alansari A, Gul A, Inanc M, Ordi J, Teh LS, Ollier WE, Gonzalez-Gay MA, Hajeer AH. Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. Saudi Med. J. 25: 1445-1448 (2004).
Alarcon de la Lastra C, Sanchez-Fidalgo S, Villegas I, Motilva V. New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists. Curr. Pharm. Des. 10: 3505-3524 (2004).
Alarcon-Riquelme ME. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res. Ther. 6: 169-173 (2004). *
Albert C, Vandenbos F, Brocq O, Carles D, Euller-Ziegler L. Legionellosis in patient treated with infliximab. Rev. Med. Interne. 25: 167-168 (2004).
Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA. Wegener's granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum. 51: 656-664 (2004). *
Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4: 223-231 (2004). *
Alberti S, Bohse K, Arndt V, Schmitz A, Hohfeld J. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15: 4003-4010 (2004). *
Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 363: 1608-1610 (2004). *
Albrecht K, Schumann R, Peitgen K, Walz MK. Laparoscopic therapy of appendicovesical fistula - two case reports. Zentralbl. Chir. 129: 396-398 (2004).
Alcala MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm. Bowel Dis. 10: 383-391 (2004). *
Alderuccio F, Toh BH. Induction of tolerance to self-antigens using genetically modified bone marrow cells. Expert Opin. Biol. Ther. 4: 1007-1014 (2004).
Alehan D, Dogan OF. Pediatric surgical image. A rare case: celiac artery compression syndrome in an asymptomatic child. J. Pediatr. Surg. 39: 645-647 (2004).
Aleman G, Torres N, Tovar AR. Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development. Rev. Invest. Clin. 56: 351-367 (2004).
Aleman M, Schierloh P, De La Barrera SS, Musella RM, Saab MA, Baldini M, Abbate E, Sasiain MC. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving Toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect. Immun. 72: 5150-5158 (2004). *
Alenius GM, Friberg C, Nilsson S, Wahlstrom J, Dahlqvist SR, Samuelsson L. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J. Rheumatol. 31: 2230-2235 (2004). *
Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 44: 509-538 (2004).
Alessandrini F, Pfister S, Kremmer E, Gerber JK, Ring J, Behrendt H. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. J. Invest. Dermatol. 123: 1030-1036 (2004). *
Alessio AC, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasco AP, Hoehr NF. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. A. 128A: 256-260 (2004).
Alexakis C, Caruelle JP, Sezeur A, Cosnes J, Gendre JP, Mosnier H, Beaugerie L, Gallot D, Malafosse M, Barritault D, Kern P. Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut 53: 85-90 (2004). *
Alexander S, Bramson J, Foley R, Xing Z. Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein. Blood 103: 93-99 (2004). *
Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529 (2004). *
Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur. J. Dermatol. 14: 364-370 (2004). *
Alfven G. Plasma oxytocin in children with recurrent abdominal pain. J. Pediatr. Gastroenterol. Nutr. 38: 513-517 (2004). *
Algood HM, Flynn JL. CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J. Immunol. 173: 3287-3296 (2004). *
Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Jarvinen HJ, Karhu A, Aaltonen LA. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res. 64: 7245-7247 (2004). *
Ali A, Santisi JM, Vargo J. Video capsule endoscopy: a voyage beyond the end of the scope. Cleve. Clin. J. Med. 71: 415-425 (2004). *
Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study. Arch. Intern. Med. 164: 963-968 (2004). *
Alimohamadi SM, Malekzadeh R, Mirmadjless SH, Mohamadnejad M, Zamani F. Herpes simplex virus encephalistis during immunosuppressive treatment of ulcerative colitis. MedGenMed. 6: 7 (2004). *
Alizadeh BZ, Njajou OT, Houwing-Duistermaat JJ, Jong Gd G, Vergeer JM, Hofman A, Pols HA, Duijn CM. Does bilirubin protect against hemochromatosis gene (HFE) related mortality? Am. J. Med. Genet. 129A: 39-43 (2004). *
Alkan SS. Monoclonal antibodies: the story of a discovery that revolutionized science and medicine. Nat. Rev. Immunol. 4: 153-156 (2004). *
Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin. Chim. Acta 350: 51-55 (2004). *
Allcock RJ, Windsor L, Gut IG, Kucharzak R, Sobre L, Lechner D, Garnier JG, Baltic S, Christiansen FT, Price P. High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Hum. Mutat. 24: 517-525 (2004).
Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 53: 1566-1570 (2004). *
Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant. 13: 765-773 (2004).
Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290 (2004). *
Allen RL, Trowsdale J. Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr. Mol. Med. 4: 59-65 (2004).
Allen S, Okoko B, Martinez E, Gregorio G, Dans L. Probiotics for treating infectious diarrhoea. Cochrane Database Syst. Rev. 2: CD003048 (2004). *
Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am. J. Vet. Res. 65: 1279-1283 (2004).
Allez M, Brimnes J, Shao L, Dotan I, Nakazawa A, Mayer L. Activation of a unique population of CD8+ T cells by intestinal epithelial cells. Ann. N. Y. Acad. Sci. 1029: 22-35 (2004). *
Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10: 666-676 (2004). *
Allocca M, Crosignani A, Battezzati PM, Gritti A, Podda M. Hypercholesterolaemia is not associated with increased carotid-artery intima and media thickness in primary biliary cirrhosis. J. Hepatol. 40 Suppl. 1: 159 (2004).
Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell PG, North BV, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot PJ, Hemmatpour SK, Froguel P, Hitman GA. The EIF2AK3 gene region and type I diabetes in subjects from South India. Genes Immun. 5: 648-652 (2004). *
Almeras L, Lefranc D, Drobecq H, De Seze J, Dubucquoi S, Vermersch P, Prin L. New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4: 2184-2194 (2004). *
Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291: 1875-1879 (2004). *
Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, Nussbaum E, Nielson D, Platzker A, Davies Z, Lieberthal A, Chin T, Shay G, Hardy K, Kharrazi M. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum. Mutat. 24: 353 (2004). *
Alpers D. The elusive causes of relapse in ulcerative colitis. Inflamm. Bowel Dis. 10: 170-171 (2004). *
Alpers DH. Why, how, and to which part of the gastrointestinal tract should forced enteral feedings be delivered in patients?. Curr. Opin. Gastroenterol. 20: 104-109 (2004).
Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M. S-Adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J. Clin. Psychopharmacol. 24: 661-664 (2004).
Alpini G, Kanno N, Phinizy JL, Glaser S, Francis H, Taffetani S, LeSage G. Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G973-G982 (2004). *
Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328: 1046 (2004). *
Alter HJ. Hepatology highlights. Hepatology 40: 771 (2004). *
Altes A, Ruiz A, Barcelo MJ, Remacha AF, Puig T, Maya AJ, Castell C, Amate JM, Saz Z, Baiget M. Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of Northern Spain. Genet. Test. 8: 407-410 (2004).
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204 (2004). *
Altschuler EL, Kast RE. Bupropion for Blau syndrome. Med. Hypotheses 62: 297-298 (2004).
Altucci L, Gronemeyer H. Retinoids and TRAIL: two cooperating actors to fight against cancer. Vitam. Horm. 67: 319-345 (2004).
Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, Garcia-Bengoechea M, Barrio J, Mujica F, Recondo JA. MR quantification of hepatic iron concentration. Radiology 230: 479-484 (2004). *
Alvarez BV, Kieller DM, Quon AL, Markovich D, Casey JR. Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart. J. Physiol. 561: 721-734 (2004). *
Alvarez F. Treatment of autoimmune hepatitis: current and future therapies. Curr. Treat. Options Gastroenterol. 7: 413-420 (2004).
Alvarez F. Round table: controversies in the treatment of autoimmune liver diseases in children. Cyclosporine indication in �autoimmune hepatitis (AIH)�. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 95-96 (2004). *
Alvarez F. Clinical and diagnostics aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88 (2004). *
Alvarez L, Jara P, Sanchez-Sabate E, Hierro L, Larrauri J, Diaz MC, Camarena C, De La Vega A, Frauca E, Lopez-Collazo E, Lapunzina P. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum. Mol. Genet. 13: 2451-2460 (2004). *
Alvarez R, Vega MJ, Kammerer S, Rossin A, Germain P, Gronemeyer H, de Lera AR. 9-cis-Retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists. Bioorg. Med. Chem. Lett. 14: 6117-6122 (2004). *
Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-Corradini S, Mancino MG, Maggioni M, Attili AF, Podda M, Gaudio E. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J. Hepatol. 41: 905-912 (2004). *
Alves A, Panis Y, Joly F, Pocard M, Lavergne-Slove A, Bouhnik Y, Valleur P. Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflamm. Bowel Dis. 10: 491-495 (2004). *
Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence Int. 35: 392-396 (2004).
Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA 3rd, Graham MF. Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G528-G537 (2004). *
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J. Immunol. 172: 6444-6452 (2004). *
Amaral MD. CFTR and chaperones: processing and degradation. J. Mol. Neurosci. 23: 41-48 (2004).
Amaral MD, Clarke LA, Ramalho AS, Beck S, Broackes-Carter F, Rowntree R, Mouchel N, Williams SH, Harris A, Tzetis M, Steiner B, Sanz J, Gallati S, Nissim-Rafinifa M, Kerem B, Hefferon T, Cutting GR, Goina E, Pagani F. Quantitative methods for the analysis of CFTR transcripts/splicing variants. J. Cyst. Fibros. 3 Suppl. 2: 17-23 (2004).
Amarapurkar AD, Kher A, Agrawal R, Meenakshi B, Kandalkar BM, Deshpande JR. A rare cause of steatohepatitis. Trop. Gastroenterol. 25: 176-177 (2004).
Amarapurkar DN, Patel ND. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values. Trop. Gastroenterol. 25: 130-134 (2004).
Amarapurkar DN, Patel ND, Amarapurkar AD, Agal S, Baigal R, Gupte P. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn's disease. J. Assoc. Physicians India 52: 863-867 (2004).
Amasheh S, Barmeyer C, Koch CS, Tavalali S, Mankertz J, Epple HJ, Gehring MM, Florian P, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology 126: 1711-1720 (2004). *
Amat di San Filippo C, Longo N. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter. J. Biol. Chem. 279: 7247-7253 (2004). *
Amcheslavsky A, Zou W, Bar-Shavit Z. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms: implications for osteoclastogenesis. J. Biol. Chem. 279: 54039-54045 (2004). *
Amela-Peris R, Aladro Y, Conde-Sendin MA, Alemany-Rodriguez MJ, Munoz-Fernandez C, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F. Familial multiple sclerosis in Canary Islands. Rev. Neurol. 39: 911-914 (2004).
Amer OT, Abd El-Rahma HA, Sherief LM, Hussein HF, Zeid AF, Abd El-Aziz AM. Role of some viral infections in neonatal cholestasis. Egypt. J. Immunol. 11: 149-155 (2004).
Amin MG, Wolf MP, Tenbrook JA Jr, Freeman RB Jr, Cheng SJ, Pratt DS, Wong JB. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 10: 1468-1475 (2004). *
Amino N, Kimura M, Tanaka S, Izumi Y, Ikemoto M, Tatsumi KI, Takano T, Hidaka Y. Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology. Rinsho Byori 52: 44-50 (2004).
Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 43: 658-661 (2004). *
Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL; Swiss Echinococcosis Study Group. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: long-term analysis of the Swiss chemotherapy trial (1976-2001). J. Hepatol. 41: 551-559 (2004).
Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J. Rheumatol. 31: 2413-2417 (2004). *
Amos J, Grody W. Development and integration of molecular genetic tests into clinical practice: the US experience. Expert Rev. Mol. Diagn. 4: 465-477 (2004).
Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117: 515-526 (2004). *
Amundsen SS, Naluai AT, Ascher H, Ek J, Gudjonsdottir AH, Wahlstrom J, Lie BA, Sollid LM. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64: 593-599 (2004). *
An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10: 268-274 (2004). *
Anagnostopoulos G, Sakorafas GH, Grigoriadis K, Margantinis G, Kostopoulos P, Tsiakos S, Arvanitidis D. Hepatitis caused by occupational chronic exposure to trichloroethylene. Acta Gastroenterol. Belg. 67: 355-357 (2004).
Anakk S, Kalsotra A, Kikuta Y, Huang W, Zhang J, Staudinger JL, Moore DD, Strobel HW. CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. Pharmacogenomics J. 4: 91-101 (2004). *
Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO. Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127: 1139-1149 (2004). *
Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ, Walsh MJ. Ligand-dependent activation of the farnesoid-X-receptor directs arginine methylation of histone H3 by CARM1. J. Biol. Chem. 279: 54348-54357 (2004). *
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J. 18: 8-30 (2004). *
Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103: 2914-2919 (2004). *
Andersen-Ranberg K, HOier-Madsen M, Wiik A, Jeune B, Hegedus L. High prevalence of autoantibodies among Danish centenarians. Clin. Exp. Immunol. 138: 158-163 (2004). *
Anderson AC, Reddy J, Nazareno R, Sobel RA, Nicholson LB, Kuchroo VK. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173: 828-834 (2004). *
Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53: 241-245 (2004). *
Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J. Gastrointest. Surg. 8: 90-97 (2004).
Anderson CM, Grenade DS, Boll M, Foltz M, Wake KA, Kennedy DJ, Munck LK, Miyauchi S, Taylor PM, Campbell FC, Munck BG, Daniel H, Ganapathy V, Thwaites DT. H+/amino acid transporter 1 (PAT1) is the imino acid carrier: an intestinal nutrient/drug transporter in human and rat. Gastroenterology 127: 1410-1422 (2004). *
Anderson G, Ramm G, Subramaniam V, Powell L. HFE gene and hemochromatosis. J. Gastroenterol. Hepatol. 19: 712 (2004). *
Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 4: 314-320 (2004).
Anderson JP, Mueller JL, Rosengren S, Boyle DL, Schaner P, Cannon SB, Goodyear CS, Hoffman HM. Structural, expression, and evolutionary analysis of mouse CIAS1. Gene 338: 25-34 (2004). *
Anderson MJ, Fritsche KL. Dietary polyunsaturated fatty acids modulate in vivo, antigen-driven CD4+ T-cell proliferation in mice. J. Nutr. 134: 1978-1983 (2004). *
Anderson NG, Garcia-Valenzuela E, Martin DF. Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis. Ophthalmology 111: 1251-1254 (2004).
Anderson P, Phillips K, Stoecklin G, Kedersha N. Post-transcriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76: 42-47 (2004). *
Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 55: 654-659 (2004). *
Anderson SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna RA, Gustafsson JA, Corton JC. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor and liver X receptor in mouse liver. Mol. Pharmacol. 66: 1440-1452 (2004). *
Anderson SP, Howroyd P, Liu J, Qian X, Bahnemann R, Swanson C, Kwak MK, Kensler TW, Corton JC. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 279: 52390-52398 (2004). *
Andersson A, Kokkola R, Wefer J, Erlandsson-Harris H, Harris RA. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. J. Leukoc. Biol. 76: 1118-1124 (2004). *
Andersson KE. Mechanisms of disease: central nervous system involvement in overactive bladder syndrome. Nat. Clin. Pract. Urol. 1: 103-108 (2004). *
Andersson U, Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J. Intern. Med. 255: 344-350 (2004). *
Andersson U, Tracey KJ. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheum. Dis. Clin. North Am. 30: 627-637, xi (2004).
Andersson UG, Tracey KJ. HMGB1, a pro-inflammatory cytokine of clinical interest: introduction. J. Intern. Med. 255: 318-319 (2004). *
Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, Fujimura A. Effects of pravastatin on the expression of ATP-binding cassette transporter A1. J. Pharmacol. Exp. Ther. 311: 420-425 (2004). *
Andoh A, Fujino S, Hirai Y, Fujiyama Y. Epimorphin expression in human colonic myofibroblasts. Int. J. Mol. Med. 13: 57-61 (2004).
Andoh A, Ogawa A, Kitamura K, Inatomi O, Fujino S, Tsujikawa T, Sasaki M, Mitsuyama K, Fujiyama Y. Suppression of interleukin-1beta- and tumor necrosis factor-.-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J. Gastroenterol. 39: 1150-1157 (2004). *
Andrade RJ, Lucena MI, Alonso A, Garcia-Cores M, Garcia-Ruiz E, Benitez R, Fernandez MC, Pelaez G, Romero M, Corpas R, Duran JA, Jimenez M, Rodrigo L, Nogueras F, Martin-Vivaldi R, Navarro JM, Salmeron J, de la Cuesta FS, Hidalgo R. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39: 1603-1612 (2004). *
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 350: 2343-2351 (2004). *
Andre T, Louvet C, de Gramont A. Colon cancer: what is new in 2004? Bull. Cancer 91: 75-80 (2004).
Andreakos E. Common and uncommon features of rheumatoid arthritis and chronic obstructive pulmonary disease: clues to a future therapy. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4: 85-92 (2004).
Andreakos E, Foxwell B, Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202: 250-265 (2004). *
Andreoni KA, Lin JI, Groben PA. Liver transplantation 27 years after bone marrow transplantation from the same living donor. N. Engl. J. Med. 350: 2624-2625 (2004).
Andrews PI. Autoimmune myasthenia gravis in childhood. Semin. Neurol. 24: 101-110 (2004).
Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 53: 1322-1328 (2004). *
Andriulli A, Annese V, Latiano A, Palmieri O, Fortina P, Ardizzone S, Cottone M, D'inca R, Riegler G. The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. Gastroenterology 126: 625-627 (2004). *
Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transpl. 10: 1355-1363 (2004). *
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47: 2176-2184 (2004). *
Anelli PL, Lattuada L, Lorusso V, Lux G, Morisetti A, Morosini P, Serleti M, Uggeri F. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging. J. Med. Chem. 47: 3629-3641 (2004). *
Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 25: 61-66 (2004). *
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur. J. Epidemiol. 19: 1085-1087 (2004). *
Angelin B, Eriksson M, Parini P, Rudling M. Bile acids and lipoproteins. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 31. June 18-19 (2004). *
Angeloni G, Latteri M, Manna R, Rumi C, Gasbarrini G, Navarra P. Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients. Eur. J. Clin. Pharmacol. 60: 161-164 (2004). *
Angeloni S, Merli M, Salvatori FM, De Santis A, Fanelli F, Pepino D, Attili AF, Rossi P, Riggio O. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results. Am. J. Gastroenterol. 99: 280-285 (2004). *
Anglicheau D, Legendre C, Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78: 311-315 (2004).
Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Buchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin. Pharmacol. Ther. 75: 422-433 (2004). *
Anglin I, Passaniti A. Runx protein signaling in human cancers. Cancer Treat. Res. 119: 189-215 (2004).
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J. Hepatol. 41: 943-949 (2004). *
Anhalt GJ. Paraneoplastic pemphigus. J. Investig. Dermatol. Symp. Proc. 9: 29-33 (2004). *
Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol. Genet. Metab. 81: 187-195 (2004). *
Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J. Clin. Endocrinol. Metab. 89: 6257-6265 (2004). *
Anke J, Ramzan I. Kava hepatotoxicity: are we any closer to the truth? Planta Med. 70: 193-196 (2004).
Annels NE, Willemze AJ, van der Velden VH, Faaij CM, van Wering E, Sie-Go DM, Egeler RM, van Tol MJ, Revesz T. Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL. Blood 103: 2806-2808 (2004). *
Annereau JP, Szakacs G, Tucker CJ, Arciello A, Cardarelli C, Collins J, Grissom S, Zeeberg B, Reinhold W, Weinstein J, Pommier Y, Paules RS, Gottesman MM. Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol. Pharmacol. 66: 1397-1405 (2004). *
Annese V, Palmieri O, Latiano A, Ardizzone S, Castiglione F, Cottone M, D'Inca R, Gionchetti P, Papi C, Riegler G, Vecchi M, Andriulli A; Italian Group for Inflammatory Bowel Disease. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig. Liver Dis. 36: 121-124 (2004).
Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol. Ther. 20: 1143-1152 (2004). *
Annilo T, Dean M. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics 84: 34-46 (2004). *
Anolik J, Sanz I. B cells in human and murine systemic lupus erythematosus. Curr. Opin. Rheumatol. 16: 505-512 (2004).
Ansaldo GL, Varaldo E, Assalino M, Borgonovo G. Artificial nutrition in inflammatory bowel disease. Ann. Ital. Chir. 75: 629-634 (2004).
Ansari AA. Autoimmunity, anergy, lentiviral immunity and disease. Autoimmun. Rev. 3: 530-540 (2004).
Antebi H, Mansoor O, Ferrier C, Tetegan M, Morvan C, Rangaraj J, Alcindor LG. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J. Parenter. Enteral Nutr. 28: 142-148 (2004). *
Antoniazi S, Price HP, Kropf P, Freudenberg MA, Galanos C, Smith DF, Muller I. Chemokine gene expression in Toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect. Immun. 72: 5168-5174 (2004). *
Antunes F, Boveris A, Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 101: 16774-16779 (2004). *
Anwar MA, Rampling MW. Erythrocyte hyper-aggregation in a patient undergoing orthotopic transplantation for primary sclerosing cholangitis complicated by biliary stricture. Clin. Hemorheol. Microcirc. 31: 169-172 (2004).
Anwer MS. Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology 39: 581-590 (2004). *
Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S. Liver involvement in primary Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 27: 397-401 (2004).
Aoki S, Watanabe M, Hasegawa H, Nishibori H, Mukai M, Kitajima M. Rectal carcinoid arising in ulcerative colitis associated with rectal adenocarcinoma. J. Gastroenterol. 39: 697-698 (2004). *
Aoki V, Millikan RC, Rivitti EA, Hans-Filho G, Eaton DP, Warren SJ, Li N, Hilario-Vargas J, Hoffmann RG, Diaz LA; Cooperative Group for Fogo Selvagem Research. Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J. Investig. Dermatol. Symp. Proc. 9: 34-40 (2004). *
Aoun NY, Velez E, Aggarwal A, Hayes GB, Kenney LA. Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man. Respir. Care 49: 1515-1521 (2004). *
Aouthmany A, Horattas MC. Ileal pouch perforation in pregnancy: report of a case and review of the literature. Dis. Colon Rectum 47: 243-245 (2004).
Appel H, Kuon W, Kuhne M, Wu P, Kuhlmann S, Kollnberger S, Thiel A, Bowness P, Sieper J. Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res. Ther. 6: R521-R534 (2004). *
Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm. Bowel Dis. 10: 106-111 (2004). *
Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J. Clin. Gastroenterol. 38: 805-809 (2004).
Ara C, Devirgiliis LC, Massimi M. Influence of retinoic acid on adhesion complexes in human hepatoma cells: a clue to its antiproliferative effects. Cell Commun. Adhes. 11: 13-23 (2004).
Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, Takahashi N, Inoue T, Nakaike S. Prostanoid DP(1) receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur. J. Pharmacol. 505: 229-235 (2004). *
Arai M, Yokosuka O, Fukai K, Kanda T, Kojima H, Kawai S, Imazeki F, Hirasawa H, Saisho H. A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to. Hepatol. Res. 28: 161-165 (2004).
Arai T, Esaki Y, Sawabe M, Honma N, Nakamura KI, Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod. Pathol. 17: 172-179 (2004). *
Arakawa Y, Amaki S, Miyakawa H, Sakai T, Gotou I, Tanaka N, Moriyama M, Iwasaki A, Sugitani M, Arakawa Y. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J. Gastroenterol. 39: 490-495 (2004). *
Arakawa Y, Moriyama M, Arakawa Y. Liver cirrhosis and metabolism (sugar, protein, fat and trace elements). Hepatol. Res. 30S: 46-58 (2004).
Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int. J. Mol. Med. 13: 577-580 (2004).
Araki Y, Noake T, Kanazawa M, Yamada K, Momosaki K, Nozoe Y, Inoue A, Ishibashi N, Ogata Y, Shirouzu K. Clipless hand-assisted laparoscopic total colectomy using Ligasure Atlas. Kurume Med. J. 51: 105-108 (2004).
Aranda V, Martinez I, Melero S, Lecanda J, Banales JM, Prieto J, Medina JF. Shared apical sorting of anion exchanger isoforms AE2a, AE2b1, and AE2b2 in primary hepatocytes. Biochem. Biophys. Res. Commun. 319: 1040-1046 (2004). *
Arasaradnam RP, Riley SA, Corfe BM. Diet and colorectal cancer: fibre back on the menu? Gut 53: 155-156 (2004). *
Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, Kraemer MH. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant. Proc. 36: 953-955 (2004). *
Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr. Opin. Pharmacol. 4: 183-188 (2004).
Araz C, Pirat A, Torgay A, Zeyneloglu P, Arslan G. Early postoperative complications of pediatric liver transplantation: experience at one center. Transplant. Proc. 36: 214-217 (2004). *
Arbour L, Field L, Ross P, Erikson A, Yoshida E. The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int. J. Circumpolar Health 63 Suppl. 2: 185-188 (2004). *
Ardehali H, Qasim A, Cappola T, Howard D, Hruban R, Hare JM, Baughman KL, Kasper EK. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am. Heart J. 147: 919-923 (2004). *
Ardizzone G, Arrigo A, Panaro F, Ornis S, Colombi R, Distefano S, Jarzembowski TM, Cerruti E. Cerebral hemodynamic and metabolic changes in patients with fulminant hepatic failure during liver transplantation. Transplant. Proc. 36: 3060-3064 (2004). *
Ardizzone S, Maconi G, Colombo E, Manzionna G, Bollani S, Porro GB. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm. Bowel Dis. 10: 91-96 (2004). *
Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 127: 730-740 (2004). *
Arend LJ, Springate JE. Interstitial nephritis from mesalazine: case report and literature review. Pediatr. Nephrol. 19: 550-553 (2004). *
Arents NL, Thijs JC, Van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur. J. Gastroenterol. Hepatol. 16: 779-783 (2004).
Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM. The molecular basis for oat intolerance in patients with celiac disease. Plos. Med. 1: e1 (2004). *
Argast GM, Campbell JS, Brooling JT, Fausto N. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279: 34530-34536 (2004). *
Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127: 514-523 (2004). *
Argov S, Sahu RK, Bernshtain E, Salman A, Shohat G, Zelig U, Mordechai S. Inflamatory bowel diseases as an intermediate stage between normal and cancer: a FTIR-microspectroscopy approach. Biopolymers 75: 384-392 (2004). *
Arguelles-Arias F, Caunedo A, Romero J, Sanchez A, Rodriguez-Tellez M, Pellicer FJ, Arguelles-Martin F, Herrerias JM. The value of capsule endoscopy in pediatric patients with a suspicion of Crohn's disease. Endoscopy 36: 869-873 (2004).
Argyropoulos C, Nikiforidis GC, Theodoropoulou M, Adamopoulos P, Boubali S, Georgakopoulos TN, Paliogianni F, Papavassiliou AG, Mouzaki A. Mining microarray data to identify transcription factors expressed in naive resting but not activated T lymphocytes. Genes Immun. 5: 16-25 (2004). *
Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur. J. Cancer 40: 1467-1473 (2004). *
Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113: 451-463 (2004). *
Arii S. Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma. J. Hepatol. 41: 333-335 (2004). *
Arikura J, Inagaki M, Huiling X, Ozaki A, Onodera K, Ogawa K, Kasai S. Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase's analbuminemic rats. J. Hepatol. 41: 215-221 (2004). *
Aringer M. Periodic fever syndromes - a clinical overview. Acta Med. Austriaca 31: 8-12 (2004).
Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum. 50: 3161-3169 (2004). *
Arluk GM, Pickhardt PJ. Images in clinical medicine. Inflammatory pseudopolyposis in Crohn's disease. N. Engl. J. Med. 350: 923 (2004). *
Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 89: 5387-5391 (2004). *
Armenakas NA, Pareek G, Fracchia JA. Iatrogenic bladder perforations: longterm followup of 65 patients. J. Am. Coll. Surg. 198: 78-82 (2004). *
Armitage EL, Aldhous MC, Anderson N, Drummond HE, Riemersma RA, Ghosh S, Satsangi J. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 127: 1051-1057 (2004). *
Armstrong VW, Shipkova M, von Ahsen N, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Ther. Drug Monit. 26: 220-226 (2004).
Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur. Rev. Med. Pharmacol. Sci. 8: 231-233 (2004).
Arnold KA, Eichelbaum M, Burk O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept. 2: 1 (2004). *
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99: 2376-2384 (2004). *
Arnott ID, Lo SK. The clinical utility of wireless capsule endoscopy. Dig. Dis. Sci. 49: 893-901 (2004). *
Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, Kelleher D, O'Sullivan M, McManus R, Satsangi J. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 5: 417-425 (2004). *
Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol. Immunol. 41: 449-456 (2004). *
Arostegui JI, Aldea A, Modesto C, Rua MJ, Arguelles F, Gonzalez-Ensenat MA, Ramos E, Rius J, Plaza S, Vives J, Yague J. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum. 50: 4045-4050 (2004). *
Arrese M, Ananthanarayanan M. The bile salt export pump: molecular properties, function and regulation. Pflugers Arch. 449: 123-131 (2004). *
Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and Toll-like receptor 4: a link between infection and acute coronary events? Heart 90: 983-988 (2004). *
Arthur GL, Schwartz MZ, Kuenzler KA, Birbe R. Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J. Pediatr. Surg. 39: 448-452 (2004).
Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J. Pediatr. Surg. 39: 139-143 (2004). *
Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm. Bowel Dis. 10: 73-78 (2004). *
Arvand M, Feldhues R, Mieth M, Kraus T, Vandamme P. Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J. Clin. Microbiol. 42: 2335-2337 (2004). *
Arya N, Nelles SE, Haber GB, Kim YI, Kortan PK. Electrohydraulic lithotripsy in 111 patients: a safe and effective therapy for difficult bile duct stones. Am. J. Gastroenterol. 99: 2330-2334 (2004). *
Asaka M, Dragosics BA. Helicobacter pylori and gastric malignancies. Helicobacter 9 Suppl. 1: 35-41 (2004).
Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J. Clin. Invest. 113: 253-264 (2004). *
Asashima N, Fujimoto M, Jinnin M, Ihn H, Kikuchi K, Takamizawa M, Tamaki K. A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations. Nihon Rinsho Meneki Gakkai Kaishi 27: 350-355 (2004).
Asatsuma M, Ito S, Watanabe M, Takeishi H, Nomura S, Wada Y, Nakano M, Gejyo F, Igarashi A. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjogren's syndrome. Clin. Chim. Acta 345: 99-104 (2004). *
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum. Reprod. 19: 2509-2514 (2004). *
Ashamiss F, Wierzbicki Z, Chrzanowska A, Scibior D, Pacholczyk M, Kosieradzki M, Lagiewska B, Porembska Z, Rowinski W. Clinical significance of arginase after liver transplantation. Ann. Transplant. 9: 58-60 (2004).
Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem. Pharmacol. 67: 353-364 (2004). *
Ashino T, Oguro T, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, Numazawa S, Yoshida T. Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab. Dispos. 32: 707-714 (2004). *
Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190: 1841-1849 (2004). *
Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24: 664-673 (2004). *
Ashwood P, Harvey R, Verjee T, Wolstencroft R, Thompson RP, Powell JJ. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis. Inflamm. Res. 53: 53-59 (2004). *
Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun. Rev. 3: 557-562 (2004).
Asimakopoulos G. Pregnancy and inflammatory bowel disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 46-50 (2004).
Aslaksen HK, Nossent HC. Fatal pulmonary hypertension in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 22: 507 (2004).
Aspinall AI, Lee SS. Concurrence of primary biliary cirrhosis and antiphospholipid antibody syndrome. Am. J. Gastroenterol. 99: 2069-2070 (2004). *
Aspinall RJ. Are adherent Escherichia coli in Crohn's disease and colon cancer truly pathogenic? Gastroenterology 127: 1649-1650 (2004). *
Assche GV, Rutgeerts P. Medical management of postoperative recurrence in Crohn's disease. Gastroenterol. Clin. North Am. 33: 347-360 (2004).
Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, Evans RM, Moore DD, Borst P, Schuetz JD. Interactions between hepatic Mrp4 and Sult2A as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 279: 22250-22257 (2004). *
Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40: 951-960 (2004). *
Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R, Visser I, Abeling NG, Duran M, Schene AH. Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins Leukot. Essent. Fatty Acids 70: 349-356 (2004). *
Ates A, Kinikli G, Turgay M, Duman M. The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis. Clin. Rheumatol. 23: 421-425 (2004). *
Ates Y, Aslan M, Tuzun A, Bagci S, Dagalp K. Ulcerative colitis case beginning during pregnancy in a patient with antiphospholipid antibody syndrome. Turk. J. Gastroenterol. 15: 263-265 (2004). *
Athanasiadou S, Kyriazakis I. Plant secondary metabolites: antiparasitic effects and their role in ruminant production systems. Proc. Nutr. Soc. 63: 631-639 (2004). *
Athman R, Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opin. Microbiol. 7: 25-32 (2004). *
Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Storkel S, Seliger B. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int. J. Cancer 109: 265-273 (2004). *
Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med. J. 45: 776-788 (2004). *
Atsumi T, Amengual O, Yasuda S, Koike T. Antiprothrombin antibodies-are they worth assaying? Thromb. Res. 114: 533-538 (2004). *
Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz. J. Med. Biol. Res. 37: 1497-1501 (2004). *
Attaran M, Schneider A, Grote C, Zwiens C, Flemming P, Gratz KF, Jochheim A, Bahr MJ, Manns MP, Ott M. Regional and transient ischemia/reperfusion injury in the liver improves therapeutic efficacy of allogeneic intraportal hepatocyte transplantation in low-density lipoprotein receptor deficient Watanabe rabbits. J. Hepatol. 41: 837-844 (2004). *
Attard TM, Horton KM, DeVito K, Darbari A, Oliva-Hemker M, Thompson R, Cuffari C. Pediatric jejunoileitis: a severe Crohn's disease phenotype that requires intensive nutritional management. Inflamm. Bowel Dis. 10: 357-360 (2004). *
Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment. Pharmacol. Ther. 20: 867-873 (2004). *
Audrezet MP, Chen JM, Raguenes O, Chuzhanova N, Giteau K, Le Marechal C, Quere I, Cooper DN, Ferec C. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum. Mutat. 23: 343-357 (2004). *
Augarten A, Paret G, Avneri I, Akons H, Aviram M, Bentur L, Blau H, Efrati O, Szeinberg A, Barak A, Kerem E, Yahav J. Systemic inflammatory mediators and cystic fibrosis genotype. Clin. Exp. Med. 4: 99-102 (2004). *
Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease. Cell. Biochem. Biophys. 40: 81-96 (2004).
Aune TM, Parker JS, Maas K, Liu Z, Olsen NJ, Moore JH. Co-localization of differentially expressed genes and shared susceptibility loci in human autoimmunity. Genet. Epidemiol. 27: 162-172 (2004). *
Aust S, Obrist P, Jaeger W, Klimpfinger M, Tucek G, Wrba F, Penner E, Thalhammer T. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium. Lab. Invest. 84: 1024-1036 (2004). *
Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 18: 1255-1257 (2004). *
Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut 53: 1032-1034 (2004). *
Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, Koller BH, Lloyd KC, Magnuson T, Moore MW, Nagy A, Pollock JD, Roses AD, et al. The knockout mouse project. Nat. Genet. 36: 921-924 (2004). *
Autran B, Carcelain G, Combadiere B, Debre P. Therapeutic vaccines for chronic infections. Science 305: 205-208 (2004). *
Autret-Leca E, Jonville-Bera AP, Beau-Salinas F. Vaccines pharmacovigilance. Rev. Prat. 54: 526-531 (2004).
Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P, Chambon P, Cox R, Davidson D, Davies K, Duboule D, Forejt J, Granucci F, Hastie N, De Angelis MH, Jackson I, Kioussis D, et al. The European dimension for the mouse genome mutagenesis program. Nat. Genet. 36: 925-927 (2004). *
Avezov SA, Mansurov FKh. Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis. Klin. Med. (Mosk.) 82: 55-58 (2004).
Avezov SA, Mansurova FKh. Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis. Klin. Med. (Mosk.) 82: 46-49 (2004).
Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C, Papaxoinis C, Manolakopoulos S, Panani A, Raptis SA. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39: 1623-1630 (2004). *
Avril A, Pichard V, Bralet MP, Ferry N. Mature hepatocytes are the source of small hepatocyte-like progenitor cells in the retrorsine model of liver injury. J. Hepatol. 41: 737-743 (2004). *
Awotesu O, Missotten T, Pitcher MC, Lynn WA, Lightman S. Uveitis in a patient receiving rifabutin for Crohn's disease. J. R. Soc. Med. 97: 440-441 (2004). *
Axelrod D, Koffron A, Dewolf A, Baker A, Fryer J, Baker T, Frederiksen J, Horvath K, Abecassis M. Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting. Liver Transpl. 10: 1386-1390 (2004). *
Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am. J. Transplant. 4: 920-927 (2004). *
Axelson M. Studies on biosynthetic pathways to bile acids in human liver cells. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 22. June 18-19 (2004). *
Ayadi H, Kacem HH, Rebai A, Farid NR. The genetics of autoimmune thyroid disease. Trends Endocrinol. Metab. 15: 234-239 (2004). *
Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G. Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and celiac disease. J. Pediatr. Endocrinol. Metab. 17: 1565-1569 (2004).
AydoGdu S, Ozgenc F, AtIk T, Unal F, Tokat Y, Yagci RV. Biliary atresia in Turkish children. Pediatr. Int. 46: 158-161 (2004). *
Ayed K, Gorgi Y, Sfar I, Khrouf M. Congenital heart block associated with maternal anti SSA/SSB antibodies: a report of four cases. Pathol. Biol. (Paris) 52: 138-147 (2004).
Ayensu WK, Tchounwou PB, McMurray RW. Molecular and cellular mechanisms associated with autoimmune diseases. Int. J. Environ. Res. Public Health 1: 39-73 (2004).
Ayuso JR, Ayuso C, Bombuy E, De Juan C, Llovet JM, De Caralt TM, Sanchez M, Pages M, Bruix J, Garcia-Valdecasas JC. Preoperative evaluation of biliary anatomy in adult live liver donors with volumetric mangafodipir trisodium enhanced magnetic resonance cholangiography. Liver Transpl. 10: 1391-1397 (2004). *
Azar D, Martin F. Paediatric uveitis: a Sydney clinic experience. Clin. Experiment. Ophthalmol. 32: 468-471 (2004).
Azer SA. Do recommended textbooks contain adequate information about bile salt transporters for medical students? Adv. Physiol. Educ. 28: 36-43 (2004). *
Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac. J. Allergy Immunol. 22: 159-163 (2004).
Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 6: R395-R400 (2004). *
Azmy IA, Hurlstone DP, Butt TF, Nasseri F, Bullimore DW, Sanders DS. Does surgical removal of mucosal associated lymphoid tissue protect against adult coeliac disease? A case controlled study. Dig. Liver Dis. 36: 187-190 (2004).
Azria D, Larbouret C, Garambois V, Gourgou S, Martineau P, Robert B, Dubois JB, Pelegrin A. A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors. Int. J. Radiat. Oncol. Biol. Phys. 58: 580-588 (2004).
Azzi A, Gysin R, Kempna P, Munteanu A, Negis Y, Villacorta L, Visarius T, Zingg JM. Vitamin E mediates cell signaling and regulation of gene expression. Ann. N. Y. Acad. Sci. 1031: 86-95 (2004). *
Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, Visarius T, Zingg JM. Regulation of gene expression by alpha-tocopherol. Biol. Chem. 385: 585-591 (2004).
Babiuk S, Mookherjee N, Pontarollo R, Griebel P, Van Drunen Littel-Van Den Hurk S, Hecker R, Babiuk L. TLR9(+/+) and TLR9(-/-) mice display similar immune responses to a DNA vaccine. Immunology 113: 114-120 (2004). *
Babu TG, Boctor D, Davey A, Bond MC, Jacobson K. Cytomegalovirus-associated hemophagocytic syndrome in a child with Crohn disease receiving azathioprine. J. Pediatr. Gastroenterol. Nutr. 39: 418-421 (2004). *
Bacchella T, Figueira ER, Makdissi FF, Rocha-Santos V, Martino RB, Andraus W, Canedo LF, Machado MA, Machado MC. Biliary reconstruction without T-tube in liver transplantation. Transplant. Proc. 36: 951-952 (2004). *
Bacha EA, Hardin J, Cronin DC, Brady L, Millis MJ, Starr JP, Koenig P, Daves S, Kahana M. Open-heart surgery in pediatric patients with end-stage liver disease. Ann. Thorac. Surg. 78: E30-E33 (2004).
Bacher S, Schmitz ML. The NF-kappa B pathway as a potential target for autoimmune disease therapy. Curr. Pharm. Des. 10: 2827-2837 (2004).
Bachmann AS. The role of polyamines in human cancer: prospects for drug combination therapies. Hawaii Med. J. 63: 371-374 (2004).
Bachmann K, Patel H, Batayneh Z, Slama J, White D, Posey J, Ekins S, Gold D, Sambucetti L. PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol. Res. 50: 237-246 (2004). *
Bachmann MF, Schwarz K, Wolint P, Meijerink E, Martin S, Manolova V, Oxenius A. Cutting edge: distinct roles for T help and CD40/CD40 ligand in regulating differentiation of proliferation-competent memory CD8+ T cells. J. Immunol. 173: 2217-2221 (2004). *
Backstrom E, Kristensson K, Ljunggren HG. Activation of natural killer cells: underlying molecular mechanisms revealed. Scand. J. Immunol. 60: 14-22 (2004). *
Bacon BR. Metabolic liver diseases. Clin. Liver Dis. 8: xi-xii (2004).
Badakere SS, Pradhan VD, Almeida AF, Pawar AR. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. J. Fluoresc. 14: 459-463 (2004). *
Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).
Badenhoop K, Boehm BO. Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease. Exp. Clin. Endocrinol. Diabetes 112: 407-415 (2004).
Badet F, Bellis G, De Braekeleer M, Nove Josserand R, Vital Durand D; The Cystic Fibrosis Centre of ONM ; Durieu I. Phenotype and genotype of French cystic fibrosis patients with long survival and follow-up. Eur. J. Intern. Med. 15: 238-241 (2004).
Badizadegan K. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 126: 1493-1494 (2004). *
Badolato R, Fontana S, Barcella L, Moratto D, D'ippolito C, Crovella S, Notarangelo LD, Duse M. Toll-like receptor-4 genotype in children with respiratory infections. Allergy 59: 1018-1019 (2004). *
Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 63: 2396-2398 (2004).
Bae SC, Choi JK. Tumor suppressor activity of RUNX3. Oncogene 23: 4336-4340 (2004). *
Bae Y, Kemper JK, Kemper B. Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, short heterodimer partner (SHP). DNA Cell Biol. 23: 81-91 (2004).
Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases. J. Exp. Med. 200: 273-276 (2004). *
Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, Ortmann WA, Espe KJ, Balasubramanian S, Hughes KM, Chan JP, Begovich A, Chang SY, Gregersen PK, Behrens TW. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun. 5: 347-353 (2004). *
Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr. Opin. Rheumatol. 16: 254-261 (2004).
Baerg J, Zuppan C, Klooster M. Biliary atresia-a fifteen-year review of clinical and pathologic factors associated with liver transplantation. J. Pediatr. Surg. 39: 800-803 (2004).
Baert F, Vermeire S, Noman M, Van Assche G, D'Haens G, Rutgeerts P. Management of ulcerative colitis and Crohn's disease. Acta Clin. Belg. 59: 304-314 (2004).
Baeten D, De Keyser F, Veys EM, Theate Y, Houssiau FA, Durez P. Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann. Rheum. Dis. 63: 489-493 (2004). *
Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De Keyser F. Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker. Arthritis Rheum. 50: 444-451 (2004). *
Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J. Biol. Chem. 279: 54708-54715 (2004). *
Baglioni S, Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am. J. Med. Genet. 129C: 35-43 (2004). *
Bagnoli S, Putignano AL, Melean G, Baglioni S, Sestini R, Milla M, d'Albasio G, Genuardi M, Pacini F, Trallori G, Papi L. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. Inflamm. Bowel Dis. 10: 705-708 (2004). *
Baguet A, Bix M. Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc. Natl. Acad. Sci. U.S.A. 101: 11410-11415 (2004). *
Baharav E, Mor F, Halpern M, Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr. 134: 1964-1969 (2004). *
Bahn A, Ebbinghaus C, Ebbinghaus D, Ponimaskin EG, Fuzesi L, Burckhardt G, Hagos Y. Expression studies and functional characterization of renal human organic anion transporter 1 isoforms. Drug Metab. Dispos. 32: 424-430 (2004). *
Bahn A, Hagos Y, Rudolph T, Burckhardt G. Mutation of amino acid 475 of rat organic cation transporter 2 (rOCT2) impairs organic cation transport. Biochimie 86: 133-136 (2004).
Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr. Diab. Rep. 4: 194-198 (2004).
Bai S, Stepkowski SM, Kahan BD, Brunner LJ. Metabolic interaction between cyclosporine and sirolimus. Transplantation 77: 1507-1512 (2004).
Baik SK, Lee SS. Cirrhotic cardiomyopathy: causes and consequences. J. Gastroenterol. Hepatol. 19: S185-S190 (2004). *
Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 170: 1531-1532 (2004). *
Bailey MA, Ingram MJ, Naughton DP. A novel anti-oxidant and anti-cancer strategy: a peptoid anti-inflammatory drug conjugate with SOD mimic activity. Biochem. Biophys. Res. Commun. 317: 1155-1158 (2004). *
Baisini O, Benini F, Petraglia F, Kuhnz W, Scalia S, Marschall HU, Brunetti G, Tauschel HD, Lanzini A. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives. Eur. J. Clin. Pharmacol. 60: 481-487 (2004). *
Baisse B, Fontolliet C, Bian YS, Vuilleumier H, Benhattar J. Synchronous ileal and colonic adenocarcinomas associated with Crohn's disease: report of a case with a focus on genetic alterations and carcinogenesis. J. Clin. Pathol. 57: 885-887 (2004). *
Baixauli J, Delaney CP, Wu JS, Remzi FH, Lavery IC, Fazio VW. Functional outcome and quality of life after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery. Dis. Colon Rectum 47: 2-11 (2004). *
Bajt ML, Knight TR, Lemasters JJ, Jaeschke H. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol. Sci. 80: 343-349 (2004). *
Baker A, Alonso ME, Aw MM, Ciocca M, Porta G, Rosenthal P. Hepatic failure and liver transplant: working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J. Pediatr. Gastroenterol. Nutr. 39: S632-S639 (2004). *
Baker DE. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody. Rev. Gastroenterol. Disord. 4: 196-210 (2004). *
Baker DE. Therapeutic equivalence of mesalamine products. Rev. Gastroenterol. Disord. 4: 25-28 (2004). *
Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev. Gastroenterol. Disord. 4: 86-91 (2004). *
Baker KP. BLyS-an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun. Rev. 3: 368-375 (2004).
Baker MJ, Hamilton KL. Genistein stimulates electrogenic Cl- secretion in the mouse jejunum. Am. J. Physiol. Cell. Physiol. 287: C1636-C1645 (2004). *
Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). Clin. Exp. Immunol. 137: 373-378 (2004). *
Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC, Dunn JC. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod. Pathol. 17: 1289-1294 (2004). *
Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA. Hearing loss in Wegener's granulomatosis. Otol. Neurotol. 25: 833-837 (2004).
Bal J, Sobczynska-Tomaszewska A, Czerska K, Obersztyn E, Sands D, Mazurczak T. Prenatal diagnostics of cystic fibrosis in risk families in Poland - results of the molecular analyses. Med. Wieku. Rozwoj. VIII: 871-883 (2004).
Balabaud C, Bioulac-Sage P, Desmouliere A. The role of hepatic stellate cells in liver regeneration. J. Hepatol. 40: 1023-1026 (2004). *
Balaji Raghavendra Rao H, Sathivel A, Devaki T. Antihepatotoxic nature of Ulva reticulata (Chlorophyceae) on acetaminophen-induced hepatoxicity in experimental rats. J. Med. Food 7: 495-497 (2004).
Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun. Rev. 3: 362-367 (2004).
Balasubramanian S, Chandraratna RA, Eckert RL. Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid. Carcinogenesis 25: 1377-1385 (2004). *
Baldan A, Relat J, Marrero PF, Haro D. Functional interaction between peroxisome proliferator-activated receptors-alpha and Mef-2C on human carnitine palmitoyltransferase 1beta (CPT1beta) gene activation. Nucleic Acids Res. 32: 4742-4749 (2004). *
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm.13: 181-187 (2004). *
Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, Persing D. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin. Biol. Ther. 4: 1129-1138 (2004).
Baliga P, Alvarez S, Lindblad A, Zeng L. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 10: 1364-1371 (2004). *
Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4: 540-550 (2004). *
Ball CG, Gmora S, Vollmer CM Jr, Dixon E. An intraluminal lesion in the mid-common bile duct and right hepatic duct causing right portal vein obstruction. J. Hepatol. 41: 1060 (2004). *
Ballok DA, Woulfe J, Sur M, Cyr M, Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14: 649-661 (2004).
Ballot E, Bandin O, Chazouilleres O, Johanet C, Poupon R. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. J. Autoimmun. 22: 153-158 (2004).
Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y. Tumour necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol. Immunol. Hung. 51: 263-269 (2004).
Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y. Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology 71: 274-280 (2004).
Balogh A, Derzbach L, Vasarhelyi B. Hepcidin, the negative regulator of iron absorbtion. Orv. Hetil. 145: 1549-1552 (2004).
Baltes S, Nau H, Lampen A. All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions. Dev. Growth Differ. 46: 503-514 (2004). *
Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J. Biol. Chem. 279: 42984-42992 (2004). *
Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906 (2004). *
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004). *
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun. 5: 203-208 (2004). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.) 61: 263-268 (2004). *
Banerjee S, Farquharson M, Cecil TD, Gold D, Moran BJ. Late-onset fistula presenting as buttock abscess in two patients with ileo-anal J-pouches for ulcerative colitis. Tech. Coloproctol. 8: 37-39 (2004). *
Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4: 675-687 (2004). *
Banks MR, Golder M, Farthing MJ, Burleigh DE. Intracellular potentiation between two second messenger systems may contribute to cholera toxin induced intestinal secretion in humans. Gut 53: 50-57 (2004). *
Bannantine JP, Barletta RG, Stabel JR, Paustian ML, Kapur V. Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen. Foodborne Pathog. Dis. 1: 3-15 (2004).
Banner KH, Cattaneo C, Net JL, Popovic A, Collins D, Gale JD. Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. Br. J. Pharmacol.143: 590-598 (2004). *
Banner KH, Trevethick MA. PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease. Trends Pharmacol. Sci. 25: 430-436 (2004). *
Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 38: 270-275 (2004). *
Bannerman DD, Eiting KT, Winn RK, Harlan JM. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am. J. Pathol. 165: 1423-1431 (2004). *
Banno T, Gazel A, Blumenberg M. Effects of tumor necrosis factor-alpha (TNFalpha) in epidermal keratinocytes revealed using global transcriptional profiling. J. Biol. Chem. 279: 32633-32642 (2004). *
Banos Madrid R, Salama Benerroch H, Moran Sanchez S, Gallardo Sanchez F, Albadalejo Merono A, Mercader Martinez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: it would be necessary to exclude the lactose products in their diet to all the patients? An. Med. Interna 21: 212-214 (2004).
Bantel H, Lugering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40: 1078-1087 (2004). *
Baptista-Gonzalez H, Gutierrez-Landeros F, Rosenfeld-Mann F, Trueba-Gomez R. Changes of coagulation inhibitors and fibrinolysis system in newborn infants with transitory neonatal cholestasis. Ann. Hepatol. 3: 26-29 (2004). *
Bar-Zohar D, Segal-Algranati D, Belson A, Reif S. Diagnosing cystic fibrosis - asthma and failure to thrive as indications for a sweat test. J. Med. 35: 93-103 (2004).
Barabas AZ, Cole CD, Barabas AD, Lafreniere R. Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model. Int. J. Exp. Pathol. 85: 321-334 (2004). *
Baragiotta A, Floreani A, Agarwal K, Venturi C, Craggs A, Jones DEJ, Donaldson PT, Bassendine MF. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study. Liver Int. 24: 646-650 (2004). *
Barbier O, Fontaine C, Fruchart JC, Staels B. Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymes. Trends Endocrinol. Metab. 15: 324-330 (2004). *
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann. Neurol. 55: 793-800 (2004).
Barchana M, Liphshitz I, Rozen P. Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations. Fam. Cancer 3: 207-214 (2004). *
Bardella MT, Cantu P, Cesana BM, Piodi LP. Severe heart disease in coeliac sprue and inflammatory bowel disease: a common pathogenesis? Scand. J. Gastroenterol. 39: 1304-1305 (2004). *
Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL, Fargion S. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 36: 333-336 (2004).
Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 71: 481-485 (2004).
Bardin T. Psoriatic rheumatism. Rev. Prat. 54: 60-68 (2004).
Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH. S-Adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc. Natl. Acad. Sci. U.S.A. 101: 4234-4239 (2004). *
Barisani D, Ceroni S, Del Bianco S, Meneveri R, Bardella MT. Hemochromatosis gene mutations and iron metabolism in celiac disease. Haematologica 89: 1299-1305 (2004). *
Barisic G, Krivokapic Z, Markovic V, Saranovic D, Masulovic D. Ulcerative colitis indications and timing for surgery. Acta Chir. Iugosl. 51: 123-126 (2004).
Barisic-Drusko V, Rucevic I. Trigger factors in childhood psoriasis and vitiligo. Coll. Antropol. 28: 277-285 (2004).
Barker CL, McHale MT, Gillies AK, Waller J, Pearce DM, Osborne J, Hutchinson PE, Smith GM, Pringle JH. The development and characterization of an in vitro model of psoriasis. J. Invest. Dermatol. 123: 892-901 (2004). *
Barland P. Antibodies to citrullinated peptides: current role in diagnosis, prognosis, and pathogenesis of rheumatoid arthritis. New Developments in Rheumatic Diseases 1: 6-9 (2004). *
Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, Cho JH, Duerr RH. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm. Bowel Dis. 10: 513-520 (2004). *
Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, Cho JH, Duerr RH. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm. Bowel Dis. 10: 15-22 (2004). *
Barmeyer C, Harren M, Schmitz H, Heinzel-Pleines U, Mankertz J, Seidler U, Horak I, Wiedenmann B, Fromm M, Schulzke JD. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G244-G252 (2004). *
Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. J. Pediatr. Gastroenterol. Nutr. 38: 509-512 (2004). *
Barnes BJ, Richards J, Mancl M, Hanash S, Beretta L, Pitha PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 279: 45194-45207 (2004). *
Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populations. Clin. Exp. Allergy 34: 736-744 (2004). *
Barnich N, Bringer MA, Claret L, Darfeuille-Michaud A. Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect. Immun. 72: 2484-2493 (2004). *
Baron RL, Brancatelli G. Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S133-S143 (2004). *
Baron TH, Harewood GC. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am. J. Gastroenterol. 99: 1455-1460 (2004). *
Barra GB, Velasco LF, Pessanha RP, Campos AM, Moura FN, Dias SM, Polikarpov I, Ribeiro RC, Simeoni LA, Neves FA. Molecular mechanism of thyroid hormone action. Arq. Bras. Endocrinol. Metabol. 48: 25-39 (2004).
Barreau F, Cartier C, Ferrier L, Fioramonti J, Bueno L. Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology 127: 524-534 (2004). *
Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur. J. Hum. Genet. 12: 620-626 (2004). *
Barry J, Kirby B. Novel biologic therapies for psoriasis. Expert Opin. Biol. Ther. 4: 975-987 (2004).
Barta Z, Csipo I, Mekkel G, Zeher M, Majoros L, Bernstein CN, Collins MT. Seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease. J. Clin. Microbiol. 42: 5432-5433 (2004). *
Barta Z, Toth L, Szabo GG, Szegedi G, Zeher M. Intravenous pulse cyclophosphamide therapy in Crohn's disease and ulcerative colitis. Gut 53: 1058 (2004). *
Bartha I, Danya T, Nemeth A. Surgical strategy in massive colorectal bleeding. Acta Chir. Iugosl. 51: 91-92 (2004).
Barthet M, Juhan V, Gasmi M, Grimaud JC. Imaging of perianal Crohn's disease. Gastroenterol. Clin. Biol. 28: S52-S60 (2004).
Bartke U, Venten I, Kreuter A, Gabbay S, Altmeyer P, Brockmeyer NH. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br. J. Dermatol. 150: 784-786 (2004).
Bartley J, Loddenkemper C, Lange J, Mechsner S, Radke C, Neuhaus P, Ebert AD. Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report. Arch. Gynecol. Obstet. 269: 290-293 (2004).
Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, Worthington J. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50: 1117-1121 (2004). *
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50: 748-752 (2004). *
Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M, Lunt M, Zeggini E, Eyre S, Hinks A, Tellam D, Brintnell B, Ollier W, Worthington J, Silman A. Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann. Rheum. Dis. 63: 280-284 (2004). *
Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J. Rheumatol. 31: 442-447 (2004). *
Barton A, Woolmore JA, Ward D, Eyre S, Hinks A, Ollier WE, Strange RC, Fryer AA, John S, Hawkins CP, Worthington J. Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain 127: 1717-1722 (2004). *
Barton EH, Barton JC, Hollowell WW, Acton RT. Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn. Dis. 14: 73-81 (2004).
Barton JC. Hemochromatosis, HFE C282Y homozygosity, and bariatric surgery: report of three cases. Obes. Surg. 14: 1409-1414 (2004).
Barton JC, Bertoli LF, Acton RT. HFE C282Y and H63D in adults with malignancies in a community medical oncology practice. BMC Cancer 4: 6 (2004). *
Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med. Genet. 5: 29 (2004). *
Barton JC, West C, Lee P, Beutler E. A previously undescribed frameshift deletion mutation of HFE (c.del277; G93fs) associated with hemochromatosis and iron overload in a C282Y heterozygote. Clin. Genet. 66: 214-216 (2004). *
Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol. Assess. 8: 1-104 (2004). *
Bartsch DK, Kress R, Sina-Frey M, Grutzmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridohl O, Ghadimi MB, Horstmann O, von Bernstorff W, Jochimsen L, Schmidt J, Eisold S, Estevez-Schwarz L, et al. Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer 110: 902-906 (2004). *
Bartsch H, Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 28: 385-391 (2004).
Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 1012: 224-236 (2004). *
Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur. J. Immunogenet. 31: 15-19 (2004). *
Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J. Allergy Clin. Immunol. 114: 80-87 (2004).
Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791 (2004). *
Bassendine MF. Infectious etiology of primary biliary cirrhosis (PBC). Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 45-46 (2004). *
Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49: 1425-1432 (2004). *
Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D. Helicobacter pylori infection: anything new should we know? Aliment. Pharmacol. Ther. 20 Suppl. 2: 31-41 (2004).
Bassett MH, Suzuki T, Sasano H, De Vries CJ, Jimenez PT, Carr BR, Rainey WE. The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase: implications for the control of adrenal functional zonation. J. Biol. Chem. 279: 37622-37630 (2004). *
Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53: 1471-1478 (2004). *
Bassi C, Falconi M. Discussion on prophylactic antibiotic treatment in patients with predicted severe pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 127: 1015-1016 (2004). *
Bassotti G, De Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int. J. Colorectal Dis. 19: 493-497 (2004). *
Bastie JN, Balitrand N, Guidez F, Guillemot I, Larghero J, Calabresse C, Chomienne C, Delva L. 1 alpha,25-Dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells. Mol. Endocrinol. 18: 2685-2699 (2004). *
Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16 (2004). *
Bastone L, Reilly M, Rader DJ, Foulkes AS. MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum. Hered. 58: 82-92 (2004).
Basu SK, Govardhan CP, Jung CW, Margolin AL. Protein crystals for the delivery of biopharmaceuticals. Expert Opin. Biol. Ther. 4: 301-317 (2004).
Bat B, Lodowska J, Orchel A, Parfiniewicz B, Weglarz L, Dzierzewicz Z, Wilczok T. Evaluation of biotransformation of sulphasalazine in the colon epithelial Caco-2 cells. Acta Pol. Pharm. 61 Suppl.: 8-10 (2004).
Bataille F, Klebl F, Rummele P, Schroeder J, Farkas S, Wild PJ, Furst A, Hofstadter F, Scholmerich J, Herfarth H, Rogler G. Morphological characterisation of Crohn's disease fistulae. Gut 53: 1314-1321 (2004). *
Batbayar B, Nagy G, Kovesi G, Zelles T, Feher E. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren's syndrome. Arch. Oral Biol. 49: 529-538 (2004).
Bateman EA, Ferry BL, Hall A, Misbah SA, Anderson R, Kelleher P. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53: 1274-1278 (2004). *
Battisti C, Dotti MT, Loudianos G, Dessi V V, Battistini S, Amato T, Rufa A, Federico A. Wilson's disease with Leu492Ser mutation and arylsulfatase A pseudodeficiency: just a coincidence? Neurol. Sci. 25: 18-20 (2004). *
Baudet JS, Medina A, Moreno A, Navazo L, Aviles J, Soriano A. Bronchobiliary fistula secondary to ruptured hepatocellular carcinoma into the bile duct. J. Hepatol. 41: 1066-1067 (2004). *
Bauditz J, Schachschal G, Wedel S, Lochs H. Thalidomide for treatment of severe intestinal bleeding. Gut 53: 609-612 (2004). *
Bauditz J, Schmidt HH, Dippe P, Lochs H, Pirlich M. Non-alcohol induced steatohepatitis in non-obese patients: treatment with ursodeoxycholic acid. Am. J. Gastroenterol. 99: 959-960 (2004). *
Baudouin C, Pisella PJ, Brignole F. Current treatments of xerophthalmia in Sjogren's syndrome. Rev. Med. Interne. 25: 376-382 (2004).
Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 66: 413-419 (2004). *
Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, Ibrahim SM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum. 50: 3721-3728 (2004). *
Bauer M, Hamm AC, Bonaus M, Jacob A, Jaekel J, Schorle H, Pankratz MJ, Katzenberger JD. Starvation response in mouse liver shows strong correlation with life-span-prolonging processes. Physiol. Genomics 17: 230-244 (2004). *
Baumgart DC, Dignass AU. Current biological therapies for inflammatory bowel disease. Curr. Pharm. Des. 10: 4127-4147 (2004).
Baumgart DC, Wiedenmann B, Dignass AU. Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis. Inflamm. Bowel Dis. 10: 421-424 (2004). *
Baurmash HD. Diagnosing primary and secondary Sjogren's syndrome. J. Oral Maxillofac. Surg. 62: 764-765 (2004).
Bavdekar A. Therapeutic and management challenges in Wilson's disease. J. Gastroenterol. Hepatol. 19: S391-S395 (2004). *
Bayer EM, Schramm C, Kanzler S, Lohse AW. Autoimmune liver disease: diagnosis and therapy. Z. Gastroenterol. 42: 19-30 (2004).
Bayer Y, Neumann S, Meyer B, Ruschendorf F, Reske A, Brix T, Hegedus L, Langer P, Nurnberg P, Paschke R. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J. Clin. Endocrinol. Metab. 89: 4044-4052 (2004). *
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find. Exp. Clin. Pharmacol. 26: 587-612 (2004).
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 5: 315-329 (2004). *
Bayliffe AI, Brigandi RA, Wilkins HJ, Levick MP. Emerging therapeutic targets in psoriasis. Curr. Opin. Pharmacol. 4: 306-310 (2004).
Bayliss M, Somers G. Isolation and culture of human hepatocytes. Methods Mol. Med. 107: 249-268 (2004).
Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Galicier L, Lepelletier Y, Webster D, Levy Y, Eibl MM, Oksenhendler E, Hermine O, Kaveri SV. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104: 2441-2443 (2004). *
Baysoy G, Ertem D, Ademoglu E, Kotiloglu E, Keskin S, Pehlivanoglu E. Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J. Pediatr. Gastroenterol. Nutr. 38: 146-151 (2004). *
Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Clin. Invest. Med. 27: 162-167 (2004).
Bazilio AP, Viana VS, Toledo R, Woronik V, Bonfa E, Monteiro RC. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol. Dial. Transplant. 19: 1427-1431 (2004). *
Beani JC. Prescription of phototherapy in psoriasis. Rev. Prat. 54: 43-47 (2004).
Beaugerie L. Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants. Gastroenterol. Clin. Biol. 28: 218-220 (2004).
Beaugerie L, Blain A, Brazier F, Gornet JM, Parc Y. Treatment of extended ulcerative colitis (severe colitis excluded). Gastroenterol. Clin. Biol. 28: 974-983 (2004).
Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 18: 337-352 (2004).
Beaugerie L, Thiefin G. Gastrointestinal complications related to NSAIDs. Gastroenterol. Clin. Biol. 28 Spec. No 3: C62-C72 (2004).
Beaumont C. Molecular mechanisms of iron homeostasis. Med. Sci. (Paris) 20: 68-72 (2004).
Beaven SW, Abreu MT. Biomarkers in inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 318-327 (2004).
Bebb JR, Scott BB. How effective are the usual treatments for Crohn's disease? Aliment. Pharmacol. Ther. 20: 151-159 (2004). *
Bebb JR, Scott BB. How effective are the usual treatments for ulcerative colitis? Aliment. Pharmacol. Ther. 20: 143-149 (2004). *
Bechade D, Desrame J, De Fuentes G, Camparo P, Raynaud JJ, Algayres JP. Common variable immunodeficiency and celiac disease. Gastroenterol. Clin. Biol. 28: 909-912 (2004).
Bechstein WO. Older livers-should they be used for transplantation? J. Hepatol. 41: 485-487 (2004). *
Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G137-G147 (2004). *
Beckebaum S, Cicinnati VR, Broelsch CE. Advances and limitations of liver transplantation in Germany. Verh. Dtsch. Ges. Pathol. 88: 45-50 (2004).
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21: 491-501 (2004). *
Becker KG. The common variants/multiple disease hypothesis of common complex genetic disorders. Med. Hypotheses 62: 309-317 (2004).
Becker-Weimann S, Wolf J, Kramer A, Herzel H. A model of the mammalian circadian oscillator including the REV-ERBalpha module. Genome Inform. 15: 3-12 (2004).
Beckstein O, Sansom MS. The influence of geometry, surface character, and flexibility on the permeation of ions and water through biological pores. Phys. Biol. 1: 42-52 (2004).
Beddy D, Watson RW, Fitzpatrick JM, O'Connell PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br. J. Surg. 91: 72-77 (2004). *
Beddy DJ, Watson WR, Fitzpatrick JM, O'Connell PR. Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intracellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease. J. Am. Coll. Surg. 199: 234-242 (2004). *
Bederman IR, Kasumov T, Reszko AE, David F, Brunengraber H, Kelleher JK. In vitro modeling of fatty acid synthesis under conditions simulating the zonation of lipogenic [13C]acetyl-CoA enrichment in the liver. J. Biol. Chem. 279: 43217-43226 (2004). *
Bederman IR, Reszko AE, Kasumov T, David F, Wasserman DH, Kelleher JK, Brunengraber H. Zonation of labeling of lipogenic acetyl-CoA across the liver: implications for studies of lipogenesis by mass isotopomer analysis. J. Biol. Chem. 279: 43207-43216 (2004). *
Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum. Immunol. 65: 632-639 (2004).
Bedogni G, Bellentani S. Fatty liver: how frequent is it and why? Ann. Hepatol. 3: 63-65 (2004). *
Bedossa P. Images in hepatology. Telangiectatic adenoma: a variant of hepatocellular adenoma. Ann. Hepatol. 3: 163 (2004). *
Bedrine-Ferran H, Le Meur N, Gicquel I, Le Cunff M, Soriano N, Guisle I, Mottier S, Monnier A, Teusan R, Fergelot P, Le Gall JY, Leger J, Mosser J. Transcriptome variations in human CaCo-2 cells: a model for enterocyte differentiation and its link to iron absorption. Genomics 83: 772-789 (2004). *
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337 (2004). *
Begum NA, Kinoshita K, Kakazu N, Muramatsu M, Nagaoka H, Shinkura R, Biniszkiewicz D, Boyer LA, Jaenisch R, Honjo T. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305: 1160-1163 (2004). *
Beharry S, Zhong M, Molday RS. N-Retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J. Biol. Chem. 279: 53972-53979 (2004). *
Behr MA, Semret M, Poon A, Schurr E. Crohn's disease, mycobacteria, and NOD2. Lancet Infect. Dis. 4: 136-137 (2004).
Beitz JM. Continent diversions: the new gold standards of ileoanal reservoir and neobladder. Ostomy Wound Manage. 50: 26-35 (2004).
Beji S, Kaaroud H, Ben Moussa F, Goucha R, Abderrahim E, El Younsi F, Ben Maiz H. Renal amyloidosis complicating the outcome of chronic inflammatory colitis. Presse. Med. 33: 862-865 (2004).
Bejrachandra S, Kitayaporn D, Kaewkungwal J, Piya-Anant M, Permpikul P, Sirikong M, Siriboonrit U, Chandanayingyong D. HLA class II (DRB1, DQA1 and DQB1) allele and haplotype frequencies among HIV-infection discordant Thai couples. Asian Pac. J. Allergy Immunol. 22: 143-151 (2004).
Beland K, Lapierre P, Marceau G, Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J. Autoimmun. 22: 159-166 (2004).
Belda A, Hinojosa J, Serra B, Garcia L, Merino C, Belda A, Moles JR. Systemic candidiasis and infliximab therapy. Gastroenterol. Hepatol. 27: 365-367 (2004).
Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun. 5: 505-512 (2004). *
Belic D, Ristic-Nikolic S, Damjan S, Ratkov I, Ceke M. Heredity of psoriasis. Med. Pregl. 57: 171-174 (2004).
Belkind-Gerson J, Fernandez-Peters A, Furnes R, Oliver M, Perrault J, Robertson M, Witt H; Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pancreatic disorders and cystic fibrosis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 2: S688-S694 (2004). *
Bell AJ, Nicholls RJ, Forbes A, Ellis HJ, Ciclitira PJ. Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole. Gut 53: 1801-1805 (2004). *
Bell J. Predicting disease using genomics. Nature 429: 453-456 (2004). *
Bellanti JA, Sabra A, Zeligs BJ. Gastrointestinal immunopathology and food allergy. Ann. Allergy Asthma Immunol. 93: S26-S32 (2004).
Belliard AM, Lacour B, Farinotti R, Leroy C. Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J. Pharm. Sci. 93: 1524-1536 (2004). *
Bellini C, Mazzella M, Scopesi F, Serra G. Spontaneous recovery in neonatal hemochromatosis. J. Hepatol. 41: 882-883 (2004). *
Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl. 10: 107-114 (2004). *
Belluzzi A. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur. Rev. Med. Pharmacol. Sci. 8: 225-229 (2004).
Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U.S.A. 101: 4894-4899 (2004). *
Beltzner CC, Pollard TD. Identification of functionally important residues of Arp2/3 complex by analysis of homology models from diverse species. J. Mol. Biol. 336: 551-565 (2004). *
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11: 625-626 (2004). *
Ben-Ari Z. Ascites after transplantation - a mystery. Liver Transpl. 10: 1221 (2004). *
Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, Yussim A, Shapira Z, Tur-Kaspa R, Mor E. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin. Transplant. 18: 130-136 (2004).
Ben-Neriah Y, Schmitz ML. Of mice and men. EMBO Rep. 5: 668-673 (2004). *
Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 23: 281-302 (2004). *
Benazzato L, D'Inca R, Grigoletto F, Perissinotto E, Medici V, Angriman I, Sturniolo GC. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. Dig. Liver Dis. 36: 461-466 (2004).
Bendet N, Scapa E, Cohen O, Bloch O, Aharoni D, Ramot Y, Weiss M, Halevi A, Rapoport MJ. Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scand. J. Gastroenterol. 39: 650-656 (2004). *
Bene L, Sapi Z, Bajtai A, Buzas E, Szentmihalyi A, Arato A, Tulassay Z, Falus A. Partial protection against dextran sodium sulphate induced colitis in histamine-deficient, histidine decarboxylase knockout mice. J. Pediatr. Gastroenterol. Nutr. 39: 171-176 (2004). *
Benjaminov FS, Heathcote J. Liver disease in pregnancy. Am. J. Gastroenterol. 99: 2479-2488 (2004). *
Bennett R. Fibromyalgia: present to future. Curr. Pain Headache Rep. 8: 379-384 (2004).
Bennink RJ, Peeters M, Rutgeerts P, Mortelmans L. Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy. J. Nucl. Med. 45: 1698-1704 (2004). *
Bennink RJ, van Montfrans C, de Jonge WJ, de Bruin K, van Deventer SJ, te Velde AA. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model. Nucl. Med. Biol. 31: 93-101 (2004). *
Benoit S, Toksoy A, Brocker EB, Gillitzer R, Goebeler M. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression. Br. J. Dermatol. 150: 1009-1012 (2004). *
Benos DJ, Berdiev BK, Ismailov II, Ostedgaard LS, Kogan I, Li C, Ramjeesingh M, Bear CE. Methods to study CFTR protein in vitro. J. Cyst. Fibros. 3 Suppl. 2: 79-83 (2004).
Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126: 1400-1408 (2004). *
Benson GD, Kikuchi K, Miyakawa H, Tanaka A, Watnik MR, Gershwin ME. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin. Dev. Immunol. 11: 129-133 (2004). *
Bentley DR. Genomes for medicine. Nature 429: 440-445 (2004). *
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53: 3007-3012 (2004). *
Bento MC, Ribeiro ML, Relvas L. Gene symbol: HFE. Disease: haemochromatosis. Hum. Genet. 114: 405 (2004).
Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 14: 964-966 (2004).
Benvenuti F, Hugues S, Walmsley M, Ruf S, Fetler L, Popoff M, Tybulewicz VL, Amigorena S. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 305: 1150-1153 (2004). *
Berard AM, Dumon MF, Darmon M. Dietary fish oil up-regulates cholesterol 7alpha-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion. FEBS Lett. 559: 125-128 (2004). *
Berard F, Guillot I, Saad N, Nicolas JF. How to understand psoriasis? Rev. Prat. 54: 28-34 (2004).
Berdah SV, Barthet M, Emungania O, Orsoni P, Alliot P, Grimaud JC, Brunet C. Two stage videoassisted restorative proctocolectomy. Early experience of 12 cases. Ann. Chir. 129: 332-336 (2004).
Berdowska I. Cysteine proteases as disease markers. Clin. Chim. Acta 342: 41-69 (2004). *
Bergasa NV. Treatment of the pruritus of cholestasis. Curr. Treat. Options Gastroenterol. 7: 501-508 (2004).
Bergasa NV. An approach to the management of the pruritus of cholestasis. Clin. Liver Dis. 8: 55-66 (2004).
Bergasa NV. Pruritus in chronic liver disease: mechanisms and treatment. Curr. Gastroenterol. Rep. 6: 10-16 (2004).
Bergasa NV. Treatment of the pruritus of cholestasis: from unbearable lightness to substance. Hepatology 39: 1450-1453 (2004). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Bergen AA, Plomp AS, Gorgels TG, de Jong PT. From gene to disease; pseudoxanthoma elasticum and the ABCC6 gene. Ned. Tijdschr. Geneeskd. 148: 1586-1589 (2004).
Berger G. Hypotheses on a germline origin of antibody diversity. Possible applications: improvement of the efficiency of immune response and autoimmune disease treatment. Med. Hypotheses 63: 847-854 (2004).
Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM. No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. Gastroenterology 127: 1381-1385 (2004). *
Bergert H, Illert T, Friedrich K, Ockert D. Fulminant liver failure following infection by Clostridium perfringens. Surg. Infect. (Larchmt.) 5: 205-209 (2004).
Bergholdt R, Heding P, Nielsen K, Nolsoe R, Sparre T, Storling J, Nerup J, Pociot F, Mandrup-Poulsen T. Type 1 database mellitus: an inflammatory disease of the islet. Adv. Exp. Med. Biol. 552: 129-153 (2004).
Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, Klareskog L, Dahlqvist SR. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res. Ther. 6: R303-R308 (2004). *
Bergman Y, Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat. Rev. Immunol. 4: 753-761 (2004). *
Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H. Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire. Eur. J. Epidemiol. 19: 411-416 (2004).
Bergquist A, Saarinen S, Lindberg G, Broome U. Familial primary sclerosing cholangitis. J. Hepatol. 40 Suppl. 1: 158 (2004).
Beris P; Anemia Working Group. Erythropoietin and intravenous iron to save blood in surgery. Schweiz. Rundsch. Med. Prax. 93: 1905-1910 (2004).
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes. J. Natl. Med. Assoc. 96: 1042-1046 (2004).
Berkenstam A, Farnegardh M, Gustafsson JA. Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Mech. Ageing Dev. 125: 707-717 (2004).
Berkovitch F, Nicolet Y, Wan JT, Jarrett JT, Drennan CL. Crystal structure of biotin synthase, an S-adenosylmethionine-dependent radical enzyme. Science 303: 76-79 (2004). *
Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol. Aging 25: 465-474 (2004).
Bermejo F, Lopez-Sanroman A, Hinojosa J, Castro L, Jurado C, Gomez-Beldal AB. Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis. Rev. Esp. Enferm. Dig. 96: 94-101 (2004).
Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pita O, Papini M, Rebora A, Bombardieri S, Fabbri P. Sjogren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin. Exp. Rheumatol. 22: 55-62 (2004).
Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J. Hepatol. 40: 192-197 (2004). *
Bernardes-Silva CF, Damiao AO, Sipahi AM, Laurindo FR, Iriya K, Lopasso FP, Buchpiguel CA, Lordello ML, Agostinho CL, Laudanna AA. Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress. Dig. Dis. Sci. 49: 1569-1574 (2004). *
Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand. J. Gastroenterol. 39: 374-379 (2004). *
Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig. Liver Dis. 36: 467-470 (2004).
Berni Canani R, Terrin G, Cirillo P, Castaldo G, Salvatore F, Cardillo G, Coruzzo A, Troncone R. Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology 127: 630-634 (2004). *
Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun. 5: 461-476 (2004). *
Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B; IBSEN Study Group. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand. J. Gastroenterol. 39: 365-373 (2004). *
Bernstein CN. Ulcerative colitis with low-grade dysplasia. Gastroenterology 127: 950-956 (2004). *
Bernstein CN. A balancing view: dysplasia surveillance in ulcerative colitis - sorting the pro from the con. Am. J. Gastroenterol. 99: 1636-1637 (2004). *
Bernstein CN. Another look at fracture risk in IBD. Inflamm. Bowel Dis. 10: 886-887 (2004). *
Bernstein CN. Complementary and alternative medicine use by patients with inflammatory bowel disease: are Canadian physicians failing with conventional therapy, or not? Can. J. Gastroenterol. 18: 47-48 (2004). *
Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 42: 1129-1135 (2004). *
Bernstein CN, Leslie WD. Osteoporosis and inflammatory bowel disease. Aliment. Pharmacol. Ther. 19: 941-952 (2004). *
Bernstein H, Payne CM, Kunke K, Crowley-Weber CL, Waltmire CN, Dvorakova K, Holubec H, Bernstein C, Vaillancourt RR, Raynes DA, Guerriero V, Garewal H. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 25: 681-692 (2004). *
Bernstine H, Mor E, Ben Ari Z, Belinki A, Hardoff R. Scintigraphic patterns of veno-occlusive disease in liver transplantation. Clin. Nucl. Med. 29: 292-295 (2004).
Bernuau J. Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J. Hepatol. 41: 152-155 (2004). *
Berquist WE, Andrus JP. The value of the PRISM scores in comparing pediatric liver transplant outcomes. Pediatr. Transplant. 8: 208-209 (2004).
Berr F. Photodynamic therapy for cholangiocarcinoma. Semin. Liver Dis. 24: 177-187 (2004).
Berry JD, Sidhu PS. Microbubble contrast-enhanced ultrasound in liver transplantation. Eur. Radiol. 14 Suppl. 8: P96-P103 (2004).
Bersani G, Rossi A, Suzzi A, Ricci G, De Fabritiis G, Alvisi V. Comparison between the two systems to evaluate the appropriateness of endoscopy of the upper digestive tract. Am. J. Gastroenterol. 99: 2128-2135 (2004). *
Berthiaume EP, Wands J. The molecular pathogenesis of cholangiocarcinoma. Semin. Liver Dis. 24: 127-137 (2004).
Bertok L. Bile acids in physico-chemical host defence. Pathophysiology 11: 139-145 (2004).
Bertola G, Balza G, Oriani A, Morganti D, Sironi C, Bonizzato S. Elevated concentration of serum carcinoembryonic antigen in hypothyroidism. Recenti Prog. Med. 95: 204-206 (2004).
Bertolino P, Bowen DG, Zen M, Holz L, Davis T, McCaughan GW. Hepatocytes as targets of autoreactivity. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 33 (2004). *
Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, Rinn JL, Tongprasit W, Samanta M, Weissman S, Gerstein M, Snyder M. Global identification of human transcribed sequences with genome tiling arrays. Science 306: 2242-2246 (2004). *
Bertram L, Tanzi RE. Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet. 13 Spec. No. 1: R135-R141 (2004). *
Bertrand-Philippe M, Ruddell RG, Arthur MJ, Thomas J, Mungalsingh N, Mann DA. Regulation of tissue inhibitor of metalloproteinase-1 gene transcription by RUNX1 and RUNX2. J. Biol. Chem. 279: 24530-24539 (2004). *
Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, Ollendorff V, Fert V, Giovaninni M, Delpero JR, Nguyen C, Viens P, Monges G, Birnbaum D, Houlgatte R. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391 (2004). *
Beskow LM, Botkin JR, Daly M, Juengst ET, Lehmann LS, Merz JF, Pentz R, Press NA, Ross LF, Sugarman J, Susswein LR, Terry SF, Austin MA, Burke W. Ethical issues in identifying and recruiting participants for familial genetic research. Am. J. Med. Genet. 130A: 424-431 (2004).
Besnard P, Landrier JF, Grober J, Niot I. Is the ileal bile acid-binding protein (I-BABP) gene involved in cholesterol homeostasis? Med. Sci. (Paris) 20: 73-77 (2004).
Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr. Patterns 5: 193-208 (2004). *
Bessard G, Hardy G, Chartier A, Stanke-Labesque F. Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine. Therapie 59: 71-75 (2004).
Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. BMC Surg. 4: 12 (2004). *
Bessis D, Moles JP, Basset-Seguin N, Tesniere A, Arpin C, Guilhou JJ. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin. Br. J. Dermatol. 151: 737-745 (2004). *
Bettencourt R, Tanji T, Yagi Y, Ip YT. Toll and Toll-9 in Drosophila innate immune response. J. Endotoxin Res. 10: 261-268 (2004). *
Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin. Exp. Immunol. 137: 225-233 (2004). *
Beuers U, Hohenester S, Wimmer R, Denk GU, Rust C. Mitogen activated protein kinases and protein kinase C: short-term mediators of the anticholestatic effect of tauroursodeoxycholic acid in bile acid-induced cholestasis? Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 61. June 18-19 (2004). *
Beuf O, Pilleul F, Armenean M, Hadour G, Saint-Jalmes H. In vivo colon wall imaging using endoluminal coils: feasibility study on rabbits. J. Magn. Reson. Imaging 20: 90-96 (2004). *
Beutler B. Innate immunity: an overview. Mol. Immunol. 40: 845-859 (2004). *
Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263 (2004). *
Beutler B, Hoebe K, Georgel P, Tabeta K, Du X. Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses. Microbes Infect. 6: 1374-1381 (2004). *
Beutler B, Hoebe K, Shamel L. Forward genetic dissection of afferent immunity: the role of TIR adapter proteins in innate and adaptive immune responses. C. R. Biol. 327: 571-580 (2004).
Beutler E. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am. J. Clin. Nutr. 80: 799-800 (2004). *
Beutler E. Enzyme replacement in Gaucher disease. PLoS Med. 1: e21 (2004). *
Beutler E. Cell biology. "Pumping" iron: the proteins. Science 306: 2051-2053 (2004). *
Beutler E. Natural history of hemochromatosis. Mayo Clin. Proc. 79: 305-306 (2004). *
Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis. 33: 344-345 (2004).
Bevan MJ. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4: 595-602 (2004). *
Bevins CL. The Paneth cell and the innate immune response. Curr. Opin. Gastroenterol. 20: 572-580 (2004).
Beyak MJ, Ramji N, Krol KM, Kawaja MD, Vanner SJ. Two TTX-resistant sodium currents in mouse colonic dorsal root ganglia neurons and their role in colitis induced hyperexcitability. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G845-G855 (2004). *
Beyer TP, Schmidt RJ, Foxworthy P, Zhang Y, Dai J, Bensch WR, Kauffman RF, Gao H, Ryan TP, Jiang XC, Karathanasis SK, Eacho PI, Cao G. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo. J. Pharmacol. Exp. Ther. 309: 861-868 (2004). *
Beylot C. Clinical aspects of psoriasis. Rev. Prat. 54: 19-27 (2004).
Beyrouti MI, Beyrouti R, Kharrat M, Kchaou I, Abbes M, Affes N, Tafech I, Ghorbel A, Krichene MS, Boudawara T, Sellami A. Intestinal Crohn disease: surgical aspects and predictive factors of risk of relapse. About 26 cases. Tunis. Med. 82: 927-940 (2004).
Bhalla S, Ozalp C, Fang S, Xiang L, Kemper JK. Ligand-activated PXR interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha: functional implications in hepatic cholesterol and glucose metabolism. J. Biol. Chem. 279: 45139-45147 (2004). *
Bharti AC, Takada Y, Shishodia S, Aggarwal BB. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J. Biol. Chem. 279: 6065-6076 (2004). *
Bhat RM. Management of pyoderma gangrenosum - an update. Indian J. Dermatol. Venereol. Leprol. 70: 329-335 (2004).
Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J. Hepatol. 41: 89-96 (2004). *
Bhattacharyya KB. Wilson's disease. J. Assoc. Physicians India 52: 595 (2004).
Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr. Opin. Gastroenterol. 20: 427-434 (2004).
Biagi F, Campanella J, Martucci S, Pezzimenti D, Ciclitira PJ, Ellis HJ, Corazza GR. A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr. Rev. 62: 360-363 (2004).
Bian H, Hammer J. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 34: 468-475 (2004). *
Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract. Res. Clin. Obstet. Gynaecol. 18: 959-975 (2004).
Bianco F, Fattapposta F, Locuratolo N, Pierallini A, Rossi M, Ruberto F, Bozzao L. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology 62: 981-983 (2004).
Biancofiore G, Bindi ML, Boldrini A, Consani G, Bisa M, Esposito M, Urbani L, Catalano G, Filipponi F, Mosca F. Intraabdominal pressure in liver transplant recipients: incidence and clinical significance. Transplant. Proc. 36: 547-549 (2004). *
Biancofiore G, Della Rocca G, Bindi L, Romanelli A, Esposito M, Meacci L, Urbani L, Filipponi F, Mosca F. Use of fenoldopam to control renal dysfunction early after liver transplantation. Liver Transpl. 10: 986-992 (2004). *
Biancone L, Tosti C, Geremia A, Fina D, Petruzziello C, Emerenziani S, Pallone F. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. Aliment. Pharmacol. Ther. 19: 755-764 (2004). *
Biasco G, Pantaleo MA, Di Febo G, Calabrese C, Brandi G, Bulow S. Risk of duodenal cancer in patients with familial adenomatous polyposis. Gut 53: 1547 (2004). *
Biasco G, Pantaleo MA, Nobili E, Monti C. Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. Am. J. Gastroenterol. 99: 1621-1622 (2004). *
Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33: 338-343 (2004).
Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis. Liver Int. 24: 345-353 (2004). *
Biedermann T, Rocken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J. Investig. Dermatol. Symp. Proc. 9: 5-14 (2004). *
Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann. Allergy Asthma Immunol. 93 (2 Suppl. 1): S45-S54 (2004).
Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5: 1109-1115 (2004). *
Biernacka JM, Sun L, Bull SB. Simultaneous localization of two linked disease susceptibility genes. Genet. Epidemiol. 28: 33-47 (2004). *
Bilbao JI, Elorz M, Vivas I, Martinez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc. Intervent. Radiol. 27: 474-480 (2004). *
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *
Bilinska M, Frydecka I, Noga L, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Pokryszko-Dragan A. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurol. Scand. 110: 67-71 (2004).
Bilodeau M, Tousignant J, Ethier C, Rocheleau B, Raymond VA, Lapointe R. Anti-apoptotic effect of insulin on normal hepatocytes in vitro and in vivo. Apoptosis 9: 609-617 (2004).
Bilsborough J, Viney JL. In vivo enhancement of dendritic cell function. Ann. N. Y. Acad. Sci. 1029: 83-87 (2004). *
Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127: 300-309 (2004). *
Bilsborough J, Viney JL. Out, out darn toxin: the role of MDR in intestinal homeostasis. Gastroenterology 127: 339-340 (2004). *
Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64: 442-451 (2004). *
Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract. Res. Clin. Gastroenterol. 18: 463-479 (2004).
Bingle CD, Craven CJ. Meet the relatives: a family of BPI- and LBP-related proteins. Trends Immunol. 25: 53-55 (2004). *
Bingle CD, Gorr SU. Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int. J. Biochem. Cell. Biol. 36: 2144-2152 (2004). *
Bingle CD, LeClair EE, Havard S, Bingle L, Gillingham P, Craven CJ. Phylogenetic and evolutionary analysis of the PLUNC gene family. Protein Sci. 13: 422-430 (2004). *
Birebent B, Lorho R, Lechartier H, de Guibert S, Alizadeh M, Vu N, Beauplet A, Robillard N, Semana G. Suppressive properties of human CD4(+)CD25(+) regulatory T cells are dependent on CTLA-4 expression. Eur. J. Immunol. 34: 3485-3496 (2004). *
Biro T, Griger Z, Kiss E, Papp H, Aleksza M, Kovacs I, Zeher M, Bodolay E, Csepany T, Szucs K, Gergely P, Kovacs L, Szegedi G, Sipka S. Abnormal cell-specific expressions of certain protein kinase C isoenzymes in peripheral mononuclear cells of patients with systemic lupus erythematosus: effect of corticosteroid application. Scand. J. Immunol. 60: 421-428 (2004). *
Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm. Bowel Dis. 10: 848-859 (2004). *
Birsner JH, Wan C, Cheng G, Evans ZP, Polito CC, Fiorini RN, Gilbert G, Haines JK, Schmidt MG, Chavin KD. Steatotic liver transplantation in the mouse: a model of primary nonfunction. J. Surg. Res. 120: 97-101 (2004). *
Bischoff S, Crowe SE. Food allergy and the gastrointestinal tract. Curr. Opin. Gastroenterol. 20: 156-161 (2004).
Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, Levi-Schaffer F, Shanahan F, Schemann M. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol. Motil. 16: 185-193 (2004).
Bisgaard ML, Ripa R, Knudsen AL, Bulow S. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53: 266-270 (2004). *
Bishop GA. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat. Rev. Immunol. 4: 775-786 (2004).
Bishop-Bailey D. FXR as a novel therapeutic target for vascular disease. Drug News Perspect. 17: 499-504 (2004).
Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proc. Natl. Acad. Sci. U.S.A. 101: 3668-3673 (2004). *
Bisschop PH, Bandsma RH, Stellaard F, Ter Harmsel A, Meijer AJ, Sauerwein HP, Kuipers F, Romijn JA. Low-fat, high-carbohydrate and high-fat, low-carbohydrate diets decrease primary bile acid synthesis in humans. Am. J. Clin. Nutr. 79: 570-576 (2004). *
Bissell DM. Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology 127: 1847-1849 (2004). *
Bissinger AL, Oettle H, Jahn G, Neuhaus P, Sinzger C. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient. J. Med. Virol. 73: 45-53 (2004). *
Bissonnette EY, Proulx LI, Turmel V, Drouin R, Purcell M. PCT-233, a novel modulator of pro- and anti-inflammatory cytokine production. Clin. Exp. Immunol. 135: 440-447 (2004). *
Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C, Saarialho-Kere U. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig. Dis. Sci. 49: 653-661 (2004). *
Bittencourt PL, Farias AQ, Abrantes-Lemos CP, Goncalves LL, Goncalves PL, Magalhaes EP, Carrilho FJ, Laudanna AA, Cancado EL. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 19: 873-878 (2004). *
Bjerkeli V, Halvorsen B, Damas JK, Nordoy I, Yndestad A, Aukrust P, Froland SS. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Ann. Rheum. Dis. 63: 1659-1663 (2004). *
Bjorkkjaer T, Brunborg LA, Arslan G, Lind RA, Brun JG, Valen M, Klementsen B, Berstad A, Froyland L. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand. J. Gastroenterol. 39: 1088-1094 (2004). *
Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 99: 502-508 (2004). *
Bjornsson E, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis-revisited. Am. J. Gastroenterol. 99: 2281 (2004). *
Bjornsson E, Simren M, Olsson R, Chapman RW. Fatigue in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 39: 961-968 (2004). *
Bjoro K, Schrumpf E. Liver transplantation for primary sclerosing cholangitis. J. Hepatol. 40: 570-577 (2004). *
Bjursten M, Hultgren OH, Hultgren Hornquist E. Enhanced pro-inflammatory cytokine production in Galphai2-deficient mice on colitis prone and colitis resistant 129Sv genetic backgrounds. Cell. Immunol. 228: 77-80 (2004). *
Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J. Hepatol. 40: 942-951 (2004). *
Black RA. TIMP3 checks inflammation. Nat. Genet. 36: 934-935 (2004). *
Blackburn CC, Manley NR. Developing a new paradigm for thymus organogenesis. Nat. Rev. Immunol. 4: 278-289 (2004). *
Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin. Liver Dis. 24: 371-379 (2004).
Blackwell J. Evaluation and treatment of hyperthyroidism and hypothyroidism. J. Am. Acad. Nurse Pract. 16: 422-425 (2004).
Blackwell NM, Sembi P, Newson JS, Lawrence T, Gilroy DW, Kabouridis PS. Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum. 50: 2675-2684 (2004). *
Bladt V, Steengaard-Pedersen K, Poulsen LH, Petersen OB, Laursen B, d'Amore F. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Eur. J. Haematol. 73: 437-440 (2004). *
Blagaic AB, Blagaic V, Romic Z, Sikiric P. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Eur. J. Pharmacol. 499: 285-290 (2004). *
Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity. BMC Med. Genet. 5: 26 (2004). *
Blaker M, Schmitz M, Gocht A, Burghardt S, Schulz M, Broring DC, Pace A, Greten H, De Weerth A. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. J. Hepatol. 41: 112-118 (2004). *
Blanch J, Sureda B, Flavia M, Marcos V, De Pablo J, De Lazzari E, Rimola A, Vargas V, Navarro V, Margarit C, Visa J. Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transpl. 10: 228-234 (2004). *
Blanchard SS, Bauman L, Czinn SJ. Treatment of Helicobacter pylori in pediatrics. Curr. Treat. Options Gastroenterol. 7: 407-412 (2004).
Blanchard TG, Drakes ML, Czinn SJ. Helicobacter infection: pathogenesis. Curr. Opin. Gastroenterol. 20: 10-15 (2004).
Blanchet E, Beau P, Frat JP. Bone marrow aplasia following dipyrone treatment in a patient with Crohn's disease receiving long-term methotrexate. Gastroenterol. Clin. Biol. 28: 502-503 (2004).
Blanchette M, Green ED, Miller W, Haussler D. Reconstructing large regions of an ancestral mammalian genome in silico. Genome Res. 14: 2412-2423 (2004). *
Blanco PG, Zaman MM, Junaidi O, Sheth S, Yantiss RK, Nasser IA, Freedman SD. Induction of colitis in cftr-/- mice results in bile duct injury. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G491-G496 (2004). *
Blank C, Sabri M, Di Lorenzo C. Pediatric gastric and duodenal disorders. Curr. Opin. Gastroenterol. 20: 551-555 (2004).
Blank M, Shani A, Goldberg I, Kopolovic J, Amigo MC, Magrini L, Shoenfeld Y. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb. Res. 114: 589-592 (2004). *
Blanquart C, Mansouri R, Paumelle R, Fruchart JC, Staels B, Glineur C. The protein kinase C signalling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha (PPARalpha). Mol. Endocrinol. 18: 1906-1918 (2004). *
Blaschke F, Bruemmer D, Law RE. Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting? Clin. Cardiol. 27: IV3-IV10 (2004).
Blasco A, Enrique E, Mateo JA, Castello JV, Ferriols R, Malek T. Positive patch test to azathioprine in inflammatory bowel disease. Allergy 59: 368-369 (2004). *
Blasi C. The role of the infectious agents in the pathogenesis and evolution of atherosclerosis. Ann. Ital. Med. Int. 19: 249-261 (2004).
Blattman JN, Greenberg PD. Cancer immunotherapy: a treatment for the masses. Science 305: 200-205 (2004). *
Blazovics A, Hagymasi K, Pronai L. Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases. Orv. Hetil. 145: 2523-2529 (2004).
Blazovics A, Szentmihalyi K, Pronai L, Hagymasi K, Lugasi A, Kovacs A, Feher J. Redox homeostasis in inflammatory bowel diseases. Orv. Hetil. 145: 1459-1166 (2004).
Blei AT. Who owns the data? Hepatology 40: 1237 (2004). *
Blei AT. Albumin dialysis for the treatment of hepatic encephalopathy. J. Gastroenterol. Hepatol. 19: S224-S228 (2004). *
Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J. Hepatol. 40: 327-330 (2004). *
Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment. J. Infect. Dis. 189: 583-586 (2004). *
Bleich A, Mahler M, Most C, Leiter EH, Liebler-Tenorio E, Elson CO, Hedrich HJ, Schlegelberger B, Sundberg JP. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm. Genome 15: 865-871 (2004).
Blendis L, Dotan I. Anti-TNF therapy for severe acute alcoholic hepatitis: what went wrong? Gastroenterology 127: 1637-1639 (2004). *
Blendis L, Halpern Z. An increasing incidence of cholangiocarcinoma: why? Gastroenterology 127: 1008-1009 (2004). *
Blenman KR, Bahjat FR, Moldawer LL, Morel L. Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse. Clin. Immunol. 110: 124-133 (2004). *
Blich M, Edoute Y. Clinical manifestations of sarcoid liver disease. J. Gastroenterol. Hepatol. 19: 732-737 (2004). *
Bliss CM Jr, Schroy PC 3rd. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr. Opin. Gastroenterol. 20: 468-473 (2004).
Bloks VW, Bakker-Van Waarde WM, Verkade HJ, Kema IP, Wolters H, Vink E, Groen AK, Kuipers F. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 47: 104-112 (2004). *
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89: 3474-3476 (2004). *
Blomhoff HK. Vitamin A regulates proliferation and apoptosis of human T- and B-cells. Biochem. Soc. Trans. 32: 982-984 (2004). *
Blonska M, You Y, Geleziunas R, Lin X. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. Mol. Cell. Biol. 24: 10757-10765 (2004). *
Bloom S, Kiilerich S, Lassen MR, Forbes A, Leiper K, Langholz E, Irvine EJ, O'Morain C, Lowson D, Orm S. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment. Pharmacol. Ther. 19: 871-878 (2004). *
Bloquel C, Bessis N, Boissier MC, Scherman D, Bigey P. Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Hum. Gene Ther. 15: 189-201 (2004). *
Blossom SJ, Pumford NR, Gilbert KM. Activation and attenuation of apoptosis of CD4(+) T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J. Autoimmun. 23: 211-220 (2004).
Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 101: 14622-14626 (2004). *
Blumenthal MN, Ober C, Beaty TH, Bleecker ER, Langefeld CD, King RA, Lester L, Cox N, Barnes K, Togias A, Mathias R, Meyers DA, Oetting W, Rich SS; CSGA. Genome scan for loci linked to mite sensitivity: the Collaborative Study on the Genetics of Asthma (CSGA). Genes Immun. 5: 226-231 (2004). *
Boberg KM, Schrumpf E. Prognosis of autoimmune liver diseases. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 81 (2004). *
Boberg KM, Schrumpf E. Diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 6: 52-59 (2004).
Bobinski R, Olczyk K, Wisowski G, Janusz W. Genetic aspect of Dupuytren's diseases. Wiad. Lek. 57: 59-62 (2004).
Bock KW, Kohle C. Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters. Drug Metab. Rev. 36: 595-615 (2004).
Bodemar G, Kechagias S, Almer S, Danielson BG. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand. J. Gastroenterol. 39: 454-458 (2004). *
Bodin K. Role of CYP3A4 as a cholesterol and bile acid metabolizing enzyme. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 25. June 18-19 (2004). *
Boehm BO, Bluestone JA. Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus. Rev. Diabet. Stud. 1: 156-164 (2004). *
Boehncke WH. The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skin. Eur. J. Dermatol. 14: 142-145 (2004).
Boes M, Ploegh HL. Translating cell biology in vitro to immunity in vivo. Nature 430: 264-271 (2004). *
Bogaard HJ, Erkelens GW, Faber WR, de Vries PJ. Cutaneous nocardiosis as an opportunistic infection. Ned. Tijdschr. Geneeskd. 148: 533-536 (2004).
Bogdanos D, Vergani D, Mieli-Vergani G. Overlap syndromes from pediatrics to adulthood. J. Gastroenterol. Hepatol. 19: S284-S286 (2004). *
Bogdanos D, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli- Vergani G, Bianchi FB, Vergani D. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int. J. Immunopathol. Pharmacol. 17: 83-92 (2004).
Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou E, Montalto P, Davies ET, Burroughs AK, Vergani D. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J. Hepatol. 40: 31-39 (2004). *
Bogdanos DP, Baum H, Gunsar F, Arioli D, Polymeros D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand. J. Gastroenterol. 39: 981-987 (2004). *
Bogdanos DP, Bianchi I, Baum H, Gunsar F, Arioli D, Ma Y, Burroughs AK, Vergani D. Extensive homology between the major immunodominant mitochondrial antigen of primary biliary cirrhosis and Helicobacter pylori does not lead to immunological crossreactivity. J. Hepatol. 40 Suppl. 1: 158-159 (2004).
Bogdanos DP, Bianchi I, Ma Y, Mitry RR, Mieli-Vergani G, Vergani D. Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis. Clin. Chem. 50: 682-683 (2004). *
Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y, Mieli-Vergani G, Vergani D. Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J. Autoimmune Dis. 1: 4 (2004). *
Bogdanos DP, Pares A, Baum H, Caballeria L, Rigopoulou EI, Ma Y, Burroughs AK, Rodes J, Vergani D. Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J. Autoimmun. 22: 353-362 (2004).
Bogdanos DP, Pares A, Rodes J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am. J. Gastroenterol. 99: 763-764 (2004). *
Bogdanos DP, Vergani D, Muratori P, Muratori L, Bianchi FB. Specificity of anti-sp100 antibody for primary biliary cirrhosis. Scand. J. Gastroenterol. 39: 405-406 (2004). *
Bogetti D, Panaro F, Jarzembowski T, Sankary H, Benedetti E, Testa G. Hepatic venous outflow reconstruction in adult living donor liver transplants without portal hypertension. Clin. Transplant. 18: 222-226 (2004).
Bogner J, Lutz B, Klein H, Pollerer C, Troendle U, Goebel F. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. HIV Med. 5: 264-272 (2004).
Bohjanen KA, Prawer SE. New biologic therapies for psoriatic disease. Minn. Med. 87: 34-36 (2004).
Bohm A, Boos W. Gene regulation in prokaryotes by subcellular relocalization of transcription factors. Curr. Opin. Microbiol. 7: 151-156 (2004). *
Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J. Clin. Microbiol. 42: 2766-2768 (2004). *
Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238 (2004). *
Bohrer D, Do Nascimento PC, Ramirez AG, Mendonca JK, De Carvalho LM, Pomblum SC. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis. Clin. Chim. Acta 345: 113-121 (2004). *
Boin IF, Leonardi MI, Pinto AO, Leme RS, Udo E, Stucchi RS, Soares EC, Leonardi LS. Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD. Transplant. Proc. 36: 920-922 (2004). *
Bojar RA, Holland KT. Acne and Propionibacterium acnes. Clin. Dermatol. 22: 375-379 (2004).
Boland CR. Biology of cancer in ulcerative colitis and consequences for chemoprevention. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 82-83. May 7-8 (2004). *
Boland CR. Understanding familial colorectal cancer-finding the corner pieces and filling in the center of the puzzle. Gastroenterology 127: 334-338 (2004). *
Boleslawski E, Conti F, Sanquer S, Podevin P, Chouzenoux S, Batteux F, Houssin D, Weill B, Calmus Y. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 77: 1815-1820 (2004).
Bolt HM. Rifampicin, a keystone inducer of drug metabolism: from Herbert Remmer's pioneering ideas to modern concepts. Drug Metab. Rev. 36: 497-509 (2004).
Bolz DD, Weis JJ. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity? Autoimmunity 37: 387-392 (2004).
Bombail V, Taylor K, Gibson GG, Plant N. Role of Sp1, C/EBPalpha, HNF3, and PXR in the basal- and xenobiotic-mediated regulation of the CYP3A4 gene. Drug Metab. Dispos. 32: 525-535 (2004). *
Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res. Ther. 6: R447-R456 (2004). *
Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, Amoura Z, Piette JC, Sabbadini MG, Rovere-Querini P, Manfredi AA. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum. 50: 1549-1560 (2004). *
Bonder CS, Ajuebor MN, Zbytnuik LD, Kubes P, Swain MG. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J. Immunol. 172: 45-53 (2004). *
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5: 142-146 (2004). *
Bonewald LF. Osteocyte biology: its implications for osteoporosis. J. Musculoskelet. Neuronal Interact. 4: 101-104 (2004).
Bongi SM, Porfirio B, Rombola G, Palasciano A, Beneforti E, Bianucci G. Shared-epitope HLA-DRB1 alleles and sex ratio in Italian patients with rheumatoid arthritis. Joint Bone Spine 71: 24-28 (2004).
Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients. Transplantation 78: 21-25 (2004).
Bonifati DM, Willcox N, Vincent A, Beeson D. Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis. Muscle Nerve 29: 436-439 (2004). *
Bonkowsky JL, Bohnsack JF, Pennington MJ, Viskochil D, Thompson JA. Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinemia (LACH) in two brothers: a novel syndrome? Am. J. Med. Genet. 128A: 52-56 (2004). *
Bonner GF, Fakhri A, Vennamaneni SR. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm. Bowel Dis. 10: 751-757 (2004). *
Boodhoo A, Wong AM, Williamson D, Voon D, Lee S, Allcock RJ, Price P. A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes. Gene Expr. 12: 1-11 (2004).
Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 171: 333-338 (2004). *
Boomkens SY, Kusters JG, Hoffmann G, Pot RG, Spee B, Penning LC, Egberink HF, van den Ingh TS, Rothuizen J. Detection of Helicobacter pylori in bile of cats. FEMS Immunol. Med. Microbiol. 42: 307-311 (2004). *
Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive. Hum. Genet. 115: 280-284 (2004). *
Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5: 1052-1060 (2004). *
Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 15: 717-721 (2004). *
Booth AD, Jayne DR, Kharbanda RK, McEniery CM, Mackenzie IS, Brown J, Wilkinson IB. Infliximab improves endothelial dysfunction in systemic vasculitis. A model of vascular inflammation. Circulation 109: 1718-1723 (2004). *
Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 50: 581-588 (2004). *
Bor MV, Nexo E, Hvas AM. Holo-transcobalamin concentrations and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12. Clin. Chem. 50: 1043-1049 (2004). *
Bora NS, Sohn JH, Kang SG, Cruz JM, Nishihori H, Suk HJ, Wang Y, Kaplan HJ, Bora PS. Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J. Immunol. 172: 7086-7094 (2004). *
Boraschi P, Braccini G, Gigoni R, Cartei F, Perri G. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial. Magn. Reson. Imaging 22: 1085-1095 (2004). *
Borchardt JK. Focus on small molecule inhibitors for treatment of inflammatory and autoimmune diseases. Drug News Perspect. 17: 607-614 (2004).
Borchers AT, Keen CL, Cheema GS, Gershwin ME. The use of methotrexate in rheumatoid arthritis. Semin. Arthritis Rheum. 34: 465-483 (2004). *
Borchers AT, Keen CL, Gershwin ME. Fatalities following allergen immunotherapy. Clin. Rev. Allergy Immunol. 27: 147-158 (2004).
Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp. Biol. Med. (Maywood) 229: 393-406 (2004). *
Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun. Rev. 3: 423-453 (2004).
Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev. 3: 401-406 (2004).
Borghaei RC, Rawlings PL Jr, Javadi M, Woloshin J. NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun. 316: 182-188 (2004). *
Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 22 (6 Suppl. 36): S79-S86 (2004).
Borjesson L, Willen R, Haboubi N, Duff SE, Hulten L. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study. Colorectal Dis. 6: 494-498 (2004). *
Bornstein SR, Schumann RR, Rettori V, McCann SM, Zacharowski K. Toll-like receptor 2 and Toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36: 470-473 (2004).
Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 16695-16700 (2004). *
Borobio E, Arin A, Valcayo A, Inarrairaegui M, Nantes O, Prieto C. Isotretinoin and ulcerous colitis. An. Sist. Sanit. Navar. 27: 241-243 (2004).
Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J. Clin. Gastroenterol. 38: 475-483 (2004).
Boros S, Kamps B, Wunderink L, de Bruijn W, de Jong WW, Boelens WC. Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-beta. FEBS Lett. 576: 57-62 (2004). *
Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig. Liver Dis. 36: 342-347 (2004).
Borst P, Balzarini J, Ono N, Reid G, de Vries H, Wielinga P, Wijnholds J, Zelcer N. The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. Antiviral Res. 62: 1-7 (2004). *
Borsutzky S, Cazac BB, Roes J, Guzman CA. TGF-beta receptor signaling is critical for mucosal IgA responses. J. Immunol. 173: 3305-3309 (2004). *
Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (5 Suppl. 2): S5-S16 (2004). *
Bosch J, Thabut D, Bendtsen F, D'amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, Erhardtsen E, De Franchis R. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127: 1123-1130 (2004). *
Bosselut R. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4: 529-540 (2004). *
Bossi A, Casazza G, Padoan R, Milani S; Assemblea Dei Direttori Dei Centri. What is the incidence of cystic fibrosis in Italy? Data from the National Registry (1988-2001). Hum. Biol. 76: 455-467 (2004).
Bossowski A, Stasiak-Barmuta A, Urban M, Rinderle C. Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy. Endokrynol. Diabetol. Chor. Przemiany. Materii. Wieku. Rozw. 10: 93-101 (2004).
Bott C, Rudolph MW, Schneider AR, Schirrmacher S, Skalsky B, Petereit HU, Langguth P, Dressman JB, Stein J. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system. Aliment. Pharmacol. Ther. 20: 347-353 (2004). *
Bottazzo GF, Locatelli M, Fierabracci A, Fruci D. The genetic basis of immune and autoimmune responses. Acta Paediatr. Suppl. 93: 38-42 (2004).
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338 (2004). *
Bottino C, Moretta L, Pende D, Vitale M, Moretta A. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41: 569-575 (2004). *
Bouchier-Hayes L, Martin SJ. CARDINAL roles in apoptosis and NFkappaB activation. Vitam. Horm. 67: 133-147 (2004).
Boudiaf M, Jaff A, Soyer P, Bouhnik Y, Hamzi L, Rymer R. Small-bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology 233: 338-344 (2004). *
Boudiaf M, Soyer P, Rymer R. Imaging of inflammatory bowel disease. Gastroenterol. Clin. Biol. 28: S46-S51 (2004).
Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).
Bouhnik Y, Alves A, Beau P, Carbonnel F, Levy P. Treatment of severe ulcerative colitis. Gastroenterol. Clin. Biol. 28: 984-991 (2004).
Boulton-Jones JR, Fenn RM, West J, Logan RF, Ryder SD. Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment. Pharmacol. Ther. 20: 551-557 (2004). *
Bouneva I, Kirby DF. Management of nonalcoholic fatty liver disease: weight control. Clin. Liver Dis. 8: 693-713, xii (2004).
Bounou S, Giguere JF, Cantin R, Gilbert C, Imbeault M, Martin G, Tremblay MJ. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context. FASEB J. 18: 1294-1296 (2004). *
Bourges O, Dorgeret S, Alberti C, Hugot JP, Sebag G, Cezard JP. Low bone mineral density in children with Crohn's disease. Arch. Pediatr. 11: 800-806 (2004).
Bourne PC, Terzyan SS, Cloud G, Landolfi NF, Vasquez M, Edmundson AB. Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms. Acta Crystallogr. D. Biol. Crystallogr. 60: 1761-1769 (2004). *
Bournerias I. Methotrexate therapy in psoriasis. Rev. Prat. 54: 52-55 (2004).
Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8: 163-174 (2004).
Bourreille A, Humbert B, Maugere P, Galmiche JP, Darmaun D. Glutamine metabolism in Crohn's disease: a stable isotope study. Clin. Nutr. 23: 1167-1175 (2004).
Bourrie B, Bribes E, Derocq JM, Vidal H, Casellas P. Sigma receptor ligands: applications in inflammation and oncology. Curr. Opin. Investig. Drugs 5: 1158-1163 (2004).
Boursi B, Arber N. Small bowel malignancies: why are they so rare? Harefuah. 143: 727-732, 765 (2004).
Bousvaros A. Mucosal healing in children with Crohn's disease: appropriate therapeutic goal or medical overkill? Inflamm. Bowel Dis. 10: 481-483 (2004). *
Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, et al. A physical and functional map of the human TNF-alpha/NF-kappaB signal transduction pathway. Nat. Cell Biol. 6: 97-105 (2004). *
Bouzaidi S, Ben Salem M, Mnif N, Ben Hammouda I, Ben Yedder J, Trabelsi S, Moussa A, Jemaa Y, Debbech R, Salem M, Najjar T, Hamza R. Bone mineral density in patients with Crohn's disease: about 53 cases. Tunis. Med. 82: 753-759 (2004).
Bove KE, Heubi JE, Balistreri WF, Setchell KD. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr. Dev. Pathol. 7: 315-334 (2004). *
Bovin LF, Rieneck K, Workman C, Nielsen H, Sorensen SF, Skjodt H, Florescu A, Brunak S, Bendtzen K. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol. Lett. 93: 217-226 (2004).
Bowcock AM. Psoriasis genetics: the way forward. J. Invest. Dermatol. 122: xv-xvii (2004). *
Bowcock AM, Cookson WO. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 13 Suppl. 1: R43-R55 (2004). *
Bowie VL, Snella KA, Gopalachar AS, Bharadwaj P. Listeria meningitis associated with infliximab. Ann. Pharmacother. 38: 58-61 (2004).
Bowles CJ, Leicester R, Romaya C, Swarbrick E, Williams CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53: 277-283 (2004). *
Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 43: 758-764 (2004). *
Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand. J. Rheumatol. 33: 39-43 (2004).
Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, Klersy C, Clementi R, De Juli E, Ferster A, Wallace D, Arico M, Danesino C, Tchilian E. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr. Res. 55: 478-484 (2004). *
Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O, Inaba M, Nishizawa Y, Dawes R, Bodmer W, Beverley PC, Tchilian EZ. Disease associations and altered immune function in CD45 138G variant carriers. Hum. Mol. Genet. 13: 2377-2384 (2004). *
Boyanova L, Gergova G, Spassova Z, Koumanova R, Yaneva P, Mitov I, Derejian S, Krastev Z. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn. Microbiol. Infect. Dis. 49: 71-74 (2004).
Boyer JL, Denk G, Bohan A, Chen WS, Soroka C, Denson L. Adaptive regulation of bile salt transporters in cholestasis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 46-47. June 18-19 (2004). *
Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, Klatzmann D. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103: 3428-3430 (2004). *
Boyer TD. HVPG measurement: is it mandatory for the management of portal hypertension? - Con. J. Gastroenterol. Hepatol. 19: S162-S164 (2004). *
Boyer TD. Aquaretics in cirrhotics with hyponatremia. J. Gastroenterol. Hepatol. 19: S191-S193 (2004). *
Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 199: 731-736 (2004). *
Boysen T, Clausen MR. A case of acute liver failure caused by herpes simplex type 2. Scand. J. Infect. Dis. 36: 529-532 (2004).
Bozkaya H, Bektas M, Metin O, Erkan O, Ibrahimoglu D, Dalva K, Akbiyik F, Gurel S, Bozdayi AM, Akay C, Yurdaydin C, Aslan O, Uzunalimoglu O. Screening for hemochromatosis in Turkey. Dig. Dis. Sci. 49: 444-449 (2004). *
Bozorgzadeh A, Jain A, Ryan C, Ornt D, Zand M, Mantry P, Lansing K, Orloff M. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 77: 1066-1070 (2004).
Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, van Deventer S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am. J. Clin. Nutr. 80: 1618-1625 (2004). *
Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin. Liver Dis. 8: 639-671, xi (2004).
Bradley PJ, Ferlito A, Devaney KO, Rinaldo A. Crohn's disease manifesting in the head and neck. Acta Otolaryngol. 124: 237-241 (2004).
Bradley RJ, Rosen MP. Subfertility and gastrointestinal disease: 'Unexplained' is often undiagnosed. Obstet. Gynecol. Surv. 59: 108-117 (2004).
Bralet MP, Duclos-Vallee JC, Castaing D, Samuel D, Guettier C. No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology 40: 762 (2004). *
Bramstedt KA, Stowe J, Kotz M. Shopping for a transplant: when noncompliant patients seek wait listing at multiple hospitals. Prog. Transplant. 14: 217-221 (2004).
Brand DA, Viola D, Rampersaud P, Patrick PA, Rosenthal WS, Wolf DC. Waiting for a liver - hidden costs of the organ shortage. Liver Transpl. 10: 1001-1010 (2004). *
Brand DD, Kang AH, Rosloniec EF. The mouse model of collagen-induced arthritis. Methods Mol. Med. 102: 295-312 (2004).
Brand RE, Ross ME, Shuber AP. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Am. J. Gastroenterol. 99: 1338-1341 (2004). *
Brandhagen D. Can liver transplantation improve our understanding of the pathophysiology of iron overload? Liver Transpl. 10: 1218-1220 (2004). *
Brandlein S, Pohle T, Vollmers C, Wozniak E, Ruoff N, Muller-Hermelink HK, Vollmers HP. CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1. Oncol. Rep. 11: 777-784 (2004).
Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Oksanen A, Ericzon B-G, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K, Schrumpf E. Chemopreventive effect of URSO in primary sclerosing cholangitis? Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 78. June 18-19 (2004). *
Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J. Hepatol. 40: 815-822 (2004). *
Brandsaeter B, Schrumpf E, Clausen OP, Abildgaard A, Hafsahl G, Bjoro K. Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge? Liver Transpl. 10: 1073-1074 (2004). *
Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Rudwaleit M, Sieper J, Braun J. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. J. Rheumatol. 31: 531-538 (2004).
Brandt J, Listing J, Sieper J, Rudwaleit M, Van Der Heijde D, Braun J. Development and preselection of criteria for short-term improvement after anti-TNFalpha therapy in ankylosing spondylitis. Ann. Rheum. Dis. 63: 1438-1444 (2004). *
Brandt S, Heller H, Schuster KD, Grote J. Tamoxifen induces suppression of cell viability and apoptosis in the human hepatoblastoma cell line HepG2 via down-regulation of telomerase activity. Liver Int. 24: 46-54 (2004). *
Brandtzaeg P, Johansen FE, Baekkevold ES, Carlsen HS, Farstad IN. The traffic of mucosal lymphocytes to extraintestinal sites. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 3: S725-S726 (2004). *
Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 25: 570-577 (2004). *
Brant SR, Shugart YY. Inflammatory bowel disease gene hunting by linkage analysis - rationale, methodology, and present status of the field. Inflamm. Bowel Dis. 10: 300-311 (2004). *
Branten AJ, Swinkels DW, Klasen IS, Wetzels JF. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol. Dial. Transplant. 19: 2754-2760 (2004). *
Braun J. Primativism, siderophilic bacteria, and Crohn's disease. Inflamm. Bowel Dis. 10: 884-885 (2004). *
Braun J. Epidemiology and prognosis of ankylosing spondylitis. Radiologe 44: 209-210, 212-216 (2004).
Braun J, Sieper J. Biological therapies in the spondyloarthritides - the current state. Rheumatology (Oxford) 43: 1072-1084 (2004). *
Braveman JM, Schoetz DJ Jr, Marcello PW, Roberts PL, Coller JA, Murray JJ, Rusin LC. The fate of the ileal pouch in patients developing Crohn's disease. Dis. Colon Rectum 47: 1613-1619 (2004).
Bray RA, Gebel HM, Ellis TM. Flow cytometric assessment of HLA alloantibodies. Curr. Protoc. Cytom. Chapter 6: Unit 6.16 (2004).
Breban M, Hacquard-Bouder C, Falgarone G. Animal models of HLA-B27-associated diseases. Curr. Mol. Med. 4: 31-40 (2004).
Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (5 Suppl. 2): S56-S61 (2004). *
Bredeson CN, Pavletic SZ. Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease. Best Pract. Res. Clin. Haematol. 17: 327-343 (2004).
Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, St Clair EW, Weisman M, Smolen J, Lipsky PE, Maini RN. Infliximab in active early rheumatoid arthritis. Ann. Rheum. Dis. 63: 149-155 (2004). *
Breen CM, Sykes DB, Baehr C, Fricker G, Miller DS. Fluorescien-methotrexate transport in rat choroid plexus analyzed using confocal microscopy. Am. J. Physiol. Renal Physiol. 287: F562-F569 (2004). *
Breidert M, Zimmermann TF, Schneider R, Ehninger G, Brabant G. Ghrelin/leptin-imbalance in patients with primary biliary cirrhosis. Exp. Clin. Endocrinol. Diabetes 112: 123-126 (2004).
Bremner AR, Griffiths DM, Beattie RM. Current therapy of ulcerative colitis in children. Expert Opin. Pharmacother. 5: 37-53 (2004).
Bremner AR, Pridgeon J, Fairhurst J, Beattie RM. Ultrasound scanning may reduce the need for barium radiology in the assessment of small-bowel Crohn's disease. Acta Paediatr. 93: 479-481 (2004).
Bren L. Psoriasis: more than cosmetic. FDA Consum. 38: 10-16 (2004).
Brennan CA, Anderson KV. Drosophila: the genetics of innate immune recognition and response. Annu. Rev. Immunol. 22: 457-483 (2004). *
Brenner DA. Data from arrays: an embarrassment of riches. Gastroenterology 127: 1659 (2004). *
Brenner DA. Gastrointestinal basic science 2002-2003: the year in review. Clin. Gastroenterol. Hepatol. 2: 9-13 (2004). *
Brenner DA, Sigmund S. Pathogenesis of alcoholic hepatitis. J. Gastroenterol. Hepatol. 19: S229-S235 (2004). *
Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E, Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. U.S.A. 101: 16016-16021 (2004). *
Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology 127: 452-456 (2004). *
Bridoux F, Kyndt X, Abou-Ayache R, Mougenot B, Baillet S, Bauwens M, Lemaitre V, Goujon JM, Touchard G, Vanhille P. Proximal tubular dysfunction in primary Sjogren's syndrome: a clinicopathological study of 2 cases. Clin. Nephrol. 61: 434-439 (2004).
Bridoux-Henno L, Maggiore G, Johanet C, Fabre M, Vajro P, Dommergues JP, Reinert P, Bernard O. Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin. Gastroenterol. Hepatol. 2: 825-830 (2004). *
Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890 (2004). *
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535 (2004). *
Brintnell W, Zeggini E, Barton A, Thomson W, Eyre S, Hinks A, Silman AJ, Worthington J. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50: 3823-3830 (2004). *
Brinton LA, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC, Hoover R. Risk of connective tissue disorders among breast implant patients. Am. J. Epidemiol. 160: 619-627 (2004). *
Brissot P, Troadec MB, Loreal O. Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process? J. Hepatol. 40: 702-709 (2004). *
Brissot P, Troadec MB, Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr. Hematol. Rep. 3: 107-115 (2004).
Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 53: 899-910 (2004). *
Britto MT, Devellis RF, Hornung RW, Defriese GH, Atherton HD, Slap GB. Health care preferences and priorities of adolescents with chronic illnesses. Pediatrics 114: 1272-1280 (2004). *
Britton WJ, Lockwood DN. Leprosy. Lancet 363: 1209-1219 (2004). *
Brogan PA, Shah V, Klein N, Dillon MJ. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum. 50: 589-597 (2004). *
Bronner MP. Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 21: 98-107 (2004).
Bronner MP, Goldblum JR. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Adv. Anat. Pathol. 11: 225-226 (2004).
Bronner MP, Goldblum JR, Kimmey MB, Brentnall TA, Rubin CE. Low-grade dysplasia in ulcerative colitis: natural history data still unknown. Gastroenterology 127: 362-363 (2004). *
Brookes MJ, Green JR. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Drugs 64: 1069-1089 (2004).
Brooks TA, Kennedy DR, Gruol DJ, Ojima I, Baer MR, Bernacki RJ. Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators. Anticancer Res. 24: 409-415 (2004).
Broome U. Long term treatment with ursodeoxycholic acid in patients with primary sclerosing cholangitis (PSC). Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 71. June 18-19 (2004). *
Brophy S, Hickey S, Menon A, Taylor G, Bradbury L, Hamersma J, Calin A. Concordance of disease severity among family members with ankylosing spondylitis? J. Rheumatol. 31: 1775-1778 (2004).
Brotman DJ, O'Brien RG. Infallibility of a normal platelet count/spleen diameter ratio in ruling out oesophageal varices? Gut 53: 1721 (2004). *
Brouard J, Freymuth F, Bach N, Vabret A, Duhamel JF. Childhood infections: friends or foes? Arch. Pediatr. 11 Suppl. 2: 98s-102s (2004).
Broudy VC, Lin NL. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25: 52-60 (2004).
Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin. Arthritis Rheum. 34: 544-548 (2004). *
Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med. 350: 1505-1515 (2004). *
Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzschel E, Bernard D, Blaton V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176: 189-195 (2004).
Brown A. Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help, or hype? Gastroenterology 126: 1195-1198 (2004). *
Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr. Clin. Care 7: 56-68 (2004). *
Brown AM, Gordon D, Lee H, Caudy M, Hardy J, Haroutunian V, Blass JP. Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population. Am. J. Med. Genet. 131B: 60-66 (2004). *
Brown C, Gaspar J, Pettit A, Lee R, Gu X, Wang H, Manning C, Voland C, Goldring SR, Goldring MB, Libermann TA, Gravalllese EM, Oettgen P. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J. Biol. Chem. 279: 12794-12803 (2004). *
Brown IL. Applications and uses of resistant starch. J. AOAC Int. 87: 727-732 (2004).
Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279: 34674-34681 (2004). *
Brown JJ, Datta V, Browning MJ, Swift PG. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion. J. Pediatr. Endocrinol. Metab. 17: 1575-1579 (2004).
Brown KA, Moonka D. Liver transplantation. Curr. Opin. Gastroenterol. 20: 264-269 (2004).
Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD. Liver and intestine transplantation. Am. J. Transplant. 4 Suppl. 9: 81-92 (2004).
Brown SJ, Miller AM, Cowan PJ, Slavin J, Connell WR, Moore GT, Bell S, Elliott PR, Desmond PV, d'Apice AJ. Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice. Inflamm. Bowel Dis. 10: 546-556 (2004). *
Browning JD, Kumar KS, Saboorian MH, Thiele DL. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am. J. Gastroenterol. 99: 292-298 (2004). *
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395 (2004). *
Broxmeyer L. Is mad cow disease caused by a bacteria? Med. Hypotheses 63: 731-739 (2004).
Brucet M, Marques L, Sebastian C, Lloberas J, Celada A. Regulation of murine Tap1 and Lmp2 genes in macrophages by interferon gamma is mediated by STAT1 and IRF-1. Genes Immun. 5: 26-35 (2004). *
Bruckner AL. Incontinentia pigmenti: a window to the role of NF-kappaB function. Semin. Cutan. Med. Surg. 23: 116-124 (2004).
Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res. Hum. Retroviruses 20: 415-423 (2004).
Bruden DL, McMahon BJ, Hennessy TW, Christensen CJ, Homan CE, Williams JL, Sullivan DG, Gretch DR, Cagle HH, Bulkow LR. Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera. Am. J. Gastroenterol. 99: 1517-1522 (2004). *
Bruey JM, Bruey-Sedano N, Newman R, Chandler S, Reed JC. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kB and caspase-1 activation in macrophages. J. Biol. Chem. 279: 51897-51907 (2004). *
Brugge W. Advanced endoscopy: a personal perspective. Curr. Opin. Gastroenterol. 20: 459 (2004).
Brugge WR. Approaches to the drainage of pancreatic pseudocysts. Curr. Opin. Gastroenterol. 20: 488-492 (2004).
Bruhl H, Cihak J, Schneider MA, Plachy J, Rupp T, Wenzel I, Shakarami M, Milz S, Ellwart JW, Stangassinger M, Schlondorff D, Mack M. Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J. Immunol. 172: 890-898 (2004). *
Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S179-S188 (2004). *
Brun P. Prescription of retinoids in psoriasis. Rev. Prat. 54: 48-51 (2004).
Brunerova L, Bartakova H, Jankovska M, Cieslarova B, Hulek P, Kozak T, Andel M. The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt. Cas. Lek. Cesk. 143: 198-201 (2004).
Bruno M. Irritable bowel syndrome and inflammatory bowel disease in pregnancy. J. Perinat. Neonatal Nurs. 18: 341-350 (2004).
Bruno ME, West RB, Schneeman TA, Bresnick EH, Kaetzel CS. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. Mol. Immunol. 40: 695-708 (2004). *
Bruno O, Brullo C, Arduino N, Schenone S, Ranise A, Bondavalli F, Ottonello L, Dapino P, Dallegri F. Synthesis and biological evaluation of neutrophilic inflammation inhibitors. Farmaco 59: 223-235 (2004).
Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis. 24: 3-20 (2004).
Brunt EM, Di Bisceglie AM. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Hum. Pathol. 35: 509-512 (2004).
Brunt EM, Neuschwander-Tetri BA, Oliver D, Wehmeier KR, Bacon BR. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum. Pathol. 35: 1070-1082 (2004).
Brunt EM, Tiniakos DG. Metabolic storage diseases: amyloidosis. Clin. Liver Dis. 8: 915-930, x (2004).
Bruzzese E, Canani RB, De Marco G, Guarino A. Microflora in inflammatory bowel diseases: a pediatric perspective. J. Clin. Gastroenterol. 38: S91-S93 (2004).
Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 20: 813-819 (2004). *
Bryant PA, Trinder J, Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat. Rev. Immunol. 4: 457-467 (2004). *
Bryndova J, ZBankova S, Kment M, Pacha J. Colitis up-regulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand. J. Gastroenterol. 39: 549-553 (2004). *
Brynskov J, Feagan BG, Jewell D, McDonald JWD, Stange EF. Cyclosporine for maintenance of remission in Crohn�s disease. Cochrane Database Syst. Rev. 2: CD004377 (2004). *
Brzozowski T, Konturek PC, Pajdo R, Kwiecien S, Sliwowski Z, Drozdowicz D, Ptak-Belowska A, Pawlik M, Konturek SJ, Pawlik WW, Hahn GG. Importance of brain-gut axis in the gastroprotection induced by gastric and remote preconditioning. J. Physiol. Pharmacol. 55: 165-177 (2004). *
Bu-Ghanim M, Suriawinata A, Killackey M, Schwartz ME, Jaffe D, Fiel MI. Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin. Liver Dis. 24: 209-213 (2004).
Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-kappaB and JNK: an intricate affair. Cell Cycle 3: 1524-1529 (2004). *
Buch MH, Conaghan PG, Quinn MA, Bingham SJ, Veale D, Emery P. True infliximab resistance in rheumatoid arthritis; a role for lymphotoxin-alpha? Ann. Rheum. Dis. 63: 1344-1346 (2004). *
Buch MH, Marzo-Ortega H, Bingham SJ, Emery P. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals. Rheumatology (Oxford) 43: 243-244 (2004). *
Buchanan FG, Chang W, Sheng H, Shao J, Morrow JD, D U Bois RN. Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. Gastroenterology 127: 1391-1400 (2004). *
Buchanan GN, Owen HA, Torkington J, Lunniss PJ, Nicholls RJ, Cohen CR. Long-term outcome following loose-seton technique for external sphincter preservation in complex anal fistula. Br. J. Surg. 91: 476-480 (2004). *
Buchkremer F, Herrmann T, Stremmel W. Mild respiratory distress after wireless capsule endoscopy. Gut 53: 472 (2004). *
Buchman AL, Miller FH, Wallin A, Chowdhry AA, Ahn C. Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn's disease recurrence involving the small intestine. Am. J. Gastroenterol. 99: 2171-2177 (2004). *
Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22: 625-655 (2004). *
Bucuvalas JC, Zeng L, Anand R, The Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl. 10: 1011-1017 (2004). *
Budagian V, Bulanova E, Orinska Z, Ludwig A, Rose-John S, Saftig P, Borden EC, Bulfone-Paus S. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J. Biol. Chem. 279: 40368-40375 (2004). *
Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: a new parameter to monitor infliximab therapy. Dig. Dis. Sci. 49: 1036-1039 (2004). *
Budzynska R, Zakliczynska H. Methotrexate in the treatment of the patients with rheumatoid arthritis. Postepy. Hig. Med. Dosw. (Online) 58: 108-117 (2004).
Buell JF, Woodle ES. Syndromic incidence of ovarian cancer after liver transplantation: is breast cancer an antecedent risk? Liver Transpl. 10: 156-157 (2004). *
Bueverov AO. Treatment of autoimmune hepatic diseases. Klin. Med. (Mosk.) 82: 62-66 (2004).
Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract. Res. Clin. Gastroenterol. 18: 1105-1116 (2004).
Buhr HJ, Utzig M, Stange E. Surgery in ulcerative colitis. Z. Gastroenterol. 42: 1026-1028 (2004).
Buijk SE, Gyssens IC, Mouton JW, Metselaar HJ, Groenland TH, Verbrugh HA, Bruining HA. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients. J. Antimicrob. Chemother. 54: 199-205 (2004). *
Buisson-Legendre N, Smith S, March L, Jackson C. Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheum. 50: 2151-2156 (2004). *
Bullock NR, Booth JC, Gibson GR. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr. Issues Intest. Microbiol. 5: 59-64 (2004).
Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J. Hepatol. 41: 685-686 (2004). *
Bulteau AL, O'Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305: 242-245 (2004). *
Buning C, Genschel J, Buhner S, Kruger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH, Lochs H. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment. Pharmacol. Ther. 19: 1073-1078 (2004). *
Buning C, Halangk J, Dignass A, Ockenga J, Deindl P, Nickel R, Genschel J, Landt O, Lochs H, Schmidt H, Witt H. Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Dig. Liver Dis. 36: 388-391 (2004).
Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am. J. Gastroenterol. 99: 523-526 (2004). *
Burakoff R. Indeterminate colitis: clinical spectrum of disease. J. Clin. Gastroenterol. 38: S41-S43 (2004).
Bureau C, Peron JM, Sirach E, Selves J, Otal P, Vinel JP. Liver nodules ressembling focal nodular hyperplasia after portal vein thrombosis. J. Hepatol. 41: 499-500 (2004). *
Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am. J. Gastroenterol. 99: 889-893 (2004). *
Burim RV, Canalle R, Martinelli Ad A, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 19: 291-298 (2004). *
Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmoller J, Zanger UM, Wojnowski L. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J. Biol. Chem. 279: 38379-38385 (2004). *
Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am. J. Transplant. 4: 686-693 (2004). *
Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20: 1223-1229 (2004).
Burnett R, Ravel G, Descotes J. Clinical and histopathological progression of lesions in lupus-prone (NZB x NZW) F1 mice. Exp. Toxicol. Pathol. 56: 37-44 (2004).
Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J. Bone Miner. Res. 19: 1961-1968 (2004).
Burns KA, Martinon F. Inflammatory diseases: is ubiquitinated NEMO at the hub? Curr. Biol. 14: R1040-R1042 (2004). *
Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Strategies for liver support: from stem cells to xenotransplantation. J. Hepatol. 41: 1050-1059 (2004). *
Burra P, Senzolo M, Pizzolato G, Ermani M, Chierichetti F, Bassanello M, Naccarato R, Dam M. Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis? Eur. J. Gastroenterol. Hepatol. 16: 885-890 (2004).
Burstein E, Ganesh L, Dick RD, Van De Sluis B, Wilkinson JC, Klomp LW, Wijmenga C, Brewer GJ, Nabel GJ, Duckett CS. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J. 23: 244-254 (2004). *
Burt AD. Spectrum of liver pathology in immune mediated liver diseases. J. Gastroenterol. Hepatol. 19: S353-S355 (2004). *
Burt RK, Verda L, Oyama Y, Statkute L, Slavin S. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin. Immunopathol. 26: 57-69 (2004). *
Burt RK, Verda L, Statkute L, Quigley K, Yaung K, Brush M, Oyama Y. Stem cell transplantation for autoimmune diseases. Clin. Adv. Hematol. Oncol. 2: 313-319 (2004).
Burt RW, Leppert MF, Slattery ML, Samowitz WS, Spirio LN, Kerber RA, Kuwada SK, Neklason DW, Disario JA, Lyon E, Hughes JP, Chey WY, White RL. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127: 444-451 (2004). *
Burton JR Jr, Sonnenberg A, Rosen HR. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transpl. 10: S59-S64 (2004). *
Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78: 576-584 (2004). *
Bush DA, Hillebrand DJ, Slater JM, Slater JD. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology 127 (5 Suppl. 2): S189-S193 (2004). *
Bush M, Patel S, Lapinski R, Stone J. Perinatal outcomes in inflammatory bowel disease. J. Matern. Fetal. Neonatal. Med. 15: 237-241 (2004).
Bush NE, Bowen DJ, Wooldridge J, Ludwig A, Meischke H, Robbins R. What do we mean by Internet access? A framework for health researchers. Prev. Chronic Dis. 1: A15 (2004).
Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, Kracht M. Phosphorylation of serine 468 by GSK-3b negatively regulates basal p65 NF-kB activity. J. Biol. Chem. 279: 49571-49574 (2004). *
Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, Elias J; NHLBI Working Group. Future research directions in asthma: an NHLBI Working Group report. Am. J. Respir. Crit. Care Med. 170: 683-690 (2004). *
Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 77: S44-S51 (2004).
Butterfield LH. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S232-S241 (2004). *
Buyse F, Vandenbranden M, Ruysschaert JM. Mistargeted MRPdeltaF728 mutant is rescued by intracellular GSH. FEBS Lett. 578: 145-151 (2004). *
Buyse IM, McCarthy SE, Lurix P, Pace RP, Vo D, Bartlett GA, Schmitt ES, Ward PA, Oermann C, Eng CM, Roa BB. Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation. Genet. Med. 6: 426-430 (2004).
Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Mario UD. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. Eur. J. Hum. Genet. 12: 1050-1054 (2004). *
Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23: 77-99 (2004). *
Byrnes V, Cardenas A, Afdhal N, Hanto D. Symptomatic focal nodular hyperplasia during pregnancy: a case report. Ann. Hepatol. 3: 35-37 (2004). *
Bzowska M, Jura N, Lassak A, Black RA, Bereta J. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 271: 2808-2820 (2004). *
Cabezas Gelabert R. Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial. Rev. Clin. Esp. 204: 632-635 (2004).
Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS. Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch. Dis. Child. 89: 69-71 (2004). *
Caenepeel S, Charydczak G, Sudarsanam S, Hunter T, Manning G. The mouse kinome: discovery and comparative genomics of all mouse protein kinases. Proc. Natl. Acad. Sci. U.S.A. 101: 11707-11712 (2004). *
Cahill BA, Braccia D. Current treatment for hepatocellular carcinoma. Clin. J. Oncol. Nurs. 8: 393-399 (2004).
Cai Z, Scott-Ward TS, Li H, Schmidt A, Sheppard DN. Strategies to investigate the mechanism of action of CFTR modulators. J. Cyst. Fibros. 3 Suppl. 2: 141-147 (2004).
Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 107: 1-11 (2004). *
Calder PC. n-3 Fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids 39: 1147-1161 (2004).
Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 595-617, x (2004).
Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S97-S103 (2004). *
Calista D, Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int. J. Dermatol. 43: 562-564 (2004).
Callan MF. Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr. Opin. Rheumatol. 16: 399-405 (2004).
Calmus Y. Graft-versus-host disease following living donor liver transplantation: high risk when the donor is HLA-homozygous. J. Hepatol. 41: 505-507 (2004). *
Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide 10: 179-193 (2004). *
Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25: 2303-2310 (2004). *
Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J. Hepatol. 41: 815-822 (2004). *
Calzolari A, Deaglio S, Sposi NM, Petrucci E, Morsilli O, Gabbianelli M, Malavasi F, Peschle C, Testa U. Transferrin receptor 2 protein is not expressed in normal erythroid cells. Biochem. J. 381: 629-634 (2004). *
Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *
Cameron ER, Neil JC. The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene 23: 4308-4314 (2004). *
Camilleri M. Is there a SERT-ain association with IBS? Gut 53: 1396-1399 (2004). *
Camilleri M. GIH clinical research 2003-2004: the year in review. Clin. Gastroenterol. Hepatol. 2: 1043-1047 (2004). *
Campatelli A, Di Candio G, Morelli L, Coletti L, De Giovanni M, Urbani L, Catalano G, Filipponi F, Mosca F. Interventional ultrasound: experience in 426 orthotopic liver transplantations. Transplant. Proc. 36: 550-551 (2004). *
Campbell JD, Deol SS, Ashcroft FM, Kerr ID, Sansom MS. Nucleotide-dependent conformational changes in HisP: molecular dynamics simulation of an ABC transporter nucleotide binding domain. Biophys. J. 87: 3703-3715 (2004). *
Campbell MS, Lichtenstein GR, Rhim AD, Faust TW. Osteopenia and osteoporosis in patients with primary sclerosing cholangitis cannot be predicted by severity of liver disease. Gastroenterology 126: A715-A716 (2004).
Campbell S, Michaelson J, Burkly L, Putterman C. The role of TWEAK/Fn14 IN the pathogenesis of inflammation and systemic autoimmunity. Front. Biosci. 9: 2273-2284 (2004).
Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L, Francoual C, Dupont C, Kapel N. High faecal calprotectin concentrations in newborn infants. Arch. Dis. Child. Fetal Neonatal Ed. 89: F353-F355 (2004).
Canani RB, Romano MT, Greco L, Terrin G, Sferlazzas C, Barabino A, Fontana M, Roggero P, Guariso G, De Angelis G, Fecarotta S, Polito G, Cucchiara S. Effects of disease activity on anti-Saccharomyces cerevisiae antibodies - Implications for diagnosis and follow-up of children with Crohn's disease. Inflamm. Bowel Dis. 10: 234-239 (2004). *
Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J. Pharmacol. Exp. Ther. 308: 1191-1196 (2004). *
Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C. Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal. Exp. Gerontol. 39: 645-652 (2004). *
Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J. History of C(2) monitoring in heart and liver transplant patients treated with cyclosporine microemulsion. Transplant. Proc. 36: S442-S447 (2004). *
Cantin AM. Potential for antioxidant therapy of cystic fibrosis. Curr. Opin. Pulm. Med. 10: 531-536 (2004).
Cantor RM, Yuan J, Napier S, Kono N, Grossman JM, Hahn BH, Tsao BP. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum. 50: 3203-3210 (2004). *
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229: 1136-1142 (2004). *
Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80: 1717S-1720S (2004). *
Cantz T, Sharma AD, Jochheim-Richter A, Arseniev L, Klein C, Manns MP, Ott M. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 13: 659-666 (2004).
Cao CM, Chen JZ, Xia Q, Zhang SZ, Lin GH, Wong TM. Interleukin-2 confers cardioprotection by inhibiting mitochondrial permeability transition pore. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5: 3618-3621 (2004).
Cao G, Liang Y, Jiang XC, Eacho PI. Liver X receptors as potential therapeutic targets for multiple diseases. Drug News Perspect. 17: 35-41 (2004).
Cao W, Vrees M, Potenti FM, Harnett KM, Fiocchi C, Pricolo VE. Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis. J. Pharmacol. Exp. Ther. 311: 60-70 (2004). *
Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G833-G843 (2004). *
Cao WM, Murao K, Imachi H, Yu X, Dobashi H, Yoshida K, Muraoka T, Kotsuna N, Nagao S, Wong NC, Ishida T. Insulin like growth factor-I regulation of hepatic scavenger receptor class BI. Endocrinology 145: 5540-5547 (2004). *
Cao X, Liu W, Lin F, Li H, Kolluri SK, Lin B, Han YH, Dawson MI, Zhang XK. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 24: 9705-9725 (2004). *
Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Ren. Fail. 26: 563-568 (2004).
Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, Trembath RC. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum. Mol. Genet. 13: 2361-2368 (2004). *
Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, Bowcock AM, Trembath RC. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J. Med. Genet. 41: 459-460 (2004). *
Capon F, Trembath RC, Barker JN. An update on the genetics of psoriasis. Dermatol. Clin. 22: 339-347, vii (2004).
Caprilli R, Angelucci E, Cocco A, Viscido A, Zippi M. Efficacy of conventional immunosuppressive drugs in IBD. Dig. Liver Dis. 36: 766-780 (2004).
Capron A, Dombrowicz D, Capron M. Helminth infections and allergic diseases: from the Th2 paradigm to regulatory networks. Clin. Rev. Allergy Immunol. 26: 25-34 (2004). *
Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, Dagata A, Fabbri P. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm. Venereol. 84: 288-290 (2004).
Capuano G, Pomponi D, Iaccarino V, Budillon G. An unusual case of ascites. Dig. Liver Dis. 36: 628-631 (2004).
Caputo I, D'Amato A, Troncone R, Auricchio S, Esposito C. Transglutaminase 2 in celiac disease: minireview article. Amino Acids 26: 381-386 (2004). *
Carbone J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E. Atypical presentation of common variable immunodeficiency without infections. Allergol. Immunopathol. (Madr.) 32: 218-222 (2004).
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40: 652-659 (2004). *
Carbonnel F. Why and how should we look for deep ulcerations in severe attacks of ulcerative colitis? Gastroenterol. Clin. Biol. 28: 215-217 (2004).
Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 53: 246-250 (2004). *
Card T, West J, Hubbard R, Logan RF. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 53: 251-255 (2004). *
Cardarelli F, Pascual M, Chung RT, Tolkoff-Rubin N, Wong W, Cosimi AB, Saidman SL. Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies. Am. J. Transplant. 4: 1352-1356 (2004).
Cardenas A. Gastric varix: radiological-endoscopic correlation. Ann. Hepatol. 3: 74 (2004). *
Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl. 10: 529-533 (2004). *
Caricato M, Ausania F, Borzomati D, Valeri S, Coppola R, Verzi A, Tonini G. Large abdominal mass in Crohn's disease. Gut 53: 1493 (2004). *
Carini R, De Cesaris MG, Splendore R, Baldanzi G, Nitti MP, Alchera E, Filigheddu N, Domenicotti C, Pronzato MA, Graziani A, Albano E. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 127: 914-923 (2004). *
Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238 (2004). *
Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat. Res. 551: 199-211 (2004).
Carlsen HS, Baekkevold ES, Morton HC, Haraldsen G, Brandtzaeg P. Monocyte-like and mature macrophages produce CXCL13 (B-cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood 104: 3021-3027 (2004). *
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429: 446-452 (2004). *
Carlson MD, Al-Mateen M, Brewer GJ. Atypical childhood Wilson's disease. Pediatr. Neurol. 30: 57-60 (2004).
Carlton VE, Pawlikowska L, Bull LN. Molecular basis of intrahepatic cholestasis. Ann. Med. 36: 606-617 (2004).
Carmena R, Betteridge DJ. Statins and diabetes. Semin. Vasc. Med. 4: 321-332 (2004).
Carneiro LA, Travassos LH, Philpott DJ. Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect. 6: 609-616 (2004). *
Carney G, Wei S, Rizzo WB. Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum. Mutat. 24: 186 (2004). *
Caro AA, Cederbaum AI. Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations. Free Radic. Biol. Med. 36: 1303-1316 (2004).
Carod Artal FJ, Vargas AP, Marinho PB, Fernandes Silva TV, Portugal D. Tourettism, hemiballism and juvenile Parkinsonism: expanding the clinical spectrum of the neurodegeneration associated to pantothenate kinase deficiency (Hallervorden Spatz syndrome). Rev. Neurol. 38: 327-331 (2004).
Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 66: 296-302 (2004).
Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol. 25: 228-234 (2004).
Carpenter E, Jackson MA, Friesen CA, Scarbrough M, Roberts CC. Crohn's-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J. Pediatr. 144: 541-544 (2004). *
Carpo M, Scarlato M, Bardella M, Terrani C, Peracchi M, Allaria S, Nobile-Orazio E, Bresolin N. Painful sensory neuropathy and dysimmunity: is there a relation? J. Peripher. Nerv. Syst. 9: 121 (2004).
Carr BI. Hepatocellular carcinoma: current management and future trends. Gastroenterology 127 (5 Suppl. 2): S218-S224 (2004). *
Carr C, Desai J. OPCAB surgery in a cirrhotic hepatocellular carcinoma patient awaiting liver transplant. Ann. Thorac. Surg. 78: 1460-1462 (2004).
Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J. Am. Acad. Dermatol. 51: 212-216 (2004).
Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4: 825-831 (2004). *
Carter JD, Chen M, Ellett JD, Smith KM, Nadler JL, Yang Z. Impact of donor immune cells in pancreatic islet transplantation. Transplant. Proc. 36: 2866-2868 (2004). *
Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J. Rheumatol. 31: 1973-1980 (2004).
Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, Duff GW, Lobo AJ, Di Giovine FS. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 5: 8-15 (2004). *
Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl. 5: V1-V16 (2004). *
Caruso C, Aquino A, Candore G, Scola L, Colonna-Romano G, Lio D. Looking for immunological risk genotypes. Ann. N. Y. Acad. Sci. 1019: 141-146 (2004). *
Carvalho AA, Lima UW, Valiente RA. Statin and fibrate associated myopathy: study of eight patients. Arq. Neuropsiquiatr. 62: 257-261 (2004). *
Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET. Neonatal chest wall rigidity following the use of remifentanil for cesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int. J. Obstet. Anesth. 13: 53-56 (2004). *
Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farre A. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 28: 374-379 (2004).
Casanas R, Scharfetter H, Altes A, Remacha A, Sarda P, Sierra J, Merwa R, Hollaus K, Rosell J. Measurement of liver iron overload by magnetic induction using a planar gradiometer: preliminary human results. Physiol. Meas. 25: 315-323 (2004). *
Casanelli JM, Keli E, N'Dri J, Bohoussou PE, Blegole C, Moussa B, N'guessan HA. Crohn's disease: first report in Cote-d'Ivoire. Med. Trop. (Mars.) 64: 384-386 (2004).
Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J. Exp. Med. 199: 1295-1299 (2004). *
Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4: 55-66 (2004). *
Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Pediatr. Transplant. 8: 362-366 (2004).
Casellas F, Alcala MJ, Prieto L, Miro JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am. J. Gastroenterol. 99: 457-461 (2004). *
Casellas F, Antoln M, Varela E, Garca-Lafuente A, Guarner F, Borruel N, Armengol Miro JR, Malagelada JR. Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis. Clin. Gastroenterol. Hepatol. 2: 683-689 (2004). *
Casellas F, Fontanet G, Borruel N, Malagelada J. The opinion of patients with inflammatory bowel disease on healthcare received. Rev. Esp. Enferm. Dig. 96: 174-184 (2004). *
Casellas Jorda F. TNF-alpha inhibitors in inflamatory bowel disease. Med. Clin. (Barc.) 123: 627-634 (2004).
Casellas Jorda F, Lopez Vivancos J. Evaluation of quality of life in digestive diseases. Gastroenterol. Hepatol. 27: 58-68 (2004).
Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47: 359-363 (2004).
Casillas S, Delaney CP, Senagore AJ, Brady K, Fazio VW. Does conversion of a laparoscopic colectomy adversely affect patient outcome? Dis. Colon Rectum 47: 1680-1685 (2004).
Casper RC. Nutrients, neurodevelopment, and mood. Curr. Psychiatry Rep. 6: 425-429 (2004).
Cassano P, Fava M. Tolerability issues during long-term treatment with antidepressants. Ann. Clin. Psychiatry 16: 15-25 (2004).
Castano G, Viudez P, Sookoian S. Losartan in preascitic cirrhosis. Am. J. Gastroenterol. 99: 2282-2283 (2004). *
Castellaneta SP, Afzal NA, Greenberg M, Deere H, Davies S, Murch SH, Walker-Smith JA, Thomson M. Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 39: 257-261 (2004). *
Castelli M, Reiners JJ, Kessel D. A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation. Cell Death Differ. 11: 906-914 (2004). *
Castellvi JM, Xiol X, Guardiola J, Sabate I I, Roca M, Lama C, Figueras J, Jaurrieta E, Casais L. Pretransplantation risk factors for graft loss after liver transplantation in cirrhotic patients; effect of cytomegalovirus serologic status. Transpl. Int. 17: 131-137 (2004).
Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 3903-3908 (2004). *
Castiglione F, De Sio I, Cozzolino A, Rispo A, Manguso F, Del Vecchio Blanco G, Di Girolamo E, Castellano L, Ciacci C, Mazzacca G. Bowel wall thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn's disease. Am. J. Gastroenterol. 99: 1977-1983 (2004). *
Castillo AI, Sanchez-Martinez R, Moreno JL, Martinez-Iglesias OA, Palacios D, Aranda A. A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid. Mol. Cell. Biol. 24: 502-513 (2004). *
Castrillo A, Tontonoz P. PPARs in atherosclerosis: the clot thickens. J. Clin. Invest. 114: 1538-1540 (2004). *
Castro B, Crespo J, Garcia-Suarez C, Fabrega E, Casafont F, Pons-Romero F. Triple immunosuppressive therapy in the treatment of severe ulcerative colitis. Gastroenterol. Hepatol. 27: 1-5 (2004).
Castro RE, Sola S, Ramalho RM, Steer CJ, Rodrigues CM. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of Bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J. Pharmacol. Exp. Ther. 311: 845-852 (2004). *
Castro-Chavez F. Microarrays, antiobesity and the liver. Ann. Hepatol. 3: 137-145 (2004). *
Catania VA, Sanchez Pozzi EJ, Luquita MG, Ruiz ML, Villanueva SS, Jones B, Mottino AD. Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2. Ann. Hepatol. 3: 11-17 (2004). *
Cater MA, Forbes J, La Fontaine S, Cox D, Mercer JF. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal binding sites. Biochem. J. 380: 805-813 (2004). *
Cato AC, Schacke H, Sterry W, Asadullah K. The glucocorticoid receptor as target for classic and novel anti-inflammatory therapy. Curr. Drug Targets Inflamm. Allergy 3: 347-353 (2004).
Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, Fornari F, Del Vecchio Blanco C, De Sio I. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 53: 1356-1362 (2004). *
Cavasotto CN, Liu G, James SY, Hobbs PD, Peterson VJ, Bhattacharya AA, Kolluri SK, Zhang XK, Leid M, Abagyan R, Liddington RC, Dawson MI. Determinants of retinoid X receptor transcriptional antagonism. J. Med. Chem. 47: 4360-4372 (2004). *
Cavill D, Waterman SA, Gordon TP. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome. Scand. J. Immunol. 59: 261-266 (2004). *
Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanche H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J. Hepatol. 41: 292-298 (2004). *
Celec P. Nuclear factor kappa B - molecular biomedicine: the next generation. Biomed. Pharmacother. 58: 365-371 (2004).
Celinska-Lowenhoff M, Undas A. Nonlipid effects of fibrates. Przegl. Lek. 61: 99-101 (2004).
Celius T, Garberg P, Lundgren B. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells. Biochem. Biophys. Res. Commun. 324: 365-371 (2004). *
Centers for Disease Control and Prevention (CDC). Investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb. Mortal. Wkly. Rep. 53: 586-589 (2004).
Centers for Disease Control and Prevention (CDC). Tuberculosis associated with blocking agents against tumor necrosis factor-alpha - California, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 53: 683-686 (2004).
Centers for Disease Control and Prevention (CDC). Update: investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb. Mortal. Wkly. Rep. 53: 615-616 (2004).
Centrella M, Christakos S, McCarthy TL. Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 342: 13-24 (2004). *
Ceriati E, Deganello F, De Peppo F, Ciprandi G, Silveri M, Marchetti P, Rava L, Rivosecchi M. Surgery for ulcerative colitis in pediatric patients: functional results of 10-year follow-up with straight endorectal pull-through. Pediatr. Surg. Int. 20: 573-578 (2004).
Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults. Mol. Diagn. 8: 43-49 (2004).
Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, De La Red G, Gil V, Ramos-Casals M, Garcia-Carrasco M, Ingelmo M, Font J. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann. Rheum. Dis. 63: 1312-1317 (2004). *
Cesaratto L, Vascotto C, Calligaris S, Tell G. The importance of redox state in liver damage. Ann. Hepatol. 3: 86-92 (2004). *
Cevik R, Nas K, Gur A, Ayyildiz O, Arica M. Small joint monoarthritis and pyoderma gangrenosum in newly diagnosed ulcerative colitis: an unusual presentation. J. Clin. Rheumatol. 10: 360-362 (2004).
Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60: 552-565 (2004). *
Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58: 329-363 (2004). *
Chae SC, Lee YC, Park YR, Shin JS, Song JH, Oh GJ, Hong ST, Pae HO, Choi BM, Chung HT. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem. Biophys. Res. Commun. 320: 131-137 (2004). *
Chae SC, Park YR, Lee YC, Lee JH, Chung HT. The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum. Immunol. 65: 1427-1431 (2004).
Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol. Lett. 95: 91-95 (2004).
Chak A, Faulx A, Kinnard M, Brock W, Willis J, Wiesner GL, Parrado AR, Goddard KA. Identification of Barrett's esophagus in relatives by endoscopic screening. Am. J. Gastroenterol. 99: 2107-2114 (2004). *
Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 126: 1287-1292 (2004). *
Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 1497-1502 (2004). *
Challis S, Surgenor S. Helping patients with Crohn's disease to stop smoking. Prof. Nurse 19: 386-389 (2004).
Chamaillard M, Inohara N, Nunez G. Battling enteroinvasive bacteria: Nod1 comes to the rescue. Trends Microbiol. 12: 529-532 (2004). *
Chamberlain AJ, Hollowood K, Turner RJ, Byren I. Tumid lupus erythematosus occurring following highly active antiretroviral therapy for HIV infection: a manifestation of immune restoration. J. Am. Acad. Dermatol. 51 (5 Suppl.): S161-S165 (2004).
Chambers MS. Sjogren's syndrome. ORL Head Neck Nurs. 22: 22-30 (2004).
Champault A, Benoist S, Alves A, Panis Y. Surgical therapy for Crohn's disease of the colon and rectum. Gastroenterol. Clin. Biol. 28: 882-892 (2004).
Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter DJ, Willett WC, Fuchs CS. A prospective study of aspirin use and the risk for colorectal adenoma. Ann. Intern. Med. 140: 157-166 (2004). *
Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies. Liver Transpl. 10: 1331-1342 (2004). *
Chan CC, Reed GF, Kim Y, Agron E, Buggage RR. A correlation of pregnancy term, disease activity, serum female hormones, and cytokines in uveitis. Br. J. Ophthalmol. 88: 1506-1509 (2004). *
Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK. Survival following the development of ascites and/or oedema in primary biliary cirrhosis: a stage prognostic model. Gut 53: A84 (2004).
Chan CW, Gunsar F, Feudjo M, Rigamonti C, Vlachogiannakos Y, Carpenter JR, Burroughs AK. Long term ursodeoxycholic acid treatment for primary biliary cirrhosis: a 12 year follow up. Gut 53: A84 (2004).
Chan DC, Watts GF, Barrett PH, Whitfield AJ, Van Bockxmeer FM. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men. Arterioscler. Thromb. Vasc. Biol. 24: 2188-2191 (2004). *
Chan FK, Hung LC, Suen BY, Wong VW, Hui AJ, Wu JC, Leung WK, Lee YT, To KF, Chung SC, Sung JJ. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial. Gastroenterology 127: 1038-1043 (2004). *
Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110: 2-12 (2004).
Chan JL, Davis-Reed L, Kimball AB. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy. J. Drugs Dermatol. 3: 315-318 (2004).
Chan PC, Chen HL, Ni YH, Hsu HY, Chang LY, Lee PI, Chang MH. Outcome predictors of fulminant hepatic failure in children. J. Formos. Med. Assoc. 103: 432-436 (2004).
Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl. 10: 1415-1421 (2004). *
Chandak GR, Idris MM, Reddy DN, Mani KR, Bhaskar S, Rao GV, Singh L. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 53: 723-728 (2004). *
Chande N, McDonald J, MacDonald J. Interventions for treating collagenous colitis. Cochrane Database Syst. Rev. 1: CD003575 (2004). *
Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis: a Cochrane inflammatory bowel disease group systematic review of randomized trials. Am. J. Gastroenterol. 99: 2459-2465 (2004). *
Chandra P, Brouwer KL. The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm. Res. 21: 719-735 (2004). *
Chandra RK. Micronutrients, probiotics and the liver. J. Gastroenterol. Hepatol. 19: S398-S400 (2004). *
Chang CI, Pili-Floury S Se, Herve M, Parquet C, Chelliah Y, Lemaitre B, Mengin-Lecreulx D, Deisenhofer J. A Drosophila pattern recognition receptor contains a peptidoglycan docking groove and unusual L,D-carboxypeptidase activity. PLoS Biol. 2: E277 (2004). *
Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterol. Clin. North Am. 33: 235-250 (2004).
Chang M, Schroy PC 3rd. Endoscopic colorectal cancer screening-can supply meet demand? Gastroenterology 126: 1482-1485 (2004). *
Chang PY, Lu SC, Su TC, Chou SF, Huang WH, Morrisett JD, Chen CH, Liau CS, Lee YT. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J. Lipid Res. 45: 2116-2122 (2004). *
Chang YT, Shiao YM, Chin PJ, Liu YL, Chou FC, Wu S, Lin YF, Li LH, Lin MW, Liu HN, Tsai SF. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111 (2004). *
Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8(+) T cell-mediated skin inflammation. Eur. J. Immunol. 34: 2520-2528 (2004). *
Chapelon-Abric C. Epidemiology of sarcoidosis and its genetic and environmental risk factors. Rev. Med. Interne. 25: 494-500 (2004).
Chapman NH, Igo RP, Thomson JB, Matsushita M, Brkanac Z, Holzman T, Berninger VW, Wijsman EM, Raskind WH. Linkage analyses of four regions previously implicated in dyslexia: confirmation of a locus on chromosome 15q. Am. J. Med. Genet. 131B: 67-75 (2004). *
Chapman RW. Novel approaches to the treatment of primary sclerosing cholangitis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 72-73 (2004). *
Chapman RW. High dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 75. June 18-19 (2004). *
Charagundla SR, Levine MS, Torigian DA, Campbell MS, Furth EE, Rombeau J. Diffuse intestinal ganglioneuromatosis mimicking Crohn's disease. AJR Am. J. Roentgenol. 182: 1166-1168 (2004). *
Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin. Drug Saf. 3: 119-129 (2004). *
Charizopoulou N, Jansen S, Dorsch M, Stanke F, Dorin JR, Hedrich HJ, Tummler B. Instability of the insertional mutation in CftrTgH(neoim)Hgu cystic fibrosis mouse model. BMC Genet. 5: 6 (2004). *
Charrow J. Ashkenazi Jewish genetic disorders. Fam. Cancer 3: 201-206 (2004). *
Chassaing N, Martin L, Mazereeuw J, Barrie L, Nizard S, Bonafe JL, Calvas P, Hovnanian A. Novel ABCC6 mutations in pseudoxanthoma elasticum. J. Invest. Dermatol. 122: 608-613 (2004). *
Chatauret N, Butterworth RF. Effects of liver failure on inter-organ trafficking of ammonia: implications for the treatment of hepatic encephalopathy J. Gastroenterol. Hepatol. 19: S219-S223 (2004). *
Chatzicostas C, Drygiannakis D, Koutroubakis I, Niniraki M, Petinaki E, Koulentaki M, Dimoulios P, Kouroumalis E. Increased prevalence of IgM anticardiolipin antibodies in patients with primary biliary cirrhosis. Gut 53: A83-A84 (2004).
Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch. Neurol. 61: 1610-1612 (2004). *
Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4: 541-552 (2004). *
Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127: 1356-1371 (2004). *
Chavanas S, Mechin MC, Takahara H, Kawada A, Nachat R, Serre G, Simon M. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene 330: 19-27 (2004). *
Chazouilleres O. Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope? J. Hepatol. 40: 857-859 (2004). *
Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J. Biol. Chem. 279: 15870-15876 (2004). *
Chebli JM, Gaburri PD, Meirelles De Souza AF, Pereira Da Silva CE, Pinto JR, Felga GE. Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: another indication for cyclosporine? J. Clin. Gastroenterol. 38: 827-828 (2004).
Cheema SR, Arif F, Charney D, Meisels IS, Cheema SS. IgA-dominant glomerulonephritis associated with hepatitis A. Clin. Nephrol. 62: 138-143 (2004).
Cheetham GM. Novel protein kinases and molecular mechanisms of autoinhibition. Curr. Opin. Struct. Biol. 14: 700-705 (2004). *
Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J. Clin. Gastroenterol. 38: S44-S50 (2004).
Cheifetz AS. You say goodbye and I say aloe. Inflamm. Bowel Dis. 10: 693-695 (2004). *
Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin. Liver Dis. 8: 807-838, viii (2004).
Chen C, Zhang J, Li J, Huang J, Yang C, Huang G, Shi J. Hydrodynamic-based in vivo transfection of retinoic X receptor-alpha gene can enhance vitamin A-induced attenuation of liver fibrosis in mice. Liver Int. 24: 679-686 (2004). *
Chen CH, Ho MC, Lee PH, Chang MH, Jeng YM, Ni YH. A child with primary sclerosing cholangitis successfully treated by liver transplantation. Acta Paediatr. Taiwan 45: 239-241 (2004).
Chen CJ, Ho TY, Lu JJ, Sheu LF, Lee SY, Tien CH, Cheng SN. Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur. J. Pediatr. 163: 536-569 (2004). *
Chen CM, Gong Y, Zhang M, Chen JJ. Reciprocal cross talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279: 25876-25882 (2004). *
Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can. J. Ophthalmol. 39: 614-620 (2004).
Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J. Pediatr. 145: 317-321 (2004). *
Chen EY, Bartlett MC, Loo TW, Clarke DM. The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 279: 39620-39627 (2004). *
Chen F. Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. Cancer Res. 64: 8135-8138 (2004). *
Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely As A, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126: 756-764 (2004). *
Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101: 7687-7692 (2004). *
Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Tracey KJ, Sama AE, Wang H. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J. Leukoc. Biol. 76: 994-1001 (2004). *
Chen G, Liang G, Ou J, Goldstein JL, Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 101: 11245-11250 (2004). *
Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J. Interferon Cytokine Res. 24: 329-333 (2004).
Chen GH, Yang Y, Lu MQ, Cai CJ, He XS, Zhu XF, Xu C, Li H, Huang JF. Liver transplantation for hepatocellular carcinoma: a report of 60 cases. Zhonghua Wai Ke Za Zhi 42: 413-416 (2004).
Chen H, Liu LL, Ye LL, McGuckin C, Tamowski S, Scowen P, Tian H, Murray K, Hatton WJ, Duan D. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart. Circulation 110: 700-704 (2004). *
Chen HW, Zhen ZJ, Su SY, Xu ZM, Fei L, Ji Y. Clinical experience with 13 cases of orthotopic liver transplantation. Di Yi Jun Yi Da Xue Xue Bao 24: 445-447 (2004).
Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int. J. Cancer 110: 617-620 (2004). *
Chen J, Liu C. Methotrexate for ankylosing spondylitis. Cochrane Database Syst. Rev. 3: CD004524 (2004). *
Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4: 336-347 (2004). *
Chen L, Zeng Y, Yang H, Lee TD, French SW, Corrales FJ, Garcia-Trevijano ER, Avila MA, Mato JM, Lu SC. Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J. 18: 914-916 (2004). *
Chen M, Abele R, Tampe R. Functional non-equivalence of ABC signature motifs in the transporter associated with antigen processing (TAP). J. Biol. Chem. 279: 46073-46081 (2004). *
Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Int. Immunol. 16: 937-946 (2004). *
Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J. Rheumatol. 31: 818-820 (2004).
Chen QB, Fan LY, Zhong RQ, Tu XQ, Yuan Y, Zhu Y, Ye WM, Lu HQ, Han HX. A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease. Zhonghua Gan Zang Bing Za Zhi 12: 356-358 (2004).
Chen RH, Chen WC, Chen CC, Tsai CH, Tsai FJ. Association between the TAP1 gene codon 637 polymorphism and Graves' disease. Endocrine 25: 137-140 (2004).
Chen S, Ho C, Feng D, Chi Z. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. IEEE Trans. Med. Imaging 23: 426-432 (2004).
Chen SY, Lin JR, Darbha R, Lin P, Liu TY, Chen YM. Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway. Cancer Res. 64: 3617-3623 (2004). *
Chen VK, Arguedas MR, Kilgore ML, Eloubeidi MA. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer. Am. J. Gastroenterol. 99: 2223-2234 (2004). *
Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am. J. Gastroenterol. 99: 628-633 (2004). *
Chen W, Gluud C. Bile acids for liver transplanted patients. Cochrane Database Syst. Rev. 2: CD004384 (2004). *
Chen WD, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 3: CD004036 (2004). *
Chen X, Jensen PE. The expression of HLA-DO (H2-O) in B lymphocytes. Immunol. Res. 29: 19-28 (2004). *
Chen X, Krakauer T, Oppenheim JJ, Howard OM. Yin zi huang, an injectable multicomponent Chinese herbal medicine, is a potent inhibitor of T-cell activation. J. Altern. Complement. Med. 10: 519-526 (2004).
Chen X, Liang H, Van Remmen H, Vijg J, Richardson A. Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch. Biochem. Biophys. 422: 197-210 (2004). *
Chen X, Oppenheim JJ, Howard OM. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell. Mol. Immunol. 1: 336-342 (2004). *
Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J. Mol. Med. 82: 232-239 (2004).
Chen Y, Altenberg GA, Reuss L. Mechanism of activation of Xenopus CFTR by stimulation of PKC. Am. J. Physiol. Cell Physiol. 287: C1256-C1263 (2004). *
Chen Y, Button B, Altenberg GA, Reuss L. Potentiation of the effect of PKA stimulation of Xenopus CFTR by activation of PKC: role of NBD2. Am. J. Physiol. Cell Physiol. 287: C1436-C1444 (2004). *
Chen Y, Chong MM, Darwiche R, Thomas HE, Kay TW. Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency. Am. J. Pathol. 165: 913-921 (2004). *
Chen Y, Ferguson SS, Negishi M, Goldstein JA. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J. Pharmacol. Exp. Ther. 308: 495-501 (2004). *
Chen Y, Gan H, Ouyang Q, Xu D, Pan Y. The effects of anti-inflammatory on activation of nuclear factor-kappaB and expression of cell adhesion molecules in patients with ulcerative colitis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21: 732-736 (2004).
Chen Y, Hu X, Wei LN. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140. Mol. Cell. Endocrinol. 226: 43-50 (2004).
Chen ZQ, Annilo T, Shulenin S, Dean M. Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse chromosome 7F3. Mamm. Genome 15: 335-343 (2004). *
Cheng G, An F, Zou MJ, Sun J, Hao XH, He YX. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid. World J. Gastroenterol. 10: 1769-1774 (2004). *
Cheng J, Zhang Y, Li Q. Real-time PCR genotyping using displacing probes. Nucleic Acids Res. 32: e61 (2004). *
Cheng JB, Motola DL, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Identification and characterization of CYP2R1, a microsomal vitamin D 25-hydroxylase. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 21. June 18-19 (2004). *
Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U.S.A. 101: 7711-7715 (2004). *
Cheng L, Enomoto T, Hirota T, Shimizu M, Takahashi N, Akahoshi M, Matsuda A, Dake Y, Doi S, Enomoto K, Yamasaki A, Fukuda S, Mao XQ, Hopkin JM, Tamari M, Shirakawa T. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 34: 1192-1201 (2004). *
Cheng Y, Ohlsson L, Duan RD. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br. J. Nutr. 91: 715-723 (2004). *
Cheng YF, Chen CL, Huang TL, Chen TY, Chen YS, Takatsuki M, Wang CC, Chiu KW, Tsang LL, Sun PL, Jawan B. Risk factors for intraoperative portal vein thrombosis in pediatric living donor liver transplantation. Clin. Transplant. 18: 390-394 (2004).
Cheng YF, Chen CL, Huang TL, Chen TY, Chen YS, Wang CC, Tsang LL, Chiu KW, Jawan B, Eng HL. 3DCT angiography for detection of vascular complications in pediatric liver transplantation. Liver Transpl. 10: 248-252 (2004). *
Cherian S, Singh P. Is routine ileoscopy useful? An observational study of procedure times, diagnostic yield, and learning curve. Am. J. Gastroenterol. 99: 2324-2329 (2004). *
Chermesh I, Eliakim R. Mesalazine-induced reversible infertility in a young male. Dig. Liver Dis. 36: 551-552 (2004).
Chernajovsky Y, Gould DJ, Podhajcer OL. Gene therapy for autoimmune diseases: quo vadis? Nat. Rev. Immunol. 4: 800-811 (2004). *
Chernavsky AC, Paladino N, Rubio AE, De Biasio MB, Periolo N, Cuarterolo M, Goni J, Galoppo C, Canero-Velasco MC, Munoz AE, Fainboim H, Fainboim L. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum. Immunol. 65: 683-691 (2004).
Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22: 217-246 (2004). *
Cheroutre H, Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat. Rev. Immunol. 4: 290-300 (2004). *
Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 32: 734-741 (2004). *
Cheung C, Akiyama TE, Ward JM, Nicol CJ, Feigenbaum L, Vinson C, Gonzalez FJ. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64: 3849-3854 (2004). *
Cheung J, Scudamore CH, Yoshida EM. Management of polycystic liver disease. Can. J. Gastroenterol. 18: 666-670 (2004). *
Chevalier E, Petoux F, Chovet M, Langlois A. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats. Life Sci. 76: 319-329 (2004). *
Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am. J. Gastroenterol. 99: 2195-2203 (2004). *
Chez MG, Chin K, Hung PC. Immunizations, immunology, and autism. Semin. Pediatr. Neurol. 11: 214-217 (2004).
Chi T. A BAF-centred view of the immune system. Nat. Rev. Immunol. 4: 965-977 (2004). *
Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40: 539-551 (2004). *
Chiang JYL, Li T, Jahan A. Mechanisms of bile acid inhibition of genes in bile acid synthesis. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 23. June 18-19 (2004). *
Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U.S.A. 101: 15178-15183 (2004). *
Chiba T, Goto S, Yokosuka O, Imazeki F, Tanaka M, Fukai K, Takahashi Y, Tsujimura H, Saisho H. Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. Eur. J. Gastroenterol. Hepatol. 16: 225-228 (2004).
Chiba T, Yokosuka O, Arai M, Tada M, Fukai K, Imazeki F, Kato M, Seki N, Saisho H. Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. J. Hepatol. 41: 436-445 (2004). *
Chicharro JL, Hoyos J, Gomez-Gallego F, Villa JG, Bandres F, Celaya P, Jimenez F, Alonso JM, Cordova A, Lucia A. Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes. Br. J. Sports Med. 38: 418-421 (2004). *
Chignard N, Beretta L. Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology 127 (5 Suppl. 2): S120-S125 (2004). *
Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).
Chinen J, Shearer WT. Advances in asthma, allergy and immunology series 2004: basic and clinical immunology. J. Allergy Clin. Immunol. 114: 398-405 (2004). *
Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun. 314: 151-158 (2004). *
Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res. Clin. Pract. 66: 79-86 (2004).
Chistiakov DA, Savost'anov KV, Turakulov RI. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab. 83: 264-270 (2004). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab. Res. Rev. 20: 219-224 (2004).
Chistiakov DA, Seryogin Y, Savost'anov KV, Zilberman LI, Titovich EV, Kuraeva TL, Dedov II, Nosikov VV. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on chromosome 10p11-q11 in a Russian population. Scand. J. Immunol. 60: 316-323 (2004). *
Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am. J. Gastroenterol. 99: 1579-1584 (2004). *
Chloupkova M, Reaves SK, LeBard LM, Koeller DM. The mitochondrial ABC transporter Atm1p functions as a homodimer. FEBS Lett. 569: 65-69 (2004). *
Chlumska A, Benes Z, Mukensnabl P. Ulcerative colitis - contemporary morphological criteria. Cesk. Patol. 40: 154-158 (2004).
Cho JH. Advances in the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6: 467-473 (2004).
Cho JJ, Joseph B, Sappal BS, Giri RK, Wang R, Ludlow JW, Furth ME, Susick R, Gupta S. Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications. Liver Int. 24: 361-370 (2004). *
Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum. 50: 776-784 (2004). *
Cho SM, Kim J, Ryu HJ, Kim JJ, Kim HH, Park JH, Kim HT, Kim KH, Cho HY, Oh B, Park C, Kimm K, Jo I, Lee JE, Shin HD, Lee JK. Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population. Hum. Immunol. 65: 710-718 (2004).
Cho WK, Siegrist VJ, Zinzow W. Impaired regulatory volume decrease in freshly isolated cholangiocytes from cystic fibrosis mice: implications for cystic fibrosis transmembrane conductance regulator effect on potassium conductance. J. Biol. Chem. 279: 14610-14618 (2004). *
Cho WS, Chae C. Expression of cyclooxygenase-2 and nitric oxide synthase 2 in swine ulcerative colitis caused by Salmonella typhimurium. Vet. Pathol. 41: 419-423 (2004). *
Cho Y, Lew BL, Seong K, Kim NI. An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J. Korean Med. Sci. 19: 859-863 (2004). *
Choda Y, Morimoto Y, Miyaso H, Shinoura S, Saito S, Yagi T, Iwagaki H, Tanaka N. Failure of the gut barrier system enhances liver injury in rats: protection of hepatocytes by gut-derived hepatocyte growth factor. Eur. J. Gastroenterol. Hepatol. 16: 1017-1025 (2004).
Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin. Microbiol. Rev. 17: 540-552 (2004). *
Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709 (2004). *
Cholongitas E, Mavrogiannaki A, Papaioannou C, Karagiannis S, Papatheodoridis GV. Pericarditis and possible antiphospholipid syndrome on primary biliary cirrhosis. Ann. Hepatol. 3: 167-168 (2004). *
Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J. Thorac. Cardiovasc. Surg. 128: 170-179 (2004). *
Chong L, McDonald H, Strauss AE. Deconstructing aging. Science 305: 1419 (2004). *
Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 5: 484-492 (2004). *
Choquet A, Yamamoto-Furusho JK, Reyes E, Takahashi-Monroy T, Vargas-Vorackova F, Uscanga L. Predictors of colectomy in patients with ulcerative colitis. A cohort analysis of 184 cases. Rev. Invest. Clin. 56: 11-15 (2004).
Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA. Risk of pancreatitis with mutation of the cystic fibrosis gene. Am. J. Gastroenterol. 99: 1358-1363 (2004). *
Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 575-594, ix (2004).
Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin. Liver Dis. 24: 349-362 (2004).
Chowers Y, Odes S, Bujanover Y, Eliakim R, Bar Meir S, Avidan B. The month of birth is linked to the risk of Crohn's disease in the Israeli population. Am. J. Gastroenterol. 99: 1974-1976 (2004). *
Christen U, von Herrath MG. Factors that determine enhancement versus abrogation of autoimmunity by viral infections. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 20 (2004). *
Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK, Miller SD, Oldstone MB, von Herrath MG. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Invest. 114: 1290-1298 (2004). *
Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol. Immunol. 40: 1113-1120 (2004). *
Christen U, von Herrath MG. Initiation of autoimmunity. Curr. Opin. Immunol. 16: 759-767 (2004). *
Christensen E. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC): which treatments are of value? [http://www.easl.ch/PGC/Erik%20Christensen.pdf] (2004). *
Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? J. Hepatol. 41: 344-350 (2004). *
Christians U. Transport proteins and intestinal metabolism: P-glycoprotein and cytochrome P4503A. Ther. Drug Monit. 26: 104-106 (2004).
Christman AK, Fermo JD, Markowitz JS. Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy 24: 1020-1036 (2004).
Chu R, Lim H, Brumfield L, Liu H, Herring C, Ulintz P, Reddy JK, Davison M. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol. Cell. Biol. 24: 6288-6297 (2004). *
Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63: 21-27 (2004). *
Chua AC, Olynyk JK, Leedman PL, Trinder D. Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis. Blood 104: 1519-1525 (2004). *
Chuang FR, Lin CC, Wang PH, Cheng YF, Hsu KT, Chen YS, Lee CH, Chen CL. Acute renal failure after cadaveric related liver transplantation. Transplant. Proc. 36: 2328-2330 (2004). *
Chuang JH, Wang PW, Tai MH. An adipocentric view of liver fibrosis and cirrhosis. Chang Gung Med. J. 27: 855-868 (2004).
Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B. CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. J. Biol. Chem. 279: 6305-6314 (2004). *
Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, Ohta T, Asaka M, Hirohashi S. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J. Hepatol. 41: 629-636 (2004). *
Chun KS, Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68: 1089-1100 (2004). *
Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim SH, Kim JG, Kim CH. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18: 1670-1681 (2004). *
Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428: 486 (2004). *
Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, Bleich A, Bogue M, Broman KW, Buck KJ, Buckler E, Burmeister M, Chesler EJ, Cheverud JM, Clapcote S, Cook MN, Cox RD, et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36: 1133-1137 (2004). *
Chutkan R. Video capsule endoscopy in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 54. May 7-8 (2004). *
Ciarimboli G, Struwe K, Arndt P, Gorboulev V, Koepsell H, Schlatter E, Hirsch JR. Regulation of the human organic cation transporter hOCT1. J. Cell. Physiol. 201: 420-428 (2004). *
Cicchillo RM, Iwig DF, Jones AD, Nesbitt NM, Baleanu-Gogonea C, Souder MG, Tu L, Booker SJ. Lipoyl synthase requires two equivalents of S-adenosyl-L-methionine to synthesize one equivalent of lipoic acid. Biochemistry 43: 6378-6386 (2004). *
Cicchillo RM, Lee KH, Baleanu-Gogonea C, Nesbitt NM, Krebs C, Booker SJ. Escherichia coli lipoyl synthase binds two distinct [4Fe-4S] clusters per polypeptide. Biochemistry 43: 11770-11781 (2004). *
Cid MC, Segarra M, Garcia-Martinez A, Hernandez-Rodriguez J. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis. Curr. Rheumatol. Rep. 6: 184-194 (2004).
Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102: 175-194 (2004).
Cima RR, Pemberton JH. Surgical indications and procedures in ulcerative colitis. Curr. Treat. Options Gastroenterol. 7: 181-190 (2004).
Cima RR, Pemberton JH. Early surgical intervention in ulcerative colitis. Gut 53: 306-307 (2004). *
Cimaz R. Any increased risk of autoimmune disease? Lupus 13: 736-739 (2004). *
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).
Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, Slavcev A. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J. Rheumatol. 31: 1206-1210 (2004).
Cioffi M, Riegler G, Vietri MT, Pilla P, Caserta L, Carratu R, Sica V, Molinari AM. Serum p53 antibodies in patients affected with ulcerative colitis. Inflamm. Bowel Dis. 10: 606-611 (2004). *
Cisse A, Morel Y, Coulibaly M, Souare IS, Cisse AF, Nabe A, Camara LM, Cisse B, Camara S, Bangoura SA, Sylla A, Dia H, Da Silva L. Wilson's disease: study of 6 neurologic forms observed at the University Hospital in Conakry. Med. Trop. (Mars.) 64: 53-57 (2004).
Ciulla A, Tomasello G, Urso G, Sanzo A, Maiorana A, Castronovo G, Damiani S. Abrikossoff's tumour: report of a rare case in anal perianal region. Ann. Ital. Chir. 75: 87-89 (2004).
Clark BS, Chang IF, Karpen SJ, Herrera L, Scott JD, Bristow LJ, Quiros-Tejeira RE, Goss JA. Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients. Transplantation 77: 1480 (2004).
Clark D. Human herpesvirus type 6 and multiple sclerosis. Herpes 11 Suppl. 2: 112A-119A (2004). *
Clark VJ, Dean M. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum. Genomics 1: 255-273 (2004).
Clark VJ, Dean M. Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation. Hum. Genomics 1: 195-207 (2004).
Clarke D, Currie E, Madhavan K, Parks R, Garden O. Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) 6: 115-119 (2004). *
Clarke GA, Bouchard G, Paigen B, Carey MC. Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse. Gut 53: 136-142 (2004). *
Clarke LL, Gawenis LR, Bradford EM, Judd LM, Boyle KT, Simpson JE, Shull GE, Tanabe H, Ouellette AJ, Franklin CL, Walker NM. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1050-G1058 (2004). *
Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Rev. Mol. Med. 6: 1-23 (2004).
Clarke P. Urticaria. Aust. Fam. Physician 33: 501-503 (2004).
Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15: 13-18 (2004).
Claudel T, Sturm E, Kuipers F, Staels B. The farnesoid X receptor: a novel drug target? Expert Opin. Investig. Drugs 13: 1135-1148 (2004).
Claustres M, Altieri JP, Guittard C, Templin C, Chevalier-Porst F, Des Georges M. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med. Genet. 5: 19 (2004). *
Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84: 282-291 (2004). *
Cleland LG, James MJ, Proudman SM. Food inflammation and the anti-inflammatory aspects of food. Asia Pac. J. Clin. Nutr. 13: S26 (2004).
Clemente MG, Musu MP, Troncone R, Volta U, Congia M, Ciacci C, Neri E, Not T, Maggiore G, Strisciuglio P, Corazza GR, Gasbarrini G, Cicotto L, Sole G, Fasano A, De Virgiliis S. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am. J. Gastroenterol. 99: 1551-1556 (2004). *
Clerici C, Castellani D, Russo G, Fiorucci S, Sabatino G, Giuliano V, Gentili G, Morelli O, Raffo P, Baldoni M, Morelli A, Toma S. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. Anticancer Res. 24: 1255-1260 (2004).
Clevers H. At the crossroads of inflammation and cancer. Cell 118: 671-674 (2004). *
Cline AM, Radic MZ. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol. 112: 175-182 (2004). *
Clough JD. Fantastic voyage: the peeping pill. Cleve. Clin. J. Med. 71: 366 (2004). *
Clough JD. Fish oil is no snake oil. Cleve. Clin. J. Med. 71: 174 (2004).
Coady-Fariborzian L, Angel LP, Procaccino JA. Perforated colon secondary to virtual colonoscopy: report of a case. Dis. Colon Rectum 47: 1247-1249 (2004). *
Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Mose PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126: 1657-1664 (2004). *
Coates SW Jr, Hogenauer C, Santa Ana CA, Rosenblatt RL, Emmett M, Fordtran JS. Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis. Gastroenterology 127: 65-72 (2004). *
Coatmeur O, Rassiat E, Bonniaud P, Jouve JL, Minello A, Bedenne L, Faivre J, Hillon P. Acute pseudo-angiocholitis due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis. Ann. Med. Interne. (Paris) 154: 547-548 (2004).
Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, Cella M, Lande R, Uze G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34: 796-805 (2004). *
Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *
Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep. 5: 142-147 (2004). *
Cocq P, Yazdanpannah Y, Mesnard B, Colombel JF. Anti-TNF therapeutic agents in inflammatory bowel disease: indications, side effects and management. Gastroenterol. Clin. Biol. 28: S61-S69 (2004).
Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4: 889-899 (2004). *
Coffey MJ, Ross L. Human subject protections in genetic research. Genet. Test. 8: 209-213 (2004).
Cogger VC, Muller M, Fraser R, McLean AJ, Khan J, Le Couteur DG. The effects of oxidative stress on the liver sieve. J. Hepatol. 41: 370-376 (2004). *
Cohen IR. Functional immunomics and immune homeostasis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 21 (2004). *
Cohen IR, Quintana FJ, Mimran A. Tregs in T cell vaccination: exploring the regulation of regulation. J. Clin. Invest. 114: 1227-1232 (2004). *
Cohen J. Medicine. Microbicide shuts the door on HIV. Science 306: 387 (2004). *
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872 (2004). *
Cohen JC, Lundblad LK, Bates JH, Levitzky M, Larson JE. The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. BMC Genet. 5: 21 (2004). *
Cohen JD, Zaltni S, Kaiser MJ, Bozonnat MC, Jorgensen C, Daures JP, Sany J. Secondary addition of methotrexate to partial responders to etanercept alone is effective in severe rheumatoid arthritis. Ann. Rheum. Dis. 63: 209-210 (2004). *
Cohen LB. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104. Can. J. Gastroenterol. 18: 419 (2004).
Cohen RD. Mesalamine in IBD: multiple hats? Gastroenterology 127: 1001-1002 (2004). *
Cohen RD. Sperm, sex, and 6-MP: the perception on conception. Gastroenterology 127: 1263-1264 (2004). *
Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm. Bowel Dis. 10: 557-563 (2004). *
Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11: 575-577 (2004).
Cohet C, Cheng S, MacDonald C, Baker M, Foliaki S, Huntington N, Douwes J, Pearce N. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J. Epidemiol. Community Health 58: 852-857 (2004). *
Cohn JA, Mitchell RM, Jowell PS. The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. Gastroenterol. Clin. North Am. 33: 817-837, vii (2004).
Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22: 789-815 (2004). *
Cole CR, Bucuvalas JC, Hornung RW, Krug S, Ryckman FC, Atherton H, Alonso MP, Balistreri WF, Kotagal U. Impact of liver transplantation on HRQOL in children less than 5 years old. Pediatr. Transplant. 8: 222-227 (2004).
Cole DK, Gao GF. CD8: adhesion molecule, co-receptor and immuno-modulator. Cell. Mol. Immunol. 1: 81-88 (2004). *
Cole E, Deshpande R. The impact of cyclosporine on the development of immunosuppressive therapy: perspective from a transplant nephrologist involved with the development of C(2). Transplant. Proc. 36: S408-S413 (2004). *
Collantes R, Ong JP, Younossi ZM. Nonalcoholic fatty liver disease and the epidemic of obesity. Cleve. Clin. J. Med. 71: 657-664 (2004). *
Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int. 24: 63-68 (2004). *
Collett A, Tanianis-Hughes J, Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochem. Pharmacol. 68: 783-790 (2004). *
Collin P, Maki M, Kaukinen K. It is the compliance, not milligrams of gluten, that is essential in the treatment of celiac disease. Nutr. Rev. 62: 490 (2004).
Collins FS. What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat. Genet. 36 (11 Suppl.): S13-S15 (2004). *
Collins JE, Heward JM, Howson JM, Foxall H, Carr-Smith J, Franklyn JA, Gough SC. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United kingdom. J. Clin. Endocrinol. Metab. 89: 6336-6339 (2004). *
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.) 60: 618-624 (2004). *
Collins JL. Therapeutic opportunities for liver X receptor modulators. Curr. Opin. Drug Discov. Devel. 7: 692-702 (2004).
Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 75: 995-1000 (2004). *
Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin. Microbiol. Rev. 17: 348-369 (2004). *
Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 101: 17216-17221 (2004). *
Colombel JF, Loftus EV Jr, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 126: 19-31 (2004). *
Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am. J. Gastroenterol. 99: 878-883 (2004). *
Colombel JF, Sandborn WJ. Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease: response. Am. J. Gastroenterol. 99: 2067 (2004). *
Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J. Hepatol. 41: 1041-1044 (2004). *
Colon AL, Madrigal JL, Menchen LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig. Dis. Sci. 49: 1713-1721 (2004). *
Colquhoun P, Chen HC, Kim JI, Efron J, Weiss EG, Nogueras JJ, Vernava AM, Wexner SD. High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up. Colorectal Dis. 6: 158-161 (2004).
Comabella M, Altet L, Peris F, Villoslada P, Sanchez A, Montalban X. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients. Mult. Scler. 10: 618-620 (2004). *
Combarros O, Infante J, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease. Neurosci. Lett. 366: 312-314 (2004). *
Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL Jr. Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. Am. J. Gastroenterol. 99: 264-268 (2004). *
Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113: 1573-1581 (2004). *
Comerford LW, Bickston SJ. Treatment of luminal and fistulizing Crohn's disease with infliximab. Gastroenterol. Clin. North Am. 33: 387-406 (2004).
Cominelli F. Cytokine-based therapies for Crohn's disease - new paradigms. N. Engl. J. Med. 351: 2045-2048 (2004). *
Conant SB, Swanborg RH. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity. J. Immunol. 172: 5322-5328 (2004). *
Conde I, Paniagua R, Fraile B, Ruiz A, Arenas MI. Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors. Int. J. Oncol. 25: 1183-1191 (2004).
Cong Y, Liu C, Weaver CT, Elson CO. Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction. Ann. N. Y. Acad. Sci. 1029: 319-320 (2004). *
Connell W. Pro: endoscopic surveillance minimizes the risk of cancer. Am. J. Gastroenterol. 99: 1631-1633 (2004). *
Conney AH. Tailoring cancer chemoprevention regimens to the individual. J. Cell. Biochem. 91: 277-286 (2004). *
Connor SJ, Paraskevopoulos N, Newman R, Cuan N, Hampartzoumian T, Lloyd AR, Grimm MC. CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 53: 1287-1294 (2004). *
Constantin A, Dieude P, Lauwers-Cances V, Jamard B, Mazieres B, Cambon-Thomsen A, Cornelis F, Cantagrel A. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum. 50: 742-747 (2004). *
Conti F, Dousset B, Cherruau B, Guerin C, Soubrane O, Houssin D, Calmus Y. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Clin. Transplant. 18: 235-241 (2004).
Contos MJ, Choudhury J, Mills AS, Sanyal AJ. The histologic spectrum of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 481-500 (2004).
Contreas G, Valletta E, Ulmi D, Cantoni S, Pinelli L. Screening of coeliac disease in north Italian children with type 1 diabetes: limited usefulness of HLA-DQ typing. Acta Paediatr. 93: 628-632 (2004).
Contu L, Orru S, Carcassi C, Giuressi E, Mulargia M, Cappai L, Valentini D, Lai S, Boero R, Masala MV, Aste N, Biggio P, Cottoni F, Cerimele D. A psoriasis vulgaris protective gene maps close to the HLA-C locus on the EH18.2-extended haplotype. Tissue Antigens 64: 43-57 (2004). *
Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979 (2004). *
Cook MC. B cell biology, apoptosis, and autoantibodies to phospholipids. Thromb. Res. 114: 307-319 (2004). *
Cook S. Update on multiple sclerosis research. Rev. Neurol. Dis. 1: 37-40 (2004).
Cook SD. Does Epstein-Barr virus cause multiple sclerosis? Rev. Neurol. Dis. 1: 115-123 (2004).
Cook SD. Multiple sclerosis. Rev. Neurol. Dis. 1: 51-52 (2004).
Cook-Mills JM, Johnson JD, Deem TL, Ochi A, Wang L, Zheng Y. Calcium mobilization and RAC1 activation are required for VCAM-1-stimulated NADPH oxidase activity. Biochem. J. 378: 539-547 (2004). *
Cooke A, Zaccone P, Raine T, Phillips JM, Dunne DW. Infection and autoimmunity: are we winning the war, only to lose the peace? Trends Parasitol. 20: 316-321 (2004). *
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta cell apoptosis and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145: 5305-5312 (2004). *
Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat. Rev. Immunol. 4: 978-988 (2004). *
Cooper GS, Koroukian SM. Geographic variation among medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am. J. Gastroenterol. 99: 1544-1550 (2004). *
Cooper GS, Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr. Rheumatol. Rep. 6: 367-374 (2004).
Cooper ZN, Nelson RM, Ross LF. Certificates of confidentiality in research: rationale and usage. Genet. Test. 8: 214-220 (2004).
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317: 269-275 (2004). *
Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr. Opin. Immunol. 16: 780-786 (2004).
Copeland BH, Aramide O, Wehbe S, Fitzgerald SM, Krishnaswamy G. Eosinophilia in a patient with cyclical vomiting: a case report. Clin. Mol. Allergy 2: 7 (2004). *
Coplan PM, Mitchnick M, Rosenberg ZF. Public health. Regulatory challenges in microbicide development. Science 304: 1911-1912 (2004). *
Coppin H, Ribouchon MT, Fontaine B, Edan G, Clanet M, Roth MP; French Multiple Sclerosis Genetics Group. A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat. Genes Immun. 5: 72-75 (2004). *
Copreni E, Penzo M, Carrabino S, Conese M. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis. Gene Ther. 11 Suppl. 1: S67-S75 (2004).
Coran AG, Rivosecchi M. Surgery for ulcerative colitis in children. Pediatr. Surg. Int. 20: 565-566 (2004). *
Corazza N, Brunner T, Buri C, Rihs S, Imboden MA, Seibold I, Mueller C. Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form. Gastroenterology 127: 816-825 (2004). *
Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, Greally P, Hayes R, Bourke B. Cystic fibrosis-associated liver disease: a population-based study. J. Pediatr. 145: 327-332 (2004). *
Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J. Hepatol. 41: 38-43 (2004). *
Cordonnier-Pratt MM, Liang C, Wang H, Kolychev DS, Sun F, Freeman R, Sullivan R, Pratt LH. MAGIC database and interfaces: an integrated package for gene discovery and expression. Comp. Funct. Genomics 5: 268-275 (2004). *
Cormet-Boyaka E, Jablonsky M, Naren AP, Jackson PL, Muccio DD, Kirk KL. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proc. Natl. Acad. Sci. U.S.A. 101: 8221-8226 (2004). *
Cornwell PD, De Souza AT, Ulrich RG. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat. Res. 549: 131-145 (2004).
Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chretien Y, Poupon RE, Poupon R. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int. 24: 187-193 (2004). *
Correa PA, Gomez LM, Anaya JM. Polymorphism of TNF-alpha in autoimmunity and tuberculosis. Biomedica 24 Supp. 1: 43-51 (2004).
Correa PA, Tobon GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1. Biomedica 24: 140-152 (2004).
Corrieri-Baizeau C, Borel I, Cottin V, Vukusic S, Scoazec JY, Audigier JC, Boillot O, Dumortier J. Autoimmune hepatitis associated with multiple sclerosis. Gastroenterol. Clin. Biol. 28: 1186 (2004).
Cortes LM, Baltazar LM, Lopez-Cardona MG, Olivares N, Ramos C, Salazar M, Sandoval L, Lorenz MG, Chakraborty R, Paterson AD, Rivas F. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65: 1469-1476 (2004).
Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, Walport MJ, Cook HT, Botto M. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur. J. Immunol. 34: 3713-3722 (2004). *
Cortez-Pinto H, Ermelinda Camilo M. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract. Res. Clin. Gastroenterol. 18: 1089-1104 (2004).
Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. Eur. J. Biochem. 271: 1814-1819 (2004). *
Cosnes J. Understanding the opposite effects of smoking in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 48. May 7-8 (2004). *
Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res. Clin. Gastroenterol. 18: 481-496 (2004).
Cosnes J, Nion-Larmurier I, Afchain P, Beaugerie L, Gendre JP. Gender differences in the response of colitis to smoking. Clin. Gastroenterol. Hepatol. 2: 41-48 (2004). *
Costa-Carvalho BT, Viana MA, Brunialti MK, Kallas EG, Salomao R. An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome. Clin. Exp. Immunol. 136: 291-296 (2004). *
Costello DJ, Walsh SL, Harrington HJ, Walsh CH. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J. Neurol. Neurosurg. Psychiatry 75: 631-633 (2004). *
Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J. Clin. Gastroenterol. 38: 801-804 (2004).
Coulombe M, Gill RG. The immunobiology of pancreatic islet transplantation. Adv. Exp. Med. Biol. 552: 154-169 (2004).
Coulouarn C, Lefebvre G, Derambure C, Lequerre T, Scotte M, Francois A, Cellier D, Daveau M, Salier JP. Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology 39: 353-364 (2004). *
Couriel DR, Saliba R, Hicks K, Ippoliti C, De Lima MJ, Hosing C, Khouri I, Andersson B, Donato M, Gajewski J, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R. Tumor necrosis factor alpha blockade for the treatment of steroid-refractory acute GVHD. Blood 104: 649-654 (2004). *
Courselaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, Leroyer P, Coppin H, Brissot P, Roth MP, Loreal O. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol. Dis. 32: 283-289 (2004).
Courtney ED, Melville DM, Leicester RJ. Review article: chemoprevention of colorectal cancer. Aliment. Pharmacol. Ther. 19: 1-24 (2004). *
Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J. Cyst. Fibros. 3: 223-231 (2004).
Courtois G, Israel A. Human pathologies associated with NF-kappaB defects. J. Soc. Biol. 198: 93-96 (2004).
Coutinho J. RUNX1: transcription factor scores a hat-trick of autoimmune diseases. Clin. Genet. 65: 180-182 (2004).
Couzin J. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 306: 384-385 (2004). *
Couzin J. Long-sought enzyme found, revealing new gene switch on histones. Science 306: 2171a (2004). *
Couzin J. Genetics. Two new asthma genes uncovered. Science 304: 185-187 (2004). *
Couzin J. Genomics. Consensus emerges on HapMap strategy. Science 304: 671-673 (2004). *
Couzin J. Basic and clinical immunology meeting. Genes crisscross disease lines. Science 305: 773 (2004). *
Couzin J. Basic and clinical immunology meeting. And action! Dendritic cells go live. Science 305: 772-773 (2004). *
Couzin J. Basic and clinical immunology meeting. An old favorite is resurrected: regulatory T cells take the stage. Science 305: 772 (2004). *
Couzin J. Putting tolerance to the test. Science 305: 194-196 (2004). *
Couzin J, Vogel G. Cell therapy. Renovating the heart. Science 304: 192-194 (2004). *
Covic A, Mutica C, Ignat A, Boaru I, Veisa G, Gusbeth-Tatomir P, Enea M, Covic M. Retrospective study of 97 ANCA-positive patients: epidemiological and clinical spectrum. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 305-310 (2004).
Covington MB. Omega-3 fatty acids. Am. Fam. Physician 70: 133-140 (2004). *
Cowie SE, Yoshida EM, Ryan AG, Chung SW, Buczkowski AK, Ho SG, Erb SR, Steinbrecher UP, Scudamore CH. Hepatic abscesses after liver transplantation secondary to traumatic intrahepatic bile duct injuries in a cadaveric allograft donor. Transpl. Int. 17: 379-383 (2004).
Cox NJ. Human genetics: an expression of interest. Nature 430: 733-734 (2004). *
Coyle AJ, Gutierrez-Ramos JC. The role of ICOS and other costimulatory molecules in allergy and asthma. Springer Semin. Immunopathol. 25: 349-359 (2004). *
Cozar-Castellano I, Del Valle Machargo M, Trujillo E, Arteaga MF, Gonzalez T, Martin-Vasallo P, Avila J. hIscA: a protein implicated in the biogenesis of iron-sulfur clusters. Biochim. Biophys. Acta 1700: 179-188 (2004). *
Crabb DW. Alcohol deranges hepatic lipid metabolism via altered transcriptional regulation. Trans. Am. Clin. Climatol. Assoc. 115: 273-287 (2004). *
Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 34: 35-38 (2004). *
Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63: 49-63 (2004). *
Crabtree MD, Fletcher C, Churchman M, Hodgson SV, Neale K, Phillips RK, Tomlinson IP. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut 53: 271-276 (2004). *
Cracowski JL. Isoprostanes: a putative key role in vascular diseases. Rev. Med. Interne. 25: 459-463 (2004).
Cracowski JL. Isoprostanes: an emerging role in vascular physiology and disease? Chem. Phys. Lipids 128: 75-83 (2004). *
Craig CE, Quaglia A, Selden C, Lowdell M, Hodgson H, Dhillon AP. The histopathology of regeneration in massive hepatic necrosis. Semin. Liver Dis. 24: 49-64 (2004).
Craig SA. Betaine in human nutrition. Am. J. Clin. Nutr. 80: 539-549 (2004). *
Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis. Liver Int. 24: 335-344 (2004). *
Crane C, Martin M. Social learning, affective state and passive coping in irritable bowel syndrome and inflammatory bowel disease. Gen. Hosp. Psychiatry 26: 50-58 (2004).
Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J. Small Anim. Pract. 45: 336-342 (2004).
Crawford CL. Does thalidomide have a role in leprosy? Lancet 363: 1911 (2004). *
Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE. Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 39: 1655-1662 (2004). *
Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit. Care Med. 32: 502-508 (2004).
Creange A. The diagnosis of acquired sensory neuropathies. Rev. Neurol. (Paris) 160: 363-370 (2004).
Cresswell P. Cell biology. Cutting and pasting antigenic peptides. Science 304: 525-527 (2004). *
Crestani M, De Fabiani E, Caruso D, Mitro N, Gilardi F, Vigil Chacon AB, Patelli R, Godio C, Galli G. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Biochem. Soc. Trans. 32: 92-96 (2004). *
Creusot RJ, Fathman CG. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. J. Clin. Invest. 114: 892-894 (2004). *
Creuzot-Garcher C, Lafontaine PO, Brignole F, Pisella PJ, d'Athis P, Bron A, Lapierre V, Baudouin C. Treating severe dry eye syndromes with autologous serum. J. Fr. Ophtalmol. 27: 346-351 (2004).
Criado PR, de Oliveira Ramos R, Vasconcellos C, Jardim Criado RF, Valente NY. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare. J. Eur. Acad. Dermatol. Venereol. 18: 603-606 (2004).
Criscuoli V, Casa A, Orlando A, Pecoraro G, Oliva L, Traina M, Rizzo A, Cottone M. Severe acute colitis associated with CMV: a prevalence study. Dig. Liver Dis. 36: 818-820 (2004).
Crispin JC, Vargas MI, Alcocer-Varela J. Immunoregulatory T cells in autoimmunity. Autoimmun. Rev. 3: 45-51 (2004).
Criswell LA. Familial clustering of disease features: implications for the etiology and investigation of systemic autoimmune disease. Arthritis Rheum. 50: 1707-1708 (2004). *
Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept. Arthritis Rheum. 50: 2750-2756 (2004). *
Crocenzi FA, Mottino AD, Roma MG. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention. Curr. Med. Chem. 11: 501-524 (2004).
Croft NM. The spice of life for cystic fibrosis. Gastroenterology 127: 1639-1640 (2004). *
Croitoru K, Zhou P. T-cell-induced mucosal damage in the intestine. Curr. Opin. Gastroenterol. 20: 581-586 (2004).
Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin. Pharmacokinet. 43: 361-394 (2004).
Crone J, Gold BD. Helicobacter pylori infection in pediatrics. Helicobacter 9 Suppl. 1: 49-56 (2004).
Cronin DC 2nd, Millis JM. Split-liver transplantation: coming of age. Liver Transpl. 10: 1326-1328 (2004). *
Crowe DL, Chandraratna RA. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res. 6: R546-R555 (2004). *
Cruickshank SM, McVay LD, Baumgart DC, Felsburg PJ, Carding SR. Colonic epithelial cell mediated suppression of CD4 T cell activation. Gut 53: 678-684 (2004). *
Cruz E, Vieira J, Goncalves R, Alves H, Almeida S, Rodrigues P, Lacerda R, Porto G. Involvement of the major histocompatibility complex region in the genetic regulation of circulating CD8 T-cell numbers in humans. Tissue Antigens 64: 25-34 (2004). *
Cserepes J, Szentpetery Z, Seres L, Ozvegy-Laczka C, Langmann T, Schmitz G, Glavinas H, Klein I, Homolya L, Varadi A, Sarkadi B, Elkind NB. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem. Biophys. Res. Commun. 320: 860-867 (2004). *
Csiszar A, Ungvari Z. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. Med. Hypotheses 63: 696-698 (2004).
Cubelic S, Misak Z, Gasparov S, Kolacek S. Nonalcoholic steatohepatitis in children. Lijec. Vjesn. 126: 197-200 (2004).
Cuchacovich M, Ferreira L, Aliste M, Soto L, Cuenca J, Cruzat A, Gatica H, Schiattino I, Perez C, Aguirre A, Salazar-Onfray F, Aguillon J. Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand. J. Rheumatol. 33: 228-232 (2004). *
Cuenca F, Garcia Paredes J, Mendoza J, Cruz D, Herrero A, Diaz-Rubio M. Experience with granulocytapheresis in Crohn's disease. Rev. Esp. Enferm. Dig. 96: 501-506 (2004).
Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2: 410-417 (2004). *
Cuffari C, Li DY, Mahoney J, Barnes Y, Bayless TM. Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy. Dig. Dis. Sci. 49: 133-137 (2004). *
Cui FL, Fan J, Li W, Fan YC, Hu ZD. Fluorescence spectroscopy studies on 5-aminosalicylic acid and zinc 5-aminosalylicylate interaction with human serum albumin. J. Pharm. Biomed. Anal. 34: 189-197 (2004).
Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, Liu YH, Dan HL, Jian YT, Chen XQ. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J. Gastroenterol. 10: 1521-1525 (2004). *
Cui J, Lew J-L, Zhao A, Huang L, Wright SD. The farnesoid X receptor controls gene expression in a ligand and promoter-selective fashion. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 32. June 18-19 (2004). *
Cukovic-Cavka S. Diffuse jejunoileitis in an adolescent. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 69. May 7-8 (2004). *
Culliford A, Markowitz D, Rotterdam H, Green PHR. Scalloping of duodenal mucosa in Crohn's disease. Inflamm. Bowel Dis. 10: 270-273 (2004). *
Cullum JL, Wojciechowski AE, Pelletier G, Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can. J. Psychiatry 49: 139-144 (2004). *
Culver DA, Thomassen MJ, Kavuru MS. Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies. Cleve. Clin. J. Med. 71: 88, 90, 92 (2004). *
Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC, Gibson GR, Guarner F, Isolauri E, Pannemans D, Shortt C, Tuijtelaars S, Watzl B. PASSCLAIM - gut health and immunity. Eur. J. Nutr. 43 Suppl. 2: II118-II173 (2004).
Cummings JH, Kong SC. Probiotics, prebiotics and antibiotics in inflammatory bowel disease. Novartis Found. Symp. 263: 99-111 (2004).
Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75: 49-58 (2004). *
Cunnick GH, Richardson NG, Ratcliffe N, Donaldson DR. Acute ulcerative colitis in a Meckel's diverticulum. Int. J. Clin. Pract. 58: 422-423 (2004).
Cuppens H, Cassiman JJ. CFTR mutations and polymorphisms in male infertility. Int. J. Androl. 27: 251-256 (2004). *
Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann. Surg. 239: 450-458 (2004). *
Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268 (2004). *
Currid A, Ortega B, Valverde MA. Chloride secretion in a morphologically differentiated human colonic cell line that expresses the epithelial Na+ channel. J. Physiol. 555: 241-250 (2004). *
Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 78: 807-814 (2004).
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 13: 285-292 (2004). *
Cuthbert AP, Fisher SA, Lewis CM, Mathew CG, Sanderson J, Forbes A. Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance? Gut 53: 1386 (2004). *
Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, Hagiwara T, Yamada M, Schneider R, Gregory PD, Tempst P, Bannister AJ, Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118: 545-553 (2004). *
Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13: 635-638 (2004).
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP. WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22: 340-346 (2004). *
Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, Caputi AP. Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab. Invest. 84: 1643-1654 (2004). *
Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Patel NS, Muia C, Threadgill MD, De Sarro A, Thiemermann C. 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn. Schmiedebergs Arch. Pharmacol. 370: 464-473 (2004). *
Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, De Sarro A, Thiemermann C. Erythropoietin reduces the development of experimental, inflammatory bowel disease. J. Pharmacol. Exp. Ther. 311: 1272-1280 (2004). *
Czaja AJ. Round table: classification of autoimmune liver diseases and diagnostic criteria. Subgroups of autoimmune hepatitis are irrelevant. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 58-59 (2004). *
Czaja AJ. Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54 (2004). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 20: 231-240 (2004).
Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J. Hepatol. 40: 646-652 (2004). *
Czaja AJ, Carpenter HA. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39: 1631-1638 (2004). *
Czaja AJ, Muratori P, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 24: 322-329 (2004). *
Czaja AJ, Shums Z, Donaldson PT, Norman GL. Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis. Dig. Dis. Sci. 49: 611-618 (2004). *
Czaja AJ, Shums Z, Norman GL. Nonstandard antibodies as prognostic markers in autoimmune hepatitis. Autoimmunity 37: 195-201 (2004).
Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP. World J. Gastroenterol. 10: 3034-3038 (2004). *
Czako L, Takacs T, Morvay Z, Csernay L, Lonovics J. Diagnostic value of secretin-enhanced magnetic resonance cholangiopancreatography (S-MRCP) after unsuccessful endoscopic retrograde cholangiopancreatography (ERCP). Orv. Hetil. 145: 529-534 (2004).
Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. Int. J. Radiat. Oncol. Biol. Phys. 58: 779-785 (2004).
Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J. Clin. Oncol. 22: 4659-4664 (2004). *
D'Apice MR, Gambardella S, Russo S, Lucidi V, Nardone AM, Pietropolli A, Novelli G. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism. Prenat. Diagn. 24: 981-983 (2004). *
D'Archivio M, Silano M, Fagnani C, Scazzocchio B, Nistico L, Giovannini C, Vari' R, D'Ippolito C, Cotichini R, Stazi MA, De Vincenzi M. Clinical evolution of celiac disease in Italy 1982-2002. J. Clin. Gastroenterol. 38: 877-879 (2004).
D'Argenio G, Farrace MG, Cosenza V, De Ritis F, Della Valle N, Manguso F, Piacentini M. Expression of apoptosis-related proteins in rat with induced colitis. Int. J. Colorectal Dis. 19: 451-460 (2004). *
D'Auria F, Rovere-Querini P, Giazzon M, Ajello P, Baldissera E, Manfredi AA, Sabbadini MG. Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies. J. Intern. Med. 255: 409-418 (2004). *
D'Cruz D, Ablamunits V. Why do we need a new journal in autoimmunity? J. Autoimmune Dis. 1: 1 (2004). *
D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Prete GD. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol. Med. 10: 316-323 (2004). *
D'Elios MM, Bergman MP, Amedei A, Appelmelk BJ, Del Prete G. Helicobacter pylori and gastric autoimmunity. Microbes Infect. 6: 1395-1401 (2004). *
D'Haens G. Optimizing the use of current drugs in IBD. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 65. May 7-8 (2004). *
D'Haens G. Mucosal healing in pediatric Crohn's disease: the goal of medical treatment. Inflamm. Bowel Dis. 10: 479-480 (2004). *
D'Haens G, Hlavaty T. Advances in medical therapy for Crohn's disease. Curr. Gastroenterol. Rep. 6: 496-505 (2004).
D'Haens G, van Bodegraven AA. Mesalazine is safe for the treatment of IBD. Gut 53: 155 (2004). *
D'Inca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm. Bowel Dis. 10: 23-27 (2004). *
D'Ovidio V, Aratari A, Viscido A, Pimpo MT, Caprilli R, Torchio P. Infliximab and quality of life in steroid-dependent Crohn's disease. Dig. Liver Dis. 36: 557-558 (2004).
Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874 (2004). *
Daberkow U, Dorffel Y, Schmidt H, Scholze J. Multifocal nodular fatty infiltration of the liver associated with porphyria and haemochromatosis. Dtsch. Med. Wochenschr. 129: 617-620 (2004).
Dabos KJ, Newsome PN, Parkinson JA, Mohammed HH, Sadler IH, Plevris JN, Hayes PC. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 77: 200-205 (2004).
Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors. Cancer Res. 64: 5407-5414 (2004). *
Dager WE, White RH. Low-molecular-weight heparin-induced thrombocytopenia in a child. Ann. Pharmacother. 38: 247-250 (2004).
Daghfous R, El Aidli S, Ben Mami N, Amrani R, Loueslati MH, Lakhal M, Belkahia C. Cholestasis soon after administration of amoxicillin-clavulanic acid. Therapie 59: 658-660 (2004).
Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J. Exp. Med. 199: 1391-1399 (2004). *
Dahl SG, Ravna AW, Sylte I. Structures and models of transporter proteins. J. Pharmacol. Exp. Ther. 309: 853-860 (2004). *
Dahlke MH, Popp FC, Larsen S, Schlitt HJ, Rasko JE. Stem cell therapy of the liver - fusion or fiction? Liver Transpl. 10: 471-479 (2004). *
Dai S, Hirayama T, Abbas S, Abu-Amer Y. The IKK inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279: 37219-37222 (2004). *
Dai SM, Matsuno H, Nakamura H, Nishioka K, Yudoh K. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 50: 432-443 (2004). *
Dai X, Yamasaki K, Shirakata Y, Sayama K, Hashimoto K. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes. J. Invest. Dermatol. 123: 1078-1085 (2004). *
Dai YS, Liang MG, Gellis SE, Bonilla FA, Schneider LC, Geha RS, Orange JS. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J. Am. Acad. Dermatol. 51: 718-722 (2004).
Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z, Jeffrey SS. A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue. BMC Genomics 5: 47 (2004). *
Dajotoy T, Andersson P, Bjartell A, Lofdahl CG, Tapper H, Egesten A. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. J. Leukoc. Biol. 76: 685-691 (2004). *
Dal Pra C, Chen S, Betterle C, Zanchetta R, McGrath V, Furmaniak J, Rees Smith B. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur. J. Endocrinol. 150: 313-321 (2004). *
Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, Herman D, McQueen FM. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Ann. Rheum. Dis. 63: 718-722 (2004). *
Daly MJ, Rioux JD. New approaches to gene hunting in IBD. Inflamm. Bowel Dis. 10: 312-317 (2004). *
Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, Becker U, Bendtsen F. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53: 750-755 (2004). *
Damiano JS, Newman RM, Reed JC. Multiple roles of CLAN (caspase-associated recruitment domain, leucine-rich repeat, and NAIP CIIA HET-E, and TP1-containing protein) in the mammalian innate immune response. J. Immunol. 173: 6338-6345 (2004). *
Damiano JS, Oliveira V, Welsh K, Reed JC. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 381: 213-219 (2004). *
Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am. J. Gastroenterol. 99: 938-945 (2004). *
Danese S, Sans M, Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut 53: 1035-1043 (2004). *
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3: 394-400 (2004).
Danese S, Scaldaferri F, Papa A, Pola R, Sans M, Gasbarrini G, Pola P, Gasbarrini A. Platelets: new players in the mucosal scenario of inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 193-198 (2004).
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350: 1387-1397 (2004). *
Daniel F, Seksik P, Cacheux W, Jian R, Marteau P. Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis. Inflamm. Bowel Dis. 10: 258-260 (2004). *
Daniele B, Bencivenga A, Megna AS, Tinessa V. alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S108-S112 (2004). *
Daniels GL, Fletcher A, Garratty G, Henry S, Jorgensen J, Judd WJ, Levene C, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox. Sang. 87: 304-316 (2004). *
Dann AT, Kenyon AP, Seed PT, Poston L, Shennan AH, Tribe RM. Glutathione S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 40: 1406-1414 (2004). *
Daperno M, D'haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 60: 505-512 (2004). *
Daperno M, Sostegni R, Lavagna A, Crocella L, Ercole E, Rigazio C, Rocca R, Pera A. The role of endoscopy in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 209-214 (2004).
Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Outcome of a conservative approach in severe ulcerative colitis. Dig. Liver Dis. 36: 21-28 (2004). *
Darabi K, Karulin AY, Boehm BO, Hofstetter HH, Fabry Z, LaManna JC, Chavez JC, Tary-Lehmann M, Lehmann PV. The third signal in T cell-mediated autoimmune disease? J. Immunol. 173: 92-99 (2004). *
Darbari A, Sena L, Argani P, Oliva-Hemker JM, Thompson R, Cuffari C. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm. Bowel Dis. 10: 67-72 (2004). *
Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421 (2004). *
Darling RL, Romero JJ, Dial EJ, Akunda JK, Langenbach R, Lichtenberger LM. The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology 127: 94-104 (2004). *
Darlow JM, Farrell AM, Stott DI. Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4. Immunology 111: 212-222 (2004). *
Darlow SJ, Mandal A, Pick B, Thomas T, Mayberry JF, Robinson RJ. The short-term effects of Eudragit-L-coated prednisolone metasulphobenzoate (Predocol) on bone formation and bone mineral density in acute ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 16: 1173-1176 (2004).
Dartt DA. Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul. Surf. 2: 76-91 (2004).
Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72: 5041-5051 (2004). *
Darwish AA, Sokal E, Stephenne X, Najimi M, De Goyet Jd J, Reding R. Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl. 10: 1213-1215 (2004). *
Das A, Saxena RK. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures. Immunol. Lett. 94: 209-214 (2004).
Das D. Cancer and hereditary haemochromatosis. QJM 97: 698-699 (2004). *
Das KM. "Is foe your friend?" Inflamm. Bowel Dis. 10: 693 (2004). *
Das KM. Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294 (2004). *
Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC. Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53: 3300-3306 (2004). *
Das UN. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases. Med. Sci. Monit. 10: HY19-HY25 (2004). *
Date RS, Panesar KJ, Neilly P. Infliximab as a therapy for non-Crohn's enterocutaneous fistulae. Int. J. Colorectal Dis. 19: 603-606 (2004). *
Davalos M, Roman R, Bustios C, Zumaeta E, Yabar A. Autoimmune hepatitis: clinical forms and related factors to their response to treatment. Rev. Gastroenterol. Peru 24: 305-313 (2004).
Davenport M, De Ville de Goyet J, Stringer MD, Mieli-Vergani G, Kelly DA, McClean P, Spitz L. Seamless management of biliary atresia in England and Wales (1999-2002). Lancet 363: 1354-1357 (2004). *
Davern TJ 2nd. Acetaminophen hepatotoxicity. Hepatology 40: 1021-1022 (2004). *
Davezac N, Tondelier D, Lipecka J, Fanen P, Demaugre F, Debski J, Dadlez M, Schrattenholz A, Cahill MA, Edelman A. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/DeltaF508-CFTR to the plasma membrane. Proteomics 4: 3833-3844 (2004). *
David CS, Taneja V. Role of major histocompatibility complex genes in murine collagen-induced arthritis: a model for human rheumatoid arthritis. Am. J. Med. Sci. 327: 180-187 (2004).
Davidson AJ, Castanon-Cervantes O, Stephan FK. Daily oscillations in liver function: diurnal vs circadian rhythmicity. Liver Int. 24: 179-186 (2004). *
Davidson DJ, Gray MA, Kilanowski FM, Tarran R, Randell SH, Sheppard DN, Argent BE, Dorin JR. Murine epithelial cells: isolation and culture. J. Cyst. Fibros. 3 Suppl. 2: 59-62 (2004).
Davidson LA, Nguyen DV, Hokanson RM, Callaway ES, Isett RB, Turner ND, Dougherty ER, Wang N, Lupton JR, Carroll RJ, Chapkin RS. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 64: 6797-6804 (2004). *
Davies DR, O'Hara AJ, Irwin PJ, Guilford WG. Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. Aust. Vet. J. 82: 58-61 (2004).
Davies E, Tsang CW, Ghazali AR, Harris RM, Waring RH. Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol. In Vitro 18: 749-754 (2004).
Davies JC, Turner MW, Klein N. Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles. Eur. Respir. J. 24: 798-804 (2004). *
Davies PS, Enns CA. Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells. J. Biol. Chem. 279: 25085-25092 (2004). *
Davies RJ, Scott IS, Morris LS, Rushbrook SM, Bird K, Vowler SL, Arends M, Miller R, Coleman N. Increased expression of minichromosome maintenance protein 2 in active inflammatory bowel disease. Colorectal Dis. 6: 103-110 (2004).
Davies SJ, Lim KC, Blank RB, Kim JH, Lucas KD, Hernandez DC, Sedgwick JD, McKerrow JH. Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int. J. Parasitol. 34: 27-36 (2004). *
Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380 (2004). *
Davis J Jr, Webb A, Lund S, Sack K. Results from an open-label extension study of etanercept in ankylosing spondylitis. Arthritis Rheum. 51: 302-304 (2004). *
Davis PB, Drumm ML. Some like it hot: curcumin and CFTR. Trends Mol. Med. 10: 473-475 (2004). *
Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am. J. Physiol. Endocrinol. Metab. 286: E272-E279 (2004). *
Davis W Jr, Boyd JT, Ile KE, Tew KD. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells. Biochim. Biophys. Acta 1683: 89-100 (2004). *
Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Rheumatology (Oxford) 43: 1488-1495 (2004). *
Dawson MI. Synthetic retinoids and their nuclear receptors. Curr. Med. Chem. Anticancer Agents 4: 199-230 (2004).
Dawson PA. Molecular pathways for intestinal bile acid transport. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 53. June 18-19 (2004). *
Day A, Whitten K, Bohane T. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J. Paediatr. Child. Health 40: 681-684 (2004).
Day CP. The potential role of genes in nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 673-691, xi (2004).
Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis. Hum. Immunol. 65: 571-577 (2004).
de Bruijn MF, Speck NA. Core-binding factors in hematopoiesis and immune function. Oncogene 23: 4238-4248 (2004). *
De Carlo E, Tamagno G, Martini C, Maffei P, Rubello D, Luca M, Sicolo N. Autoimmune diabetes mellitus, Hodgkin's disease and Graves' ophthalmopathy in a patient with 8.1 ancestral haplotype. Horm. Metab. Res. 36: 97-100 (2004).
De Carolis S, Botta A, Fatigante G, Garofalo S, Ferrazzani S, Gasbarrini A,. Celiac disease and inflammatory bowel disease in pregnancy. Lupus 13: 653-658 (2004).
De Fabiani E, Mitro N, Godio C, Gilardi F, Caruso D, Crestani M. Bile acid signaling to the nucleus: finding new connections in the transcriptional regulation of metabolic pathways. Biochimie 86: 771-778 (2004).
de Franchis R, Dell'Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig. Liver Dis. 36: 787-798 (2004).
De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. Haematologica 89: 1161-1167 (2004). *
De Gottardi A, Touri F, Maurer CA, Perez A, Maurhofer O, Ventre G, Bentzen CL, Niesor EJ, Dufour JF. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig. Dis. Sci. 49: 982-989 (2004). *
de Groot CJ, Jansen MW, Bertina RM, Schonkeren JJ, Helmerhorst FM, Huizinga TW. Interleukin 10-2849AA genotype protects against pre-eclampsia. Genes Immun. 5: 313-314 (2004). *
de Groot PG, Derksen RH. Pathophysiology of antiphospholipid antibodies. Neth. J. Med. 62: 267-272 (2004). *
De Hertogh G, Geboes K. Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14 (2004). *
de Hoyos A, Loredo ML, Martinez MA, Gil MR. Use of a stiff guidewire in transjugular liver biopsy in patients with a pronounced angle of the suprahepatic veins. Ann. Hepatol. 3: 72-73 (2004). *
De Jager PL, Walsh EC, Rioux JD, Hafler DA. Re: GAMES issue study: are international genetic consortia functional? J. Neuroimmunol. 153: 5-6 (2004).
De Jesus LE, Marques AM, Rocha MS, Brom BR, Siqueira RR. Left colon stenosis caused by tuberculosis. J. Pediatr. Surg. 39: e5-e7 (2004).
De Jesus-Monge WE, Torres EA, Baez VM, De Jesus O, Rivera L, Gonzalez-Keelan C. Crohn's disease associated to chordoma: a case report. P. R. Health Sci. J. 23: 233-236 (2004).
de Jong DJ, Drenth JP. Absence of an association of the IBD2 locus gene keratin 8 and inflammatory bowel disease in a large genetic association study. Dig. Liver Dis. 36: 380-383 (2004).
De Jong DJ, Goullet M, Naber TH. Side effects of azathioprine in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 16: 207-212 (2004).
De Jong YP, Rietdijk ST, Faubion WA, Abadia-Molina AC, Clarke K, Mizoguchi E, Tian J, Delaney T, Manning S, Gutierrez-Ramos JC, Bhan AK, Coyle AJ, Terhorst C. Blocking inducible co-stimulator in the absence of CD28 impairs T(h)1 and CD25(+) regulatory T cells in murine colitis. Int. Immunol. 16: 205-213 (2004). *
De Keyser F, Baeten D, Van den Bosch F, Kruithof E, Verbruggen G, Mielants H, Veys E. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis. Drugs 64: 2793-2811 (2004).
de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34: 2480-2488 (2004). *
De Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol. 4: 9 (2004). *
de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, Staudt LM, Martinez-Climent JA, Lam WL. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum. Mol. Genet. 13: 1827-1837 (2004). *
de Lujan Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC, Carrillo MC. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40: 394-402 (2004). *
De Marco F, Liguori R, Giardina MG, D'Armiento M, Angelucci E, Lucariello A, Morante R, Cimino L, Galeota-Lanza A, Tarantino G, Ascione A, Budillon G, Vecchione R, Martinelli R, Matarazzo M, De Simone V. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy. Clin. Chem. Lab. Med. 42: 17-24 (2004).
De Meyts P, Palsgaard J, Sajid W, Theede AM, Aladdin H. Structural biology of insulin and IGF-1 receptors. Novartis Found. Symp. 262: 160-171 (2004).
de Moreno de Leblanc A, Perdigon G. Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 10: BR96-BR104 (2004). *
De Palma GD, Rega M, Puzziello A, Aprea G, Ciacci C, Castiglione F, Ciamarra P, Persico M, Patrone F, Mastantuono L, Persico G. Capsule endoscopy is safe and effective after small-bowel resection. Gastrointest. Endosc. 60: 135-138 (2004). *
De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut 53: 1520-1535 (2004). *
De Quatrebarbes J, Cordel N, Bravard P, Lenormand B, Joly P. Miescher's cheilitis and lymphocytic clonal expansion: 2 cases. Ann. Dermatol. Venereol. 131: 55-57 (2004).
de Rosbo NK, Kaye JF, Eisenstein M, Mendel I, Hoeftberger R, Lassmann H, Milo R, Ben-Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173: 1426-1435 (2004). *
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann. Rheum. Dis. 63: 1587-1593 (2004). *
De Sanctis LB, Mandreoli M, Poggi C, Pileri S, Casanova S, Santoro A. Acute renal failure in a young woman with Fisher-Evans' syndrome. J. Nephrol. 17: 739-743 (2004).
de Saussure P, Lavergne-Slove A, Mazeron MC, Alain S, Matuchansky C, Bouhnik Y. A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease. Aliment. Pharmacol. Ther. 20: 1323-1327 (2004). *
De Seze J, Dubucquoi S, Fauchais AL, Hachulla E, Matthias T, Lefranc D, Hatron PY, Vermersch P, Witte T. Autoantibodies against alpha-fodrin in Sjogren's syndrome with neurological manifestations. J. Rheumatol. 31: 500-503 (2004).
de Silva E, Stumpf MP. HIV and the CCR5-Delta32 resistance allele. FEMS Microbiol. Lett. 241: 1-12 (2004). *
De Simone M, Cioffi U, Contessini-Avesani E, Oreggia B, Paliotti R, Pierini A, Bolla G, Oggiano E, Ferrero S, Magrini F, Ciulla MM. Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol. 4: 29 (2004). *
De Tena JG, Manzano L, Leal JC, Antonio ES, Sualdea V, Alvarez-Mon M. Active Crohn's disease patients show a distinctive expansion of circulating memory CD4(+)CD45RO(+)CD28(null) T cells. J. Clin. Immunol. 24: 185-196 (2004). *
de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 17: 270-274 (2004). *
De Vos M. Joint involvement in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 36-42 (2004). *
De Vos Tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H, Vasen HF. Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer 109: 468-471 (2004). *
De Vries J, Michielsen H, Van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br. J. Health Psychol. 9: 279-291 (2004).
Decaens T, Maitre S, Marfaing A, Naveau S, Chaput JC, Mathurin P. Inflammatory bowel disease and latent thrombocythemia: a novel cause of hepatic vein thrombosis. Gastroenterol. Clin. Biol. 28: 394-397 (2004).
Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. Eur. Respir. J. 23: 679-684 (2004). *
Deenadayalu VP, Chadalawada V, Rex DK. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates. Am. J. Gastroenterol. 99: 2138-2142 (2004). *
DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int. J. Clin. Pract. Suppl. 143: 9-21 (2004).
Degner D, Grohmann R, Kropp S, Ruther E, Bender S, Engel RR, Schmidt LG. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37 Suppl. 1: S39-S45 (2004).
Degre D, Bourgeois N, Boon N, Le Moine O, Louis H, Donckier V, El Nakadi I, Closset J, Lingier P, Vereerstraeten P, Gelin M, Adler M. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl. Int. 17: 31-38 (2004).
Deguti MM, Genschel J, Cancado EL, Barbosa ER, Bochow B, Mucenic M, Porta G, Lochs H, Carrilho FJ, Schmidt HH. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum. Mutat. 23: 398 (2004). *
Deitch HR, Huppert J, Adams Hillard PJ. Unusual vulvar ulcerations in young adolescent females. J. Pediatr. Adolesc. Gynecol. 17: 13-16 (2004).
Dekker E, Fockens P. New endoscopic tools for the IBD physician. Inflamm. Bowel Dis. 10 Suppl. 1: S7-S10 (2004). *
Dekker L, Armbrust W, Rademaker CM, Prakken B, Kuis W, Wulffraat NM. Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22: 252-258 (2004).
Del Barrio M, Lacunza MM, Armendariz AC, Margall MA, Asiain MC. Liver transplant patients: their experience in the intensive care unit. A phenomenological study. J. Clin. Nurs. 13: 967-976 (2004).
del Castillo-Olivares A, Campos JA, Pandak WM, Gil G. The role of alpha1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis. J. Biol. Chem. 279: 16813-16821 (2004). *
Del Compare ME, D'Agostino D, Ferraris JR, Boldrini G, Waisman G, Krmar RT. Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr. Transplant. 8: 496-501 (2004). *
Del Giudice G, Michetti P. Inflammation, immunity and vaccines for Helicobacter pylori. Helicobacter 9 Suppl. 1: 23-28 (2004).
Delarue J, LeFoll C, Corporeau C, Lucas D. n-3 Long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev. 44: 289-299 (2004).
Delatycki M, Allen K, Gow P, MacFarlane J, Radomski C, Thompson J, Hayden M, Goldberg Y, Samuels M. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin. Genet. 65: 378-383 (2004). *
Delatycki MB, Powell LW, Allen KJ. Hereditary hemochromatosis genetic testing of at-risk children: what is the appropriate age? Genet. Test. 8: 98-103 (2004).
Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B. Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol. Endocrinol. 18: 2378-2387 (2004). *
Delgado J, Delgado B, Fich A, Odes S. Microscopic colitis. Isr. Med. Assoc. J. 6: 482-484 (2004). *
Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 127: 1685-1694 (2004). *
Delhalle S, Blasius R, Dicato M, Diederich M. A beginner's guide to NF-kappaB signaling pathways. Ann. N. Y. Acad. Sci. 1030: 1-13 (2004). *
Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, et al. The DNA sequence and comparative analysis of human chromosome 10. Nature 429: 375-381 (2004). *
Demetriou AA, Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239: 660-667 (2004). *
Demidova TN, Hamblin MR. Macrophage-targeted photodynamic therapy. Int. J. Immunopathol. Pharmacol. 17: 117-126 (2004).
Deng M, Rutherford MS, Abrahamsen MS. Host intestinal epithelial response to Cryptosporidium parvum. Adv. Drug Deliv. Rev. 56: 869-884 (2004).
Denicourt C, Dowdy SF. Medicine. Targeting apoptotic pathways in cancer cells. Science 305: 1411-1413 (2004). *
Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 101: 12634-12639 (2004). *
Denk GU, Soroka CJ, Mennone A, Koepsell H, Beuers U, Boyer JL. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology 39: 1382-1389 (2004). *
Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J. Hepatol. 40: 585-591 (2004). *
Denk H. Pathology of portal hypertension. J. Gastroenterol. Hepatol. 19: S346-S348 (2004). *
Denk H, Stumptner C, Fuchsbichler A, Zatloukal K. Mallory bodies and liver diseases. J. Gastroenterol. Hepatol. 19: S349-S352 (2004). *
Denkers EY, Butcher BA, Del Rio L, Kim L. Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection. Immunol. Rev. 201: 191-205 (2004). *
Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T. Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.) 52: 389-400 (2004).
Denman AM, Rager-Zisman B. Viruses and autoimmune diseases-adapting Koch's postulates. Autoimmun. Rev. 3: 355-361 (2004).
Dennis CL. Preventing postpartum depression part I: a review of biological interventions. Can. J. Psychiatry 49: 467-475 (2004).
Derichs N, Mekus F, Bronsveld I, Bijman J, Veeze HJ, von der Hardt H, Tummler B, Ballmann M. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients. Pediatr. Res. 55: 69-75 (2004). *
Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, Curvers WL, Van Deventer SJ, Hommes DW, Hooymans PM. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy. Ther. Drug Monit. 26: 311-318 (2004).
Derk CT, Vivino FB. A primary care approach to Sjogren's syndrome. Helping patients cope with sicca symptoms, extraglandular manifestations. Postgrad. Med. 116: 49-54, 59, 65 (2004).
Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Clin. Ther. 26: 1599-1607 (2004). *
des Georges M, Guittard C, Altieri JP, Templin C, Sarles J, Sarda P, Claustres M. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France. J. Cyst. Fibros. 3: 265-272 (2004).
Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 77: 99-106 (2004).
Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, Seidman EG. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 139-146 (2004). *
Desmet VJ. Pathogenesis of ductal plate malformation. J. Gastroenterol. Hepatol. 19: S356-S360 (2004). *
Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J. Hepatol. 40: 860-867 (2004). *
Desmond CP, Roberts SK. Exercise-related abdominal pain as a manifestation of the median arcuate ligament syndrome. Scand. J. Gastroenterol. 39: 1310-1313 (2004). *
Desreumaux P, Romano O. 5-Aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease? Gastroenterol. Clin. Biol. 28: 509 (2004).
Deters M, Kirchner G, Koal T, Resch K, Kaever V. Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats. Dig. Dis. Sci. 49: 30-37 (2004). *
Dethloff T, Hansen BA, Larsen FS. Tacrolimus ameliorates cerebral vasodilatation and intracranial hypertension in the rat with portacaval anastomosis and hyperammonemia. Liver Transpl. 10: 922-927 (2004). *
Detry O, De Roover A, Coimbra C, Delwaide J, Szapiro D, Kaba A, Joris J, Damas P, Meurisse M, Honore P. Autoimmune cirrhosis treated by liver transplantation using the right hepatic lobe from a living related donor. Rev. Med. Liege. 59: 69-74 (2004).
Detry O, De Roover A, Delwaide J, Coimbra C, Kaba A, Joris J, Damas P, Meurisse M, Honore P. Living related liver transplantation in adults: first year experience at the University of Liege. Acta Chir. Belg. 104: 166-171 (2004).
Deugnier Y. Hemochromatosis. Rev. Prat. 54: 669-673 (2004).
Deugnier Y, Le Gall JY. Should we support large-scale screening for genetic haemochromatosis in France? Bull. Acad. Natl. Med. 188: 265-272 (2004).
Devany M, Kotharu NP, Matsuo H. Solution NMR structure of the C-terminal domain of the human protein DEK. Protein Sci. 13: 2252-2259 (2004). *
Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun. 5: 597-608 (2004). *
Devaux J, Beeton C, Beraud E, Crest M. Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers. Rev. Neurol. (Paris) 160: 16-27 (2004).
Devchand PR, Ziouzenkova O, Plutzky J. Oxidative stress and peroxisome proliferator-activated receptors: reversing the curse? Circ. Res. 95: 1137-1139 (2004). *
Devendra D, Galloway TS, Horton SJ, Wilkin TJ. Exploring the idiotypes of insulin antibodies as markers for remission in type 1 diabetes. Diabet. Med. 21: 1316-1324 (2004). *
Devenny A, Wassall H, Ninan T, Omran M, Khan SD, Russell G. Respiratory symptoms and atopy in children in Aberdeen: questionnaire studies of a defined school population repeated over 35 years. BMJ 329: 489-490 (2004). *
Devitt A, Parker KG, Ogden CA, Oldreive C, Clay MF, Melville LA, Bellamy CO, Lacy-Hulbert A, Gangloff SC, Goyert SM, Gregory CD. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 167: 1161-1170 (2004). *
Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can. J. Gastroenterol. 18: 321-326 (2004). *
Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of coeliac disease. Int. J. Biochem. Cell. Biol. 36: 17-24 (2004). *
Dhawan A. Acute liver failure in childhood. J. Gastroenterol. Hepatol. 19: S382-S385 (2004). *
Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr. Transplant. 8: 584-588 (2004).
Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, Arya R, Wade JJ, Verma A, Heaton ND, Rela M, Mieli-Vergani G. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78: 1812-1814 (2004).
Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology 127: 1855-1857 (2004). *
Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S104-S107 (2004). *
Di Bisceglie AM. Screening for hepatocellular carcinoma: being old is not all bad. Am. J. Gastroenterol. 99: 1477-1478 (2004). *
Di Bisceglie AM, Loyet M, Peters M. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Minerva Med. 95: 529-534 (2004).
Di Fiore F, Lecleire S, Herve S, Savoye G, Lerebours E. Life-threatening bleeding revealing gastric involvement in a Crohn's disease patient. J. Clin. Gastroenterol. 38: 833-834 (2004).
Di Lorenzo G, Pacor ML, Mansueto P, Lo Bianco C, Di Natale E, Rapisarda F, Pellitteri ME, Ditta V, Gioe A, Giammarresi G, Rini GB, Li Vecchi M. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis. J. Nephrol. 17: 800-807 (2004).
Di Mola FF, Di Sebastiano P, Gardini A, Innocenti P, Zimmermann A, Buchler MW, Friess H. Differential expression of connective tissue growth factor in inflammatory bowel disease. Digestion 69: 245-253 (2004).
Di Rocco P, Manco M, Rosa G, Greco AV, Mingrone G. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes. Res. 12: 734-739 (2004). *
Di Sabatino A, Armellini E, Corazza GR. Doppler sonography in the diagnosis of inflammatory bowel disease. Dig. Dis. 22: 63-66 (2004).
Di Sabatino A, Carsetti R, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Tinozzi FP, Tinozzi S, Corazza GR. Immunoglobulin M memory B cell decrease in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 8: 199-203 (2004).
Di Sabatino A, Ciccocioppo R, Armellini E, Morera R, Ricevuti L, Cazzola P, Fulle I, Corazza GR. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease. Inflamm. Bowel Dis. 10: 573-577 (2004). *
Di Sabatino A, Ciccocioppo R, Benazzato L, Sturniolo GC, Corazza GR. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. Aliment. Pharmacol. Ther. 19: 1019-1024 (2004). *
Di Sabatino A, Ciccocioppo R, Cinque B, Millimaggi D, Morera R, Ricevuti L, Cifone MG, Corazza GR. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut 53: 70-77 (2004). *
Di Sario A, Bendia E, Macarri G, Candelaresi C, Taffetani S, Marzioni M, Omenetti A, De Minicis S, Trozzi L, Benedetti A. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. Dig. Liver Dis. 36: 744-751 (2004).
Di Stefano G, Derenzini M, Kratz F, Lanza M, Fiume L. Liver-targeted doxorubicin: effects on rat regenerating hepatocytes. Liver Int. 24: 246-252 (2004). *
Di Tola M, Sabbatella L, Anania MC, Viscido A, Caprilli R, Pica R, Paoluzi P, Picarelli A. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin. Chem. Lab. Med. 42: 1092-1097 (2004).
Di-Poi N, Michalik L, Desvergne B, Wahli W. Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis. Lipids 39: 1093-1099 (2004).
Dia D, Ba-Fall K, Bouldouyre M, Chevalier B, Debonne JM. DRESS syndrome to allopurinol: a case in Dakar. Dakar Med. 49: 114-115 (2004).
Diab A, Hussain RZ, Lovett-Racke AE, Chavis JA, Drew PD, Racke MK. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148: 116-126 (2004).
Diaco M, Ancarini F, Montalto M, Verrechia E, Evoli A, Servidei S, Gasbarrini G, Manna R. Association of myasthenia gravis and antisynthetase syndrome: a case report. Int. J. Immunopathol. Pharmacol. 17: 395-400 (2004).
Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M. Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 39: 302-303 (2004). *
Diamantis I, Boumpas DT. Autoimmune hepatitis: evolving concepts. Autoimmun. Rev. 3: 207-214 (2004).
Diaz FJ, Davalos MM, Roman VR, Bustios SC, Zumaeta VE. Hepatotoxicity and pancreatitis associated with gold salts: case report. Rev. Gastroenterol. Peru 24: 353-356 (2004).
Diaz Rodriguez C, Gonzalez Rivero C, Trinidad San Jose JC, Del Rio Romero D, Moreno Fernandez A, Granja Romero E. Osteal complications as first manifestation in a patient with primary Sjogren's syndrome and with associated distal tubular acidosis (type 1) and chronic renal insufficiency. Therap. Apher. Dial. 8: 160-163 (2004).
Diaz Rodriguez C, Granja E, Vazquez Martul E, Sacristan F, Moreno Fernandez A, Gonzalez Rivero C, del Rio Romero D, Trinidad JC. Association between membranous glomerulonephritis and Crohn's disease. Nefrologia 24: 368-371 (2004).
Diaz VM, Hurtado M, Thomson TM, Reventos J, Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 53: 993-1000 (2004). *
Diaz-Lopez C, Geli C, Corominas H, Malat N, Diaz-Torner C, Llobet JM, De La Serna AR, Laiz A, Moreno M, Vazquez G. Are there clinical or serological differences between male and female patients with primary Sjogren's syndrome? J. Rheumatol. 31: 1352-1355 (2004). *
Diaz-Valle D, Benitez del Castillo JM, Fernandez Acenero MJ, Pascual Allen D, Moriche Carretero M. Bilateral lid margin ulcers as the initial manifestation of Crohn disease. Am. J. Ophthalmol. 138: 292-294 (2004). *
DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am. J. Gastroenterol. 99: 1823-1832 (2004). *
Dice JP. Physical urticaria. Immunol. Allergy Clin. North Am. 24: 225-246, vi (2004).
Dickey W, Hughes DF. Histology of the terminal ileum in coeliac disease. Scand. J. Gastroenterol. 39: 665-667 (2004). *
Dickins M. Induction of cytochromes P450. Curr. Top. Med. Chem. 4: 1745-1766 (2004).
Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E; Eurobank members. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 127: 479-490 (2004). *
Diczfalusy U. Analysis of cholesterol oxidation products in biological samples. J. AOAC Int. 87: 467-473 (2004).
Diebold MD, Samalin E, Merle C, Bouche O, Higuero T, Jolly D, Ramaholimihaso F, Renard P, Yaziji N, Thiefin G, Cadiot G. Colonic flat neoplasia: frequency and concordance between endoscopic appearance and histological diagnosis in a French prospective series. Am. J. Gastroenterol. 99: 1795-1800 (2004). *
Diebold SS, Kaisho T, Hemmi H, Akira S, Reis E Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531 (2004). *
Diedegraefe B. Giving the NOD to a new understanding of Crohn's disease: mother nature has finally started to show her CARDs. Inflamm. Bowel Dis. 10: 171-172 (2004). *
Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 619-638, x (2004).
Diehl AM. Fatty liver, hypertension, and the metabolic syndrome. Gut 53: 923-924 (2004). *
Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, Lenz LL, Cado D, Riley LW, Winoto A. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 21: 877-889 (2004). *
Dieleman LA, Hoentjen F, Qian BF, Sprengers D, Tjwa E, Torres MF, Torrice CD, Sartor RB, Tonkonogy SL. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin. Exp. Immunol. 136: 30-39 (2004). *
Dienes HP. Liver histology in autoimmune hepatitis - diagnostic implications. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 51 (2004). *
Dierkes J, Westphal S, Luley C. The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels. Expert Opin. Drug Saf. 3: 101-111 (2004).
Dieter MZ, Maher JM, Cheng X, Klaassen CD. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 139: 209-218 (2004). *
Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 53: 401-405 (2004). *
Dietrich CG, Gartung C, Lorenzen J, Geier A, Wasmuth HE, Matern S, Lammert F. Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma. Ann. Hepatol. 3: 118-120 (2004). *
Dietrich CG, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink RP, Matern S, Gartung C. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology 126: 1044-1053 (2004). *
Dietrich CG, Geier A, Wasmuth HE, Matern S, Gartung C, de Waart DR, Oude Elferink RP. Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen. Gut 53: 1850-1855 (2004). *
Dieude P, Osorio J, Petit-Teixeira E, Moreno S, Garnier S, Cailleau-Moindrault S, Stalens C, Lasbleiz S, Bardin T, Prum B, Cornelis F. A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum. 50: 413-419 (2004). *
Dif F, Marty C, Baudoin C, De Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone 35: 595-603 (2004).
Dignass AU, Baumgart DC, Sturm A. The aetiopathogenesis of inflammatory bowel disease - immunology and repair mechanisms. Aliment. Pharmacol. Ther. 20 Suppl. 4: 9-17 (2004). *
Dijkmans BA, Jansen G. Antimetabolites in the treatment of arthritis: current status of the use of antimetabolites. Nucleosides Nucleotides Nucleic Acids 23: 1083-1088 (2004).
Dijkstra G, Blokzijl H, Bok L, Homan M, van Goor H, Nico Faber K, Jansen PL, Moshage H. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol. 204: 296-303 (2004). *
Dijkstra G, van Goor H, Jansen PL, Moshage H. Targeting nitric oxide in the gastrointestinal tract. Curr. Opin. Investig. Drugs 5: 529-536 (2004).
Dikopoulos N, Wegenka U, Kroger A, Hauser H, Schirmbeck R, Reimann J. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse. Hepatology 39: 1256-1266 (2004). *
Dikow R, Degenhard M, Kraus T, Sauer P, Schemmer P, Uhl W, Buchler M, Zeier M. Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. Transplant. Proc. 36: 1512-1515 (2004). *
Diks SH, Kok K, O'Toole T, Hommes DW, Van Dijken P, Joore J, Peppelenbosch MP. Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells. J. Biol. Chem. 279: 49206-49213 (2004). *
Dilger K, Schwab M, Fromm MF. Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm. Bowel Dis. 10: 578-583 (2004). *
Dillon FX. Anesthesia issues in the perioperative management of myasthenia gravis. Semin. Neurol. 24: 83-94 (2004).
Dimagno MJ, Dimagno EP. Chronic pancreatitis. Curr. Opin. Gastroenterol. 20: 444-451 (2004).
Dimakou K, Papaioannides D, Latsi P, Katsimboula S, Korantzopoulos P, Orphanidou D. Disseminated tuberculosis complicating anti-TNF-alpha treatment. Int. J. Clin. Pract. 58: 1052-1055 (2004). *
Dimasi N, Moretta L, Biassoni R. Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules. Immunol. Res. 30: 95-104 (2004). *
Dimoulios F, Kolios G, Notas G, Xidakis C, Tsagarakis N, Kouroumalis A, Kouroumalis E. Increased circulating endothelin-2 may be a fundamental abnormality in primary biliary cirrhosis. J. Hepatol. 40 Suppl. 1: 160 (2004).
Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharmacol. 4: 378-385 (2004).
Ding JW, Wang K, Brems JJ, Gamelli RL. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent. J. Am. Coll. Surg. 198: 67-77 (2004). *
Ding LA, Li JS, Li YS, Zhu NT, Liu FN, Tan L. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378 (2004). *
Ding SZ, O'hara AM, Denning TL, Dirden-Kramer B, Mifflin RC, Reyes VE, Ryan KA, Elliott SN, Izumi T, Boldogh I, Mitra S, Ernst PB, Crowe SE. Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127: 845-858 (2004). *
Ding WX, Ni HM, DiFrancesca D, Stolz DB, Yin XM. Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes. Hepatology 40: 403-413 (2004). *
Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell. Mol. Med. 8: 445-454 (2004). *
Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, Crusius JB, Meijer JW, Duggan DJ, Mulder CJ, Holstege FC, Wijmenga C. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 53: 944-951 (2004). *
Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, Petersen BT, Jaffe PE, Morales TG, Hixson LJ, Sherman S, Lehman GA, Jamal MM, Al-Kawas FH, Khandelwal M, Moore JP, Derfus GA, Jamidar PA, Ramirez FC, Ryan ME, Woods KL, Carr-Locke DL, Alder SC. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127: 1291-1299 (2004). *
Dissemond J. Oral lichen planus: an overview. J. Dermatolog. Treat. 15: 136-140 (2004).
Distante S, Robson KJ, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum. Genet. 115: 269-279 (2004). *
Ditsworth D, Zong WX. NF-kappaB: key mediator of inflammation-associated cancer. Cancer Biol. Ther. 3: 1214-1216 (2004). *
Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114: 57-66 (2004). *
Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss Hepatology 39: 1647-1654 (2004). *
Djilali-Saiah I, Renous R, Caillat-Zucman S, Debray D, Alvarez F. Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients. J. Hepatol. 40: 904-909 (2004).
Doboseru R, Drug VL, Azoicai D, Mitrica D, Mihai C, Tarasi I, Popa I, Cijevschi-Prelipcean C, Stanciu C. The changing spectrum of lower gastrointestinal haemorrhages. Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 90-93 (2004).
Dodgson JB, Romanov MN. Use of chicken models for the analysis of human disease. Curr. Protoc. Hum. Genet. Chapter 15: Unit 15.5 (2004).
Dodig S, Cepelak I. The facts and controversies about selenium. Acta Pharm. 54: 261-276 (2004).
Dodon MD, Li Z, Hamaia S, Gazzolo L. Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells. J. Gen. Virol. 85: 1921-1932 (2004). *
Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N, Ruemmele FM. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn�s disease. Gut 53: 1632-1638 (2004). *
Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova JL, Longhurst HJ, Kumararatne DS. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin. Infect. Dis. 38: e10-e14 (2004). *
Doganci T, Bozkurt S. Celiac disease with various presentations. Pediatr. Int. 46: 693-696 (2004).
Doganci T, Sayli T, Gulderen F, Erden E, Sencer H. Case of disseminated Langerhans' cell histiocytosis presenting with sclerosing cholangitis. Int. J. Dermatol. 43: 673-675 (2004). *
Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocul. Surf. 2: 59-75 (2004).
Doherty MJ, Healy M, Richardson SG, Fisher NC. Total body iron overload in welder's siderosis. Occup. Environ. Med. 61: 82-85 (2004). *
Doherty TM, Fitzpatrick LA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clin. Proc. 79: 197-210 (2004). *
Dohi T, Fujihashi K, Koga T, Etani Y, Yoshino N, Kawamura YI, McGhee JR. CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. Am. J. Pathol. 165: 1257-1268 (2004). *
Dohmen K, Mizuta T, Nakamuta M, Shimohashi N, Ishibashi H, Yamamoto K. Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J. Gastroenterol. 10: 894-898 (2004). *
Dolegowska B, Chlubek D. Isoprostanes - new possibility of the oxidative stress estimation. Przegl. Lek. 61: 1410-1414 (2004).
Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G. Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127: 1513-1524 (2004). *
Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D. The prevalence of celiac disease among family members of celiac disease patients. Wien. Klin. Wochenschr. 116 Suppl. 2: 8-12 (2004).
Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment. Pharmacol. Ther. 20: 615-621 (2004). *
Domagk D, Wessling J, Reimer P, Hertel L, Poremba C, Senninger N, Heinecke A, Domschke W, Menzel J. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am. J. Gastroenterol. 99: 1684-1689 (2004). *
Domenech E, Hinojosa J, Esteve-Comas M, Gomollon F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA; for the Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment. Pharmacol. Ther. 20: 1347-1352 (2004). *
Domenech E, Scala L, Bernal I, Garcia-Planella E, Casalots A, Pinol M, Esteve-Comas M, Cabre E, Boix J, Gassull MA. Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study. Gastroenterol. Hepatol. 27: 563-567 (2004).
Domenech Morral E. Serologic disease markers in inflammatory bowel disease. Med. Clin. (Barc.) 122: 138-139 (2004).
Doms RW. Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. Top. HIV Med. 12: 100-103 (2004). *
Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M, Robert A, Deville A, Mazingue F, David M, Brauner R, Cabrol S, Garel C, Polak M; French LCH Study Group. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J. Clin. Endocrinol. Metab. 89: 604-609 (2004). *
Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 3: 19 (2004). *
Donaldson PT. The role of genetics in immunopathogenesis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 47-48 (2004). *
Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53: 599-608 (2004). *
Donaldson PT. Genetics of autoimmune and viral liver diseases; understanding the issues. J. Hepatol. 41: 327-332 (2004). *
Donate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res. 64: 5812-5817 (2004). *
Donate F, McCrae K, Shaw DE, Mazar AP. Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapy. Curr. Cancer Drug Targets 4: 543-553 (2004).
Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, Bolondi L. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 53: 1020-1023 (2004). *
Dong H, Zhu G, Tamada K, Flies DB, Van Deursen JM, Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 20: 327-336 (2004). *
Dong J, Lai R, Nielsen K, Fekete CA, Qiu H, Hinnebusch AG. The essential ATP-binding cassette protein RLI1 functions in translation by promoting preinitiation complex assembly. J. Biol. Chem. 279: 42157-42168 (2004). *
Dong WG, Liu SP, Zhu HH, Luo HS, Yu JP. Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitis. World J. Gastroenterol. 10: 606-609 (2004). *
Dong Z, Wei H, Sun R, Hu Z, Gao B, Tian Z. Involvement of natural killer cells in PolyI:C-induced liver injury. J. Hepatol. 41: 966-973 (2004). *
Donmez B, Ozakbas S, Oktem MA, Gedizlioglu M, Coker I, Genc A, Idiman E. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum. Immunol. 65: 752-757 (2004).
Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J. Invest. Dermatol. 123: 484-487 (2004). *
Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 76: 314-321 (2004). *
Donner MG, Warskulat U, Saha N, Haussinger D. Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol. Chem. 385: 331-339 (2004).
Donninger H, Cashmore TJ, Scriba T, Petersen DC, Janse van Rensburg E, Hayes VM. Functional analysis of novel SLC11A1 (NRAMP1) promoter variants in susceptibility to HIV-1. J. Med. Genet. 41: e49 (2004). *
Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, Elson CO. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm. Bowel Dis. 10: 1-14 (2004). *
Doria A, Iaccarino L, Ghirardello A, Briani C, Zampieri S, Tarricone E, Gambari PF. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease. Lupus 13: 690-695 (2004).
Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 127: 714-722 (2004). *
Doring F, Rimbach G, Lodge JK. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life. 56: 615-620 (2004). *
Dorlochter L, Carlsson M, Olafsdottir EJ, Roksund OD, Rosendahl K, Fluge G. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J. Cyst. Fibros. 3: 179-183 (2004).
Dorn SD, Abad JF, Panagopoulos G, Korelitz BI. Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna classification. Inflamm. Bowel Dis. 10: 201-206 (2004). *
Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res. Ther. 6: R199-R207 (2004). *
Dorsey RR, Andresen EM, Moore TL. Health-related quality of life and support group attendance for patients with systemic lupus erythematosus. J. Clin. Rheumatol. 10: 6-9 (2004).
Dorwart M, Thibodeau P, Thomas P. Cystic fibrosis: recent structural insights. J. Cyst. Fibros. 3 Suppl. 2: 91-94 (2004).
Doshi M, Watanabe S, Niimoto T, Kawashima H, Ishikura Y, Kiso Y, Hamazaki T. Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice. Biol. Pharm. Bull. 27: 319-323 (2004). *
Douglas G, Reilly C, Dooley MA, Page G, Cooper G, Gilkeson G. Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J. Rheumatol. 31: 1756-1762 (2004).
Douwes J, Le Gros G, Gibson P, Pearce N. Can bacterial endotoxin exposure reverse atopy and atopic disease? J. Allergy Clin. Immunol. 114: 1051-1054 (2004). *
Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 279: 21924-21928 (2004). *
Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br. J. Dermatol. 151: 766-775 (2004). *
Doyle H, Gass A, Kennison R. Open access and scientific societies. PLoS Biol. 2: E156 (2004). *
Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M. Hypervariable genes - experimental error or hidden dynamics. Nucleic Acids Res. 32: e147 (2004). *
Drakes M, Blanchard T, Czinn S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72: 3299-3309 (2004). *
Drakes ML, Czinn SJ, Blanchard TG. Isolation and purification of colon lamina propria dendritic cells from mice with colitis. Cytotechnology 46: 151-161 (2004). *
Dranoff JA, Kruglov EA, Toure J, Braun N, Zimmermann H, Jain D, Knowles AF, Sevigny J. Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis. J. Investig. Med. 52: 475-482 (2004).
Dranoff JA, Ogawa M, Kruglov EA, Gaca MD, Sevigny J, Robson SC, Wells RG. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G417-G424 (2004). *
Drastich P, Ryska M, Trunecka P, Martinek J, Spicak J. Activity and neoplastic potential of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis. Gastroenterology 126: A649 (2004).
Dray X, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin. Gastroenterol. Hepatol. 2: 498-503 (2004). *
Drazen JM, Curfman GD. Public access to biomedical research. N. Engl. J. Med. 351: 1343 (2004). *
Dresner-Pollak R, Ackerman Z, Eliakim R, Karban A, Chowers Y, Fidder HH. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genet. Test. 8: 417-420 (2004).
Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127: 792-801 (2004). *
Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 135: 64-73 (2004). *
Drosos AA, Georgiadis AN, Metafratzi ZM, Voulgari PV, Efremidis SC, Bai M. Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome. Scand. J. Rheumatol. 33: 119-122 (2004). *
Du C, Fujii Y, Ito M, Harada M, Moriyama E, Shimada R, Ikemoto A, Okuyama H. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J. Nutr. Biochem. 15: 273-280 (2004). *
Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol. Res. 30: 261-278 (2004). *
Du ZY, Demizieux L, Degrace P, Gresti J, Moindrot B, Liu YJ, Tian LX, Cao JM, Clouet P. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout. Lipids 39: 849-855 (2004).
Duan RS, Chen Z, Bao L, Quezada HC, Nennesmo I, Winblad B, Zhu J. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis. Neurobiol. Dis. 16: 630-637 (2004).
Duan YY, Wu J, Zhu JL, Liu SL, Ozaki I, Strayer DS, Zern MA. Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology 127: 1222-1232 (2004). *
Dubcenco E, Jeejeebhoy KN, Tang SJ, Baker JP. The value of capsule endoscopy in the diagnosis and management of Crohn's disease: report of two cases. Gastrointest. Endosc. 59: 314-316 (2004). *
Dubertret L. Psoriasis: a disease of the quality of life. Rev. Prat. 54: 17-18 (2004).
Dubertret L. Therapeutic negotiation in psoriasis. Rev. Prat. 54: 35-39 (2004).
Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin. Gastroenterol. Hepatol. 2: 731-743 (2004). *
Dubinsky MC. Targeting therapy in pediatric inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 7: 391-405 (2004).
Dubinsky MC. Diffuse jejunoileitis in adolescence. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 70. May 7-8 (2004). *
Dubois RN. Disease prevention: the future is here. Gastroenterology 127: 1289 (2004). *
DuBois S, Kowdley KV. Targeted screening for hereditary haemochromatosis in high-risk groups. Aliment Pharmacol. Ther. 20: 1-14 (2004). *
Ducasse E, Roy F, Chevalier J, Massouille D, Smith M, Speziale F, Fiorani P, Puppinck P. Aneurysm of the pancreaticoduodenal arteries with a celiac trunk lesion: current management. J. Vasc. Surg. 39: 906-911 (2004). *
Duch BU, Andersen H, Gregersen H. Mechanical properties of the porcine bile duct wall. Biomed. Eng. Online 3: 23 (2004). *
Duda K, Chi YI, Shoelson SE. Structural basis for HNF-4alpha activation by ligand and coactivator binding. J. Biol. Chem. 279: 23311-23316 (2004). *
Dudda JC, Simon JC, Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J. Immunol. 172: 857-863 (2004). *
Dudley F. Management of refractory ascites. J. Gastroenterol. Hepatol. 19: S194-S199 (2004). *
Duenas AI, Orduna A, Sanchez Crespo M, Garcia-Rodriguez C. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int. Immunol. 16: 1467-1475 (2004). *
Duet M, Liote F. Somatostatin and somatostatin analog scintigraphy: any benefits for rheumatology patients? Joint Bone Spine 71: 530-535 (2004).
Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am. J. Gastroenterol. 99: 2178-2185 (2004). *
Dugueperoux I, Bellis G, Lesure JF, Renouil M, Flodrops H, De Braekeleer M. Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation. J. Cyst. Fibros. 3: 185-188 (2004).
Dugueperoux I, De Braekeleer M; The Participating Centres to the French National Cystic Fibrosis Registry. Genotype-phenotype relationship for five CFTR mutations frequently identified in Western France. J. Cyst. Fibros. 3: 259-263 (2004).
Dujardin HC, Burlen-Defranoux O, Boucontet L, Vieira P, Cumano A, Bandeira A. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells. Proc. Natl. Acad. Sci. U.S.A. 101: 14473-14478 (2004). *
Dulai GS, Jensen DM, Kovacs TO, Gralnek IM, Jutabha R. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 36: 68-72 (2004).
Dulos J, Verbraak E, Bagchus WM, Boots AM, Kaptein A. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta. Arthritis Rheum. 50: 3346-3353 (2004). *
Dulundu E, Sugawara Y, Makuuchi M. Revolution and refinement of surgical techniques for living donor partial liver transplantation. Yonsei Med. J. 45: 1076-1088 (2004). *
Dunajska K, Szymczak J. Autoimmune multiglandular syndrome type I - a case study. Pol. Merkuriusz. Lek. 17: 625-628 (2004).
Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM et al. The DNA sequence and analysis of human chromosome 13. Nature 428: 522-528 (2004). *
Dunn P, Kuo TT, Shih LY, Lin TL, Wang PN, Kuo MC, Tang CC. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Haematol. 112: 203-208 (2004).
Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 173: 1166-1170 (2004). *
Duplantier JG, Dubuisson L, Senant N, Freyburger G, Laurendeau I, Herbert JM, Desmouliere A, Rosenbaum J. A role for thrombin in liver fibrosis. Gut 53: 1682-1687 (2004). *
Durakovic C, Ray S, Holick MF. Topical paricalcitol (19-nor-1alpha,25-dihydroxyvitamin D) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. Br. J. Dermatol. 151: 190-195 (2004).
Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, Staels B. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53: 890-898 (2004). *
Durand DV, Francois S, Nove-Josserand R, Durupt S, Durieu I, Morel Y, Rousset H. Haemochromatosis screening in 120 patients complaining with persistant fatigue. Rev. Med. Interne. 25: 623-628 (2004).
Durand E, Boutin P, Meyre D, Charles MA, Clement K, Dina C, Froguel P. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 53: 2483-2486 (2004). *
Durant S, Pederzoli M, Lepelletier Y, Canteloup S, Nusbaum P, Lesavre P, Witko-Sarsat V. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation. J. Leukoc. Biol. 75: 87-98 (2004). *
Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, Goldstein RL, Ghobrial M, Busuttil RW. Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 99: 950-952 (2004). *
Durazzo M, Premoli A, Morello E. Autoimmune hepatitis: present knowledges. Minerva Med. 95: 1-9 (2004).
Durazzo M, Rosina F, Premoli A, Morello E, Fagoonee S, Innarella R, Solerio E, Pellicano R, Rizzetto M. Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. World J. Gastroenterol. 10: 3179-3181 (2004). *
Durie PR, Kent G, Phillips MJ, Ackerley CA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am. J. Pathol. 164: 1481-1493 (2004). *
Durst KL, Hiebert SW. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene 23: 4220-4224 (2004). *
Duseja A, Murlidharan R, Bhansali A, Sharma S, Das A, Das R, Chawla Y. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis - a preliminary report. Indian J. Gastroenterol. 23: 12-15 (2004). *
Duseja A, Nanda M, Das A, Das R, Bhansali A, Chawla Y. Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis. Trop. Gastroenterol. 25: 15-17 (2004).
Duthie SJ, Narayanan S, Sharp L, Little J, Basten G, Powers H. Folate, DNA stability and colo-rectal neoplasia. Proc. Nutr. Soc. 63: 571-578 (2004). *
Duty SM, Calafat AM, Silva MJ, Brock JW, Ryan L, Chen Z, Overstreet J, Hauser R. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. J. Androl. 25: 293-302 (2004).
Duval C, Fruchart JC, Staels B. PPAR alpha, fibrates, lipid metabolism and inflammation. Arch. Mal. Coeur. Vaiss. 97: 665-672 (2004).
Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens 63: 13-20 (2004). *
Duvoix A, Delhalle S, Blasius R, Schnekenburger M, Morceau F, Fougere M, Henry E, Galteau MM, Dicato M, Diederich M. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 68: 1101-1011 (2004). *
Duvoux C. Severe hepatitis during Wilson's disease. Gastroenterol. Clin. Biol. 28: 202-205 (2004).
Duvoux C, Radier C, Roudot-Thoraval F, Maille F, Anglade MC, Van Nhieu JT, Rosa I, Hospitel S, Abd-Alsamad I, Sitruk V, Seror O, Ziol M, Blondon H, Dhumeaux D, Richardet JP. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis. Hepatology 40: 1370-1378 (2004). *
Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA, Adjei AA. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J. Clin. Oncol. 22: 4810-4815 (2004). *
Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 3: 104-110 (2004).
Dyment DA, Sadovnick AD, Willer CJ, Armstrong H, Cader ZM, Wiltshire S, Kalman B, Risch N, Ebers GC; Canadian Collaborative Study Group. An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group. Hum. Mol. Genet. 13: 1005-1015 (2004). *
Dyment DA, Steckley JL, Morrison K, Willer CJ, Cader MZ, DeLuca GC, Sadovnick AD, Risch N, Ebers GC; Canadian Collaborative Study Group. TCR beta polymorphisms and multiple sclerosis. Genes Immun. 5: 337-342 (2004). *
Dzhagalov I, Giguere V, He YW. Lymphocyte development and function in the absence of retinoic acid-related orphan receptor alpha. J. Immunol. 173: 2952-2959 (2004). *
Dziarski R. Peptidoglycan recognition proteins (PGRPs). Mol. Immunol. 40: 877-886 (2004). *
Dzidzuguri DV, Bakuradze ED, Kakhidze IG, Megrelishvili GZ, Kordzaia DD. Regeneration of white rat liver during cholestasis. Tsitologiia 46: 411-415 (2004).
Dzierzewicz Z, Cwalina B, Weglarz L, Wisniowska B, Szczerba J. Susceptibility of Desulfovibrio desulfuricans intestinal strains to sulfasalazine and its biotransformation products. Med. Sci. Monit. 10: BR185-BR190 (2004). *
Dziki A, Galbfach P. Crohn's disease - when to operate? Acta Chir. Iugosl. 51: 61-68 (2004).
Ea CK, Sun L, Inoue JI, Chen ZJ. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. U.S.A. 101: 15318-15323 (2004). *
Eaden J. Colorectal carcinoma and inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 24-30 (2004). *
Eapen CE, Santhosh S, Shaji RV, Chandy M, Chandy GM. Gene symbol: ATP7B. Disease: Wilson's disease. Hum. Genet. 114: 606 (2004).
Ebbeson RL, Schreiber RA. Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? Clin. Gastroenterol. Hepatol. 2: 935-940 (2004). *
Eberl G, Littman DR. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305: 248-251 (2004). *
Ebinger M, Leidl R, Thomas S, Von Tirpitz C, Reinshagen M, Adler G, Konig HH. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J. Gastroenterol. Hepatol. 19: 192-199 (2004). *
Ebrahimi Daryani N, Aghamohammadi A, Mousavi Mirkala MR, Bashashati M, Rezaei N, Haghpanah B, Hashtroudi AA, Sayyah A. Gastrointestinal complications in two patients with common variable immunodeficiency. Iran. J. Allergy Asthma Immunol. 3: 149-152 (2004).
Echchgadda I, Song CS, Oh TS, Cho SH, Rivera OJ, Chatterjee B. Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR). Mech. Ageing Dev. 125: 733-745 (2004).
Echchgadda I, Song CS, Roy AK, Chatterjee B. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol. Pharmacol. 65: 720-729 (2004). *
Ecker GF, Pleban K, Kopp S, Csaszar E, Poelarends GJ, Putman M, Kaiser D, Konings WN, Chiba P. A three dimensional model for the substrate binding domain of the multidrug ABC transporter LmrA. Mol. Pharmacol. 66: 1169-1179 (2004). *
Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr. Opin. Gastroenterol. 20: 82-88 (2004).
Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99: 2393-2404 (2004). *
Edfeldt K, Bennet AM, Eriksson P, Frostegard J, Wiman B, Hamsten A, Hansson GK, Faire Ud U, Yan ZQ. Association of hypo-responsive Toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25: 1447-1453 (2004). *
Edna TH, Bjerkeset T, Skreden K. Abdominal surgery for Crohn's disease during 30 years in Middle Norway. Hepatogastroenterology 51: 481-484 (2004).
Edsbacker S, Andersson T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin. Pharmacokinet. 43: 803-821 (2004).
Edwards E, Harper A. Does MELD work for relisted candidates? Liver Transpl. 10: S10-S16 (2004). *
Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin. Immunol. 111: 93-97 (2004). *
Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult. Scler. 10: 575-581 (2004). *
Eerligh P, Koeleman BP, Dudbridge F, Jan Bruining G, Roep BO, Giphart MJ. Functional genetic polymorphisms in cytokines and metabolic genes as additional genetic markers for susceptibility to develop type 1 diabetes. Genes Immun. 5: 36-40 (2004). *
Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 53 Suppl. 3: S75-S78 (2004). *
Efremov RG, Kosinsky YA, Nolde DE, Tsivkovskii R, Arseniev AS, Lutsenko S. Molecular modeling of the nucleotide-binding domain of the Wilson' disease protein: location of the ATP-binding site, domain dynamics, and potential effects of the major disease mutations. Biochem. J. 382: 293-305 (2004). *
Egan LJ. Drug interactions in gastroenterology: mechanisms, consequences, and how to avoid. Clin. Gastroenterol. Hepatol. 2: 725-730 (2004). *
Egan LJ. Mechanism of action of established drugs: cyclosporine, methotrexate and others. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 63-64. May 7-8 (2004). *
Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, Myhre GM, Robine S, Karin M, Kagnoff MF. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 101: 2452-2457 (2004). *
Egan LJ, Sandborn WJ. Advances in the treatment of Crohn's disease. Gastroenterology 126: 1574-1581 (2004). *
Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304: 600-602 (2004). *
Egerman RS, Riely CA. Predicting fetal outcome in intrahepatic cholestasis of pregnancy: is the bile acid level sufficient? Hepatology 40: 287-288 (2004). *
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463 (2004). *
Ehehalt R, Wagenblast J, Erben G, Lehmann WD, Hinz U, Merle U, Stremmel W. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry. Scand. J. Gastroenterol. 39: 737-742 (2004). *
Ehling R, Gassner Ch, Lutterotti A, Strasser-Fuchs S, Kollegger H, Kristoferitsch W, Reindl M, Berger T. Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis. Tissue Antigens 63: 28-33 (2004). *
Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39: 970-977 (2004). *
Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200: 277-285 (2004). *
Ehresmann C, Ehresmann B, Ennifar E, Dumas P, Garber M, Mathy N, Nikulin A, Portier C, Patel D, Serganov A. Molecular mimicry in translational regulation: the case of ribosomal protein S15. RNA Biol. 1: 66-73 (2004).
Ehrhardt M, Lindenmaier H, Burhenne J, Haefeli WE, Weiss J. Influence of lipid lowering fibrates on P-glycoprotein activity in vitro. Biochem. Pharmacol. 67: 285-292 (2004). *
Eiberg H, Norgaard-Pedersen B, Nielsen IM. Cholestasis Familiaris Groenlandica/Byler-like disease in Greenland - a population study. Int. J. Circumpolar Health 63 Suppl. 2: 189-191 (2004).
Eibl G, Reber HA, Hines OJ, Go VL. COX and PPAR: possible interactions in pancreatic cancer. Pancreas 29: 247-253 (2004).
Eibl RH, Benoit M. Molecular resolution of cell adhesion forces. IEE Proc. Nanobiotechnol. 151: 128-132 (2004).
Eichelbaum M, Fromm MF, Schwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther. Drug Monit. 26: 180-185 (2004).
Eichhorst ST, Krueger A, Muerkoster S, Fas SC, Golks A, Gruetzner U, Schubert L, Opelz C, Bilzer M, Gerbes AL, Krammer PH. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat. Med. 10: 602-609 (2004). *
Eisenbach C, Gehrke SG, Stremmel W. Iron, the HFE gene, and hepatitis C. Clin. Liver Dis. 8: 775-785, vii-viii (2004).
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N. Engl. J. Med. 350: 2068-2079 (2004). *
Eisenstein M. A modern examination of an ancient cure. Lab. Anim. (N.Y.) 33: 8-9 (2004).
Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm. Bowel Dis. 10 Suppl. 1: S32-S34 (2004). *
Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract. Res. Clin. Gastroenterol. 18: 497-508 (2004).
Ekkelenkamp MB, de Jong W, Hustinx W, Thijsent S. Streptomyces thermovulgaris bacteremia in Crohn's disease patient. Emerg. Infect. Dis. 10: 1883-1885 (2004).
Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hubscher SG, Briskin M, Salmon M, Adams DH. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J. Exp. Med. 200: 1511-1517 (2004). *
Eksteen B, Miles AE, Grant AJ, Adams DH. Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease. Clin. Med. 4: 173-180 (2004). *
Ekstein J, Rubin BY, Anderson SL, Weinstein DA, Bach G, Abeliovich D, Webb M, Risch N. Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population. Am. J. Med. Genet. 129A: 162-164 (2004). *
El Euch D, Zakraoui H, Ben Jannet S, Cherif F, Mokni M, Ben Tekaya N, Azaiz MI, Ben Osman Dhahri A. Squamous cell carcinoma and discoid lupus erythematosus. About two cases. Tunis. Med. 82: 980-983 (2004).
El Miedany YM, Ahmed I, Mourad HG, Mehanna AN, Aty SA, Gamal HM, El Baddini M, Smith P, El Gafaary M. Quantitative ultrasonography and magnetic resonance imaging of the parotid gland: can they replace the histopathologic studies in patients with Sjogren's syndrome? Joint Bone Spine 71: 29-38 (2004).
El Miedany YM, Ahmed I, Moustafa H, El Baddini M. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation? Joint Bone Spine 71: 203-208 (2004).
El-Badri NS, Maheshwari A, Sanberg PR. Mesenchymal stem cells in autoimmune disease. Stem Cells Dev. 13: 463-472 (2004).
El-Harith el-HA. The cytokine TNF-alpha. Genetics and suitability for prenatal risks assessment. Saudi Med. J. 25: 135-140 (2004).
El-Husseini R, Kaplan MM. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia. Am. J. Gastroenterol. 99: 1859-1860 (2004). *
El-Rifai N, Gottrand F. Role of ursodeoxycholic acid in pediatric cholestatic disease. Gastroenterol. Clin. Biol. 28: 852-859 (2004).
El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127 (5 Suppl. 2): S27-S34 (2004). *
El-Shabrawi Y, Walch A, Hermann J, Egger G, Foster CS. Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor. J. Neuroimmunol. 155: 13-20 (2004).
El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J. Biol. Chem. 279: 20794-20806 (2004). *
El-Tawil AM. High incidence of Crohn's disease in pre-menopausal women: Escherichia coli may be contributing. Int. J. Colorectal Dis. 19: 498 (2004). *
Elbekai RH, Korashy HM, El-Kadi AOS. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Curr. Drug Metab. 5: 157-167 (2004).
Eleazar JA, Memeo L, Jhang JS, Mansukhani MM, Chin S, Park SM, Lefkowitch JH, Bhagat G. Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J. Hepatol. 41: 983-991 (2004). *
Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM. LPS-induced down-regulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1008-G1016 (2004). *
Eliakim R. Wireless capsule video endoscopy: three years of experience. World J. Gastroenterol. 10: 1238-1239 (2004). *
Eliakim R, Adler SN. Capsule video endoscopy in Crohn's disease-the European experience. Gastrointest. Endosc. Clin. N. Am. 14: 129-137 (2004).
Eliakim R, Suissa A, Yassin K, Katz D, Fischer D. Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn's disease - final report. Dig. Liver Dis. 36: 519-522 (2004).
Elias E. Hepatology highlights. Hepatology 40: 1238-1239 (2004). *
Elias E. Hepatology highlights. Hepatology 39: 1467-1468 (2004). *
Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum. 33: 283-288 (2004). *
Elkins CA, Savage DC. CbsT2 from Lactobacillus johnsonii 100-100 is a transport protein of the major facilitator superfamily that facilitates bile acid antiport. J. Mol. Microbiol. Biotechnol. 6: 76-87 (2004).
Elkowitz D, Daum F, Markowitz J, Proccaccino J, Boas E, Cuomo J, Kahn E. Risk factors for carcinoma of the pelvic ileal pouch/anal canal in ulcerative colitis. Ann. Clin. Lab. Sci. 34: 143-149 (2004).
Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur. J. Immunol. 34: 2690 (2004). *
Elliott J, Johnston JA. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol. 25: 434-440 (2004). *
Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Ericzon B-G, Bjorkhem I, Einarsson C. Regulation of bile acid synthesis in primary human hepatocytes. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 30. June 18-19 (2004). *
Ellis I. Genetic counseling for hereditary pancreatitis - the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1. Gastroenterol. Clin. North Am. 33: 839-854 (2004).
Elomaa O, Majuri I, Suomela S, Asumalahti K, Jiao H, Mirzaei Z, Rozell B, Dahlman-Wright K, Pispa J, Kere J, Saarialho-Kere U. Transgenic mouse models support HCR as an effector gene in the PSORS1 locus. Hum. Mol. Genet. 13: 1551-1561 (2004). *
Elseviers MM, D'Haens G, Lerebours E, Plane C, Stolear JC, Riegler G, Capasso G, Van Outryve M, Mishevska-Mukaetova P, Djuranovic S, Pelckmans P, De Broe ME; 5-ASA Study Group. Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy? Clin. Nephrol. 61: 83-89 (2004).
Elso C, Kumar B, Smyth G, Foote S, Handman E. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major. Genes Immun. 5: 188-196 (2004). *
Elso CM, Roberts LJ, Smyth GK, Thomson RJ, Baldwin TM, Foote SJ, Handman E. Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun. 5: 93-100 (2004). *
Elson CO, Cong Y, Lorenz R, Weaver CT. New developments in experimental models of inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 360-367 (2004).
Elson CO, Konrad A, Cong Y, Weaver CT. Gene disruption and immunity in experimental colitis. Inflamm. Bowel Dis. 10 Suppl. 1: S25-S28 (2004). *
Elvin SJ, Williamson ED, Scott JC, Smith JN, Perez De Lema G, Chilla S, Clapham P, Pfeffer K, Schlondorff D, Luckow B. Evolutionary genetics: ambiguous role of CCR5 in Y. pestis infection. Nature 430: 417 (2004).
Emery P, Reppert SM. A rhythmic Ror. Neuron 43: 443-446 (2004). *
Emini EA, Koff WC. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Science 304: 1913-1914 (2004). *
Enarson P, Rattner JB, Ou Y, Miyachi K, Horigome T, Fritzler MJ. Autoantigens of the nuclear pore complex. J. Mol. Med. 82: 423-433 (2004). *
Encke J, Uhl W, Stremmel W, Sauer P. Immunosuppression and modulation in liver transplantation. Nephrol. Dial. Transplant. 19 Suppl. 4: iv22-iv25 (2004). *
ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306: 636-640 (2004). *
Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun. 5: 426-430 (2004). *
Engedal N, Ertesvag A, Blomhoff HK. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int. Immunol. 16: 443-453 (2004). *
Engel W, Adham IM, Nayernia K, Neesen J. Genetic causes of male infertility. Verh. Dtsch. Ges. Pathol. 88: 130-135 (2004).
Engelmann H, Aderka D, Wallach D. Purification of TNF binding proteins. Methods Mol. Med. 98: 23-32 (2004).
Enjoji M, Yamaguchi K, Nakamuta M, Nakashima M, Kotoh K, Tanaka M, Nawata H, Watanabe T. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases. Dig. Liver Dis. 36: 622-627 (2004).
Enjoji M, Yamaguchi K, Nakashima M, Ohta S, Kotoh K, Fukushima M, Kuniyoshi M, Tanaka M, Nakamuta M, Watanabe T, Nawata H. Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease. Liver Int. 24: 330-334 (2004). *
Enns R, Go K, Chang H, Pluta K. Capsule endoscopy: a single-centre experience with the first 226 capsules. Can. J. Gastroenterol. 18: 555-558 (2004). *
Enomoto K, Nishikawa Y, Omori Y, Tokairin T, Yoshida M, Ohi N, Nishimura T, Yamamoto Y, Li Q. Cell biology and pathology of liver sinusoidal endothelial cells. Med. Electron Microsc. 37: 208-215 (2004).
Enomoto M, Nishiguchi S, Seki S, Yamane T, Hino M. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma. Am. J. Gastroenterol. 99: 1619-1620 (2004). *
Epstein MP, Kaplan MM. A pilot study of etanercept in the treatment of primary sclerosing cholangitis. Dig. Dis. Sci. 49: 1-4 (2004). *
Epstein SK, Freeman RB, Khayat A, Unterborn JN, Pratt DS, Kaplan MM. Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transpl. 10: 418-424 (2004). *
Equils O, Shapiro A, Madak Z, Liu C, Lu D. Human immunodeficiency virus type 1 protease inhibitors block Toll-like receptor 2 (TLR2)- and TLR4-induced NF-kappaB activation. Antimicrob. Agents Chemother. 48: 3905-3911 (2004). *
Eraly SA, Bush KT, Sampogna RV, Bhatnagar V, Nigam SK. The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol. Pharmacol. 65: 479-487 (2004). *
Eraly SA, Monte JC, Nigam SK. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiol. Genomics 18: 12-24 (2004). *
Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Kardiol. Pol. 60: 454-458 (2004).
Erdal ME, Tursen U, Kaya TI, Kanik A, Derici E, Ikizoglu G. Association between catechol-O-methyltransferase polymorphism and psoriasis. Int. J. Dermatol. 43: 312-314 (2004). *
Erden S, Cagatay T, Buyukozturk S, Kiyan E, Cuhadaroglu C. Hashimoto thyroiditis and obstructive sleep apnea syndrome: is there any relation between them? Eur. J. Med. Res. 9: 570-572 (2004).
Eren M, Nur Saltik-Temizel I, Kocak N. Serum homocysteine concentrations in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 39: 215-216 (2004). *
Eri R, Jonsson JR, Pandeya N, Purdie DM, Clouston AD, Martin N, Duffy D, Powell EE, Fawcett J, Florin TH, Radford-Smith GL. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. Genes Immun. 5: 444-450 (2004). *
Ericsson A, Svensson M, Arya A, Agace WW. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes. Eur. J. Immunol. 34: 2720-2729 (2004). *
Eriksson AS, Gretzer C, Wallerstedt S. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis. Hepatogastroenterology 51: 505-509 (2004).
Eriksson C, Rustum C, Hallberg E. Dynamic properties of nuclear pore complex proteins in gp210 deficient cells. FEBS Lett. 572: 261-265 (2004). *
Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren's syndrome, rheumatoid arthritis and healthy controls. Clin. Exp. Immunol. 137: 617-620 (2004). *
Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Sjogren's syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells. J. Rheumatol. 31: 729-735 (2004).
Erkelens GW, Van Deventer SJ. Endoscopic treatment of strictures in Crohn's disease. Best Pract. Res. Clin. Gastroenterol. 18: 201-207 (2004).
Erlandsson Harris H, Andersson U. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34: 1503-1512 (2004). *
Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 291: 585-590 (2004). *
Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J. Med. Microbiol. 53: 735-740 (2004). *
Ersvaer E, Bertelsen LT, Espenes LC, Bredholt T, Boe SO, Iversen BM, Bruserud O, Ulvestad E, Gjertsen BT. Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand. J. Immunol. 60: 189-198 (2004). *
Escher JC. Mucosal healing in pediatric Crohn's disease: pro/con balance. Inflamm. Bowel Dis. 10: 484 (2004). *
Escher JC; European Collaborative Research Group on Budesonide in Paediatric IBD. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial. Eur. J. Gastroenterol. Hepatol. 16: 47-54 (2004).
Escher R, Jones A, Hagos F, Carmichael C, Horwitz M, Olopade OI, Scott HS. Chromosome band 16q22-linked familial AML: exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms. Genes Chromosomes Cancer 41: 278-282 (2004). *
Escobar Castro H, Garcia Novo Mf MD, Olivares P. Biliary lithiasis in childhood. Therapeutic approaches. An. Pediatr. (Barc.) 60: 170-174 (2004).
Esparza EM, Arch RH. TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation. Cell. Mol. Life Sci. 61: 3087-3092 (2004). *
Esparza J, Kruse M, Lee J, Michaud M, Madri JA. MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity. FASEB J. 18: 1682-1691 (2004). *
Espejo C, Brieva L, Ruggiero G, Rio J, Montalban X, Martinez-Caceres EM. IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis. Mult. Scler. 10: 630-635 (2004). *
Esser AC, Abril A, Fayne S, Doyle JA. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J. Am. Acad. Dermatol. 50: 75S-77S (2004).
Esters N, Pierik M, van Steen K, Vermeire S, Claessens G, Joossens S, Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am. J. Gastroenterol. 99: 299-305 (2004). *
Esteve M, Saro C, Gonzalez-Huix F, Suarez F, Forne M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 53: 1363-1365 (2004). *
Etienney I, Bouhnik Y, Gendre JP, Lemann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC. Crohn's disease over 20 years after diagnosis in a referral population. Gastroenterol. Clin. Biol. 28: 1233-1239 (2004). *
Etokebe GE, Abrahamsen TG, Bogen B, Spurkland A. Tumour necrosis factor receptor superfamily member 6 gene mutation detection by denaturing high-performance liquid chromatography. Scand. J. Immunol. 59: 496-503 (2004). *
Etzioni A, Ochs HD. The hyper IgM syndrome - an evolving story. Pediatr. Res. 56: 519-525 (2004). *
Eubanks M. The danger of extrapolation. Humans and rodents differ in response to PCBs. Environ. Health Perspect. 112: A113 (2004). *
Evans B, Clark W, Moore D, Whorwell, PJ. Tegaserod for the treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. 1: CD003960 (2004). *
Evans DM, Zhu G, Duffy DL, Frazer IH, Montgomery GW, Martin NG. A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes Immun. 5: 548-552 (2004). *
Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat. Med. 10: 355-361 (2004). *
Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 429: 464-468 (2004). *
Evens AM, Gartenhaus RB. Treatment of T-cell non-Hodgkin's lymphoma. Curr. Treat. Options Oncol. 5: 289-303 (2004).
Evereklioglu C. Managing the symptoms of Behcet's disease. Expert Opin. Pharmacother. 5: 317-328 (2004).
Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology 40: 774-782 (2004). *
Ewer AK, Al-Salti W, Coney AM, Marshall JM, Ramani P, Booth IW. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 53: 207-213 (2004). *
Exley MA, Koziel MJ. To be or not to be NKT: natural killer T cells in the liver. Hepatology 40: 1033-1040 (2004). *
Eyre S, Barton A, Shephard N, Hinks A, Brintnell W, MacKay K, Silman A, Ollier W, Wordsworth P, John S, Worthington J. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum. 50: 729-735 (2004). *
Eysenbach G. Peer-review and publication of research protocols and proposals: a role for open access journals. J. Med. Internet Res. 6: e37 (2004).
Fabiani E, Peruzzi E, Mandolesi A, Garbuglia G, Fanciulli G, D�Appello AR, Gasparin M, Bravi E, Bearzi I, Galeazzi R, Catassi C. Anti-human versus anti-guinea pig tissue transglutaminase antibodies as the first-level serological screening test for coeliac disease in the general population. Dig. Liver Dis. 36: 671-676 (2004).
Fabien N, Desbos A, Bienvenu J, Magdalou J. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis. Autoimmun. Rev. 3: 1-9 (2004). *
Faenza S, Mancini E, Petrini F, Santoro A, Zanoni A, Martinelli G. Role of intensive therapy in liver transplant recipients: experience in blood purification and biosynthetic techniques. Transplant. Proc. 36: 555-557 (2004). *
Fagarasan S, Honjo T. Regulation of IgA synthesis at mucosal surfaces. Curr. Opin. Immunol. 16: 277-283 (2004).
Fageras Bottcher M, Hmani-Aifa M, Lindstrom A, Jenmalm MC, Mai XM, Nilsson L, Zdolsek HA, Bjorksten B, Soderkvist P, Vaarala O. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 114: 561-567 (2004). *
Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin. Exp. Immunol. 137: 379-385 (2004). *
Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M, Saibeni S, Biguzzi E, Cordani N, Franchi F, Bosari S, Cattaneo M. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit. Care Med. 32: S266-S270 (2004).
Fairbanks KD, Solga SS, Cohen CK, Klein KS, Rai R. Impact of MELD for patients with primary sclerosing cholangitis awaiting liver transplantation. Gastroenterology 126: A714 (2004).
Fairbanks KD, Thuluvath PJ. Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience. Liver Transpl. 10: 1189-1194 (2004). *
Fairley JA, Woodley DT, Chen M, Giudice GJ, Lin MS. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. J. Am. Acad. Dermatol. 51: 118-122 (2004).
Fairweather D. Women and autoimmune diseases. Emerg. Infect. Dis. 10: 2005-2011 (2004). *
Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37: 131-145 (2004).
Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 15: 17-27 (2004).
Faiz SA, Nainar SI, Addar MH. Herpes gestationis. Saudi Med. J. 25: 792-794 (2004).
Fajac I, Hubert D, Guillemot D, Honore I, Bienvenu T, Volter F, Dall'Ava-Santucci J, Dusser DJ. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax 59: 971-976 (2004). *
Falcone FH, Loukas A, Quinnell RJ, Pritchard DI. The innate allergenicity of helminth parasites. Clin. Rev. Allergy Immunol. 26: 61-72 (2004). *
Falcone M, Facciotti F, Ghidoli N, Monti P, Olivieri S, Zaccagnino L, Bonifacio E, Casorati G, Sanvito F, Sarvetnick N. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 172: 5908-5916 (2004). *
Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits? Pediatr. Transplant. 8: 233-236 (2004).
Faller M, Niederweis M, Schulz GE. The structure of a mycobacterial outer-membrane channel. Science 303: 1189-1192 (2004). *
Fallon KE. Utility of hematological and iron-related screening in elite athletes. Clin. J. Sport Med. 14: 145-152 (2004).
Fan L, Zhu Y, Zhong R, Tu X, Chen Q, Zhou L, Liu H, Kong X. Study on the relationship of CTLA-4 -318, +49 polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21: 440-443 (2004).
Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, Zhong RQ. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J. Gastroenterol. 10: 3056-3059 (2004). *
Fan LY, Zhong RQ, Tu XQ, Thomas P, Ralph F, Zhu Y, Zhou L. Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Zhonghua Gan Zang Bing Za Zhi 12: 160-162 (2004).
Fan LY, Zhu Y, Zhong RQ, Tu XQ, Ye WM, Chen QB, Zeng WJ, Kong XT. Genetic association between interleukins gene polymorphisms with primary biliary cirrhosis in Chinese population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 26: 505-509 (2004).
Fan P, Zhang B, Kuroki S, Saku K. Pitavastatin, a potent hydroxymethylglutaryl coenzyme A reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells. Circ. J. 68: 1061-1066 (2004). *
Fan ST. Debate on live related liver transplant: pro. J. Gastroenterol. Hepatol. 19: S302-S303 (2004). *
Fan ST. Reducing blood loss in liver surgery. J. Gastroenterol. Hepatol. 19: S414-S415 (2004). *
Fan ST. Resecting hepatocellular carcinoma in cirrhotic liver. J. Gastroenterol. Hepatol. 19: S416-S418 (2004). *
Fan X, Roy EM, Murphy TC, Nanes MS, Kim S, Pike JW, Rubin J. Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J. Cell. Biochem. 93: 807-818 (2004). *
Fan YY, Ly LH, Barhoumi R, McMurray DN, Chapkin RS. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 173: 6151-6160 (2004). *
Fanet-Goguet M, Martin S, Fernandez C, Fautrel B, Bourgeois P. Focus on biological agents in rheumatoid arthritis: newer treatments and therapeutic strategies. Therapie 59: 451-461 (2004).
Fang C, Yoon S, Tindberg N, Jarvelainen HA, Lindros KO, Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol. 67: 1389-1397 (2004). *
Fang CW, Yao YM, Zhai HX, Yu Y, Wu Y, Lu LR, Sheng ZY, Y Sheng C. Tissue lipopolysaccharide-binding protein expression in rats after thermal injury: potential role of TNF-alpha. Burns 30: 225-231 (2004).
Fang P, Dong L, Luo JY, Wan XL, Du KX, Chai NL. Effects of motilin and ursodeoxycholic acid on gastrointestinal myoelectric activity of different origins in fasted rats. World J. Gastroenterol. 10: 2509-2513 (2004). *
Fang P, Hwa V, Rosenfeld R. IGFBPs and cancer. Novartis Found. Symp. 262: 215-230 (2004).
Fang Y, Han SI, Mitchell C, Gupta S, Studer E, Grant S, Hylemon PB, Dent P. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40: 961-971 (2004). *
Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153 (2004). *
Farahani P, Chiu S, Bowlus CL, Boffelli D, Lee E, Fisler JS, Krauss RM, Warden CH. Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. Obes. Res. 12: 191-204 (2004). *
Farber L, Haus U, Spath M, Drechsler S. Physiology and pathophysiology of the 5-HT3 receptor. Scand. J. Rheumatol. Suppl. 119: 2-8 (2004).
Fardy J, MacIntosh D, Borgaonkar M, Gonsalves C. Antibiotics for induction of remission in Crohn�s disease. Cochrane Database Syst. Rev. 2: CD000295 (2004). *
Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, Peter HH, Breedveld FC, Fibbe WE, Black C, Denton C, Koetter I, Locatelli F, Martini A, Schattenberg AV, van den Hoogen F, van de Putte L, Lanza F, Arnold R, Bacon PA, Bingham S, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann. Rheum. Dis. 63: 974-981 (2004). *
Fargion S, Valenti L, Dongiovanni P, Fracanzani AL. TNFalpha promoter polymorphisms. Methods Mol. Med. 98: 47-58 (2004).
Farinha CM, Mendes F, Roxo-Rosa M, Penque D, Amaral MD. A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein. Mol. Cell. Probes 18: 235-242 (2004).
Farinha CM, Penque D, Roxo-Rosa M, Lukacs G, Dormer R, McPherson M, Pereira M, Bot AG, Jorna H, Willemsen R, Dejonge H, Heda GD, Marino CR, Fanen P, Hinzpeter A, Lipecka J, Fritsch J, Gentzsch M, Edelman A, Amaral MD. Biochemical methods to assess CFTR expression and membrane localization. J. Cyst. Fibros. 3 Suppl. 2: 73-77 (2004).
Farkkila M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, Karkkainen P. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 40: 1379-1386 (2004). *
Farnbacher MJ, Reisch A, Lederer R, Schneider T. Cooperative use of video capsule endoscopy: effective and economic. Z. Gastroenterol. 42: 505-508 (2004).
Farrar MD, Ingham E. Acne: inflammation. Clin. Dermatol. 22: 380-384 (2004).
Farraye F, Schroy PC. Tailoring use of screening colonoscopy: are we up to the challenge? Gastroenterology 127: 673-675 (2004). *
Farrell DJ, Birchley DW, Edwards CM. Histiocytic infiltration in ulcerative colitis, simulating malignancy. Histopathology 45: 638-640 (2004). *
Farrell GC. Probing Prometheus: fat fueling the fire? Hepatology 40: 1252-1255 (2004). *
Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest. Endosc. 60: 927-936 (2004). *
Farrell RJ. Coeliac disease: proceedings of the Xth international symposium on coeliac disease. Gastroenterology 127: 1859-1860 (2004). *
Farshad Sh, Alborzi A, Malek Hosseini SA, Oboodi B, Rasouli M, Japoni A, Nasiri J. Identification of Helicobacter pylori DNA in Iranian patients with gallstones. Epidemiol. Infect. 132: 1185-1189 (2004).
Fasolino M, Sabatini P, Cuomo T, Liguori G. Paraneoplastic subacute sensory neuronopathy associated with anti-ri antibodies. J. Peripher. Nerv. Syst. 9: 109 (2004).
Fass R. Noncardiac chest pain. Gastroenterol. Clin. North Am. 33: xi-xii (2004). *
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40: 820-826 (2004). *
Fatini C, Guiducci S, Abbate R, Matucci-Cerinic M. Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism. Curr. Rheumatol. Rep. 6: 149-155 (2004).
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (5 Suppl. 2): S35-S50 (2004). *
Faubion WA, De Jong YP, Molina AA, Ji H, Clarke K, Wang B, Mizoguchi E, Simpson SJ, Bhan AK, Terhorst C. Colitis is associated with thymic destruction attenuating CD425 regulatory T cells in the periphery. Gastroenterology 126: 1759-1770 (2004). *
Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, Hebbar M, Hachulla E, Devulder B, Hatron PY. Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13: 245-248 (2004).
Faure M, Moennoz D, Mettraux C, Montigon F, Schiffrin EJ, Obled C, Breuille D, Boza J. The chronic colitis developed by HLA-B27 transgenic rats is associated with altered in vivo mucin synthesis. Dig. Dis. Sci. 49: 339-346 (2004). *
Fauser S, Kalbacher H, Alteheld N, Koizumi K, Krohne TU, Joussen AM. Pharmacokinetics and safety of intravitreally delivered etanercept. Graefes Arch. Clin. Exp. Ophthalmol. 242: 582-586 (2004). *
Faust TW, Reddy KR. Postoperative jaundice. Clin. Liver Dis. 8: 151-166 (2004).
Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39: 1477-1487 (2004). *
Fauzi AR, Kong NC, Chua MK, Jeyabalan V, Idris MN, Azizah R. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med. J. Malaysia 59: 372-377 (2004).
Favaloro EJ, Posen J, Ramakrishna R, Soltani S, McRae S, Just S, Aboud M, Low J, Gemmell R, Kershaw G, Coleman R, Dean M. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul. Fibrinolysis 15: 637-647 (2004).
Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am. Fam. Physician 69: 1417-1424 (2004). *
Fayard E, Auwerx J, Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 14: 250-260 (2004). *
Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl. 10: 1060-1064 (2004). *
Fayer R. Cryptosporidium: a water-borne zoonotic parasite. Vet. Parasitol. 126: 37-56 (2004).
Fazio S, Linton MF. The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy. Curr. Atheroscler. Rep. 6: 148-157 (2004).
Feagan BG. Endoscopic scoring system for Crohn's disease: viva the evolution! Gastrointest. Endosc. 60: 590-591 (2004). *
Feagan BG. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion. Clin. Gastroenterol. Hepatol. 2: 376-378 (2004). *
Feagan BG, Alfadhli A. Methotrexate in inflammatory bowel disease. Gastroenterol. Clin. North Am. 33: 407-420 (2004).
Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South. Med. J. 97: 169-171 (2004).
Fedorak RN. Is it time to re-classify Crohn's disease? Best Pract. Res. Clin. Gastroenterol. 18 Suppl.: 99-106 (2004).
Fedorak RN. Conservative approach to severe ulcerative colitis. Dig. Liver Dis. 36: 4-6 (2004). *
Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Curr. Opin. Gastroenterol. 20: 146-155 (2004).
Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm. Bowel Dis. 10: 286-299 (2004). *
Feeney GP, Ashfield-Watt PA, Burr ML, Dunstan FD, McDowell IF, Worwood M. Heterozygosity for the haemochromatosis mutation HFE C282Y is not a risk factor for angina. Heart 90: 939-940 (2004). *
Fefferman DS, Farrell RJ. Making sense of antisense: ISIS 2302 (Alicaforsen) in the treatment of pouchitis. Inflamm. Bowel Dis. 10: 487-488 (2004). *
Fefferman DS, Lodhavia PJ, Alsahli M, Falchuk KR, Peppercorn MA, Shah SA, Farrell RJ. Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease. Inflamm. Bowel Dis. 10: 346-351 (2004). *
Fefferman DS, Wolf JL. Limb-ited abnormalities in the offspring of ulcerative colitis patients. Inflamm. Bowel Dis. 10: 330-331 (2004). *
Fehervari Z, Sakaguchi S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16: 1769-1780 (2004). *
Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).
Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am. J. Physiol. Endocrinol. Metab. 286: E201-E207 (2004). *
Feist E, Hermann KG, Filimonow S, Ruckert RI, Dorner T, Hiepe F. Benefit of immunosuppression for severe Takayasu's arteritis and coincident primary biliary cirrhosis. Ann. Rheum. Dis. 63: 889-890 (2004). *
Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, Matri LE, Mebazaa A, Kaabachi N. Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease. Clin. Chem. Lab. Med. 42: 1417-1423 (2004).
Feld AD. Malpractice risks associated with colon cancer and inflammatory bowel disease. Am. J. Gastroenterol. 99: 1641-1644 (2004). *
Feldman S, Careccia RE, Barham KL, Hancox J. Diagnosis and treatment of acne. Am. Fam. Physician 69: 2123-2130 (2004). *
Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found. Symp. 256: 53-69 (2004).
Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am. J. Gastroenterol. 99: 1718-1719 (2004). *
Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD. Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann. Rheum. Dis. 63: 156-161 (2004). *
Felipe F, Bonet ML, Ribot J, Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53: 882-889 (2004). *
Felley C, Michetti P. Safety of infliximab in patients suffering from inflammatory bowel disease. Digestion 70: 1-2 (2004). *
Felley C, Morris MA, Wonkam A, Hirschel B, Flepp M, Wolf K, Furrer H, Battegay M, Bernasconi E, Telenti A, Frossard JL. The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study. AIDS 18: 1521-1527 (2004).
Fellstrom B. Cyclosporine nephrotoxicity. Transplant. Proc. 36: 220S-223S (2004).
Feng ML, Guo XJ, Zhang JY, Xie JH, Chen L, Lu Q, Yang JH, Ji Y, Qian KC. Study on the haplotypes of MICA and MICB microsatellite and HLA-B locus in the Guangzhou Han population. Tissue Antigens 64: 281-285 (2004). *
Feng XB, Shen N, Luo WQ, Zhang LH, Qian J, Sun L, Chen SL. OAZ gene polymorphism in Chinese patients with systemic lupus erythematosus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21: 430-434 (2004).
Fenton C, Plosker GL. Calcipotriol/Betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris. Am. J. Clin. Dermatol. 5: 463-478 (2004).
Ferahbas A, Turan MT, Esel E, Utas S, Kutlugun C, Kilic CG. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J. Dermatolog. Treat. 15: 153-157 (2004).
Feranchak AP. Hepatobiliary complications of cystic fibrosis. Curr. Gastroenterol. Rep. 6: 231-239 (2004).
Feranchak AP, Doctor RB, Troetsch M, Brookman K, Johnson SM, Fitz JG. Calcium-dependent regulation of secretion in biliary epithelial cells: the role of apamin-sensitive SK channels. Gastroenterology 127: 903-913 (2004). *
Ferec C, Le Marechal C, Audrezet MP, Farinha CM, Amaral MD, Gallati S, Sanz J, Steiner B, Mouchel N, Harris A, Schwarz MJ. Analysis of genomic CFTR DNA. J. Cyst. Fibros. 3 Suppl. 2: 7-10 (2004).
Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab. Brain Dis. 19: 229-239 (2004).
Ferenci P. Diagnosis and current therapy of Wilson's disease. Aliment. Pharmacol. Ther. 19: 157-165 (2004). *
Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. U.S.A. 101: 16606-16611 (2004). *
Fernandez AZ. PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome. Curr. Opin. Investig. Drugs 5: 936-940 (2004).
Fernandez J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jimenez W, Bosch J, Arroyo V. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J. Hepatol. 41: 384-390 (2004). *
Fernandez JP, Llana B, Dominguez L, Roiz C, Zeidan N, Garcia L. False-positive Tc-99m HMPAO leukocyte scan secondary to adenocarcinoma of the Ileum. Clin. Nucl. Med. 29: 63-64 (2004).
Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Pena AS, Diaz-Rubio M, de la Concha EG. IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm. Bowel Dis. 10: 715-722 (2004). *
Fernandez O, Fernandez V, Alonso A, Caballero A, Luque G, Bravo M, Leon A, Mayorga C, Leyva L, de Ramon E. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J. Neurol. 251: 440-444 (2004).
Fernandez P, Guillen MI, Gomar F, Aller E, Molina P, Alcaraz MJ. A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis. Biochem. Pharmacol. 68: 417-421 (2004). *
Fernandez-Blanco L, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A. A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 50: 328-329 (2004). *
Fernandez-Checa JC. A hidden face of hope for the liver. J. Hepatol. 41: 888-889 (2004). *
Fernandez-Flores A, Dajil S. Enterobiasis mimicking Crohn's disease. Indian J. Gastroenterol. 23: 149-150 (2004). *
Fernandez-Martinez A, Callejas NA, Casado M, Bosca L, Martin-Sanz P. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes. J. Hepatol. 40: 963-970 (2004). *
Fernandez-Mestre MT, Vargas V, Montagnani S, Cotua M, Ogando V, Layrisse Z. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. Hum. Immunol. 65: 54-59 (2004).
Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML, Lledo JL, Santander C, Fernandez TP, Tomas E, Cacho G, Walker JM. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. Liver Int. 24: 477-483 (2004). *
Fernandez-Veledo S, Valdes R, Wallenius V, Casado FJ, Pastor-Anglada M. Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells. J. Hepatol. 41: 538-544 (2004). *
Fernando NH, Hurwitz HI. Targeted therapy of colorectal cancer: clinical experience with bevacizumab. Oncologist 9 Suppl. 1: 11-18 (2004). *
Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, McMahan CA. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 231: 231-236 (2004). *
Ferrandez A, Samowitz W, DiSario JA, Burt RW. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am. J. Gastroenterol. 99: 2012-2018 (2004). *
Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM 97: 407-412 (2004). *
Ferrari-Lacraz S, Zanelli E, Neuberg M, Donskoy E, Kim YS, Zheng XX, Hancock WW, Maslinski W, Li XC, Strom TB, Moll T. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J. Immunol. 173: 5818-5826 (2004). *
Ferraz AA, Sette MJ, Maia M, Lopes EP, Godoy MM, Petribu AT, Meira M, Borges OD. Liver transplant for the treatment of giant hepatic hemangioma. Liver Transpl. 10: 1436-1437 (2004). *
Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl. 1: S43-S50 (2004). *
Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, Gonzalez A. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 50: 2590-2597 (2004). *
Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch. Gynecol. Obstet. 270: 79-85 (2004).
Ferrucci JT, Schroy PC. Virtual colonoscopy: good results and not so good results-why the difference? Gastroenterology 127: 1633-1635 (2004). *
Ferstl B, Zacher T, Lauer B, Blagitko-Dorfs N, Carl A, Wassmuth R. Allele-specific quantification of HLA-DQB1 gene expression by real-time reverse transcriptase-polymerase chain reaction. Genes Immun. 5: 405-416 (2004). *
Ferstl FJ, Obert R. Computed tomography (CT) of acute diverticulitis of the cecum and ascending colon. Rofo. 176: 1257-1264 (2004).
Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol. Biomarkers Prev. 13: 1502-1508 (2004). *
Festi D, Capodicasa S, Vestito A, Mazzella G, Roda E, Vitacolonna E, Petrolati A, Angelico M, Colecchia A. Breath tests with stable isotopes: have they a role in liver transplantation? Eur. Rev. Med. Pharmacol. Sci. 8: 55-58 (2004).
Feuchtinger M, Dengjel J, Stevanovic S, Klein R. Identification of F1-ATPse as a new target antigen of antimitochondrial antibodies (AMA) in primary biliary cirrhosis (PBC). J. Hepatol. 40 Suppl. 1: 159 (2004).
Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, Marschall HU, Denk H, Trauner M. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (abcb4) knockout mice. Gastroenterology 127: 261-274 (2004). *
Fiddian-Green RG. Diagnostic endoscopy: does it help? Gut 53: 913 (2004). *
Field CJ, Schley PD. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am. J. Clin. Nutr. 79: 1190S-1198S (2004). *
Field FJ, Born E, Mathur SN. LXR/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells. J. Lipid Res. 45: 905-913 (2004). *
Fietta P. Autoinflammatory diseases: the hereditary periodic fever syndromes. Acta Biomed. Ateneo. Parmense. 75: 92-99 (2004).
Fife RS, Stott B, Carr RE. Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro. Cancer Biol. Ther. 3: 228-232 (2004). *
Figge A, Lammert F, Paigen B, Henkel A, Matern S, Korstanje R, Shneider BL, Chen F, Stoltenberg E, Spatz K, Hoda F, Cohen DE, Green RM. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J. Biol. Chem. 279: 2790-2799 (2004). *
Filaci G, Fravega M, Fenoglio D, Rizzi M, Negrini S, Viggiani R, Indiveri F. Non-antigen specific CD8+ T suppressor lymphocytes. Clin. Exp. Med. 4: 86-92 (2004). *
Filali M, Le Jeunne C, Durand E, Grinda JM, Roetto A, Daraio F, Bruneval P, Jeunemaitre X, Gimenez-Roqueplo AP. Juvenile hemochromatosis HJV-related revealed by cardiogenic shock. Blood Cells Mol. Dis. 33: 120-124 (2004).
Filik L, Ulker A, Tunc B, Disibeyaz S, Dagli U. Liver abscess: a rare but an important complication that must be considered in Crohn's disease. Acta Gastroenterol. Belg. 67: 303-305 (2004).
Filippi C, Keatch SA, Rangar D, Nelson LJ, Hayes PC, Plevris JN. Improvement of C3A cell metabolism for usage in bioartificial liver support systems. J. Hepatol. 41: 599-605 (2004). *
Filler G, Lepage N. To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. Pediatr. Nephrol. 19: 962-965 (2004).
Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol. Diagn. 8: 207-212 (2004).
Finkel Y, Bjarnason I, Lindblad A, Lange S. Specially processed cereals: a clinical innovation for children suffering from inflammatory bowel disease? Scand. J. Gastroenterol. 39: 87-88 (2004). *
Finkelstein SE, Heimann DM, Klebanoff CA, Antony PA, Gattinoni L, Hinrichs CS, Hwang LN, Palmer DC, Spiess PJ, Surman DR, Wrzesiniski C, Yu Z, Rosenberg SA, Restifo NP. Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J. Leukoc. Biol. 76: 333-337 (2004). *
Finlay AY, Ortonne JP. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J. Cutan. Med. Surg. 8: 310-320 (2004). *
Finn TP, Jones RE, Rich C, Dahan R, Link J, David CS, Chou YK, Offner H, Vandenbark AA. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. J. Neurosci. Res. 78: 100-114 (2004).
Finotto S, Glimcher L. T cell directives for transcriptional regulation in asthma. Springer Semin. Immunopathol. 25: 281-294 (2004). *
Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, Protschka M, Doganci A, Lehr HA, Trautwein C, Khosravi-Far R, Strand D, Lohse A, Galle PR, Blessing M, Neurath MF. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53: 392-400 (2004). *
Fiocchi C. Closing fistulas in Crohn's disease - should the accent be on maintenance or safety? N. Engl. J. Med. 350: 934-936 (2004). *
Fiocchi C. Inflammatory bowel disease: new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. Curr. Opin. Gastroenterol. 20: 309-310 (2004).
Fiorucci S, Antonelli E, Distrutti E, Mencarelli A, Farneti S, Soldato PD, Morelli A. Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Br. J. Pharmacol. 143: 33-42 (2004). *
Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, Morelli A. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127: 1497-1512 (2004). *
Fiorucci S, Antonelli E, Tocchetti P, Morelli A. Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. Cardiovasc. Drug Rev. 22: 135-146 (2004). *
Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M. MMP-9 microsatellite polymorphism and multiple sclerosis. J. Neuroimmunol. 152: 147-153 (2004).
Fireman Z, Eliakim R, Adler S, Scapa E. Capsule endoscopy in real life: a four-centre experience of 160 consecutive patients in Israel. Eur. J. Gastroenterol. Hepatol. 16: 927-931 (2004).
Fireman Z, Kopelman Y, Fish L, Sternberg A, Scapa E, Mahaina E. Effect of oral purgatives on gastric and small bowel transit time in capsule endoscopy. Isr. Med. Assoc. J. 6: 521-523 (2004). *
Firestein GS. NF-kappaB: Holy Grail for rheumatoid arthritis? Arthritis Rheum. 50: 2381-2386 (2004). *
Firneisz G, Szonyi L, Ferenci P, Willheim C, Horvath A, Folhoffer A, Tulassay Z, Szalay F. The other mutation is found: follow-up of an exceptional family with Wilson disease. Am. J. Gastroenterol. 99: 2504-2505 (2004). *
Firoved AM, Ornatowski W, Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect. Immun. 72: 5012-5018 (2004). *
Firpi RJ, Tran TT, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling JM, Poordad FF. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. Aliment. Pharmacol. Ther. 19: 1033-1039 (2004). *
First MR. Tacrolimus based immunosuppression. J. Nephrol. 17 Suppl. 8: S25-31 (2004).
First MR, Fitzsimmons WE. Modified release tacrolimus. Yonsei Med. J. 45: 1127-1131 (2004). *
Fischer F, Bruch HP, Roblick U, Schwandner O, Schiedeck T. Early results of laparoscopic surgical procedures in Crohn's disease. Zentralbl. Chir. 129: 200-204 (2004).
Fischer H, Schwarzer C, Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc. Natl. Acad. Sci. U.S.A. 101: 3691-3696 (2004). *
Fischer S, Muller I, Zundt BZ, Jungst C, Meyer G, Jungst D. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. Eur. J. Gastroenterol. Hepatol. 16: 305-311 (2004).
Fischler B, Pettersson M, Hjern A, Nemeth A. Association between low Apgar score and neonatal cholestasis. Acta Paediatr. 93: 368-371 (2004).
Fish D, Kugathasan S. Inflammatory bowel disease. Adolesc. Med. Clin. 15: 67-90 (2004).
Fisher A, Seguel JM, De La Torre AN, Wilson D, Merchant A, Arora RK, Koneru B. Effect of sirolimus on infection incidence in liver transplant recipients. Liver Transpl. 10: 193-198 (2004). *
Fisher AA, Davis MW, Budge MM. Should we screen adults with osteoporotic fractures for coeliac disease? Gut 53: 154-155 (2004). *
Fisher DA, Martin C, Galanko J, Sandler RS, Noble MD, Provenzale D. Risk factors for advanced disease in colorectal cancer. Am. J. Gastroenterol. 99: 2019-2024 (2004). *
Fisher NL. Genetic testing and health insurance: can they coexist? Cleve. Clin. J. Med. 71: 8-9 (2004).
Fisher R, Maluf D, Cotterell A, Stravitz T, Wolfe L, Luketic V, Sterling R, Shiffman M, Posner M. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin. Transplant. 18: 502-512 (2004). *
Fisher RA. On comparing adult living donor liver transplantation to adult deceased donor liver transplantation: what have we learned? Liver Transpl. 10: 1269-1270 (2004). *
Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 23: 6524-6534 (2004). *
Fishman G, DeRowe A, Wasserman D, Leider-Trejo L, Reif S. Inflammatory bowel disease and sclerosing cholangitis with ulcerative lesions on skin and soft palate. Int. J. Pediatr. Otorhinolaryngol. 68: 1349-1352 (2004).
Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, Macfarlane S. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53: 523-529 (2004). *
Fitzgerald ML, Okuhira KI, Short GF 3rd, Manning JJ, Bell SA, Freeman MW. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and apoA-I binding activities. J. Biol. Chem. 279: 48477-48485 (2004). *
Fix OK, Soto JA, Andrews CW, Farraye FA. Gastroduodenal Crohn's disease. Gastrointest. Endosc. 60: 985 (2004). *
Flamenbaum M, Costes-Chalret N, Ruskone-Fourmestraux A, Chapuis C, Monzy F, Kemeny JL, Cassan P. Gastric high-grade B-cell lymphoma associated with primary biliary cirrhosis regression after eradication of Helicobacter pylori. Gastroenterol. Clin. Biol. 28: 1179-1180 (2004).
Flanders KC. Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85: 47-64 (2004). *
Flavell RA. Molecular immunologic approaches to the study of inflammatory bowel diseases. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 19 (2004). *
Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 279: 17607-17616 (2004). *
Fleischmann R, Stern R, Iqbal I. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis. Expert Opin. Biol. Ther. 4: 1333-1344 (2004).
Fleischmann RM, Iqbal I, Stern RL. Considerations with the use of biological therapy in the treatment of rheumatoid arthritis. Expert Opin. Drug Saf. 3: 391-403 (2004).
Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathogenesis of hereditary hemochromatosis. Clin. Liver Dis. 8: 755-773, vii (2004).
Flemming JA, Perkins KH, Luus L, Ferguson AR, Corley RB. Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cells. Cell. Immunol. 229: 68-77 (2004). *
Flintoft L. Human genetics. No simple answer to complex disease. Nat. Rev. Genet. 5: 886 (2004). *
Flood KL, Carr DB. Nutrition in the elderly. Curr. Opin. Gastroenterol. 20: 125-129 (2004).
Flores AM, Li L, Aneskievich BJ. Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator. J. Invest. Dermatol. 123: 1092-1101 (2004). *
Florin TH, Pandeya N, Radford-Smith GL. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 53: 973-979 (2004). *
Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C, Sheiner P. The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin. Transplant. 18: 152-155 (2004).
Flourie B, Abitbol V, Lavergne-Slove A, Tennenbaum R, Tiret E. Treatment of ulcerative colitis: special situations. Gastroenterol. Clin. Biol. 28: 1031-1038 (2004).
Fluri S, Gebbers JO. Langerhans cell histiocytoses: 50 years to histiocytosis X. Schweiz. Rundsch. Med. Prax. 93: 559-565 (2004).
Flutter B, Gao B. MHC class I antigen presentation - recently trimmed and well presented. Cell. Mol. Immunol. 1: 22-30 (2004). *
Flynn JC, Gardas A, Wan Q, Gora M, Alsharabi G, Wei WZ, Giraldo AA, David CS, Kong YM, Banga JP. Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice. Clin. Exp. Immunol. 137: 503-512 (2004). *
Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50: 3762-3771 (2004). *
Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 50: 1286-1295 (2004). *
Foerster J, Nolte I, Schweiger S, Ehlert C, Bruinenberg M, Spaar K, van der Steege G, Mulder M, Kalscheuer V, Moser B, Kijas Z, Seeman P, Stander M, Sterry W, te Meerman G. Evaluation of the IRF-2 gene as a candidate for PSORS3. J. Invest. Dermatol. 122: 61-64 (2004). *
Fogt F, Brown CA, Badizadegan K, Zimmerman RL, Odze R. Low prevalence of loss of heterozygosity and SMAD4 mutations in sporadic and familial juvenile polyposis syndrome-associated juvenile polyps. Am. J. Gastroenterol. 99: 2025-2031 (2004). *
Fogt F, Pascha TL, Zhang PJ, Gausas RE, Rahemtulla A, Zimmerman RL. Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int. J. Mol. Med. 13: 211-214 (2004).
Folsch UR, Grebe J, Schreiber S. Competence network "inflammatory bowel diseases". Internist (Berl.) 45: 402-408 (2004).
Folwaczny C, Glas J, Mussack T, Torok HP. Adoptive transfer of genetic susceptibility to Crohn's disease. Gut 53: 473 (2004). *
Folwaczny M, Glas J, Torok HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol. 135: 330-335 (2004). *
Folwaczny M, Glas J, Torok HP, Mauermann D, Folwaczny C. The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease. Eur. J. Oral Sci. 112: 316-319 (2004).
Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40: 1333-1341 (2004). *
Fondon JW 3rd, Garner HR. Molecular origins of rapid and continuous morphological evolution. Proc. Natl. Acad. Sci. U.S.A. 101: 18058-18063 (2004). *
Fonseca Chebli JM, Gaburri PD, Ferreira Pinto JR. Enterovesical fistula in Crohn's disease. Lancet 364: 68 (2004). *
Fonseca T, Cardoso T, Perdigao S, Sarmento A, Morgado R, Costa MM. Guillain-Barre syndrome. Acta Med. Port. 17: 119-122 (2004).
Fontanet G, Casellas F, Malagelada JR. The Crohn-Colitis Care Unit: analysis of the first 3 years of activity. Gac. Sanit. 18: 483-485 (2004).
Fontecave M, Atta M, Mulliez E. S-Adenosylmethionine: nothing goes to waste. Trends Biochem. Sci. 29: 243-249 (2004). *
Foote LC, Evans JW, Cifuni JM, Siracusa MC, Monteforte GM, McCole JL, D'orazio CC, Hastings WD, Rothstein TL. Interleukin-4 produces a breakdown of tolerance in vivo with autoantibody formation and tissue damage. Autoimmunity 37: 569-577 (2004).
Footz T, Somerville MJ, Tomaszewski R, Elyas B, Backhouse CJ. Integration of combined heteroduplex/restriction fragment length polymorphism analysis on an electrophoresis microchip for the detection of hereditary haemochromatosis. Analyst 129: 25-31 (2004). *
Forbes A. Parenteral nutrition: new advances and observations. Curr. Opin. Gastroenterol. 20: 114-118 (2004).
Forbes E, Murase T, Yang M, Matthaei KI, Lee JJ, Lee NA, Foster PS, Hogan SP. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J. Immunol. 172: 5664-5675 (2004). *
Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126: 955-963 (2004). *
Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53: 1117-1122 (2004). *
Ford AC, Rotimi O, Everett SM. Sporadic duodenal adenoma and colorectal neoplasia. Gut 53: 1056-1057 (2004). *
Forman MR, Hursting SD, Umar A, Barrett JC. Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Annu. Rev. Nutr. 24: 223-254 (2004). *
Fornage M, Doris PA. Single-nucleotide polymorphism genotyping for disease association studies. Methods Mol. Med. 108: 159-172 (2004).
Forrest G. Gastrointestinal infections in immunocompromised hosts. Curr. Opin. Gastroenterol. 20: 16-21 (2004).
Forrest K, Symmons D, Foster P. Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment. Pharmacol. Ther. 20: 1035-1043 (2004). *
Forsberg G, Fahlgren A, Horstedt P, Hammarstrom S, Hernell O, Hammarstrom ML. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol. 99: 894-904 (2004). *
Forster T, Chapman K, Marcelline L, Mustafa Z, Southam L, Loughlin J. Finer linkage mapping of primary osteoarthritis susceptibility loci on chromosomes 4 and 16 in families with affected women. Arthritis Rheum. 50: 98-102 (2004). *
Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 53: 587-592 (2004). *
Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CE. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br. J. Dermatol. 151: 1219-1226 (2004).
Fouad D, Siendones E, Costan G, Muntane J. Role of NF-kappaB activation and nitric oxide expression during PGE protection against D-galactosamine-induced cell death in cultured rat hepatocytes. Liver Int. 24: 227-236 (2004). *
Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; for the DAIS investigators. Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. Pharmacogenetics 14: 823-829 (2004).
Foulongne V, Turriere C, Diafouka F, Abraham B, Lastere S, Segondy M. Ganciclovir resistance mutations in UL97 and UL54 genes of human cytomegalovirus isolates resistant to ganciclovir. Acta Virol. 48: 51-55 (2004).
Fouquet S, Lugo-Martinez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, Pincon-Raymond M, Thenet S. Early loss of E-cadherin from cell-cell contacts is involved in the onset of anoikis in enterocytes. J. Biol. Chem. 279: 43061-43069 (2004). *
Fourneau JM, Bach JM, van Endert PM, Bach JF. The elusive case for a role of mimicry in autoimmune diseases. Mol. Immunol. 40: 1095-1102 (2004). *
Fox IJ, Chowdhury JR. Hepatocyte transplantation. Am. J. Transplant. 4 Suppl. 6: 7-13 (2004).
Fox IJ, Roy-Chowdhury J. Hepatocyte transplantation. J. Hepatol. 40: 878-886 (2004). *
Fox PC. Salivary enhancement therapies. Caries Res. 38: 241-246 (2004).
Fracchia M, Galatola G, Corradi F, Dall'Omo AM, Rovera L, Pera A, Vitale C, Bertero MT. Coeliac disease associated with Sjogren's syndrome, renal tubular acidosis, primary biliary cirrhosis and autoimmune hyperthyroidism. Dig. Liver Dis. 36: 489-491 (2004).
Fraenkel L, Bogardus ST, Concato J, Felson DT, Wittink DR. Patient preferences for treatment of rheumatoid arthritis. Ann. Rheum. Dis. 63: 1372-1378 (2004). *
Fraidenraich D, Stillwell E, Romero E, Wilkes D, Manova K, Basson CT, Benezra R. Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells. Science 306: 247-252 (2004). *
Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 24: 277-298 (2004). *
Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S, Perez-Mateo M, Such J. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 53: 860-864 (2004). *
Franceschi F, Satta MA, Mentella MC, Penland R, Candelli M, Grillo RL, Leo D, Fini L, Nista EC, Cazzato IA, Lupascu A, Pola P, Pontecorvi A, Gasbarrini G, Genta RM, Gasbarrini A. Helicobacter pylori infection in patients with Hashimoto's thyroiditis. Helicobacter 9: 369 (2004). *
Franchi C, Cainelli G, Frigerio E, Garutti C, Altomare GF. Association of cyclosporine and 311 nM UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach. Int. J. Immunopathol. Pharmacol. 17: 401-406 (2004).
Franchimont D. Mechanisms of steroid refractory disease. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 72-73. May 7-8 (2004). *
Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53: 987-992 (2004). *
Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment. Pharmacol. Ther. 20: 607-614 (2004). *
Franchimont N, Reenaers C, Lambert C, Belaiche J, Bours V, Malaise M, Delvenne P, Louis E. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin. Exp. Immunol. 138: 491-498 (2004). *
Franchini M, Gandini G, Veneri D, De Matteis G, Federici F, Solero P, Aprili G. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia. Transfusion 44: 833-837 (2004). *
Franchini M, Veneri D. Hereditary hemocromatosis. Recenti Prog. Med. 95: 457-462 (2004).
Francis H, Glaser S, Ueno Y, LeSage G, Marucci L, Benedetti A, Taffetani S, Marzioni M, Alvaro D, Venter J, Reichenbach R, Fava G, Phinizy JL, Alpini G. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J. Hepatol. 41: 528-537 (2004). *
Franco-Ruiz CA. Thrombosis of the cerebral venous sinuses associated to ulcerative colitis. A case report. Rev. Neurol. 39: 396-397 (2004).
Francoeur C, Escaffit F, Vachon PH, Beaulieu JF. Pro-inflammatory cytokines TNFalpha and IFNgamma alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G592-G598 (2004). *
Frank A, Seitz HK, Bartsch H, Frank N, Nair J. Immunohistochemical detection of 1,N6-ethenodeoxadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. Carcinogenesis 25: 1027-1031 (2004). *
Frank B, Niesler B, Bondy B, Spath M, Pongratz DE, Ackenheil M, Fischer C, Rappold G. Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin. Rheumatol. 23: 338-344 (2004).
Frank J, Witte K, Schrodl W, Schutt C. Chronic alcoholism causes deleterious conditioning of innate immunity. Alcohol. Alcohol. 39: 386-392 (2004). *
Fraquelli M, Conte D, Camma C, Casazza G, Di Bona D, Rebulla P, Prati D. Quality-related variables at hepatological websites. Dig. Liver Dis. 36: 533-538 (2004).
Fraquelli M, Conte D, Camma C, Casazza G, Prati D. Unsatisfactory quality of hepatological information on the internet. J. Hepatol. 41: 171-172 (2004). *
Fraser AG. Low-dose methotrexate in ulcerative colitis: still a matter of debate: reply. Eur. J. Gastroenterol. Hepatol. 16: 1072 (2004).
Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 55: 891-896 (2004). *
Frazer DM, Inglis HR, Wilkins SJ, Millard KN, Steele TM, McLaren GD, McKie AT, Vulpe CD, Anderson GJ. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 53: 1509-1515 (2004). *
Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 4: 46-54 (2004). *
Freda BJ, Davidson MB, Hall PM. Evaluation of hyponatremia: a little physiology goes a long way. Cleve. Clin. J. Med. 71: 639-650 (2004). *
Frederiksen SL, Chen W. D-penicillamine for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 2: CD004182 (2004). *
Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 350: 560-569 (2004). *
Freeman HJ. Primary biliary cirrhosis in genetically identical twins. Gastroenterology 127: 1645 (2004). *
Freeman HJ. Long-term prognosis of early-onset Crohn's disease diagnosed in childhood or adolescence. Can. J. Gastroenterol. 18: 661-665 (2004). *
Freeman HJ. Antineoplastic effects of 5-aminosalicylates and potential cancer preventive role in inflammatory bowel disease. Can. J. Gastroenterol. 18: 407-408 (2004). *
Freeman HJ. Comparison of longstanding pediatric-onset and adult-onset Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 39: 183-186 (2004). *
Freeman HJ, Davis JE, Prest ME, Lawson EJ. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease. Can. J. Gastroenterol. 18: 687-690 (2004). *
Freeman LA, Kennedy A, Wu J, Bark S, Remaley AT, Santamarina-Fojo S, Brewer HB. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J. Lipid Res. 45: 1197-1206 (2004). *
Freeman ML. Is there a pharmacological solution for post-ERCP pancreatitis? Rev. Gastroenterol. Disord. 4: 44-46 (2004). *
Freeman MP, Helgason C, Hill RA. Selected integrative medicine treatments for depression: considerations for women. J. Am. Med. Womens Assoc. 59: 216-224 (2004). *
Freeman R. Heterogeneity in liver allocation. Liver Transpl. 10: 1075-1077 (2004). *
Freeman RB. 2004 AASLD / ILTS transplant course indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl. 10: S1 (2004). *
Freeman RB. Overview of the MELD / PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl. 10: S2-S3 (2004). *
Freeman RB. Mortality risk versus other endpoints: who should come first on the liver transplant waiting list? Liver Transpl. 10: 675-677 (2004). *
Freeman RB Jr. MELD and liver allocation: continuous quality improvement. Hepatology 40: 787-789 (2004). *
Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl. 10: 7-15 (2004). *
Freeman SL, MacNaughton WK. Nitric oxide inhibitable isoforms of adenylate cyclase mediate epithelial secretory dysfunction following exposure to ionising radiation. Gut 53: 214-221 (2004). *
Freie BW, Ciccone SL, Li X, Plett PA, Orschell CM, Srour EF, Hanenberg H, Schindler D, Lee SH, Clapp DW. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint. J. Biol. Chem. 279: 50986-50993 (2004). *
Freimer N, Sabatti C. The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat. Genet. 36: 1045-1051 (2004). *
French SW. The role of hypoxia in the pathogenesis of alcoholic liver disease. Hepatol. Res. 29: 69-74 (2004).
Freyer DR, Gowans LK, Warzynski M, Lee WI. Flow cytometric diagnosis of X-linked hyper-IgM syndrome: application of an accurate and convenient procedure. J. Pediatr. Hematol. Oncol. 26: 363-370 (2004).
Freyschmidt-Paul P, Happle R, Hoffman R. Alopecia areata in animal models - new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder. J. Dtsch. Dermatol. Ges. 2: 260-273 (2004).
Friedlich MS, Guindi M, Stern HS. The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance. Can. J. Surg. 47: 212-214 (2004).
Friedman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterol. Clin. North Am. 33: 191-208 (2004).
Friedman SL. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology 40: 1041-1043 (2004). *
Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 98-105 (2004). *
Friedman SL. The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common? J. Hepatol. 40: 1050-1052 (2004). *
Fries W, Mazzon E, Sturiale S, Giofre MR, Lo Presti MA, Cuzzocrea S, Campo GM, Caputi AP, Longo G, Sturniolo GC. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat. Life Sci. 74: 2749-2756 (2004). *
Friesen CA, Calabro C, Christenson K, Carpenter E, Welchert E, Daniel JF, Haslag S, Roberts CC. Safety of infliximab treatment in pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 39: 265-269 (2004). *
Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J. Clin. Invest. 114: 1343-1353 (2004). *
Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 99: 45-51 (2004). *
Fromm MF. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 25: 423-429 (2004). *
Frossard CP, Hauser C, Eigenmann PA. Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy. J. Allergy Clin. Immunol. 114: 377-382 (2004). *
Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonsson OG, Kanerva J, Schmiegelow K, Larsson R, Lonnerholm G. Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia: on behalf of the Nordic Society for Paediatric Haematology and Oncology. Blood 104: 2452-2457 (2004). *
Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in mouse skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways. Am. J. Physiol. Cell Physiol. 287: C1605-C1615 (2004). *
Frota ML Jr, Klamt F, Dal-Pizzol F, Schiengold M, Moreira JC. Retinol-induced mdr1 and mdr3 modulation in cultured rat Sertoli cells is attenuated by free radical scavengers. Redox Rep. 9: 161-165 (2004).
Fruhauf NR, Malago M, Frilling A, Beckebaum S, Broelsch CE. Latest development in split liver transplantation. Surg. Technol. Int. 13: 183-189 (2004).
Frydecka I, Daroszewski J, Suwalska K, Zoledziowska M, Tutak A, Slowik M, Potoczek S, Dobosz T. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region. Arch. Immunol. Ther. Exp. (Warsz.) 52: 369-374 (2004).
Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am. J. Transplant. 4: 1614-1627 (2004). *
Fu X, Tan L, Liu S, Li H, Chen L, Qin J, Wu M, Wang H. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J. Cancer Res. Clin. Oncol. 130: 514-520 (2004). *
Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev. Diabet. Stud. 1: 39-41 (2004). *
Fuertes MB, Molinero LL, Toscano MA, Ilarregui JM, Rubinstein N, Fainboim L, Zwirner NW, Rabinovich GA. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell. Biochem. 267: 177-185 (2004).
Fugate SE, Ramsey AM. Resistance to oral vitamin K for reversal of overanticoagulation during Crohn's disease relapse. J. Thromb. Thrombolysis 17: 219-223 (2004). *
Fujii S, Fujimori T, Kawamata H, Takeda J, Kitajima K, Omotehara F, Kaihara T, Kusaka T, Ichikawa K, Ohkura Y, Ono Y, Imura J, Yamaoka S, Sakamoto C, Ueda Y, Chiba T. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 53: 710-716 (2004). *
Fujii T, Koshikawa K, Nomoto S, Okochi O, Kaneko T, Inoue S, Yatabe Y, Takeda S, Nakao A. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J. Hepatol. 41: 104-111 (2004). *
Fujiki K, Ishiguro H, Ko SB, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S. Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J. Med. Genet. 41: e55 (2004). *
Fujimoto E, Fujimoto N, Kuroda K, Tajima S. Leukocytapheresis treatment for pyoderma gangrenosum. Br. J. Dermatol. 151: 1090-1092 (2004). *
Fujimoto T, Yamazaki S, Eto-Kimura A, Takeshige K, Muta T. The amino-terminal region of Toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279: 47431-47437 (2004). *
Fujino K, Takami Y, G de la Fuente S, Ludwig KA, Mantyh CR. Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis. J. Gastrointest. Surg. 8: 842-848 (2004).
Fujino T, Une M, Imanaka T, Inoue K, Nishimaki-Mogami T. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J. Lipid Res. 45: 132-138 (2004). *
Fujio K, Okamoto A, Tahara H, Abe M, Jiang Y, Kitamura T, Hirose S, Yamamoto K. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease. J. Immunol. 173: 2118-2125 (2004). *
Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, Chiao PJ. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol. Cell. Biol. 24: 7806-7819 (2004). *
Fujisaki S, Tomita R, Park YJ, Kimizuka K, Sugitoh K, Inoue M, Fukuzawa M. Semiquantative analysis of expression of mucosal addressin cell adhesion molecule-1 during small bowel graft rejection in rats. Transplant Proc. 36: 348-349 (2004). *
Fujita N, Kaito M, Tanaka H, Horiike S, Adachi Y. Reduction of serum HCV RNA titer by bezafibrate therapy in patients with chronic hepatitis C. Am. J. Gastroenterol. 99: 2280 (2004). *
Fujiu K, Kanno R, Shio Y, Ohsugi J, Nozawa Y, Gotoh M. Triad of thymoma, myasthenia gravis and pure red cell aplasia combined with Sjogren's syndrome. Jpn. J. Thorac. Cardiovasc. Surg. 52: 345-348 (2004).
Fukamachi H, Ito K. Growth regulation of gastric epithelial cells by Runx3. Oncogene 23: 4330-4335 (2004). *
Fukamachi H, Ito K, Ito Y. Runx3-/- gastric epithelial cells differentiate into intestinal type cells. Biochem. Biophys. Res. Commun. 321: 58-64 (2004). *
Fukuda H, Ebara M, Okabe S, Yoshikawa M, Sugiura N, Saisho H, Kondo F, Yukawa M. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy. J. Lab. Clin. Med. 143: 333-339 (2004). *
Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Matsumoto T, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J. Gastroenterol. 39: 1158-1164 (2004). *
Fukushima K, Fiocchi C. Paradoxical decrease of mitochondrial DNA deletions in epithelial cells of active ulcerative colitis patients. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G804-G813 (2004). *
Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M, Kamakura S, Kitakaze M, Tomoike H, Saito Y, Sawada J. Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab. Pharmacokinet. 19: 239-244 (2004). *
Fukutani T, Hiromatsu Y, Kaku H, Miyake I, Mukai T, Imamura Y, Kohno S, Takane N, Shoji S, Otabe S, Yamada K. A polymorphism of interferon-gamma gene associated with changes of anti-thyrotropin receptor antibodies induced by antithyroid drug treatment for Graves' disease in Japanese patients. Thyroid 14: 93-97 (2004).
Fulcher AS. CT cholangiography: advantages and disadvantages compared with MR cholangiography in the evaluation of the biliary tract following liver transplantation. Liver Transpl. 10: 1071-1072 (2004). *
Fulford A, Scolapio JS, Aranda-Michel J. Parenteral nutrition-associated hepatotoxicity. Nutr. Clin. Pract. 19: 274-283 (2004). *
Fulop AK, Falus A. Possibilities and results in the wide-scale genomic analysis of inflammation. Looking for the child among many midwives. Inflamm. Res. 53: 517-522 (2004). *
Fulop M, Mackay M. Renal tubular acidosis, Sjogren syndrome, and bone disease. Arch. Intern. Med. 164: 905-909 (2004). *
Funayama Y, Fukushima K, Shibata C, Koyama K, Miura K, Takahashi K, Hashimoto A, Sasaki I, Kinouchi Y, Hiwatashi N, Takeda K, Matsuno S. Acute pancreatitis complicating ulcerative colitis under administration of corticosteroid in surgical cases. J. Gastroenterol. 39: 592-594 (2004). *
Fung CH, Woo HE, Asch SM. Controversies and legal issues of prescribing and dispensing medications using the Internet. Mayo Clin. Proc. 79: 188-194 (2004). *
Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl. 10: S39-S53 (2004). *
Furlan R, Salani G, Bergami A, Martino G. Detection of TNF and TNF receptor mRNA in cells and tissues. Methods Mol. Med. 98: 59-72 (2004).
Furlan R, Villa P, Senaldi G, Martino G. TNFalpha in experimental diseases of the CNS. Methods Mol. Med. 98: 171-190 (2004).
Furness JB, Kearney K, Robbins HL, Hunne B, Selmer IS, Neylon CB, Chen MX, Tjandra JJ. Intermediate conductance potassium (IK) channels occur in human enteric neurons. Auton. Neurosci. 112: 93-97 (2004). *
Furnham N, Ruffle S, Southan C. Splice variants: a homology modeling approach. Proteins 54: 596-608 (2004). *
Furrie E, Macfarlane S, Cummings JH, Macfarlane GT. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response. Gut 53: 91-98 (2004). *
Furst DE, Nash R, Sullivan KM, Saccardi R, McSweeney P. High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward. J. Rheumatol. 31: 2331-2335 (2004).
Furugaki K, Shirasawa S, Ishikawa N, Ito K, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet. 49: 166-168 (2004). *
Furukawa A, Saotome T, Yamasaki M, Maeda K, Nitta N, Takahashi M, Tsujikawa T, Fujiyama Y, Murata K, Sakamoto T. Cross-sectional imaging in Crohn disease. Radiographics 24: 689-702 (2004). *
Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israel A, Courtois G, D'Urso M, Ursini MV. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Hum. Mol. Genet. 13: 1763-1773 (2004). *
Fuss IJ. Treatment of ulcerative colitis with infliximab: are we there yet? J. Pediatr. Gastroenterol. Nutr. 38: 247-249 (2004). *
Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113: 1490-1497 (2004). *
Fuss M, Salter BJ, Herman TS, Thomas CR. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology 127 (5 Suppl. 2): S206-S217 (2004). *
Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS liver transplant registry. Clin. Transpl. 2004: 315-329 (2004).
Fux M, Benjamin J, Nemets B. A placebo-controlled cross-over trial of adjunctive EPA in OCD. J. Psychiatr. Res. 38: 323-325 (2004). *
Gabriely I, Shamoon H. Hypoglycemia in diabetes: common, often unrecognized. Cleve. Clin. J. Med. 71: 335-342 (2004). *
Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4: 941-952 (2004). *
Gacka M, Adamiec R. Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications. Postepy. Hig. Med. Dosw. (Online) 58: 483-489 (2004).
Gade JN. Clinical update on alefacept: consideration for use in patients with psoriasis. J. Manag. Care Pharm. 10 (3 Suppl. B): S33-S37 (2004).
Gade-Andavolu R, Comings DE, MacMurray J, Rostamkhani M, Cheng LS, Tourtellotte WW, Cone LA. Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genet. Med. 6: 126-131 (2004).
Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin - a soluble pattern recognition molecule. Mol. Immunol. 41: 113-121 (2004). *
Gaertner S, De Graaf KL, Wienhold W, Wiesmuller KH, Melms A, Weissert R. Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor epsilon-chain. J. Neuroimmunol. 152: 44-56 (2004).
Gaffen SL. Biology of recently discovered cytokines: interleukin-17 - a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res. Ther. 6: 240-247 (2004). *
Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, Mancini M, Pini P, Fornari F, Bolondi L. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J. Hepatol. 41: 421-426 (2004). *
Gaines DI, Fallon MB. Hepatopulmonary syndrome. Liver Int. 24: 397-401 (2004). *
Galdeano CM, Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol. 97: 673-681 (2004). *
Gale CP, Grant PJ. The characterisation and functional analysis of the human glyoxalase-1 gene using methods of bioinformatics. Gene 340: 251-260 (2004). *
Galesic K, Morovic-Vergles J, Vergles D, Racic I, Horvatic I. Primary Sjogren's syndrome and hypokalaemic paralysis - case report. Reumatizam 51: 19-22 (2004).
Galgani A, Petrone A, Spoletini M, Hodge A, Del Buono ML, Locatelli M, Buzzetti R; Diabfin Study Group. HLA class II typing in newborns reveals a low frequency of the DRB1*04 allele and a high frequency of DRB1*11 allele in three regions of continental Italy. Hum. Immunol. 65: 366-372 (2004).
Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr. Gastroenterol. Rep. 6: 44-51 (2004).
Galicia JC, Tai H, Komatsu Y, Shimada Y, Akazawa K, Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 5: 513-516 (2004). *
Galietta LJ, Folli C, Caci E, Pedemonte N, Taddei A, Ravazzolo R, Zegarra-Moran O. Effect of inflammatory stimuli on airway ion transport. Proc. Am. Thorac. Soc. 1: 62-65 (2004). *
Galietta LJ, Moran O. Identification of CFTR activators and inhibitors: chance or design? Curr. Opin. Pharmacol. 4: 497-503 (2004).
Galimberti S, Guerrini F, Palumbo GA, Consoli U, Fazzi R, Morabito F, Santini V, Petrini M. Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients. Leuk. Res. 28: 367-372 (2004).
Galka E, Thompson JL, Zhang WJ, Poritz LS, Koltun WA. Stat6(null phenotype) human lymphocytes exhibit increased apoptosis. Surg. Res. 122: 14-20 (2004). *
Gallagher S. Omega 3 oils and pregnancy. Midwifery Today Int. Midwife 69: 26-31 (2004).
Gallagher SF, Yang J, Baksh K, Haines K, Carpenter H, Epling-Burnette PK, Peng Y, Norman J, Murr MM. Acute pancreatitis induces FasL gene expression and apoptosis in the liver. J. Surg. Res. 122: 201-209 (2004).
Gallego F, Gelpi C. The IL-12 role in donor cell engraftment in a murine model of semiallogenic GVH disease with signs of autoimmune disease. Autoimmunity 37: 155-170 (2004).
Gallegos AM, Bevan MJ. Driven to autoimmunity: the nod mouse. Cell 117: 149-151 (2004). *
Gallerani I, Innocenti DD, Coronella G, Berti S, Amato L, Moretti S, Fabbri P. Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome. Pediatr. Dermatol. 21: 39-43 (2004). *
Galli A, Bergamaschi G, Recalde H, Biasiotto G, Santambrogio P, Boggi S, Levi S, Arosio P, Cazzola M. Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br. J. Haematol. 127: 598-603 (2004).
Galli A, Ceni E, Crabb DW, Mello T, Salzano R, Grappone C, Milani S, Surrenti E, Surrenti C, Casini A. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut 53: 1688-1697 (2004). *
Galligan JJ. 5-Hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: molecular connections. Gastroenterology 126: 1897-1899 (2004). *
Galluhn D, Langer T. Reversible assembly of the ABC-transporter Mdl1 with the F1FO-ATP synthase in mitochondria. J. Biol. Chem. 279: 38338-38345 (2004). *
Galmarini CM. OSI-461 (OSI). Curr. Opin. Investig. Drugs 5: 648-656 (2004).
Galvin P, Clarke LA, Harvey S, Amaral MD. Microarray analysis in cystic fibrosis. J. Cyst. Fibros. 3 Suppl. 2: 29-33 (2004).
Gambelunghe G, Ghaderi M, Gharizadeh B, Brozzetti A, Tortoioli C, Del Sindaco P, Sanjeevi CB, Hjelmstrom P, Sirsjo A, Nyren P, Santeusanio F, Falorni A. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease. Eur. J. Immunogenet. 31: 73-76 (2004). *
Gan SI, Urbanski S, Coderre SP, Panaccione R. Isolated visceral small artery fibromuscular hyperplasia-induced ischemic colitis mimicking inflammatory bowel disease. Am. J. Gastroenterol. 99: 2058-2062 (2004). *
Ganapathy V, Smith SB, Prasad PD. SLC19: the folate/thiamine transporter family. Pflugers Arch. 447: 641-646 (2004). *
Ganaraja B, Pavithran P, Ghosh S. Effect of estrogen on plasma ceruloplasmin level in rats exposed to acute stress. Indian J. Med. Sci. 58: 150-154 (2004). *
Gane E, Bergman R, Hutchinson D. Resolution of alcoholic neuropathy following liver transplantation. Liver Transpl. 10: 1545-1548 (2004). *
Gangi E, Kapatral V, El-Azami El-Idrissi M, Martinez O, Prabhakar BS. Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor. Autoimmunity 37: 515-520 (2004).
Gangloff M, Gay NJ. MD-2: the Toll 'gatekeeper' in endotoxin signalling. Trends Biochem. Sci. 29: 294-300 (2004). *
Ganguli SC, Cawdron R, Irvine EJ. Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am. J. Gastroenterol. 99: 319-326 (2004). *
Ganly P, Walker LC, Morris CM. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk. Lymphoma 45: 1-10 (2004).
Ganschow R, Richter A, Grabhorn E, Schulz A, Von Hugo A, Mir TS, Broering DC, Rogiers X, Hinrichs B, Burdelski M. C blood concentrations of orally administered cyclosporine in pediatric liver graft recipients with a body weight below 10 kg. Pediatr. Transplant. 8: 185-188 (2004). *
Ganschow R, Schulz T, Meyer T, Broering DC, Burdelski M. Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients. J. Pediatr. Gastroenterol. Nutr. 38: 198-203 (2004). *
Ganslmayer M, Ocker M, Kraemer G, Zopf S, Hahn EG, Schuppan D, Herold C. The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma. J. Hepatol. 40: 952-956 (2004). *
Ganz T. Hepcidin in iron metabolism. Curr. Opin. Hematol. 11: 251-254 (2004).
Gao B, St Pierre MV, Stieger B, Meier PJ. Differential expression of bile salt and organic anion transporters in developing rat liver. J. Hepatol. 41: 201-208 (2004). *
Gao B, Williams A, Sewell A, Elliott T. Generation of a functional, soluble tapasin protein from an alternatively spliced mRNA. Genes Immun. 5: 101-108 (2004). *
Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjogren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum. 50: 2615-2621 (2004). *
Gao LH, Zheng SS. Cytomegalovirus and chronic allograft rejection in liver transplantation. World J. Gastroenterol. 10: 1857-1861 (2004). *
Gao Q, Hogezand RA, Lamers CB, Verspaget HW. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Aliment. Pharmacol. Ther. 20: 585-592 (2004). *
Gao ZH, McAlister VC, Wright JR, McAlister CC, Peltekian K, MacDonald AS. Immunoglobulin-G subclass antidonor reactivity in transplant recipients. Liver Transpl. 10: 1055-1059 (2004). *
Garcia CE, Garcia RF, Gunson B, Christensen E, Neuberger J, McMaster P, Mirza DF. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp. Clin. Transplant. 2: 183-188 (2004).
Garcia Ruiz P, Canora Lebrato J, Diez Ruiz A, Fuchs D, Wachter H. Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis. Med. Clin. (Barc.) 122: 441-443 (2004).
Garcia YR, Krolick KA. Short-circuiting autoimmune disease by target-tissue-derived nitric oxide. Clin. Immunol. 113: 74-80 (2004). *
Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat. Biotechnol. 22: 535-546 (2004). *
Garcia-Compean D, Cortes C. Transjugular liver biopsy. An update. Ann. Hepatol. 3: 100-103 (2004). *
Garcia-Pagan JC, Bosch J. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators (J Hepatol 1985; 1: 325-337). J. Hepatol. 40: 887-890 (2004). *
Garcia-Planella E, Domenech E. Osteopenia and osteoporosis in inflammatory bowel disease. Gastroenterol. Hepatol. 27: 417-424 (2004).
Garcia-Porrua C, Margarinos CC, Gonzalez-Gay MA. Raynaud's phenomenon and serotonin reuptake inhibitors. J. Rheumatol. 31: 2090 (2004). *
Garcia-Ruiz JC, Amutio E, Ponton J. Invasive fungal infection in immunocompromised patients. Rev. Iberoam. Micol. 21: 55-62 (2004).
Garcia-Sanchez Mdel V, Gomez-Camacho F, Poyato-Gonzalez A, Iglesias-Flores EM, de Dios-Vega JF, Sancho-Zapatero R. Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection. Inflamm. Bowel Dis. 10: 701-702 (2004). *
Garcia-Suarez C, Crespo J, Fernandez-Gil PL, Amado JA, Garcia-Unzueta MT, Pons Romero F. Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gastroenterol. Hepatol. 27: 47-50 (2004).
Garcia-Tsao G. Portal hypertension. Curr. Opin. Gastroenterol. 20: 254-263 (2004).
Garcia-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav. Res. Ther. 42: 367-383 (2004). *
Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM, Diaz-Gonzalez F. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50: 3866-3877 (2004). *
Gardner-Stephen D, Heydel JM, Goyal A, Lu Y, Xie W, Lindblom T, Mackenzie P, Radominska-Pandya A. Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab. Dispos. 32: 340-347 (2004). *
Garenc C, Aubert S, Laroche J, Girouard J, Vohl MC, Bergeron J, Rousseau F, Julien P. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. J. Hum. Genet. 49: 691-700 (2004). *
Garidou L, Laffont S, Douin-Echinard V, Coureau C, Krust A, Chambon P, Guery JC. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 173: 2435-2442 (2004). *
Garmory HS, Titball RW. ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect. Immun. 72: 6757-6763 (2004). *
Garred P, Madsen HO. Genetic susceptibility to sepsis: a possible role for mannose-binding lectin. Curr. Infect. Dis. Rep. 6: 367-373 (2004).
Garrido A, Martinez M, Ortega J, Lobato A, Rodriguez M, Guerrero F. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev. Esp. Enferm. Dig. 96: 687-694 (2004).
Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am. J. Ophthalmol. 138: 925-930 (2004).
Garside H, Stevens A, Farrow S, Normand C, Houle B, Berry A, Maschera B, Ray D. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain. J. Biol. Chem. 279: 50050-50059 (2004). *
Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses. Ann. N. Y. Acad. Sci. 1029: 9-15 (2004). *
Garza-Madrid ME, Borbolla-Escoboza JR, Lopez-Hernandez MA. Autologous bone marrow transplantation as a treatment for autoimmune disease: mechanisms and results. Gac. Med. Mex. 140: 531-539 (2004).
Gasbarri A, Sciacchitano S, Marasco A, Papotti M, Di Napoli A, Marzullo A, Yushkov P, Ruco L, Bartolazzi A. Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis. Br. J. Cancer 91: 1096-1104 (2004). *
Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA. Helicobacter pylori and extragastric diseases - other Helicobacters. Helicobacter 9 Suppl. 1: 57-66 (2004).
Gasche C. The chemoprevention of colorectal carcinoma. Aliment. Pharmacol. Ther. 20 Suppl. 4: 31-35 (2004). *
Gasche C, Carethers JM. NOD2 and colorectal cancer: guilt by non-association. Cancer Res. 64: 5525 (2004). *
Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 53: 1190-1197 (2004). *
Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187 (2004). *
Gasparini P, Camaschella C. Hereditary hemochromatosis: is the gene race over? Eur. J. Hum. Genet. 12: 341-342 (2004). *
Gassler N, Kopitz J, Tehrani A, Ottenwalder B, Schnolzer M, Kartenbeck J, Lyer S, Autschbach F, Poustka A, Otto HF, Mollenhauer J. Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine. J. Pathol. 202: 188-196 (2004). *
Gassull MA. The role of nutrition in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 79-83 (2004). *
Gasztonyi B, Hunyady B. Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders. Orv. Hetil. 145: 2177-2181 (2004).
Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F. Hepatorenal syndrome. Clin. Ter. 155: 375-389 (2004).
Gaur LK. Nonhuman primate models for islet transplantation in type 1 diabetes research. ILAR J. 45: 324-333 (2004).
Gautier G, Pilleul F, Crombe-Ternamian A, Gruner L, Ponchon T, Barth X, Valette PJ. Contribution of magnetic resonance cholangiopancreatography to the management of patients with suspected common bile duct stones. Gastroenterol. Clin. Biol. 28: 129-134 (2004). *
Gawenis LR, Boyle KT, Palmer BA, Walker NM, Clarke LL. Lateral intercellular space volume as a determinant of CFTR-mediated anion secretion across small intestinal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1015-G1023 (2004). *
Gawenis LR, Hut H, Bot AG, Shull GE, De Jonge HR, Stien X, Miller ML, Clarke LL. Electroneutral sodium absorption and electrogenic anion secretion across murine small intestine are regulated in parallel. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1140-G1149 (2004). *
Gawenis LR, Ledoussal C, Judd LM, Prasad V, Alper SL, Stuart-Tilley A, Woo AL, Grisham C, Sanford LP, Doetschman T, Miller ML, Shull GE. Mice with a targeted disruption of the AE2 Cl-/HCO3- exchanger are achlorhydric. J. Biol. Chem. 279: 30531-30539 (2004). *
Gay G, Delvaux M, Rey JF. The role of video capsule endoscopy in the diagnosis of digestive diseases: a review of current possibilities. Endoscopy 36: 913-920 (2004).
Gaya DR, Black RA, MacKenzie JF. Crohn's disease and MAP. Lancet 364: 2179 (2004). *
Gaya DR, McLay AL, Oien KA, Spooner RJ, Reilly TG. A tale of two sisters. J. Clin. Pathol. 57: 439-441 (2004). *
Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R. HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum. Immunol. 65: 39-46 (2004).
Gazouli M, Zacharatos P, Gorgoulis V, Mantzaris G, Papalambros E, Ikonomopoulos J. The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population. Gastroenterology 126: 367-369 (2004). *
Gazouli M, Zacharatos P, Mantzaris GJ, Barbatis C, Ikonomopoulos I, Archimandritis AJ, Lukas JC, Papalambros E, Gorgoulis V. Association of NOD2/CARD15 variants with Crohn's disease in a Greek population. Eur. J. Gastroenterol. Hepatol. 16: 1177-1182 (2004).
Gazzinelli RT, Ropert C, Campos MA. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol. Rev. 201: 9-25 (2004). *
Gbaguidi GF, Agellon LB. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver X receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer. Nucleic Acids Res. 32: 1113-1121 (2004). *
Ge L, Wang Z, Wang M, Kar S, Carr BI. Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog. J. Hepatol. 41: 823-829 (2004). *
Ge N, Muise CN, Gong X, Linsdell P. Direct comparison of the functional roles played by different membrane spanning regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore. J. Biol. Chem. 279: 55283-55289 (2004). *
Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy in diagnosis of small bowel Crohn's disease. World J. Gastroenterol. 10: 1349-1352 (2004). *
Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy and push enteroscopy in the diagnosis of obscure gastrointestinal bleeding. Chin. Med. J. (Engl.) 117: 1045-1049 (2004).
Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol. Drug Saf. 13: 563-567 (2004). *
Gearry RB, Roberts RL, Barclay ML, Kennedy MA. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 14: 779-781 (2004).
Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in new zealand. Dis. Colon Rectum 47: 314-322 (2004). *
Geboes K. Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ? Acta Gastroenterol. Belg. 67: 285-289 (2004).
Geen J, Howells RC, Ludgate M, Hullin DA, Hogg SI. The prevalence of anti-acetylcholinesterase antibodies in autoimmune disease. Autoimmunity 37: 579-585 (2004).
Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. J. Med. Virol. 73: 432-438 (2004). *
Geier A, Gartung C, Matern S. Regulation of hepatobiliary transporters in cholestatic liver disease. Med. Klin. (Munich) 99: 7-17 (2004).
Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brugmann M, Gressner AM, Matern S, Lammert F. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int. 24: 285-294 (2004). *
Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin. Exp. Rheumatol. 22: 749-755 (2004).
Geier MR, Geier DA. Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Hepatogastroenterology 51: 762-767 (2004).
Gelfand EW. Use of IGIV in the treatment of immune-mediated dermatologic disorders. J. Investig. Dermatol. Symp. Proc. 9: 92-96 (2004). *
Gelinas DS, DaSilva K, Fenili D, St George-Hyslop P, McLaurin J. Immunotherapy for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101: 14657-14662 (2004). *
Geller SA, Dubinsky MC, Poordad FF, Vasiliauskas EA, Cohen AH, Abreu MT, Tran T, Martin P, Vierling JM, Targan SR. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am. J. Surg. Pathol. 28: 1204-1211 (2004).
Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD. Analysis of cystic fibrosis gene product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am. J. Gastroenterol. 99: 1557-1562 (2004). *
Gelsi E, Ruitord F, Saint-Paul MC, Filippi J, Arab K, Hebuterne X. Association of Budd-Chiari syndrome with a coeliac disease in patient native from North Africa. Gastroenterol. Clin. Biol. 28: 903-905 (2004).
Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, Witkin SS; The MAP Study Group. Relationship between a Toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 116: 152-156 (2004).
Genc S, Genc K, Sercan O, Kizildag S, Gulay Z, Atay T, Dundar B, Sakizli M, Buyukgebiz A. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population. J. Pediatr. Endocrinol. Metab. 17: 731-735 (2004).
Gendek-Kubiak H, Gendek EG. Expression of tissue transglutaminase in blood and lymphatic vessel endothelia and in mesothelium. Rocz. Akad. Med. Bialymst. 49 Suppl. 1: 195-197 (2004).
Generini S, Giacomelli R, Fedi R, Fulminis A, Pignone A, Frieri G, Del Rosso A, Viscido A, Galletti B, Fazzi M, Tonelli F, Matucci Cerinic M. Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy in inducing and maintaining remission of musculoskeletal and gut manifestations. Ann. Rheum. Dis. 63: 1664-1669 (2004). *
Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ, Davies EG. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood 103: 1152-1157 (2004). *
Gennuso F, Fernetti C, Tirolo C, Testa N, L'Episcopo F, Caniglia S, Morale MC, Ostrow JD, Pascolo L, Tiribelli C, Marchetti B. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc. Natl. Acad. Sci. U.S.A. 101: 2470-2475 (2004). *
Genolet R, Wahli W, Michalik L. PPARs as drug targets to modulate inflammatory responses? Curr. Drug Targets Inflamm. Allergy 3: 361-375 (2004).
Genovese D, Dettori S, Argentini C, Kondili LA, La Sorsa V, Tisone G, Angelico M, Rapicetta M. Molecular characterisation of SENV and TTV infections in hepatopathic liver-transplant patients. Arch. Virol. 149: 1423-1433 (2004). *
Gentile V, Cooper AJ. Transglutaminases - possible drug targets in human diseases. Curr. Drug Target CNS Neurol. Disord. 3: 99-104 (2004).
Gentilini P, Bernardi M, Bolondi L, Craxi A, Gasbarrinie G, Ideo G, Laffi G, La Villa G, Salerno F, Ventura E, Pulazzini A, Segantini L, Romanelli RG. The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. Dig. Liver Dis. 36: 539-546 (2004).
Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J. Hand Surg. [Br.] 29: 423-426 (2004).
George J. Artificial liver support systems. J. Assoc. Physicians India. 52: 719-722 (2004).
George JN. For low platelets, how low is dangerous? Cleve. Clin. J. Med. 71: 277-278 (2004). *
George JN, Vesely SK. How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin. Proc. 79: 456-457 (2004). *
Gerbitz A, Schultz M, Wilke A, Linde HJ, Scholmerich J, Andreesen R, Holler E. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103: 4365-4367 (2004). *
Gerhard GS, Chorney MJ. Genes for gestational iron loading? Gastroenterology 127: 1861 (2004). *
Gerke H, Baillie J. To cut or stretch? Am. J. Gastroenterol. 99: 1461-1463 (2004). *
Gerloff T. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution. Naunyn. Schmiedebergs Arch. Pharmacol. 369: 69-77 (2004). *
Gershonowitz A, Itach EG, Shouval D, Mitrani D, Ilan Y, Mitrani E. Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs. J. Hepatol. 41: 950-956 (2004). *
Gershwin ME. Primary biliary cirrhosis: from induction through destruction. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 39-40 (2004). *
Gershwin ME, Incaudo G. Topics in allergy and immunology during pregnancy and early infancy. Clin. Rev. Allergy Immunol. 26: 127-128 (2004).
Gershwin ME, Selmi C. Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis. Am. J. Gastroenterol. 99: 2356-2358 (2004). *
Gerster JC, Dudler M, Halkic N, Gillet M. Gout in liver transplant patients receiving tacrolimus. Ann. Rheum. Dis. 63: 894-895 (2004). *
Gerth AJ, Lin L, Neurath MF, Glimcher LH, Peng SL. An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells. Gastroenterology 126: 1115-1121 (2004). *
Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 577: 563-569 (2004). *
Gervois P, Fruchart JC, Staels B. Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARalpha and PPARgamma agonists. Int. J. Clin. Pract. Suppl. 143: 22-29 (2004).
Gervois P, Kleemann R, Pilon A, Percevault F, Koenig W, Staels B, Kooistra T. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J. Biol. Chem. 279: 16154-1660 (2004). *
Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, Roberts CA, Goin JE. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S194-S205 (2004). *
Getachew Y, Oh E, Mills SA, Contos M, Markin R, Rubin R, Wheeler D, Flye N, Huet B, Combes B, Mayo M. Serum markers of fibrosis in primary biliary cirrhosis. Gastroenterology 126: A713 (2004).
Geuken E, Visser D, Kuipers F, Blokzijl H, Leuvenink HG, de Jong KP, Peeters PM, Jansen PL, Slooff MJ, Gouw AS, Porte RJ. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J. Hepatol. 41: 1017-1025 (2004). *
Gey T, Bergoin C, Just N, Paupard T, Cazals-Hatem D, Xuan KH, Tavernier JY, Wallaert B. Langerhans cell histiocytosis and sclerosing cholangitis in adults. Rev. Mal. Respir. 21: 997-1000 (2004).
Geyer J, Godoy JR, Petzinger E. Identification of a sodium-dependent organic anion transporter from rat adrenal gland. Biochem. Biophys. Res. Commun. 316: 300-306 (2004). *
Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Mohammad Pezeshki A, Doroudchi M, Dehaghani AS. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res. Treat. 86: 1-7 (2004). *
Ghadiali AH, Strother M, Naser SA, Manning EJ, Sreevatsan S. Mycobacterium avium subsp. paratuberculosis strains isolated from Crohn's disease patients and animal species exhibit similar polymorphic locus patterns. J. Clin. Microbiol. 42: 5345-5348 (2004). *
Ghali P, Lindor KD. Hepatotoxicity of drugs used for treatment of obesity and its comorbidities. Semin. Liver Dis. 24: 389-397 (2004).
Gharib AM, Thomasson D, Li KC. Molecular imaging of hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S153-S158 (2004). *
Ghazalpour A, Doss S, Yang X, Aten J, Toomey EM, Van Nas A, Wang S, Drake TA, Lusis AJ. Toward a biological network for atherosclerosis. J. Lipid Res. 45: 1793-1805 (2004). *
Gheduzzi D, Guidetti R, Anzivino C, Tarugi P, Di Leo E, Quaglino D, Ronchetti IP. ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum (PXE). Hum. Mutat. 24: 438-439 (2004). *
Gheller-Rigoni AI, Yale SH, Abdulkarim AS. Celiac disease: celiac sprue, gluten-sensitive enteropathy. Clin. Med. Res. 2: 71-72 (2004). *
Gheorghe C, Pascu O, Gheorghe L, Iacob R, Dumitru E, Tantau M, Vadan R, Goldis A, Balan G, Iacob S, Dobru D, Saftoiu A. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur. J. Gastroenterol. Hepatol. 16: 1153-1159 (2004).
Gheorghe L, Iacob S, Bolog N, Stoicescu A, Parvulescu I, Popescu I. Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma. Case report. Rom. J. Gastroenterol. 13: 33-38 (2004).
Gheorghe L, Iacob S, Gheorghe C, Iacob R, Simionov I, Vadan R, Becheanu G, Parvulescu I, Toader C. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur. J. Gastroenterol. Hepatol. 16: 585-592 (2004).
Gheorghe L, Popescu I, Iacob S, Gheorghe C, Vaidan R, Constantinescu A, Iacob R, Becheanu G, Angelescu C, Diculescu M. Wilson's disease: a challenge of diagnosis. The 5-year experience of a tertiary centre. Rom. J. Gastroenterol. 13: 179-185 (2004). *
Ghezzi P, Cerami A. Tumor necrosis factor as a pharmacological target. Methods Mol. Med. 98: 1-8 (2004).
Ghibellini G, Johnson BM, Kowalsky RJ, Heizer WD, Brouwer KL. A novel method for the determination of biliary clearance in humans. AAPS J. 6: e33 (2004). *
Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta32 deletion. J. Vasc. Surg. 40: 995-1000 (2004).
Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D, Bizzaro N, Piccoli A, Gambari PF. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J. Autoimmun. 22: 235-240 (2004).
Ghoreschi K, Rocken M. Immune deviation strategies in the therapy of psoriasis. Curr. Drug Targets Inflamm. Allergy 3: 193-198 (2004).
Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Integration of nuclear receptors and cell signaling pathways on bile acid physiology. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 44. June 18-19 (2004). *
Ghose R, Zimmerman TL, Thevananther S, Karpen SJ. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl. Recept. 2: 4 (2004). *
Ghosh JB, Chakrabarty S, Singh AK, Gupta D. Wilson's disease - unusual features. Indian J. Pediatr. 71: 937-938 (2004). *
Ghosh S. Anti-TNF therapy in Crohn's disease. Novartis Found. Symp. 263: 193-205 (2004).
Ghosh S. Maintenance therapy versus episodic therapy with infliximab for Crohn�s disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 80-81 (2004). *
Ghosh S, van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 53: 620-622 (2004). *
Giachino D, Van Duist MM, Regazzoni S, Gregori D, Bardessono M, Salacone P, Scaglione N, Sostegni R, Sapone N, Bresso F, Sambataro A, Gaia E, Pera A, Astegiano M, De Marchi M. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur. J. Hum. Genet. 12: 206-212 (2004). *
Giacopelli F, Marciano R, Pistorio A, Catarsi P, Canini S, Karsenty G, Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 20: 87-96 (2004). *
Giannetti AM, Bjorkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J. Biol. Chem. 279: 25866-25875 (2004). *
Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int. 24: 465-470 (2004). *
Giannini E, Romagnoli P, Tenconi GL, Botta F, Malfatti F, Chiarbonello B, Mamone M, Barreca T, Testa R. High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels. Dig. Dis. Sci. 49: 275-280 (2004). *
Giannouli S, Anagnostou D, Soliotis F, Voulgarelis M. Autoimmune manifestations in common variable immunodeficiency. Clin. Rheumatol. 23: 449-452 (2004). *
Giardina E, Capon F, De Rosa MC, Mango R, Zambruno G, Orecchia A, Chimenti S, Giardina B, Novelli G. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann. Hum. Genet. 68: 639-645 (2004). *
Giardina E, Novelli G, Costanzo A, Nistico S, Bulli C, Sinibaldi C, Sorgi ML, Chimenti S, Pallone F, Taccari E, Borgiani P. Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J. Invest. Dermatol. 122: 1106-1107 (2004). *
Giardina E, Sinibaldi C, Novelli G. The psoriasis genetics as a model of complex disease. Curr. Drug Targets Inflamm. Allergy 3: 129-136 (2004).
Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J. Immunol. 173: 2280-2287 (2004). *
Gibbons RD. Racial disparities in liver transplantation. Liver Transpl. 10: 842-843 (2004). *
Gibbs S, Surridge H, Adamson R, Cohen B, Bentham G, Reading R. Atopic dermatitis and the hygiene hypothesis: a case-control study. Int. J. Epidemiol. 33: 199-207 (2004). *
Gibson PR. Apoptosis or necrosis - colonic epithelial cell survival. Novartis Found. Symp. 263: 133-145 (2004).
Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut 53: 1724-1725 (2004). *
Gieling RG, Ruijter JM, Maas AA, Van den Bergh Weerman MA, Dingemans KP, Ten Kate FJ, Lekanne Dit Deprez RH, Moorman AF, Lamers WH. Hepatic response to right ventricular pressure overload. Gastroenterology 127: 1210-1221 (2004). *
Giessmann T, Modess C, Hecker U, Zschiesche M, Dazert P, Kunert-Keil C, Warzok R, Engel G, Weitschies W, Cascorbi I, Kroemer HK, Siegmund W. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin. Pharmacol. Ther. 75: 213-222 (2004). *
Gigliozzi A, Alpini G, Svegliati Baroni G, Marucci L, Drudi Metalli V, Glaser SS, Francis H, Grazia Mancino M, Ueno Y, Barbaro B, Benedetti A, Attili AF, Alvaro D. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127: 1198-1209 (2004). *
Gijsbers K, Van Assche G, Joossens S, Struyf S, Proost P, Rutgeerts P, Geboes K, Van Damme J. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur. J. Immunol. 34: 1992-2000 (2004). *
Gil J, Wojtun S, Stec-Michalska K, Chojnacki C. Inflammatory bowel diseases - imaging diagnostics. Pol. Merkuriusz. Lek. 17 Suppl. 1: 27-31 (2004).
Gilbert KM, Whitlow AB, Pumford NR. Environmental contaminant and disinfection by-product trichloroacetaldehyde stimulates T cells in vitro. Int. Immunopharmacol. 4: 25-36 (2004).
Gilbert-Barness E, Fox T, Morrow G, Luquette M, Pomerance H. Williams syndrome associated with Crohn disease, multiple infections, and chronic granulomatous disease. Pediatr. Pathol. Mol. Med. 23: 29-37 (2004).
Gilbertson B, Germano S, Steele P, Turner S, de St Groth BF, Cheers C. Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. Infect. Immun. 72: 6884-6891 (2004). *
Gilburd B, Abu-Shakra M, Shoenfeld Y, Giordano A, Bocci EB, delle Monache F, Gerli R. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation - a homogeneous, multiplexed system. Clin. Dev. Immunol. 11: 53-56 (2004). *
Giles JT, Bathon JM. Serious infections associated with anticytokine therapies in the rheumatic diseases. J. Intensive Care Med. 19: 320-334 (2004). *
Gilgenkrantz H. Mesenchymal stem cells: an alternative source of hepatocytes? Hepatology 40: 1256-1259 (2004). *
Gilissen LP, Derijks LJ, Bos LP, Bus PJ, Hooymans PM, Engels LG. Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy. Clin. Drug Investig. 24: 479-486 (2004).
Gilissen LP, Derijks LJ, Bos LP, Verhoeven HM, Bus PJ, Hooymans PM, Engels LG. Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. Eur. J. Gastroenterol. Hepatol. 16: 705-710 (2004).
Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad. Med. J. 80: 516-526 (2004). *
Gill TS, Karantana A, Rees J, Pandey S, Dixon AR. Laparoscopic proctocolectomy with restorative ileal-anal pouch. Colorectal Dis. 6: 458-461 (2004). *
Gillet JP, Efferth T, Steinbach D, Hamels J, de Longueville F, Bertholet V, Remacle J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 64: 8987-8993 (2004). *
Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS. Multiplicity of the antibody response to GAD65 in type I diabetes. Clin. Exp. Immunol. 138: 337-341 (2004). *
Gilliet M, Conrad C, Geiges M, Cozzio A, Thurlimann W, Burg G, Nestle FO, Dummer R. Psoriasis triggered by Toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch. Dermatol. 140: 1490-1495 (2004). *
Gilliland DG, Jordan CT, Felix CA. The molecular basis of leukemia. Hematology (Am. Soc. Hematol. Educ. Program) 2004: 80-97 (2004). *
Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N. Engl. J. Med. 350: 1646-1654 (2004). *
Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. Re-examination of the role of SOCS1 in the regulation of Toll-like receptor signaling. J. Biol. Chem. 279: 54702-54707 (2004). *
Gionchetti P, Morselli C, Rizzello F, Romagnoli R, Campieri M, Poggioli G, Laureti S, Ugolini F, Pierangeli F. Management of pouch dysfunction or pouchitis with an ileoanal pouch. Best Pract. Res. Clin. Gastroenterol. 18: 993-1006 (2004).
Gionchetti P, Rizzello F, Morselli C, Campieri M. Problematic proctitis and distal colitis. Aliment. Pharmacol. Ther. 20 Suppl. 4: 93-96 (2004). *
Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, Fontana L. Assessment of autonomic function in untreated adult coeliac disease. World J. Gastroenterol. 10: 2715-2718 (2004). *
Gipson IK, Hori Y, Argueso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul. Surf. 2: 131-148 (2004).
Girard H, Court MH, Bernard O, Fortier LC, Villeneuve L, Hao Q, Greenblatt DJ, Von Moltke LL, Perussed L, Guillemette C. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14: 501-515 (2004).
Girardin SE, Philpott DJ. Mini-review: the role of peptidoglycan recognition in innate immunity. Eur. J. Immunol. 34: 1777-1782 (2004). *
Giraud M, Beaurain G, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. Genes Immun. 5: 398-404 (2004). *
Giraud M, Eymard B, Tranchant C, Gajdos P, Garchon HJ. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis. Genes Immun. 5: 80-83 (2004). *
Giri RK, Rajagopal V, Kalra VK. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J. Neurochem. 91: 1199-1210 (2004). *
Girkontaite I, Sakk V, Wagner M, Borggrefe T, Tedford K, Chun J, Fischer KD. The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J. Exp. Med. 200: 1491-1501 (2004). *
Giron RM, Sanchez Molini P, Almonacid C, Jimenez I, Rodriguez Salvanes F, Garcia Vadillo A, Quintana ML, Hurtado J, Ancochea J. A study of bone mineral density in adult patients with cystic fibrosis. Med. Clin. (Barc.) 123: 81-84 (2004).
Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, Macias MA, Rendon P, Diaz F, Fernandez-Gutierrez C, Martin-Herrera L. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int. 24: 437-445 (2004). *
Gisbert JP, Luna M, Legido J, Hermida C, Mate J, Pajares JM. Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease. Med. Clin. (Barc.) 122: 134-135 (2004).
Givissis P, Karataglis D, Christodoulou A, Terzidis I, Pournaras J. Wilson osteotomy stabilised by means of internal fixation for the treatment of hallux valgus. Acta Orthop. Belg. 70: 57-63 (2004).
Glabinski AR, Bielecki B, Kawczak JA, Tuohy VK, Selmaj K, Ransohoff RM. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression. Autoimmunity 37: 465-471 (2004).
Gladyshev VN, Kryukov GV, Fomenko DE, Hatfield DL. Iidentification of trace element-containing proteins in genomic databases. Annu. Rev. Nutr. 24: 579-596 (2004). *
Glant TT, Adarichev VA, Nesterovitch AB, Szanto S, Oswald JP, Jacobs JJ, Firneisz G, Zhang J, Finnegan A, Mikecz K. Disease-associated qualitative and quantitative trait loci in proteoglycan-induced arthritis and collagen-induced arthritis. Am. J. Med. Sci. 327: 188-195 (2004).
Glantz A, Lammert FL, Mattsson L-A, Marschall H-U. Intrahepatic cholestasis of pregnancy: results from the Swedish observation and intervention trials. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 79. June 18-19 (2004). *
Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40: 467-474 (2004). *
Glas J, Folwaczny M, Folwaczny C. Crohn's disease recurrence in small bowel transplant. Am. J. Gastroenterol. 99: 2067 (2004). *
Glas J, Torok HP, Schiemann U, Folwaczny C. MDR1 gene polymorphism in ulcerative colitis. Gastroenterology 126: 367 (2004). *
Glass EJ. Genetic variation and responses to vaccines. Anim. Health Res. Rev. 5: 197-208 (2004).
Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 1: 27-42 (2004). *
Gleeson F, Ryan E, Barrett S, Crowe J. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur. J. Gastroenterol. Hepatol. 16: 859-863 (2004).
Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am. J. Surg. Pathol. 28: 190-197 (2004).
Glimcher LH, Townsend MJ, Sullivan BM, Lord GM. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4: 900-911 (2004). *
Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut 53: 1352-1355 (2004). *
Glintborg B, Nielsen AM. Probiotic therapy: mechanisms of action and indications in adult gastrointestinal disease. Ugeskr. Laeger. 166: 135-139 (2004).
Gloth FM 3rd, Greenough WB 3rd. Vitamin D deficiency as a contributor to multiple forms of chronic pain. Mayo Clin. Proc. 79: 696, 699 (2004). *
Glotzbecker MP, Carpentieri DF, Dormans JP. Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J. Pediatr. Orthop. 24: 123-129 (2004).
Glusman G, Kaur A, Hood L, Rowen L. An enigmatic fourth runt domain gene in the fugu genome: ancestral gene loss versus accelerated evolution. BMC Evol. Biol. 4: 43 (2004). *
Gnann A, Riordan JR, Wolf DH. CFTR degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol. Biol. Cell 15: 4125-4135 (2004). *
Gnerre C, Blattler S, Kaufmann MR, Looser R, Meyer UA. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14: 635-645 (2004).
Gockel HR, Lugering A, Heidemann J, Schmidt M, Domschke W, Kucharzik T, Lugering N. Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway. J. Immunol. 172: 5103-5109 (2004). *
Godeberge P, Desreumaux P, Slim K, Dupas JL, Marteau P, Beaugerie L, Bouhnik Y, Flourie B, Gambiez L, Reimund JM, Seksik P. Recommendations for clinical practice for the treatment of ulcerative colitis: general method. Gastroenterol. Clin. Biol. 28: 951-953 (2004).
Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237 (2004). *
Godfrey DI, Pellicci DG, Smyth MJ. Immunology. The elusive NKT cell antigen - is the search over? Science 306: 1687-1689 (2004). *
Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int. J. Cancer 112: 754-759 (2004). *
Goetz FW, Planas JV, MacKenzie S. Tumor necrosis factors. Dev. Comp. Immunol. 28: 487-497 (2004).
Goffe B. Etanercept (Enbrel(R)) - an update. Skin Therapy Lett. 9: 1-4 (2004). *
Goggin MM, Nelsen CJ, Kimball SR, Jefferson LS, Morley SJ, Albrecht JH. Rapamycin-sensitive induction of eukaryotic initiation factor 4F in regenerating mouse liver. Hepatology 40: 537-544 (2004). *
Gohda J, Matsumura T, Inoue JI. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173: 2913-2917 (2004). *
Goicoechea M, Fierer J, Johns S. Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin. Clin. Infect. Dis. 38: 1040-1041 (2004). *
Goland S, Beilinson N, Kaftouri A, Shimoni S, Caspi A, Malnick SD. Hemochromatosis mutations are not linked to dilated cardiomyopathy in Israeli patients. Eur. J. Heart Fail. 6: 547-550 (2004).
Gold BD. Epidemiology and management of gastro-oesophageal reflux in children. Aliment. Pharmacol. Ther. 19 Suppl. 1: 22-27 (2004).
Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Multiple sclerosis after infectious mononucleosis: record linkage study. J. Epidemiol. Community Health 58: 1032-1035 (2004). *
Goldberg R, Zohar Y, Wildbaum G, Geron Y, Maor G, Karin N. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 173: 6465-6471 (2004). *
Goldenberg BA, Rawsthorne P, Bernstein CN. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease. Am. J. Gastroenterol. 99: 1744-1748 (2004). *
Goldfarb NI, Pizzi LT, Fuhr JP, Salvador C, Sikirica V, Kornbluth A, Lewis B. Diagnosing Crohn's disease: an economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures. Dis. Manag. 7: 292-304 (2004).
Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, Park BK. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology 39: 1267-1276 (2004). *
Goldrosen MH, Straus SE. Complementary and alternative medicine: assessing the evidence for immunological benefits. Nat. Rev. Immunol. 4: 912-921 (2004). *
Goldstein B, Faeder JR, Hlavacek WS. Mathematical and computational models of immune-receptor signalling. Nat. Rev. Immunol. 4: 445-456 (2004). *
Goldstein DB, Hirschhorn JN. In genetic control of disease, does 'race' matter? Nat. Genet. 36: 1243-1244 (2004). *
Goldstein ES, Marion JF, Present DH. 6-Mercaptopurine is effective in Crohn's disease without concomitant steroids. Inflamm. Bowel Dis. 10: 79-84 (2004). *
Goldstein NS. Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue. Am. J. Clin. Pathol. 121: 546-550 (2004). *
Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg. Oral Med. Oral Pathol Oral Radiol. Endod. 98: 516-521 (2004). *
Golovanova EV, Il'chenko LIu, Tsaregorodtseva TM, Serova TI, Gudkova RB. Cytokines in primary biliary cirrhosis (diagnostic and prognostic value). Ter. Arkh. 76: 8-11 (2004).
Gomez FE, Cassis-Nosthas L, Morales-De-Leon JC, Bourges H. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sjogren's syndrome. Eur. J. Clin. Nutr. 58: 629-636 (2004). *
Gomez FP, Martinez-Palli G, Barbera JA, Roca J, Navasa M, Rodriguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 40: 660-666 (2004). *
Gomez-Llorente C, Antunez A, Blanco S, Suarez A, Gomez-Capilla JA, Farez-Vidal ME. Multiplex analysis of the most common mutations related to hereditary haemochromatosis: two methods combining specific amplification with capillary electrophoresis. Eur. J. Haematol. 72: 121-129 (2004). *
Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, Nukiwa T. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 126: 95-99 (2004). *
Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM, Emre S, Miller CM, Schwartz ME. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann. Surg. 239: 142-149 (2004). *
Gondolesi GE, Yoshizumi T, Bodian C, Kim-Schluger L, Schiano T, Fishbein T, Schwartz M, Miller C, Emre S. Accurate method for clinical assessment of right lobe liver weight in adult living-related liver transplant. Transplant. Proc. 36: 1429-1433 (2004).
Gong H, Xie W. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential. Expert Opin. Ther. Targets 8: 49-54 (2004).
Gong X, Linsdell P. Maximization of the rate of chloride conduction in the CFTR channel pore by ion-ion interactions. Arch. Biochem. Biophys. 426: 78-82 (2004). *
Gong Y, Frederiksen S, Gluud C. D-penicillamine for primary biliary cirrhosis. Cochrane Database Syst. Rev. 4: CD004789 (2004). *
Gong Y, Gluud C. Colchicine for primary biliary cirrhosis. Cochrane Database Syst. Rev. 2: CD004481 (2004). *
Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, Milla ME. Inhibition of the TNFalpha converting enzyme (TACE) by its pro domain. J. Biol. Chem. 279: 31638-31645 (2004). *
Gonzalez A, Ramirez V, Cuenca P, Sierra R. Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility. Rev. Biol. Trop. 52: 591-600 (2004).
Gonzalez C, Garcia-Berrocal B, Herraez O, Navajo JA, Gonzalez-Buitrago JM. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus. Clin. Chem. Lab. Med. 42: 266-272 (2004).
Gonzalez L, Blanc JF, Sa Cunha A, Rullier A, Saric J, Le Bail B, Balabaud C, Bioulac-Sage P. Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient. Semin. Liver Dis. 24: 415-419 (2004).
Gonzalez MA, Roma MG, Bernal CA, Alvarez Mde L, Carrillo MC. Biliary secretory function in rats chronically intoxicated with aluminum. Toxicol. Sci. 79: 189-195 (2004). *
Gonzalez S, Rodrigo L, Lopez-Vazquez A, Fuentes D, Agudo-Ibanez L, Rodriguez-Rodero S, Fdez-Morera JL, Martinez-Borra J, Lopez-Larrea C. Association of MHC class I related gene B (MICB) to celiac disease. Am. J. Gastroenterol. 99: 676-680 (2004). *
Gonzalez-Escribano MF, Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A. CD38 polymorphisms in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 65: 660-664 (2004).
Gonzalez-Moreno O, Calvo A, Joshi BH, Abasolo I, Leland P, Wang Z, Montuenga L, Puri RK, Green JE. Gene expression profiling identifies IL-13 receptor alpha2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. Int. J. Cancer 114: 870-878 (2004). *
Goodman JE, Hofseth LJ, Hussain SP, Harris CC. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ. Mol. Mutagen. 44: 3-9 (2004). *
Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocr. Relat. Cancer 11: 255-263 (2004). *
Goodwin B, Moore JT. CAR: detailing new models. Trends Pharmacol. Sci. 25: 437-441 (2004). *
Goodwin FC, Beattie RM, Millar J, Kirkham FJ. Celiac disease and childhood stroke. Pediatr. Neurol. 31: 139-142 (2004).
Goodwin L. Asymptomatic primary biliary cirrhosis. J. Insur. Med. 36: 341-342 (2004).
Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP. Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochem. Biophys. Res. Commun. 320: 795-801 (2004). *
Gordon AC, Lagan AL, Aganna E, Cheung L, Peters CJ, McDermott MF, Millo JL, Welsh KI, Holloway P, Hitman GA, Piper RD, Garrard CS, Hinds CJ. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun. 5: 631-640 (2004). *
Gordon C. Pregnancy and autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 18: 359-379 (2004).
Gordon FD, Simpson M. Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients. J. Clin. Gastroenterol. 38: 729-730 (2004).
Gordon KB, Valentine J. The efficacy of alefacept in the treatment of chronic plaque psoriasis. J. Cutan. Med. Surg. 8 Suppl. 2: 3-9 (2004).
Gordon TP, Cavill D, Neufing P, Zhang YJ, Pietropaolo M. ICA69 autoantibodies in primary Sjogren's syndrome. Lupus 13: 483-484 (2004).
Goren JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BM. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy 24: 1501-1507 (2004).
Gores GJ, Baskin-Bey ES, Baron TH, Alberts SR. Treatment endpoints for advanced cholangiocarcinoma. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 4-5 (2004). *
Gorfine SR, Harris MT, Bub DS, Bauer JJ. Restorative proctocolectomy for ulcerative colitis complicated by colorectal cancer. Dis. Colon Rectum 47: 1377-1385 (2004).
Gorgun E, Remzi FH, Goldberg JM, Thornton J, Bast J, Hull TL, Loparo B, Fazio VW. Fertility is reduced after restorative proctocolectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery 136: 795-803 (2004). *
Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum. 50: 3476-3484 (2004). *
Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum. 50: 753-762 (2004). *
Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 50: 400-412 (2004). *
Gorman N, Trask HW, Bement WJ, Szakacs JG, Elder GH, Balestra D, Jacobs NJ, Jacobs JM, Sinclair JF, Gerhard GS, Sinclair PR. Genetic factors influence ethanol-induced uroporphyria in Hfe(-/-) mice. Hepatology 40: 942-950 (2004). *
Gorog D. Surgical treatment of liver tumors. Orv. Hetil. 145: 387-389 (2004).
Goronzy JJ, Weyand CM. T-cell regulation in rheumatoid arthritis. Curr. Opin. Rheumatol. 16: 212-217 (2004).
Gortzen A, Schluter S, Veh RW. Anti-astrocyte autoantibodies in Guillain-Barre syndrome - possible involvement in the pathophysiology of a psychosyndrome? Autoimmunity 37: 521-528 (2004).
Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis. Colon Rectum 47: 1519-1525 (2004). *
Gosselink MP, Schouten WR, Van Lieshout LM, Hop WC, Laman JD, Ruseler-Van Embden JG. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis. Colon Rectum 47: 876-884 (2004). *
Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Okuda M, Tanaka K, Inui K. CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation. Pharmacogenetics 14: 471-478 (2004).
Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V, Charron D, Miceli C, Sibilia J, Mariette X. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum. 50: 570-580 (2004). *
Gotter J, Kyewski B. Regulating self-tolerance by deregulating gene expression. Curr. Opin. Immunol. 16: 741-745 (2004).
Gottlieb AB. Alefacept is well tolerated in patients with chronic plaque psoriasis. J. Cutan. Med. Surg. 8 Suppl. 2: 14-19 (2004).
Gottlieb AB. Novel immunotherapies for psoriasis: clinical research delivers new hope for patients and scientific advances. J. Investig. Dermatol. Symp. Proc. 9: 79-83 (2004). *
Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL; EFALIZUMAB STUDY GROUP. Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. J. Drugs Dermatol. 3: 614-624 (2004).
Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J. Immunol. 172: 3678-3685 (2004). *
Gough S. The thyroglobulin gene: the third locus for autoimmune thyroid disease or a false dawn? Trends Mol. Med. 10: 302-305 (2004). *
Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4: 630-640 (2004). *
Goulding NJ. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr. Opin. Pharmacol. 4: 629-636 (2004).
Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur. Radiol. 14: 1017-1024 (2004). *
Gouvea EF, Branco RC, Monteiro RC, Halpern M, Ribeiro-Filho J, Silveira VG, Tavares GC, Rodrigues MS, Coelho HS, Basto ST, Santoro-Lopes G. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant. Proc. 36: 958-960 (2004). *
Gouysse G, Frachon S, Hervieu V, Fiorentino M, D'Errico A, Dumortier J, Boillot O, Partensky C, Grigioni WF, Scoazec JY. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. J. Hepatol. 41: 259-266 (2004). *
Gow PJ, Jones RM, Dobson JL, Angus PW. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J. Gastroenterol. Hepatol. 19: 154-159 (2004). *
Grabiec A, Meng G, Fichte S, Bessler W, Wagner H, Kirschning CJ. Human but not murine Toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J. Biol. Chem. 279: 48004-48012 (2004). *
Graefe SE, Jacobs T, Wachter U, Broker BM, Fleischer B. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection. Parasite Immunol. 26: 19-28 (2004). *
Graf GA, Cohen JC, Hobbs HH. Missense mutations in ABCG5 and ABCG8 disrupt heterodimerization and trafficking. J. Biol. Chem. 279: 24881-24888 (2004). *
Graf SA, Haigh SE, Corson ED, Shirihai OS. Targeting, import, and dimerization of a mammalian mitochondrial ABC transporter, ABCB10 (ABCme). J. Biol. Chem. 279: 42954-42963 (2004). *
Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292: 2585-2590 (2004). *
Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 53: 1437-1444 (2004). *
Gramling R, Trask P, Nash J, Culpepper L. Family physicians' beliefs about genetic testing. Fam. Med. 36: 691-692 (2004). *
Gran B, Zhang GX, Rostami A. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit. Rev. Immunol. 24: 111-128 (2004).
Grando SA. New approaches to the treatment of pemphigus. J. Investig. Dermatol. Symp. Proc. 9: 84-91 (2004). *
Granet C, Maslinski W, Miossec P. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res. Ther. 6: R190-R198 (2004). *
Granet C, Miossec P. Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells. Cytokine 26: 169-177 (2004).
Granito A, Muratori P, Cassani F, Pappas G, Muratori L, Agostinelli D, Veronesi L, Bortolotti R, Petrolini N, Bianchi FB, Volta U. Anti-actin IgA antibodies in severe coeliac disease. Clin. Exp. Immunol. 137: 386-392 (2004). *
Grant AJ, Eksteen B, Miles A, Lalor PF, Hubscher SG, Briskin M, Adams DH. CCL25 (TECK) mediates recruitment of CCR9H IGH gut homing lymphocytes to hepatic endothelium in primary sclerosing cholangitis. Gut 53: A11-A12 (2004).
Grant LM, Lisker-Melman M. Nonalcoholic fatty liver disease. Ann. Hepatol. 3: 93-99 (2004). *
Granzotto M, Drigo I, Candussio L, Rosati A, Bartoli F, Giraldi T, Decorti G. Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells. Cancer Lett. 205: 107-115 (2004). *
Grassi A, Susca M, Ravaioli M, Grazi GL, D'Errico A, Bontadini A, Zauli D, Pinna A, Bianchi FB, Ballardini G. Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens. Liver Transpl. 10: 1406-1414 (2004). *
Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford) 43: 410-415 (2004). *
Grateau G, Granel B, Hentgen V, Dode C, Cuisset L, Delpech M. Hereditary intermittant fever. Presse. Med. 33: 1195-1206 (2004).
Grau R, Lang KS, Wernet D, Lang P, Niethammer D, Pusch CM, Handgretinger R. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Exp. Mol. Pathol. 76: 90-98 (2004). *
Graudal N. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand. J. Rheumatol. Suppl. 118: 1-38 (2004).
Grauslund J, Wang P. Microchimerism - a possible cause of autoimmune disease? Ugeskr. Laeger. 166: 2882-2885 (2004).
Gray MA. Bicarbonate secretion: it takes two to tango. Nat. Cell Biol. 6: 292-294 (2004). *
Greco F, Pavone P, Falsaperla R, Sorge G. Peripheral neuropathy as first sign of ulcerative colitis in a child. J. Clin. Gastroenterol. 38: 115-117 (2004).
Greco L, Veneziano A, Di Donato L, Zampella C, Pecoraro M, Paladini D, Paparo F, Vollaro A, Martinelli P. Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy. Gut 53: 149-151 (2004). *
Green BT, Rockey DC. Gastrointestinal endoscopic evaluation of premenopausal women with iron deficiency anemia. J. Clin. Gastroenterol. 38: 104-109 (2004).
Green JR, Swan CH, Gibson JA, Kerr GD, Swarbrick ET, Thornton PC. Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study. Aliment. Pharmacol. Ther. 19: 435-442 (2004). *
Green PH, Rampertab SD. Small bowel carcinoma and coeliac disease. Gut 53: 774 (2004). *
Greenamyre JT, Hastings TG. Biomedicine. Parkinson's - divergent causes, convergent mechanisms. Science 304: 1120-1122 (2004). *
Greenberg GR. Antibiotics should be used as first-line therapy for Crohn's disease. Inflamm. Bowel Dis. 10: 318-320 (2004). *
Greenstein RJ, Collins MT. Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet 364: 396-397 (2004). *
Greer RM, Buntain HM, Lewindon PJ, Wainwright CE, Potter JM, Wong JC, Francis PW, Batch JA, Bell SC. Vitamin A levels in patients with CF are influenced by the inflammatory response. J. Cyst. Fibros. 3: 143-149 (2004).
Gregerson DS, Kawashima H. APC derived from donor splenocytes support retinal autoimmune disease in allogeneic recipients. J. Leukoc. Biol. 76: 383-387 (2004). *
Gregor PD, Wolchok JD, Ferrone CR, Buchinshky H, Guevara-Patino JA, Perales MA, Mortazavi F, Bacich D, Heston W, Latouche JB, Sadelain M, Allison JP, Scher HI, Houghton AN. CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine 22: 1700-1708 (2004).
Gregory CD, Devitt A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113: 1-14 (2004). *
Grehan M, Danon S, Lee A, Daskalopoulos G, Mitchell H. Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J. Clin. Microbiol. 42: 874-876 (2004). *
Greicius G, Arulampalam V, Pettersson S. A CLA's act: feeding away inflammation. Gastroenterology 127: 994-996 (2004). *
Greig E, Boot-Handford R, Mani V, Sandle G. Decreased expression of apical Na+ channels and basolateral Na+, K+-ATPase in ulcerative colitis. J. Pathol. 204: 84-92 (2004). *
Gress TM. Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures. Gut 53: 1727-1729 (2004). *
Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296 (2004). *
Greten FR, Karin M. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett. 206: 193-199 (2004). *
Greth J, Torok HP, Koenig A, Folwaczny C. Comparison of inflammatory bowel disease at younger and older age. Eur. J. Med. Res. 9: 552-554 (2004).
Greve B, Reddy J, Waldner HP, Sobel RA, Kuchroo VK. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes. Eur. J. Immunol. 34: 1828-1838 (2004). *
Greve B, Vijayakrishnan L, Kubal A, Sobel RA, Peterson LB, Wicker LS, Kuchroo VK. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J. Immunol. 173: 157-163 (2004). *
Griffin IJ, Kim SC, Hicks PD, Liang LK, Abrams SA. Zinc metabolism in adolescents with Crohn's disease. Pediatr. Res. 56: 235-239 (2004). *
Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract. Res. Clin. Gastroenterol. 18: 509-523 (2004).
Griga T, Tromm A, Schmiegel W, Pfisterer O, Muller KM, Brasch F. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms. Eur. J. Gastroenterol. Hepatol. 16: 397-402 (2004).
Grimm D. Genetics. Disease backs cancer origin theory. Science 306: 389 (2004). *
Grimm MC, Pavli P. NOD2 mutations and Crohn�s disease: are Paneth cells and their antimicrobial peptides the link? Gut 53: 1558-1560 (2004). *
Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U et al. The DNA sequence and biology of human chromosome 19. Nature 428: 529-535 (2004). *
Grip O, Janciauskiene S, Lindgren S. Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin. Inflamm. Bowel Dis. 10: 193-200 (2004). *
Grodzicki M, Pawlak J, Chrzanowska A, Porembska Z, Krawczyk M. Arginase activity concentration marking in monitoring of hepatocytes function after orthotopic liver transplantation - preliminary report. Ann. Transplant. 9: 54-57 (2004).
Groen AK, Kosters A, Kunne C, Oude Elferink RPJ. The molecular mechanism of biliary lipid secretion - influence of bile salt hydrophilicity and role of Abcg5 and Abcg8. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 50. June 18-19 (2004). *
Groen AK, Oude Elferink RP, Verkade HJ, Kuipers F. The ins and outs of reverse cholesterol transport. Ann. Med. 36: 135-145 (2004).
Grogan PM, Katz JS. Inflammatory myopathies. Curr. Treat. Options Neurol. 6: 155-161 (2004).
Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, Guittard C, Koudova M, Fallin MD, Nemeth K, Fekete G, Kadasi L, Friedman K, Schwarz M et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am. J. Hum. Genet. 74: 176-179 (2004). *
Groneberg DA, Witt H, Adcock IM, Hansen G, Springer J. Smads as intracellular mediators of airway inflammation. Exp. Lung Res. 30: 223-250 (2004).
Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3: 950-964 (2004). *
Gronski MA. Novel insights in the regulation of the immune system: a report on the FASEB Summer Research Conference on Autoimmunity (June 14-19, 2003, Saxton's River, Vermont, USA). Rev. Diabet. Stud. 1: 47-50 (2004). *
Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B, Gallimore A, Gascoigne NR, Ohashi PS. TCR affinity and negative regulation limit autoimmunity. Nat. Med. 10: 1234-1239 (2004). *
Grool TA, Kuipers EJ. Inflammatory bowel disease in three elderly patients; an unexpected diagnosis in long-standing abdominal complaints. Ned. Tijdschr. Geneeskd. 148: 1849-1852 (2004).
Gross CR, Kreitzer MJ, Russas V, Treesak C, Frazier PA, Hertz MI. Mindfulness meditation to reduce symptoms after organ transplant: a pilot study. Adv. Mind Body Med. 20: 20-29 (2004).
Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS; CDC. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm. Rep. 53 (RR-13): 1-36 (2004).
Grossman CJ, Hydo LJ, Wang JC, Pochapin M, Barie PS. Devastating presentations of regional enteritis (Crohn's disease): two reports of survival following severe multiple organ dysfunction syndrome. Surg. Infect. (Larchmt.) 5: 301-307 (2004).
Grossman I, Avidan N, Singer C, Paperna T, Lancet D, Beckmann JS, Miller A. Genomic profiling of interpopulation diversity guides prioritization of candidate-genes for autoimmunity. Genes Immun. 5: 493-504 (2004).
Grossman Z, Min B, Meier-Schellersheim M, Paul WE. Concomitant regulation of T-cell activation and homeostasis. Nat. Rev. Immunol. 4: 387-395 (2004). *
Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin. Gastroenterol. Hepatol. 2: 813-819 (2004). *
Grubic Z, Peric P, Cecuk-Jelicic E, Zunec R, Curkovic B, Kerhin-Brkljacic V. The distribution of HLA alleles class I and class II among patientes with psoriatic arthritis in Croatia. Reumatizam 51: 5-11 (2004).
Grubic Z, Peric P, Eeeuk-Jelicic E, Zunec R, Stingl K, Curkovic B, Kerhin-Brkljacic V. The MICA-A4 triplet repeats polymorphism in the transmembrane region confers additional risk for development of psoriatic arthritis in the Croatian population. Eur. J. Immunogenet. 31: 93-98 (2004). *
Gruenwald J, Graubaum HJ, Hansen K, Grube B. Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders. Adv. Ther. 21: 197-201 (2004).
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program; National Heart, Lung, and Blood Institute. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler. Thromb. Vasc. Biol. 24: e149-e161 (2004). *
Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med. 169: 696-702 (2004). *
Grunhage F, Spengler U, Fischer HP, Sauerbruch T. Autoimmune hepatitis - sequel of a relapsing hepatitis A in a 75-year-old woman. Digestion 70: 187-191 (2004).
Gruttadauria S, Doria C, Vitale CH, Cintorino D, Foglieni CS, Fung JJ, Marino IR. Preliminary report on surgical technique in hepatic parenchymal transection for liver tumors in the elderly: a lesson learned from living-related liver transplantation. J. Surg. Oncol. 88: 229-233 (2004).
Grypiotis P, Cozzi F, Ruffatti A. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis. J. Rheumatol. 31: 1468-1469 (2004). *
Grzybowska K, Gwozdzinski K, Zalesna G, Kisiel A, Grzybowski P, Planeta-Malecka I. Mucus physicochemical properties in children with ulcerative colitis. Pol. Merkuriusz. Lek. 17 Suppl. 1: 19-21 (2004).
Grzybowska K, Kisiel A, Fornalczyk-Wachowska E, Pokoca L, Planeta-Malecka I. Neutrophils and selected cytokines in ulcerative colitis pathomechanism. Pol. Merkuriusz. Lek. 17 Suppl. 1: 14-18 (2004).
Gu MM, Yuan WT, Yang JQ, Zhang J, Xiong XY, Yao FJ, Lu ZY, Wang ZG, Huang W, Fan LA. A genomewide scan for the susceptibility gene loci to ankylosing spondylitis in Chinese Han population. Yi Chuan Xue Bao 31: 217-220 (2004).
Gu Q, Xia HH, Wang WH, Wang JD, Wong WM, Chan AO, Yuen MF, Lam SK, Cheung HK, Liu XG, Wong BC. Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. Aliment. Pharmacol. Ther. 20: 675-681 (2004). *
Guagnozzi D, Cossu A, Viscido A, Corleto V, Annese V, Latiano A, Delle Fave G, Caprilli R. Acute intestinal obstruction and NOD2/CARD15 mutations among Italian Crohn's disease patients. Eur. Rev. Med. Pharmacol. Sci. 8: 179-185 (2004).
Guan JZ, Tamasawa N, Brunham LR, Matsui J, Murakami H, Suda T, Ochiai S, Tsutsui M, Kudou K, Satoh K, Hayden MR. A case of Tangier disease with a novel mutation in the C-terminal region of ATP-binding cassette transporter A1. Am. J. Med. Genet. 130A: 398-401 (2004). *
Guan R, Malchiodi EL, Wang Q, Schuck P, Mariuzza RA. Crystal structure of the C-terminal peptidoglycan-binding domain of human peptidoglycan recognition protein Ialpha. J. Biol. Chem. 279: 31873-31882 (2004). *
Guan X, Juarez JC, Qi X, Shipulina NV, Shaw DE, Morgan WT, McCrae KR, Mazar AP, Donate F. Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells. Thromb. Haemost. 92: 403-412 (2004).
Guan Y. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J. Am. Soc. Nephrol. 15: 2801-2815 (2004). *
Guariso G, Brotto F, Basso D, Alaggio R, Betterle C. Organ-specific autoantibodies in children with Helicobacter pylori infection. Helicobacter 9: 622-628 (2004).
Guarnieri G, Biolo G, Zanetti M, Barazzoni R. Chronic systemic inflammation in uremia: potential therapeutic approaches. Semin. Nephrol. 24: 441-445 (2004).
Guastafierro S, Sessa F, Cuomo C, Tirelli A. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies. Ann. Hematol. 83: 307-308 (2004). *
Guda NM, Freeman ML. True culprit or guilt by association? Is sphincter of Oddi manometry the cause of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction, or is it the patients' susceptibility? Rev. Gastroenterol. Disord. 4: 211-213 (2004). *
Gudbrandsdottir S, Larsen R, Sorensen LK, Nielsen S, Hansen MB, Svenson M, Bendtzen K, Muller K. TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 22: 118-124 (2004).
Gudjonsdottir AH, Nilsson S, Ek J, Kristiansson B, Ascher H. The risk of celiac disease in 107 families with at least two affected siblings. J. Pediatr. Gastroenterol. Nutr. 38: 338-342 (2004). *
Guennoc AM, Corcia P, Maisonobe T, Lefrancq T, De Toffol B, Autret A. Demyelinating neuropathy and Sjogren's syndrome: a diagnostic pitfall. Rev. Neurol. (Paris) 160: 717-720 (2004).
Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. J. Cutan. Med. Surg. 8: 321-337 (2004). *
Guerra L, Favia M, Fanelli T, Calamita G, Svelto M, Bagorda A, Jacobson KA, Reshkin SJ, Casavola V. Stimulation of Xenopus P2Y1 receptor activates CFTR in A6 cells. Pflugers Arch. 449: 66-75 (2004). *
Guevara M, Fernandez-Esparrach G, Alessandria C, Torre A, Terra C, Montana X, Piera C, Alvarez ML, Jimenez W, Gines P, Arroyo V. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 40: 646-651 (2004). *
Guevara M, Fernandez-Esparrach G, Gines P. Contrast medium-associated renal dysfunction in patients with cirrhosis. Hepatology 40: 1474 (2004). *
Gugger M, Waser B, Kappeler A, Schonbrunn A, Reubi JC. Cellular detection of sst2A receptors in human gastrointestinal tissue. Gut 53: 1431-1436 (2004). *
Guggino WB. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc. Am. Thorac. Soc. 1: 28-32 (2004). *
Guggino WB, Banks-Schlegel SP. Macromolecular interactions and ion transport in cystic fibrosis. Am. J. Respir. Crit. Care Med. 170: 815-820 (2004). *
Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism. Liver Transpl. 10: 638-647 (2004). *
Guidi L, Minordi LM, Semeraro S, De Vitis I, Roberto I, Ennas S, Guglielmo S, Di Candia L, Papa A, Urgesi R, Grillo A, Brizi MG, Vecchioli A, Fedeli G. Clinical correlations of small bowel CT and contrast radiology findings in Crohn's disease. Eur. Rev. Med. Pharmacol. Sci. 8: 215-217 (2004).
Guillem JG, Moore HG, Palmer C, Glogowski E, Finch R, Nafa K, Markowitz AJ, Offit K, Ellis NA. A636P testing in Ashkenazi Jews. Fam. Cancer 3: 223-227 (2004). *
Guillen M, Corella D, Cabello ML, Gonzalez JI, Sabater A, Chaves JF, Hernandez-Yago J. Identification of novel SLC3A1 gene mutations in Spanish cystinuria families and association with clinical phenotypes. Clin. Genet. 67: 240-251 (2004). *
Guimaraes CP, Domingues P, Aubourg P, Fouquet F, Pujol A, Jimenez-Sanchez G, Sa-Miranda C, Azevedo JE. Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. Biochim. Biophys. Acta 1689: 235-243 (2004). *
Guindi M, Riddell RH. Indeterminate colitis. J. Clin. Pathol. 57: 1233-1244 (2004). *
Guirl MJ, Weinstein JS, Goldstein RM, Levy MF, Klintmalm GB. Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl. 10: 564-570 (2004). *
Guitaoui M, Parquet M, Aubert C, Montet AM, Montet JC. Conjugation with taurine prevents side-chain desaturation of ursodeoxycholic and beta-muricholic acids in bile fistula rats. Fundam. Clin. Pharmacol. 18: 457-464 (2004). *
Guja C, Guja L, Nutland S, Rance H, Sebastien M, Todd JA, Ionescu-Tirgoviste C. Type 1 diabetes genetic susceptibility encoded by HLA DQB1 genes in Romania. J. Cell. Mol. Med. 8: 249-256 (2004). *
Guja C, Guja L, Nutland S, Rance H, Todd JA, Ionescu-Tirgoviste C. Strong association of insulin gene INS-VNTR polymorphisms with type 1 diabetes in the Romanian population. Rom. J. Intern. Med. 42: 313-323 (2004).
Gujral JS, Liu J, Farhood A, Jaeschke H. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 40: 998-1007 (2004). *
Gulati S, Mathur P, Saini D, Mannan R, Kalra V. Erythema annulare centrifugum with autoimmune hepatitis. Indian J. Pediatr. 71: 541-542 (2004). *
Gulec B, Yasar M, Yildiz S, Oter S, Akay C, Deveci S, Sen D. Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol. Res. 53: 493-500 (2004). *
Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, Rubbia-Brandt L, Mensi N, Angelillo-Scherrer A, Martinez-Soria E, Tacchini-Cottier F, Garcia I. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41: 773-781 (2004). *
Guliter S, Erdem O, Isik M, Yamac K, Uluoglu O. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case. Tumori. 90: 517-520 (2004). *
Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro. Pediatr. Res. 55: 814-821 (2004). *
Gunawan B, Kaplowitz N. Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab. Rev. 36: 301-312 (2004). *
Gundala S, Wells LD, Milliano MT, Talkad V, Luxon BA, Neuschwander-Tetri BA. The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin alpha-amanitin. Arch. Toxicol. 78: 68-73 (2004). *
Gundling F, Reitmeier F, Tannapfel A, Schutz A, Weber A, Ussmuller J, Keim V, Mossner J, Teich N. Chronic parotitis: not another SPINKosis. Dig. Dis. 22: 292-295 (2004).
Gunn IR, Maxwell FK, Gaffney D, McMahon AD, Packard CJ. Haemochromatosis gene mutations and risk of coronary heart disease: a west of Scotland coronary prevention study (WOSCOPS) substudy. Heart 90: 304-306 (2004). *
Gunnarsson O, Indriethason OS, Franzson L, Halldorsdottir E, Sigurethsson G. Vitamin-D homeostasis amongst adult Icelandic population. Laeknabladid. 90: 29-36 (2004).
Gunthert AR, Hinney B, Nesselhut K, Hanf V, Emons G. Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn's disease: a case report. Am. J. Obstet. Gynecol. 191: 1719-1720 (2004).
Guo GL, Moffit J, Nicol CJ, Ward JM, Aleksunes L, Slitt A, Kliewer SA, Manautou J, Gonzalez FJ. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol. Sci. 82: 374-380 (2004). *
Guo L, Haga S, Enosawa S, Naruse K, Harihara Y, Sugawara Y, Irani K, Makuuchi M, Ozaki M. Improved hepatic regeneration with reduced injury by redox factor-1 in a rat small-sized liver transplant model. Am. J. Transplant. 4: 879-887 (2004). *
Guo L, Li XK, Enosawa S, Funeshima N, Suzuki S, Kimura H, Sugawara Y, Tezuka K, Makuuchi M. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transpl. 10: 743-747 (2004). *
Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, Arteel GE. Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40: 583-589 (2004). *
Guo QS, Xia B, Jiang Y, Qu Y, Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol. 10: 1069-1071 (2004). *
Guo RF, Riedemann NC, Ward PA. Role of C5a-C5aR interaction in sepsis. Shock 21: 1-7 (2004). *
Guo SM, Tong HB, Bai LS, Yang W. Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats. World J. Gastroenterol. 10: 1914-1917 (2004). *
Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Floyd RA, Broyles RH. Reactive oxygen species in choline deficiency-induced apoptosis in rat hepatocytes. Free Radic. Biol. Med. 37: 1081-1089 (2004).
Gupta A, Paski S, Issenman R, Webber C. Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD. J. Clin. Densitom. 7: 290-295 (2004).
Gupta AK, Langley R, Poulin Y, Lui H, Searles G, Carey W, Toole J, Inniss K. Pathogenesis of psoriasis and current challenges. J. Cutan. Med. Surg. 8 Suppl.: 3-7 (2004). *
Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J. Cutan. Med. Surg. 8: 77-89 (2004). *
Gupta M, Ludvigsson J, Sanjeevi CB. Frequency of MICA in all babies in Southeast Sweden (ABIS) positive for high-risk HLA-DQ associated with type 1 diabetes. Ann. N. Y. Acad. Sci. 1037: 138-144 (2004). *
Gupta RP, Hollis BW, Patel SB, Patrick KS, Bell NH. CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J. Bone Miner. Res. 19: 680-688 (2004). *
Gupta SK, Fitzgerald JF, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm. Bowel Dis. 10: 240-244 (2004). *
Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, Madan A, Amarapurkar A, Hafeezunnisa. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J. Gastroenterol. Hepatol. 19: 854-858 (2004). *
Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax - pathophysiology, diagnosis and treatment - review of the literature. Liver Int. 24: 281-284 (2004). *
Gurnell M, Chatterjee VK. Nuclear receptors in disease: thyroid receptor beta, peroxisome-proliferator-activated receptor gamma and orphan receptors. Essays Biochem. 40: 169-189 (2004).
Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 4: 669-677 (2004).
Gustafsson J, Alimohammadi M, Ekwall O, Gebre-Medhin G, Halldin-Stenlid M, Hedstrand H, Landgren E, Nilsson T, Rorsman F, Skoldberg F, Winqvist O, Kampe O. APS I - a severe autoimmune disease with endocrine and non-endocrine symptoms. Lakartidningen 101: 2096-2098, 2101-2103 (2004).
Gutierrez J, Guzman C, Correa G, Restrepo J, Sepulveda E, Yepes N, Gutierrez M, Gomez F, Duque E, Tobon R, Duque J, Velasquez A. Liver transplantation in Medellin, Colombia: initial experience. Transplant Proc. 36: 1677-1680 (2004). *
Gutierrez S, Liu J, Javed A, Montecino M, Stein GS, Lian JB, Stein JL. The vitamin D response element in the distal osteocalcin promoter contributes to chromatin organization of the proximal regulatory domain. J. Biol. Chem. 279: 43581-43588 (2004). *
Guven K, Acunas B. Multidetector computed tomography angiography of the abdomen. Eur. J. Radiol. 52: 44-55 (2004).
Guy-Grand D, Vassalli P. Immunology. Tracing an orphan's genealogy. Science 305: 185-187 (2004). *
Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279: 27849-27854 (2004). *
Gylling H, Hallikainen M, Pihlajamaki J, Agren J, Laakso M, Rajaratnam RA, Rauramaa R, Miettinen TA. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J. Lipid Res. 45: 1660-1665 (2004). *
Gyorffy B, Kocsis I, Vasarhelyi B. Biallelic genotype distributions in papers published in Gut between 1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium. Gut 53: 614-615 (2004). *
Haahr S, Plesner AM, Vestergaard BF, Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol. Scand. 109: 270-275 (2004). *
Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT. Guillain-Barre syndrome following influenza vaccination. JAMA 292: 2478-2481 (2004). *
Haber PS. Genetic disorders in pancreatitis. J. Gastroenterol. Hepatol. 19: 939 (2004). *
Habib GS, Nashashibi M. Hypergammaglobulinemic purpura in two sisters with Sjogren's syndrome responding to colchicine treatment. Clin. Rheumatol. 23: 170-171 (2004).
Habior A. Association of autoimmune liver diseases. Eur. J. Gastroenterol. Hepatol. 16: 503 (2004).
Haboubi NY, Shaath NM, Safarani MN, Ghafar F. Improved diagnostic accuracy of inflammatory bowel disease: a clinicopathological collaborative approach. Tech. Coloproctol. 8: 117-121 (2004). *
Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, Hull J, Udalova IA. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun. 5: 274-282 (2004). *
Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34 (2004). *
Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 28: 289-294 (2004). *
Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, Smahi A. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology 127: 1386-1390 (2004). *
Haegert DG. Analysis of the threshold liability model provides new understanding of causation in autoimmune diseases. Med. Hypotheses 63: 257-261 (2004).
Hagel I, Di Prisco MC, Goldblatt J, Le Souef PN. The role of parasites in genetic susceptibility to allergy: IgE, helminthic infection and allergy, and the evolution of the human immune system. Clin. Rev. Allergy Immunol. 26: 75-83 (2004). *
Hagen KA, Moses CT, Drasler EF, Podetz-Pedersen KM, Jameson SC, Khoruts A. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells. J. Immunol. 173: 3909-3915 (2004). *
Hagenauer B, Maier-Salamon A, Thalhammer T, Zollner P, Senderowicz A, Jager W. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides. Oncol. Rep. 11: 1069-1075 (2004).
Hagenbuch B, Dawson P. The sodium bile salt cotransport family SLC10. Pflugers Arch. 447: 566-570 (2004). *
Haghighi DB, Lashner BA. Left-sided ulcerative colitis. Gastroenterol. Clin. North Am. 33: 271-284 (2004).
Haglund S, Lindqvist M, Almer S, Peterson C, Taipalensuu J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 50: 288-295 (2004). *
Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 101: 13850-13855 (2004). *
Hahnloser D, Pemberton JH, Wolff BG, Larson D, Harrington J, Farouk R, Dozois RR. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis. Colon Rectum 47: 1127-1135 (2004). *
Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis. Ann. Surg. 240: 615-623 (2004). *
Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab. 5: 21-53 (2004).
Haimeur A, Conseil G, Deeley RG, Cole SP. Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). Mol. Pharmacol. 65: 1375-1385 (2004). *
Haimila K, Smedberg T, Mustalahti K, Maki M, Partanen J, Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun. 5: 85-92 (2004). *
Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression? Am. J. Psychiatry 161: 567-569 (2004). *
Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Food and nutrient intake in relation to mental wellbeing. Nutr. J. 3: 14 (2004). *
Hakoda Y, Aoshima M, Kinoshita M, Sakurai M, Ohyashiki K. A case of eosinophilic pneumonia possibly associated with 5-aminosalicylic acid (5-ASA). Nihon Kokyuki Gakkai Zasshi 42: 404-409 (2004).
Halangk J, Berg T, Puhl G, Mueller T, Nickel R, Kage A, Landt O, Luck W, Wiedenmann B, Neuhaus P, Witt H. Keratin 8 Y54H and G62C mutations are not associated with liver disease. J. Med. Genet. 41: e92 (2004). *
Hale LP. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int. Immunopharmacol. 4: 255-264 (2004).
Haley H, Cantrell W, Smith K. Infliximab therapy for sarcoidosis (lupus pernio). Br. J. Dermatol. 150: 146-149 (2004). *
Half EE, Bresalier RS. Clinical management of hereditary colorectal cancer syndromes. Curr. Opin. Gastroenterol. 20: 32-42 (2004).
Hall IP. Expression profiling: fishing and chips. Gut 53: 917-918 (2004). *
Hall J, Singh G, Hood D, Mateo R, Weaver F, Selby R, Genyk Y, Jabbour N. Management of an abdominal aortic aneurysm in a patient with end-stage liver disease. Am. J. Transplant. 4: 666-668 (2004). *
Hallas J, Gaist D, Sorensen HT. Does appendectomy reduce the risk of ulcerative colitis? Epidemiology 15: 173-178 (2004).
Hallas J, Gaist D, Vach W, Sorensen HT. Appendicectomy has no beneficial effect on admission rates in patients with ulcerative colitis. Gut 53: 351-354 (2004). *
Hallberg K, Fandriks L, Strandvik B. Duodenogastric bile reflux is common in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 38: 312-316 (2004). *
Halldorsson BV, Istrail S, De La Vega FM. Optimal selection of SNP markers for disease association studies. Hum. Hered. 58: 190-202 (2004).
Haller D, Holt L, Parlesak A, Zanga J, Bauerlein A, Sartor RB, Jobin C. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology 112: 310-320 (2004). *
Haller K, Kisand K, Nemvalts V, Laine AP, Ilonen J, Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur. J. Clin. Invest. 34: 543-548 (2004).
Hallett WH, Murphy WJ. Natural killer cells: biology and clinical use in cancer therapy. Cell. Mol. Immunol. 1: 12-21 (2004). *
Halloran PF. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351: 2715-2729 (2004). *
Halme L, Turunen U, Paavola-Sakki P, Helio T, Lappalainen M, Farkkila M, Kontula K, Repo H. CARD15 frameshift mutation in patients with CROHN disease is associated with immune dysregulation. Scand. J. Gastroenterol. 39: 1243-1249 (2004). *
Halonen M, Kangas H, Ruppell T, Ilmarinen T, Ollila J, Kolmer M, Vihinen M, Palvimo J, Saarela J, Ulmanen I, Eskelin P. APECED-causing mutations in AIRE reveal the functional domains of the protein. Hum. Mutat. 23: 245-257 (2004). *
Halsted CH. Nutrition and alcoholic liver disease. Semin. Liver Dis. 24: 289-304 (2004).
Hama K, Miwa H, Nishino I, Nonaka I, Kondo T. Inclusion body myositis associated with chronic thyroiditis, Sjogren's syndrome and autoimmune cholangitis. No To Shinkei 56: 503-507 (2004).
Hamada M, Tokumoto Y, Furukawa S, Minami H, Hiasa Y, Michitaka K, Horiike N, Onji M. Hepatopulmonary syndrome in a patient with primary biliary cirrhosis. Intern. Med. 43: 458-460 (2004). *
Hamann L, Kumpf O, Muller M, Visintin A, Eckert J, Schlag PM, Schumann RR. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun. 5: 283-288 (2004). *
Hamburger J. Guidelines for the management of Sjogren's syndrome in secondary care. Dent. Update 31: 178 (2004).
Hamilton C, Seidner DL. Metabolic bone disease and parenteral nutrition. Curr. Gastroenterol. Rep. 6: 335-341 (2004).
Hamlin PJ, Shah MN, Scott N, Wyatt JI, Howdle PD. Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature. Postgrad. Med. J. 80: 233-235 (2004). *
Hamm B, Rogalla P. The transparent abdomen. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 57. May 7-8 (2004). *
Hammond A, Andus T, Gierend M, Ecker KW, Scholmerich J, Herfarth H; German Budesonide Foam Study Group. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis. Hepatogastroenterology 51: 1345-1349 (2004).
Hampton T. Scientists explore pathogenesis of IBD. JAMA 292: 2708-2713 (2004). *
Hampton T. Monoclonal antibodies target inflammatory bowel disease. JAMA 292: 29-30 (2004). *
Han A, Robinson V, Judd M, Taixiang W, Wells G, Tugwell P. Tai chi for treating rheumatoid arthritis. Cochrane Database Syst. Rev. 3: CD004849 (2004).
Han BK, Inaganti K, Fahmi S, Reimold A. Polyarteritis nodosa complicated by catastrophic antiphospholipid syndrome. J. Clin. Rheumatol. 10: 210-213 (2004).
Han P, McDonald T, Hodge G. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway. Immunology 113: 26-34 (2004). *
Han PD, Cohen RD. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease. Drugs 64: 1767-1777 (2004).
Han YK, Chen JM. Current concept of clinical researches of autoimmune hepatitis. Zhonghua Gan Zang Bing Za Zhi 12: 180-181 (2004).
Hanai H, Kanauchi O, Mitsuyama K, Andoh A, Takeuchi K, Takayuki I, Araki Y,. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int. J. Mol. Med. 13: 643-647 (2004).
Hanai H, Takeuchi K, Iida T, Kashiwagi N, Saniabadi AR, Matsushita I, Sato Y, Kasuga N, Nakamura T. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig. Dis. Sci. 49: 1438-1443 (2004). *
Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Kikuch K, Saniabadi AR. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 70: 36-44 (2004).
Hanai H, Watanabe F, Yamada M, Sato Y, Takeuchi K, Iida T, Tozawa K, Tanaka T, Maruyama Y, Matsushita I, Iwaoka Y, Saniabadi A. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am. J. Gastroenterol. 99: 1532-1538 (2004). *
Hanauer S, Lukas M, Macintosh D, Rutgeerts P, Sandborn W, Pollack P. A randomized, double-blind, placebo-controlled trial of the human anti-TNF-alpha monoclonal antibody adalimumab for the induction of remission in patients with moderate to severely active Crohn's disease. Gastroenterology 127: 332 (2004). *
Hanauer SB. Aminosalicylates in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 60-65 (2004). *
Hanauer SB. The long-term management of ulcerative colitis. Aliment. Pharmacol. Ther. 20 Suppl. 4: 97-101 (2004). *
Hanauer SB. Update on the etiology, pathogenesis and diagnosis of ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 26-31 (2004). *
Hanauer SB. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies. Rev. Gastroenterol. Disord. 4 Suppl. 3: S18-S24 (2004). *
Hanauer SB. Optimal approach to perianal Crohn's disease. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 75. May 7-8 (2004). *
Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 126: 1582-1592 (2004). *
Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127: 723-729 (2004). *
Hanauer SB, Sandborn WJ, Davis GL, Keeffe EB, Vakil N, Katz PO, Talley NJ, Rex DK, Guda NM, Freeman ML, Hawes RH. Highlights from the 2004 digestive disease week. Rev. Gastroenterol. Disord. 4: 129-161 (2004). *
Hanauer SB, Sparrow M. COLAL-PRED Alizyme. Curr. Opin. Investig. Drugs 5: 1192-1197 (2004).
Hanauer SB, Sparrow M. Therapy of ulcerative colitis. Curr. Opin. Gastroenterol. 20: 345-350 (2004).
Hanauer SB, Stromberg U. Oral pentasa in the treatment of active Crohn's disease: a meta-analysis of double-blind, placebo-controlled trials. Clin. Gastroenterol. Hepatol. 2: 379-388 (2004). *
Hanauer SB, Wagner CL, Bala M, Mayer L, Travers S, Diamond RH, Olson A, Bao W, Rutgeerts P. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 542-553 (2004). *
Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150 (2004). *
Hancock R, Koren G. Celiac disease during pregnancy. Can. Fam. Physician 50: 1361-1363 (2004).
Handa R. Management of rheumatoid arthritis. Natl. Med. J. India 17: 143-151 (2004).
Handschin C, Blaettler S, Roth A, Looser R, Oscarson M, Kaufmann MR, Podvinec M, Gnerre C, Meyer UA. The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals. Nucl. Recept. 2: 7 (2004). *
Hang J, Zhou W, Zhang H, Sun B, Dai H, Su L, Christiani DC. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J. Endotoxin Res. 10: 238-240 (2004). *
Hanif M, Raza J, Qureshi H, Issani Z. Etiology of chronic liver disease in children. J. Pak. Med. Assoc. 54: 119-122 (2004).
Hanigan MD, Crompton LA, Reynolds CK, Wray-Cahen D, Lomax MA, France J. An integrative model of amino acid metabolism in the liver of the lactating dairy cow. J. Theor. Biol. 228: 271-289 (2004). *
Hanninen A, Harrison LC. Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans? Rev. Diabet. Stud. 1: 113-121 (2004). *
Hanrahan JW, Wioland MA. Revisiting cystic fibrosis transmembrane conductance regulator structure and function. Proc. Am. Thorac. Soc. 1: 17-21 (2004). *
Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, Dorner T. Abnormalities in peripheral B cell memory of patients with primary Sjogren's syndrome. Arthritis Rheum. 50: 1897-1908 (2004). *
Hansen KE, Cush J, Singhal A, A Cooley D, Cohen S, Patel SR, Genovese M, Sundaramurthy S, Schiff M. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis. Arthritis Rheum. 51: 228-232 (2004). *
Hansen LB, Vondracek SF. Prevention and treatment of nonpostmenopausal osteoporosis. Am. J. Health Syst. Pharm. 61: 2637-2654 (2004). *
Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53: 1570-1576 (2004). *
Hanses F, Muller-Ladner U, Scholmerich J, Schaffler A. 33 year old patient with thoraco-abdominal pain and differences of blood pressure. Internist (Berl.) 45: 1423-1427 (2004).
Hansson AS, Johansson AC, Holmdahl R. Critical role of the major histocompatibility complex and IL-10 in matrilin-1-induced relapsing polychondritis in mice. Arthritis Res. Ther. 6: R484-R491 (2004). *
Hansson M, Abedi-Valugerdi M. Mercuric chloride induces a strong immune activation, but does not accelerate the development of dermal fibrosis in tight skin 1 mice. Scand. J. Immunol. 59: 469-477 (2004). *
Hansson M, Gao Y, Rosen H, Tapper H, Olsson I. Hematopoietic secretory granules as vehicles for the local delivery of cytokines and soluble cytokine receptors at sites of inflammation. Eur. Cytokine Netw. 15: 167-176 (2004).
Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A, Nakanuma Y. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40: 925-932 (2004). *
Haranaka M, Kumagi M, Hino I, Watanabe K, Tatsukawa H, Ishii K, Yoshimatsu H. A case of lupus cystitis with a history of idiopathic thrombocytopenic purpura. Mod. Rheumatol. 14: 61-65 (2004).
Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sorensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63: 237-247 (2004). *
Hardcastle J, Harwood MD, Taylor CJ. Absorption of taurocholic acid by the ileum of normal and transgenic DeltaF508 cystic fibrosis mice. J. Pharm. Pharmacol. 56: 445-452 (2004).
Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J. Invest. Dermatol. 123: 522-529 (2004). *
Harder KW, Quilici C, Naik E, Inglese M, Kountouri N, Turner A, Zlatic K, Tarlinton DM, Hibbs ML. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood 104: 3901-3910 (2004). *
Hardin JA, Wallace LE, Wong JF, O'Loughlin EV, Urbanski SJ, Gall DG, MacNaughton WK, Beck PL. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis. Cell Tissue Res. 318: 313-323 (2004). *
Hardman WE. (n-3) Fatty acids and cancer therapy. J. Nutr. 134: 3427S-3430S (2004). *
Hardwick JC, Van Santen M, Van Den Brink GR, Van Deventer SJ, Peppelenbosch MP. DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis 25: 1293-1298 (2004). *
Harewood GC. Economic comparison of current endoscopic practices: Barrett's surveillance vs. ulcerative colitis surveillance vs. biopsy for sprue vs. biopsy for microscopic colitis. Dig. Dis. Sci. 49: 1808-1814 (2004). *
Harewood GC. Assessment of clinical impact of endoscopic ultrasound on rectal cancer. Am. J. Gastroenterol. 99: 623-627 (2004). *
Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR. Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am. J. Gastroenterol. 99: 1464-1469 (2004). *
Harewood GC, Holub JL, Lieberman DA. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am. J. Gastroenterol. 99: 1790-1794 (2004). *
Harewood GC, Wright CA, Baron TH. Assessment of patients' perceptions of bowel preparation quality at colonoscopy. Am. J. Gastroenterol. 99: 839-843 (2004). *
Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 36: 1206-1237 (2004). *
Harlozinska-Szmyrka A, Strutynska-Karpinska M. The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis. Gut 53: 469-470 (2004). *
Harms B, Bremner AR, Mulligan J, Fairhurst J, Griffiths DM, Salmon T, Beattie RM. Crohn's disease post-cardiac transplantation presenting with severe growth failure and delayed onset of puberty. Pediatr. Allergy Immunol. 15: 186-189 (2004). *
Harner KC, Jackson LW, Drabick JJ. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome. Rheumatology (Oxford) 43: 1309-1310 (2004). *
Harpavat M, Keljo DJ, Regueiro MD. Metabolic bone disease in inflammatory bowel disease. J. Clin. Gastroenterol. 38: 218-224 (2004).
Harper L, Williams JM, Savage CO. The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis. Biochem. Soc. Trans. 32: 502-506 (2004). *
Harrell LE, Hanauer SB. Mesalamine derivatives in the treatment of Crohn's disease. Gastroenterol. Clin. North Am. 33: 303-317 (2004).
Harrell LE, Rubin DT, Hanauer SB. Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 113-116 (2004). *
Harris LR, Kamarainen OP, Sevakivi M, Miller GC, Clarke JW, Potter JL, Bridgewater LC. A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation. Biochem. J. 383: 37-43 (2004). *
Harris MJ, Kagawa T, Dawson PA, Arias IM. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells. J. Gastroenterol. Hepatol. 19: 819-825 (2004). *
Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4: 868-877 (2004). *
Harris WS. Fish oil supplementation: evidence for health benefits. Cleve. Clin. J. Med. 71: 208-210, 212, 215-218 (2004). *
Harrison E, Porter B. A nurse-led, patient-centred mitoxantrone service in neurology. Br. J. Nurs. 13: 1021-1023 (2004).
Harrison SA, Neuschwander-Tetri BA. Pharmacologic management of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 715-728, xii (2004).
Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin. Liver Dis. 8: 861-879, ix (2004).
Harrison SA, Ward JA, Schenker S. The role of vitamin E and C therapy in NASH. Am. J. Gastroenterol. 99: 1862 (2004). *
Hart AL, Kamm MA, Knight SC, Stagg AJ. Prospective evaluation of intestinal homing memory T cells in ulcerative colitis. Inflamm. Bowel Dis. 10: 496-503 (2004). *
Hart AL, Kamm MA, Knight SC, Stagg AJ. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin. Exp. Immunol. 135: 137-145 (2004). *
Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA, Knight SC, Stagg AJ. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602-1609 (2004). *
Hartkamp A, Geenen R, Bijl M, Kruize AA, Godaert GL, Derksen RH. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1335-1337 (2004). *
Hartleb M, Nowak A, Gabriel A. Benign form of idiopathic biliary ductopenia in adult woman. Wiad. Lek. 57: 171-173 (2004).
Hartleb M, Pilch-Kowalczyk J, Cholewka A, Kajor M, Blaszczynska M. Hepatic arterial dot signs in isolated small duct primary sclerosing cholangitis. J. Gastroenterol. Hepatol. 19: 475-477 (2004). *
Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SE, Ulrich RG, Rushmore TH, Evers R, Evans DC. Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Mol. Pharmacol. 65: 1159-1171 (2004). *
Hartley JE, Fazio VW, Remzi FH, Lavery IC, Church JM, Strong SA, Hull TL, Senagore AJ, Delaney CP. Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis. Colon Rectum 47: 1808-1815 (2004).
Hartman C, Eliakim R, Shamir R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease. Isr. Med. Assoc. J. 6: 221-226 (2004). *
Hartwig D, Schoeneich L, Greeve J, Schutte C, Dorn I, Kirchner H, Hennig H. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection. J. Hepatol. 41: 667-672 (2004). *
Hartwig W, Werner J, Warshaw AL, Antoniu B, Fernandez-Del Castillo C, Gebhard MM, Uhl W, Buchler MW. Membrane-bound ICAM-1 is upregulated by trypsin and contributes to leukocyte migration in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1194-G1199 (2004). *
Hasan MK, Tierney WM, Baker MZ. Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine. Am. J. Med. Sci. 328: 348-350 (2004).
Hasan UA, Dollet S, Vlach J. Differential induction of gene promoter constructs by constitutively active human TLRs. Biochem. Biophys. Res. Commun. 321: 124-131 (2004). *
Hasegawa K, Kokudo N, Imamura H, Sano K, Aoki T, Miki K, Hashimoto T, Sugawara Y, Makuuchi M. Bilioenteric reconstruction for small bile ducts without mucosa-to-mucosa alignment: long-term results. Arch. Surg. 139: 1050-1054 (2004). *
Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303: 685-689 (2004). *
Hasegawa M, Abe M, Ohnishi K, Shoji C, Ishikawa O. Clinical usefulness of a long-term treatment with an antithyroid drug for psoriasis vulgaris. J. Dermatol. 31: 794-797 (2004).
Hasegawa M, Sato S, Takehara K. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Arch. Dermatol. Res. 296: 89-93 (2004). *
Hasegawa M, Sato S, Yanaba K, Komura K, Yamazaki M, Takehara K. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis. Ann. Rheum. Dis. 63: 1514-1517 (2004). *
Hasegawa S, Nishikawa S, Miura T, Saito Y, Madarame H, Sekikawa K, Tagawa Y, Iwakura Y, Nakane A. Tumor necrosis factor-alpha is required for gastritis induced by Helicobacter felis infection in mice. Microb. Pathog. 37: 119-124 (2004). *
Hashiguchi K, Iwai A, Inoue T, Okudaira K, Miyazaki J, Matsuzaki K, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Sato K, Miura S. Extramedullary plasmacytoma of the rectum arising in ulcerative colitis: case report and review. Gastrointest. Endosc. 59: 304-307 (2004). *
Hashimoto M, Akabane Y, Heianna J, Tate E, Ishiyama K, Nishii T, Watarai J. Hepatic infarction following selective hepatic artery embolization with microcoils for iatrogenic biliary hemorrhage. Hepatol. Res. 30: 42-50 (2004).
Hashimoto N, Iwasaki T, Sekiguchi M, Takatsuka H, Okamoto T, Hashimoto T, Sano H. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant. 33: 863-866 (2004). *
Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Cancer Lett. 211: 19-24 (2004). *
Hashizume M. Formation, hemodynamics and new management options for gastric varices. J. Gastroenterol. Hepatol. 19: S165-S167 (2004). *
Hasin Y, Avidan N, Bercovich D, Korczyn A, Silman I, Beckmann JS, Sussman JL. A paradigm for single nucleotide polymorphism analysis: the case of the acetylcholinesterase gene. Hum. Mutat. 24: 408-416 (2004). *
Hasler WL. Lysine as a serotonin receptor antagonist: using the diet to modulate gut function. Gastroenterology 127: 1004-1006 (2004). *
Hasnain BI, Mooradian AD. Recent trials of antioxidant therapy: what should we be telling our patients? Cleve. Clin. J. Med. 71: 327-334 (2004). *
Hassanein T. Mitochondrial dysfunction in liver disease and organ transplantation. Mitochondrion 4: 609-620 (2004).
Hata K, Watanabe T, Shinozaki M, Kojima T, Nagawa H. To dye or not to dye? That is beyond question! Optimising surveillance colonoscopy is indispensable for detecting dysplasia in ulcerative colitis. Gut 53: 1722 (2004). *
Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4: 688-694 (2004). *
Hatano E, Tanaka A, Kanazawa A, Tsuyuki S, Tsunekawa S, Iwata S, Takahashi R, Chance B, Yamaoka Y. Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase. Liver Int. 24: 384-393 (2004). *
Hatao F, Muroi M, Hiki N, Ogawa T, Mimura Y, Kaminishi M, Tanamoto KI. Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein. J. Leukoc. Biol. 76: 904-908 (2004). *
Haufroid V, Mourad M, Van Kerckhove V, Wawrzyniak J, De Meyer M, Eddour DC, Malaise J, Lison D, Squifflet JP, Wallemacq P. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Pharmacogenetics 14: 147-154 (2004).
Haugen BR, Jensen DR, Sharma V, Pulawa LK, Hays WR, Krezel W, Chambon P, Eckel RH. Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145: 3679-3685 (2004). *
Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr. Blood Cancer 42: 438-444 (2004). *
Hauret L, Ait-Ameur A, Dion A, Bellaiche R, Mennecier D, Boyer B. The fat halo sign in the small intestine: diagnostic implications? J. Radiol. 85: 1947-1949 (2004).
Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. Medications as a source of human exposure to phthalates. Environ. Health Perspect. 112: 751-753 (2004). *
Hauser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, Stallmach A. Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Z. Gastroenterol. 42: 131-139 (2004).
Hauser W, Dietz N, Steder-Neukamm U, Janke KH, Stallmach A. Biopsychosocial determinants of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Inflamm. Bowel Dis. 10: 399-407 (2004). *
Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J. Bone Miner. Res. 19: 1873-1881 (2004). *
Hausmann M, Obermeier F, Schreiter K, Spottl T, Falk W, Scholmerich J, Herfarth H, Saftig P, Rogler G. Cathepsin D is up-regulated in inflammatory bowel disease macrophages. Clin. Exp. Immunol. 136: 157-167 (2004). *
Haussinger D, Kubitz R, Reinehr R, Bode JG, Schliess F. Molecular aspects of medicine: from experimental to clinical hepatology. Mol. Aspects Med. 25: 221-360 (2004).
Haussinger D, Reinehr R. Bile acids and CD95 activation. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 62. June 18-19 (2004). *
Hawk ET, Umar A, Viner JL. Colorectal cancer chemoprevention - an overview of the science. Gastroenterology 126: 1423-1447 (2004). *
Hawk J. Benign summer light eruption and polymorphic light eruption: genetic and functional studies suggest that a revised nomenclature is required. J. Cosmet. Dermatol. 3: 173-175 (2004).
Hawkey CJ. Stem cell transplantation for Crohn's disease. Best Pract. Res. Clin. Haematol. 17: 317-325 (2004).
Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 50: 607-612 (2004). *
Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples LD, Adams JE. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 59: 613-617 (2004). *
Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9: 180-197 (2004). *
Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, Arundel M, Bernal W, Gunson B, Hudson M, Suri D, Simpson K. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 329: 1076 (2004). *
Hay RT. Modifying NEMO. Nat. Cell Biol. 6: 89-91 (2004). *
Hayashi H, Suzuki R, Wakusawa S. Wilson's disease and its pharmacological treatment. Yakugaku Zasshi 124: 711-724 (2004).
Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl. 10: 42-48 (2004). *
Hayashi R, Wada H, Ito K, Adcock IM. Effects of glucocorticoids on gene transcription. Eur. J. Pharmacol. 500: 51-62 (2004). *
Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, Broide DH, Carson DA, Raz E. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114: 270-279 (2004). *
Hayashi T, Uchida K, Takebe G, Takahashi K. Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins. Free Radic. Biol. Med. 36: 1025-1033 (2004).
Hayashi Y, Ishimaru N, Arakaki R, Tsukumo S, Fukui H, Kishihara K, Shiota H, Yasutomo K, Hayashi Y. Effective treatment of a mouse model of Sjogren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody. Arthritis Rheum. 50: 2903-2910 (2004). *
Hayashida K, Kume N, Minami M, Inui-Hayashida A, Mukai E, Toyohara M, Kita T. Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif. Biochem. Biophys. Res. Commun. 323: 1116-1123 (2004). *
Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224 (2004). *
Hayes KS, Bancroft AJ, Grencis RK. Immune-mediated regulation of chronic intestinal nematode infection. Immunol. Rev. 201: 75-88 (2004). *
Hayes MJ, Cambridge G. An IgM class anti-neutrophil cytoplasm antibody inhibits neutrophil adhesion and apoptosis via a Syk dependent signaling cascade. Mol. Immunol. 41: 457-468 (2004). *
Haynes H, Farroni J. Successful combined heart-liver transplantation in a patient with hemochromatosis. Prog. Transplant. 14: 39-40 (2004).
Haynes P, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease in individuals with severe obesity. Clin. Liver Dis. 8: 535-547, viii (2004).
Haywood S, Muller T, Mackenzie AM, Muller W, Tanner MS, Heinz-Erian P, Williams CL, Loughran MJ. Copper-induced hepatotoxicosis with hepatic stellate cell activation and severe fibrosis in North Ronaldsay lambs: a model for non-Wilsonian hepatic copper toxicosis of infants. J. Comp. Pathol. 130: 266-277 (2004). *
Hazuda DJ, Young SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, Dornadula G, Danovich RM, Witmer MV, Wilson KA, Tussey L, Schleif WA, Gabryelski LS, Jin L, Miller MD, Casimiro DR, Emini EA, Shiver JW. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305: 528-532 (2004). *
Hazzan D, Fishman E, Heller E, Chapman M, Bauer JJ. Liver abscess in Crohn's disease: a report of three cases. Mt. Sinai J. Med. 71: 351-354 (2004). *
He L, Grammer AC, Wu X, Lipsky PE. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-kB activation. J. Biol. Chem. 279: 55855-55865 (2004). *
He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 10: 309-318 (2004). *
Head HW, Dodd GD. Thermal ablation for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S167-S178 (2004). *
Head K, Jurenka JS. Inflammatory bowel disease part II: Crohn's disease - pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 9: 360-401 (2004). *
Heaney AP. PPAR-gamma in Cushing's disease. Pituitary 7: 265-269 (2004).
Heathcote EJ. Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S294-S302 (2004). *
Heathcote J. Abnormal liver function found after an unplanned consultation: case outcome. BMJ 329: 500 (2004). *
Heathcote J. Round table: classification of autoimmune liver diseases and diagnostic criteria. Overlap syndromes � don�t exist. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 61-62 (2004). *
Heathcote J. Diagnosis of primary biliary liver diseases, overlap syndromes and changing diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 55 (2004). *
Hebbar M, Jeannin P, Magistrelli G, Hatron PY, Hachulla E, Devulder B, Bonnefoy JY, Delneste Y. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis. Clin. Exp. Immunol. 136: 388-392 (2004). *
Hebeis BJ, Vigorito E, Turner M. The p110delta subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells. Biochem. Soc. Trans. 32: 789-791 (2004). *
Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 50: 145-149 (2004). *
Hediger MA. Physiology and biochemistry of uric acid. Ther. Umsch. 61: 541-545 (2004).
Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch. 447: 465-468 (2004). *
Heeringa P, Schreiber A, Falk RJ, Jennette JC. Pathogenesis of pulmonary vasculitis. Semin. Respir. Crit. Care Med. 25: 465-474 (2004).
Heeringa P, Tervaert JW. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int. 65: 1564-1567 (2004). *
Heesen M, Kunz D, Wessiepe M, Van Der Poll T, Zwinderman AH, Blomeke B. Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha) -863C/A promoter polymorphism that determines TNF-alpha response. Clin. Chem. 50: 226-228 (2004).
Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin. Exp. Dermatol. 29: 1-7 (2004). *
Heggelund L, Damas JK, Yndestad A, Holm AM, Muller F, Lien E, Espevik T, Aukrust P, FrOland SS. Stimulation of Toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences. Clin. Exp. Immunol. 138: 116-121 (2004). *
Heggelund L, Muller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Froland SS. Increased expression of Toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin. Infect. Dis. 39: 264-269 (2004). *
Heidemann J, Ogawa H, Otterson MF, Shidham VB, Binion DG. Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases. Dis. Colon Rectum 47: 118-122 (2004). *
Heidemann J, Ogawa H, Rafiee P, Lugering N, Maaser C, Domschke W, Binion DG, Dwinell MB. Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1059-G1068 (2004). *
Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303: 1526-1529 (2004). *
Heiligenhaus A, Rebmann V, Neubert A, Plewa S, Ferencik S, Vogeler U, Steuhl KP, Grosse-Wilde H. Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis. Tissue Antigens 63: 369-375 (2004). *
Heim MH. Autoimmune hepatitis. Ther. Umsch. 61: 499-504 (2004).
Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin. Liver Dis. 24: 201-207 (2004).
Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 10 Suppl. 10: S65-S68 (2004). *
Heimpel H. Congenital dyserythropoietic anemias: epidemiology, clinical significance, and progress in understanding their pathogenesis. Ann. Hematol. 83: 613-621 (2004). *
Heine RG. Pathophysiology, diagnosis and treatment of food protein-induced gastrointestinal diseases. Curr. Opin. Allergy Clin. Immunol. 4: 221-229 (2004).
Heino TJ, Hentunen TA, Vaananen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp. Cell Res. 294: 458-468 (2004). *
Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS. T cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103: 3457-3464 (2004). *
Heinz C, Steuhl KP, Meller D. Corneal perforation associated with vitamin A deficiency. Ophthalmologe 101: 614-617 (2004).
Heissmeyer V, Macian F, Im SH, Varma R, Feske S, Venuprasad K, Gu H, Liu YC, Dustin ML, Rao A. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265 (2004). *
Heitmeier MR, Kelly CB, Ensor NJ, Gibson KA, Mullis KG, Corbett JA, Maziasz TJ. Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets. J. Biol. Chem. 279: 53145-53151 (2004). *
Hekmatdoost A, Ghaziani T, Esteghamathanzaie F, Alavian S, Mohaghegh H, Zali M. Transfusion transmitted virus and autoimmune hepatitis. Is there any association? Saudi Med. J. 25: 1760-1761 (2004).
Helenius LM, Hallikainen D, Helenius I, Meurman JH, Koskimies S, Tervahartiala P, Kivisaari L, Hietanen J, Suuronen R, Lindqvist C, Leirisalo-Repo M. HLA-DRB1* alleles and temporomandibular joint erosion in patients with various rheumatic diseases. Scand. J. Rheumatol. 33: 24-29 (2004).
Hellemans K, Verbuyst P, Quartier E, Schuit F, Rombouts K, Chandraratna RA, Schuppan D, Geerts A. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology 39: 97-108 (2004). *
Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int. J. Cancer 111: 611-616 (2004). *
Hellings N, Raus J, Stinissen P. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action. Autoimmun. Rev. 3: 267-275 (2004).
Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, Wahl W, Lyer S, Poustka A, Otto HF, Deichmann M. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology 127: 1815-1820 (2004). *
Helmy A. Responses to endothelin-1 in patients with advanced cirrhosis before and after liver transplantation. Gut 53: 470-471 (2004). *
Helwig U, Gionchetti P, Rizzello F, Lammers K, Kuhbacher T, Schreiber S, Baggiolini M, Uguccioni M, Campieri M. CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int. J. Colorectal Dis. 19: 165-170 (2004). *
Hemalatha V, Srikanth P, Mallika M. Superantigens - concepts, clinical disease and therapy. Indian J. Med. Microbiol. 22: 204-211 (2004).
Hendrickson RG, Morocco AP, Greenberg MI. Pilocarpine toxicity and the treatment of xerostomia. J. Emerg. Med. 26: 429-432 (2004).
Hendrickson RJ, Karrer FM, Wachs ME, Slater K, Bak TE, Kam I. Pediatric liver transplantation. Curr. Opin. Pediatr. 16: 309-313 (2004).
Hendrikse NH, Kuipers F, Meijer C, Havinga R, Bijleveld CM, Van Der Graaf WT, Vaalburg W, De Vries EG. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein. Cancer Chemother. Pharmacol. 54: 131-138 (2004). *
Hengge UR, Ruzicka T. Topical immunomodulation in dermatology: potential of Toll-like receptor agonists. Dermatol. Surg. 30: 1101-1112 (2004).
Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am. J. Respir. Cell Mol. Biol. 31: 86-91 (2004). *
Henning JS. Pityriasis lichenoides chronica. Dermatol. Online J. 10: 8 (2004). *
Henriksson G, Sallmyr A, Du L, Larsson A, Manthorpe R, Bredberg A. Enhanced DNA-dependent protein kinase activity in Sjogren's syndrome B cells. Rheumatology (Oxford) 43: 1109-1115 (2004). *
Hensrud DD. Diet and obesity. Curr. Opin. Gastroenterol. 20: 119-124 (2004).
Henzel K, Thorborg C, Hofmann M, Zimmer G, Leuschner U. Toxicity of ethanol and acetaldehyde in hepatocytes treated with ursodeoxycholic or tauroursodeoxycholic acid. Biochim. Biophys. Acta 1644: 37-45 (2004). *
Heresbach D, Alexandre JL, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Pennognon L, Richecoeur M, Politis J, Robaszkiewicz M, Seyrig JA, Tron I; ABERMAD. Crohn's disease in the over-60 age group: a population based study. Eur. J. Gastroenterol. Hepatol. 16: 657-664 (2004).
Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis. Eur. J. Gastroenterol. Hepatol. 16: 55-62 (2004).
Herfarth H, Gross V, Andus T, Caesar I, Vogelsang H, Adler G, Malchow H, Petri A, Gierend M, Scholmerich J. Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization. Int. J. Colorectal Dis. 19: 147-152 (2004). *
Herkel J. Autoantibodies to SLA/LP: specificity and pathogenetic relevance? Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 34 (2004). *
Herlenius G, Krantz M, Finkel Y, Meurling S, Duraj F, Olausson M. Intestinal transplantation - an experimental therapy which has become a realistic alternative. Lakartidningen 101: 2874-2878 (2004).
Hermann R, Bartsocas CS, Soltesz G, Vazeou A, Paschou P, Bozas E, Malamitsi-Puchner A, Simell O, Knip M, Ilonen J. Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence. Diabetes Metab. Res. Rev. 20: 322-329 (2004). *
Hermann R, Soltesz G. Predictive genetic screening for type-1 diabetes in the Hungarian population. Orv. Hetil. 145: 337-342 (2004).
Hermoso MA, Matsuguchi T, Smoak K, Cidlowski JA. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate Toll-like receptor 2 gene expression. Mol. Cell. Biol. 24: 4743-4756 (2004). *
Hernandez V, Pascual I, Almela P, Anon R, Herreros B, Sanchiz V, Minguez M, Benages A. Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy. Am. J. Gastroenterol. 99: 2417-2423 (2004). *
Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, Garcia-Pagan JC. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40: 1197-1202 (2004). *
Hernandez-Illas M, Tozman E, Fulcher SF, Jundt JW, Davis J, Pflugfelder SC. Recombinant human tumor necrosis factor receptor Fc fusion protein (etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 30: 2-5 (2004).
Herr AL, Latulippe JF, Carignan S, Mitchell A, Belanger R, Roy J. Is severe intestinal chronic graft-versus-host disease an indication for surgery? A report of two cases. Transplantation 77: 1617-1620 (2004).
Herrera AG. Helicobacter pylori and food products: a public health problem. Methods Mol. Biol. 268: 297-301 (2004).
Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J, Prieto J. Herpes zoster after liver transplantation: incidence, risk factors, and complications. Liver Transpl. 10: 1140-1143 (2004). *
Herrlinger K, Stange EF. Inflammatory bowel disease - case report. Dtsch. Med. Wochenschr. 129: 2243 (2004).
Herrlinger K, Stange EF. Inflammatory bowel disease - diagnostics. Dtsch. Med. Wochenschr. 129: 2244-2245 (2004).
Herrlinger K, Stange EF. Inflammatory bowel disease - therapy. Dtsch. Med. Wochenschr. 129: 2246-2250 (2004).
Herrlinger KR, Borutta A, Meinhardt G, Stange EF, Fellermann K. Fatal staphylococcal sepsis in Crohn's disease after infliximab. Inflamm. Bowel Dis. 10: 655-656 (2004). *
Herrlinger KR, Dittmann R, Weitz G, Wehkamp J, Ludwig D, Schwab M, Stange EF, Fellermann K. Serum procalcitonin differentiates inflammatory bowel disease and self- limited colitis. Inflamm. Bowel Dis. 10: 229-233 (2004). *
Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. Aliment. Pharmacol. Ther. 19: 1269-1276 (2004). *
Herrmann J, Arias M, Van De Leur E, Gressner AM, Weiskirchen R. CSRP2, TIMP-1, and SM22alpha promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo. Liver Int. 24: 69-79 (2004). *
Hershfield NB. Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can. J. Gastroenterol. 18: 101-104 (2004). *
Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS. Results of a phase I multiple-dose clinical study of ursodeoxycholic acid. Cancer Epidemiol. Biomarkers Prev. 13: 861-867 (2004). *
Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172: 3157-3166 (2004). *
Hesselink DA, Van Dam T, Metselaar HJ, Balk AH, Mathot RA, Smak Gregoor PJ, Weimar W, Van Gelder T. The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapy. Transpl. Int. 17: 495-504 (2004).
Hesselink DA, Van Gelder T, Van Schaik RH, Balk AH, Van der Heiden IP, Van Dam T, Van der Werf M, Weimar W, Mathot RA. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes. Clin. Pharmacol. Ther. 76: 545-556 (2004). *
Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40: 802-810 (2004). *
Hevia C H, Suarez MJ, Vergara AMT. Peri-ileostomic pyoderma gangrenosum. Report of one case. Rev. Med. Chil. 132: 747-749 (2004).
Hevia H, Varela-Rey M, Corrales FJ, Berasain C, Martinez-Chantar ML, Latasa MU, Lu SC, Mato JM, Garcia-Trevijano ER, Avila MA. 5-Methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology 39: 1088-1098 (2004). *
Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.) 61: 269-272 (2004). *
Hewins P, Williams JM, Wakelam MJ, Savage CO. Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18. J. Am. Soc. Nephrol. 15: 796-808 (2004). *
Hiatt K, Ingram DA, Huddleston H, Spandau DF, Kapur R, Clapp DW. Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells. Am. J. Pathol. 164: 1471-1479 (2004). *
Hibi T, Yoshizawa S. Anti tumor necrosis factor-alpha antibody: biological significance and therapeutic target for Crohn's disease. Nihon Rinsho Meneki Gakkai Kaishi 27: 16-21 (2004).
Hicken BL, Calhoun DA, Barton JC, Tucker DC. Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet. Test. 8: 90-97 (2004).
Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 53: 413-419 (2004). *
Hida S, Miura NN, Adachi Y, Ohno N. Influence of arginine deimination on antigenicity of fibrinogen. J. Autoimmun. 23: 141-150 (2004).
Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Kanamaru A, Yoshie O. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J. Immunol. 173: 3668-3675 (2004). *
Hietaranta A, Mustonen H, Puolakkainen P, Haapiainen R, Kemppainen E. Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-kappaB. Biochem. Biophys. Res. Commun. 323: 192-196 (2004). *
Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J. Biol. Chem. 279: 51-60 (2004). *
Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 63. June 18-19 (2004). *
Higuero T, Merle C, Thiefin G, Coussinet S, Jolly D, Diebold MD, Zeitoun P, Cadiot G. Jejunoileal Crohn's disease: a case-control study. Gastroenterol. Clin. Biol. 28: 160-166 (2004). *
Hilakivi-Clarke L, Wang C, Kalil M, Riggins R, Pestell RG. Nutritional modulation of the cell cycle and breast cancer. Endocr. Relat. Cancer 11: 603-622 (2004). *
Hilario MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE. Frequency of antinuclear antibodies in healthy children and adolescents. Clin. Pediatr. (Phila.) 43: 637-642 (2004).
Hildinger M, Auricchio A. Advances in AAV-mediated gene transfer for the treatment of inherited disorders. Eur. J. Hum. Genet. 12: 263-271 (2004). *
Hilgard P, Schreiter T, Stockert RJ, Gerken G, Treichel U. Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis. Hepatology 39: 1398-1407 (2004). *
Hill DB, McClain CJ. Anti-TNF therapy in alcoholic hepatitis. Am. J. Gastroenterol. 99: 261-263 (2004). *
Hill KA, Wang KL, Stryker SJ, Gupta R, Weinrach DM, Rao MS. Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer. Oncol. Rep. 11: 951-956 (2004).
Hilmy KM. Synthesis of new pyrrolo[2, 3-b]pyridines as a potent inhibitor of tumour necrosis factor alpha. Arch. Pharm. (Weinheim.) 337: 15-19 (2004). *
Hilsden R. The economic impact of inflammatory bowel disease in Canada. Can. J. Gastroenterol. 18: 255-257 (2004). *
Hindorf U, Lyrenas E, Nilsson A, Schmiegelow K. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Scand. J. Gastroenterol. 39: 1105-1112 (2004). *
Hines OJ, Reber HA. Pancreatic neoplasms. Curr. Opin. Gastroenterol. 20: 452-458 (2004).
Hino A, Kweon MN, Fujihashi K, McGhee JR, Kiyono H. Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea. Am. J. Pathol. 164: 1327-1335 (2004). *
Hinrichsen H, Benhamou Y, Wedemeyer H, Reiser M, Sentjens RE, Calleja JL, Forns X, Erhardt A, Cronlein J, Chaves RL, Yong CL, Nehmiz G, Steinmann GG. Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology 127: 1347-1355 (2004). *
Hinson JA, Reid AB, McCullough SS, James LP. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 36: 805-822 (2004).
Hinterhuber L, Graziadei IW, Kahler CM, Jaschke W, Vogel W. Endothelin-receptor antagonist treatment of portopulmonary hypertension. Clin. Gastroenterol. Hepatol. 2: 1039-1042 (2004).
Hirabayashi T, Murayama T, Shimizu T. Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol. Pharm. Bull. 27: 1168-1173 (2004). *
Hiraga Y, Yuhki Y, Itoh K, Tadano K, Takahashi Y, Mukai M. Pharmacokinetics and efficacy of low-dose methotrexate in patients with rheumatoid arthritis. Mod. Rheumatol. 14: 135-142 (2004).
Hiraiwa T, Ito M, Imagawa A, Isotani H, Takamatsu J, Kuma K, Miyauchi A, Hanafusa T. High diagnostic value of a radioiodine uptake test with and without iodine restriction in Graves' disease and silent thyroiditis. Thyroid 14: 531-535 (2004).
Hirano K, Komatsu Y, Yamamoto N, Nakai Y, Sasahira N, Toda N, Isayama H, Tada M, Kawabe T, Omata M. Pancreatic mass lesions associated with raised concentration of IgG4. Am. J. Gastroenterol. 99: 2038-2040 (2004). *
Hirano T, Onda K, Toma T, Miyaoka M, Moriyasu F, Oka K. MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration. J. Clin. Pharmacol. 44: 481-486 (2004). *
Hirashima M, Fukazawa T, Abe K, Morita Y, Kusaoi M, Hashimoto H. Expression and activity analyses of CTLA4 in peripheral blood lymphocytes in systemic lupus erythematosus patients. Lupus 13: 24-31 (2004).
Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y,Hamanaka Y, Hinoda Y. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Carcinogenesis 25: 2379-2384 (2004). *
Hirche TO, Russler J, Braden B, Schuessler G, Zeuzem S, Wehrmann T, Seifert H, Dietrich CF. Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int. J. Colorectal Dis. 19: 586-594 (2004). *
Hirohashi K, Tanaka H, Kanazawa A, Kubo S, Ohno K, Tsukamoto T, Hamba H, Shuto T, Takemura S, Yamamoto T, Tanaka K, Kinoshita H. Living-related liver transplantation in a patient with end-stage hepatolithiasis and a biliary-bronchial fistula. Hepatogastroenterology 51: 822-824 (2004).
Hirokane H, Nakahara M, Tachibana S, Shimizu M, Sato R. Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J. Biol. Chem. 279: 45685-45692 (2004). *
Hirokawa M, Takeuchi T, Chu S, Akiba Y, Wu V, Guth PH, Engel E, Montrose MH, Kaunitz JD. Cystic fibrosis gene mutation reduces epithelial cell acidification and injury in acid-perfused mouse duodenum. Gastroenterology 127: 1162-1173 (2004). *
Hirota T, Fukada Y. Resetting mechanism of central and peripheral circadian clocks in mammals. Zoolog. Sci. 21: 359-368 (2004).
Hirouchi M, Suzuki H, Itoda M, Ozawa S, Sawada J, Ieiri I, Ohtsubo K, Sugiyama Y. Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2. Pharm. Res. 21: 742-748 (2004). *
Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279: 41197-41207 (2004). *
Hirtz S, Gonska T, Seydewitz HH, Thomas J, Greiner P, Kuehr J, Brandis M, Eichler I, Rocha H, Lopes AI, Barreto C, Ramalho A, Amaral MD, Kunzelmann K, Mall M. CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 127: 1085-1095 (2004). *
Hisaeda K, Inokuchi A, Nakamura T, Iwamoto Y, Kohno K, Kuwano M, Uchiumi T. Interleukin-1 represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells. Hepatology 39: 1574-1582 (2004). *
Hisaka T, Yano H, Ogasawara S, Momosaki S, Nishida N, Takemoto Y, Kojiro S, Katafuchi Y, Kojiro M. Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo. J. Hepatol. 41: 782-789 (2004). *
Hitchon CA, Alex P, Erdile LB, Frank MB, Dozmorov I, Tang Y, Wong K, Centola M, El-Gabalawy HS. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J. Rheumatol. 31: 2336-2346 (2004).
Hitomi Y, Tsuchiya N, Kawasaki A, Ohashi J, Suzuki T, Kyogoku C, Fukazawa T, Bejrachandra S, Siriboonrit U, Chandanayingyong D, Suthipinittharm P, Tsao BP, Hashimoto H, Honda Z, Tokunaga K. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B. Hum. Mol. Genet. 13: 2907-2917 (2004). *
Hivnor C, Williams N, Singh F, VanVoorhees A, Dzubow L, Baldwin D, Seykora J. Gene expression profiling of porokeratosis demonstrates similarities with psoriasis. J. Cutan. Pathol. 31: 657-664 (2004). *
Ho CY, Kuo TH, Chen TS, Tsay SH, Chang FY, Lee SD. Fenofibrate-induced acute cholestatic hepatitis. J. Chin. Med. Assoc. 67: 245-247 (2004). *
Ho GT, Lees C, Satsangi J. Pharmacogenetics and inflammatory bowel disease: progress and prospects. Inflamm. Bowel Dis. 10: 148-158 (2004). *
Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment. Pharmacol. Ther. 19: 1079-1087 (2004). *
Ho J, Rothchild YH, Sengelmann R. Vitamin B12-associated localized scleroderma and its treatment. Dermatol. Surg. 30: 1252-1255 (2004). *
Ho P, Barton A, Worthington J. Genetic epidemiology of psoriatic arthritis. Mod. Rheumatol. 14: 91-100 (2004).
Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15: 657-663 (2004). *
Hobbs HH, Cohen JC. ABCG5 and ABCG8 play major role in defense against sterol accumulation. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 55. June 18-19 (2004). *
Hochman JH, Pudvah N, Qiu J, Yamazaki M, Tang C, Lin JH, Prueksaritanont T. Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin. Pharm. Res. 21: 1686-1691 (2004). *
Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. U.S.A. 101: 11416-11421 (2004). *
Hocking B. Thyroiditis and inflammatory bowel disease associated with 50 Hz magnetic field exposure. Occup. Med. (Lond.) 54: 435 (2004). *
Hodgson RS, Taylor-Robinson SD, Jackson JE. Haematochezia in Crohn's disease caused by late-onset haemobilia following percutaneous liver biopsy. Eur. J. Gastroenterol. Hepatol. 16: 229-232 (2004).
Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat. Immunol. 5: 971-974 (2004). *
Hoek JB, Pastorino JG. Cellular signaling mechanisms in alcohol-induced liver damage. Semin. Liver Dis. 24: 257-272 (2004).
Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53: 1329-1333 (2004). *
Hoffjan S, Ostrovnaja I, Nicolae D, Newman DL, Nicolae R, Gangnon R, Steiner L, Walker K, Reynolds R, Greene D, Mirel D, Gern JE, Lemanske RF Jr, Ober C. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J. Allergy Clin. Immunol. 113: 511-518 (2004). *
Hoffman GS. Determinants of vessel targeting in vasculitis. Clin. Dev. Immunol. 11: 275-279 (2004). *
Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364: 1779-1785 (2004). *
Hoffman RW, Gazitt T, Foecking MF, Ortmann RA, Misfeldt M, Jorgenson R, Young SL, Greidinger EL. U1 RNA induces innate immunity signaling. Arthritis Rheum. 50: 2891-2896 (2004). *
Hoffmann JC. Inflammatory bowel disease: anti-TNF strategies and beyond. Dtsch. Med. Wochenschr. 129 Suppl. 2: S76-S78 (2004).
Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Folsch UR, Herrlinger K, Hohne W, Jantschek G, Kaltz B, et al. Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German Society of Digestive and Metabolic Diseases and the Competence Network on Inflammatory Bowel Disease. Z. Gastroenterol. 42: 979-983 (2004).
Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm. Bowel Dis. 10: 140-147 (2004). *
Hoffmann U, Kroemer HK. The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab. Rev. 36: 669-701 (2004). *
Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-penicillamine2,5]enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems. J. Pharmacol. Exp. Ther. 311: 1203-1210 (2004). *
Hofman MK, Weggemans RM, Zock PL, Schouten EG, Katan MB, Princen HM. CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans. J. Nutr. 134: 2200-2204 (2004). *
Hofman P, Waidner B, Hofman V, Bereswill S, Brest P, Kist M. Pathogenesis of Helicobacter pylori infection. Helicobacter 9 Suppl. 1: 15-22 (2004).
Hofmann AF. Molecular pathogenesis of cholestasis. Gastroenterology 127: 1642-1644 (2004). *
Hofmann AF. Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab. Rev. 36: 703-722 (2004).
Hofmann AF. Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man [J Clin Invest 1968;47:1043-1052]. J. Hepatol. 41: 195-200 (2004). *
Hogaboam CM, Takahashi K, Ezekowitz RA, Kunkel SL, Schuh JM. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J. Leukoc. Biol. 75: 805-814 (2004). *
Hogan SP, Rothenberg ME. Review article: the eosinophil as a therapeutic target in gastrointestinal disease. Aliment. Pharmacol. Ther. 20: 1231-1240 (2004). *
Hogberg L, Laurin P, Falth-Magnusson K, Grant C, Grodzinsky E, Jansson G, Ascher H, Browaldh L, Hammersjo JA, Lindberg E, Myrdal U, Stenhammar L. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 53: 649-654 (2004). *
Hogg RC, Bertrand D. Neuroscience. What genes tell us about nicotine addiction. Science 306: 983-955 (2004). *
Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC. Characterization of IDN-6556 (3-{2-(2-tert-Butyl-phenylaminooxalyl)-amino]-propionylamino}-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J. Pharmacol. Exp. Ther. 309: 634-640 (2004). *
Hohlfeld R, Wekerle H. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc. Natl. Acad. Sci. U.S.A. 101: 14599-14606 (2004). *
Hokama A, Mizoguchi E, Sugimoto K, Shimomura Y, Tanaka Y, Yoshida M, Rietdijk ST, De Jong YP, Snapper SB, Terhorst C, Blumberg RS, Mizoguchi A. Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681-693 (2004). *
Holden C. Neuroscience. Mutant gene tied to poor serotonin production and depression. Science 306: 2023 (2004). *
Holgate ST. Genetic common ground between allergic and autoimmune disease: the role of cytotoxic T-lymphocyte antigen 4. J. Allergy Clin. Immunol. 114: 277-279 (2004). *
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80: 1678S-1688S (2004). *
Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin. Exp. Immunol. 138: 183-192 (2004). *
Holland S. When less is not more but at least equivalent. Inflamm. Bowel Dis. 10: 890-891 (2004). *
Hollenbach E, Neumann M, Vieth M, Roessner A, Malfertheiner P, Naumann M. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J. 18: 1550-1552 (2004). *
Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J, Eissner G, Schoelmerich J, Andreesen R. Both, donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104: 889-894 (2004). *
Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br. J. Surg. 91: 1646-1651 (2004).
Hollis BW, Wagner CL. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am. J. Clin. Nutr. 79: 717-726 (2004). *
Holm P, Rydlander B, Luthman H, Kockum I; European Consortium for IDDM Genome Studies. Interaction and association analysis of a type 1 diabetes susceptibility locus on chromosome 5q11-q13 and the 7q32 chromosomal region in Scandinavian families. Diabetes 53: 1584-1591 (2004). *
Holm TL, Nielsen J, Claesson MH. CD4CD25 regulatory T cells: I. Phenotype and physiology. APMIS 112: 629-641 (2004).
Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H. MT1-MMP: a tethered collagenase. J. Cell Physiol. 200: 11-19 (2004). *
Holopainen P, Naluai AT, Moodie S, Percopo S, Coto I, Clot F, Ascher H, Sollid L, Ciclitira P, Greco L, Clerget-Darpoux F, Partanen J; Members of the European Genetics Cluster on Coeliac Disease. Candidate gene region 2q33 in European families with coeliac disease. Tissue Antigens 63: 212-222 (2004). *
Holtmann MH, Galle PR. Current concept of pathophysiological understanding and natural course of ulcerative colitis. Langenbecks. Arch. Surg. 389: 341-349 (2004). *
Holtmann MH, Neurath MF. T helper cell polarisation in coeliac disease: any (T-)bet ? Gut 53: 1065-1067 (2004). *
Holzer K, Thalhammer A, Bechstein WO. Splenic trauma - a rare complication during colonoscopy. Z. Gastroenterol. 42: 509-512 (2004).
Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur. J. Pharmacol. 500: 231-241 (2004). *
Holzheimer RG. Hemorrhoidectomy: indications and risks. Eur. J. Med. Res. 9: 18-36 (2004).
Hommes D, Mikhajlova T, Stoinov S, Stimac D, Vucelic B, Lonovics J, Zakuciova M, D'haens G, Van Assche G, Pearce T. Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn's disease. Gastroenterology 127: 332 (2004). *
Hommes DW. Signalling proteins. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 42. May 7-8 (2004). *
Hommes DW, Sterringa G, van Deventer SJH, TytgatGNJ, Weel J. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm. Bowel Dis. 10: 245-250 (2004). *
Hommes DW, Van Deventer SJ. Endoscopy in inflammatory bowel diseases. Gastroenterology 126: 1561-1573 (2004). *
Homo-Delarche F. Neuroendocrine immuno-ontogeny of the pathogenesis of autoimmune disease in the nonobese diabetic (NOD) mouse. ILAR J. 45: 237-258 (2004). *
Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 101: 15416-15421 (2004). *
Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br. J. Pharmacol. 143: 856-864 (2004). *
Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40: 933-941 (2004). *
Hong K, Presta LG, Lu Y, Penn A, Adams C, Chuntharapai A, Yang J, Wong WL, Meng YG. Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20. J. Immunol. Methods 294: 189-197 (2004). *
Hong M, Zhou F, You G. Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1. J. Biol. Chem. 279: 31478-31482 (2004). *
Hong SE, Ahn IS, Jung HS, Rayner DV, Do MS. Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro. J. Med. Food 7: 320-326 (2004).
Hong SN, Lee JK, Lee KT, Heo JS, Choi SH, Rhee PL, Paik SW, Yoo BC, Rhee JC. Usefulness of gallbladder ejection fraction estimation to predict the recurrence of biliary pain in patients with symptomatic gallstones who did not undergo cholecystectomy. Dig. Dis. Sci. 49: 820-827 (2004). *
Hong-Curtis J, Yeh MM, Jain D, Lee JH. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis. J. Clin. Gastroenterol. 38: 906-909 (2004).
Honorati MC, Cattini L, Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 12: 683-691 (2004).
Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643 (2004). *
Hoofnagle JH. Drug-induced liver injury network (DILIN). Hepatology 40: 773 (2004). *
Hoofnagle JH. Hepatocellular carcinoma: summary and recommendations. Gastroenterology 127 (5 Suppl. 2): S319-S323 (2004). *
Hoofnagle JH. Action plan for liver disease research. Hepatology 40: 1240 (2004). *
Hoofnagle JH. Hepatobiliary pathophysiology study section. Hepatology 39:1476-1476 (2004). *
Hoogerwerf WA, Shenoy M, Winston JH, Xiao SY, He Z, Pasricha PJ. Trypsin mediates nociception via the proteinase-activated receptor 2: a potentially novel role in pancreatic pain. Gastroenterology 127: 883-891 (2004). *
Hooijberg JH, Jansen G, Assaraf YG, Kathmann I, Pieters R, Laan AC, Veerman AJ, Kaspers GJ, Peters GJ. Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem. Pharmacol. 67: 1541-1548 (2004). *
Hook CC, DiMagno EP, Tefferi A. Primer on medical genomics. Part XIII: Ethical and regulatory issues. Mayo Clin. Proc. 79: 645-650 (2004). *
Hookey LC, Depew WT, Vanner SJ. A prospective randomized trial comparing low-dose oral sodium phosphate plus stimulant laxatives with large volume polyethylene glycol solution for colon cleansing. Am. J. Gastroenterol. 99: 2217-2222 (2004). *
Hopfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherubl H. Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. J. Hepatol. 41: 1008-1016 (2004). *
Hopkins AM, Baird AW, Nusrat A. ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv. Drug Deliv. Rev. 56: 763-778 (2004). *
Hoppe H, Netzer P, Spreng A, Quattropani C, Mattich J, Dinkel HP. Prospective comparison of contrast enhanced CT colonography and conventional colonoscopy for detection of colorectal neoplasms in a single institutional study using second-look colonoscopy with discrepant results. Am. J. Gastroenterol. 99: 1924-1935 (2004). *
Hoppe L, Bressane R, Lago LS, Schiavo FL, Marroni CA, Keiserman DR, Brandao AB, Junior AM, Cassal AP, Zanotelli ML, Cantisani GP. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients. Transplant. Proc. 36: 961-963 (2004). *
Hoppenreijs EP, van Dijken PJ, Kabel PJ, Th Draaisma JM. Hereditary C1q deficiency and secondary Sjogren's syndrome. Ann. Rheum. Dis. 63: 1524-1525 (2004). *
Hopper AD, Atkinson R, Prtak L, Sanders DS. Research trends in British gastroenterology: publication rates in newly appointed NHS consultants over a nine year period. Gut 53: 913 (2004). *
Hoppin AG. Obesity and the liver: developmental perspectives. Semin. Liver Dis. 24: 381-387 (2004).
Hoppmann P, Koch W, Schomig A, Kastrati A. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur. Heart J. 25: 335-341 (2004). *
Horcada Rubio ML, Delgado Beltran C, Armas Ramirez C. Autoinflammatory disorders: a new concept in hereditary periodic fever syndromes. An. Med. Interna. 21: 143-147 (2004).
Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J. Investig. Dermatol. Symp. Proc. 9: 73-78 (2004). *
Horejs� V, Zhang W, Schraven B. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat. Rev. Immunol. 4: 603-616 (2004). *
Horikawa M, Kato Y, Tyson CA, Sugiyama Y. Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab. Pharmacokinet. 18: 16-22 (2004). *
Horita T, Merrill JT. Genetics of antiphospholipid syndrome. Curr. Rheumatol. Rep. 6: 458-462 (2004).
Horiuchi A, Nakayama Y, Kajiyama M, Fujii H, Tanaka N. Usefulness of a small-caliber, variable-stiffness colonoscope as a backup in patients with difficult or incomplete colonoscopy. Am. J. Gastroenterol. 99: 1936-1940 (2004). *
Horiuchi H, Hashikura Y, Hisa K, Saito N, Ikegami T, Nakazawa Y, Karakida O, Kobayashi S, Nawata M, Kawasaki S, Takaoka K. Osteonecrosis of the femoral head in Japanese adults after liver transplantation: a preliminary report. J. Orthop. Sci. 9: 119-121 (2004). *
Horiuchi T, Tsukamoto H, Mitoma H, Miyagawa H, Tamimoto Y, Yoshizawa S, Harada M, Hayashi K, Hashimura C, Oribe M, Okamura S. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int. J. Mol. Med. 14: 813-818 (2004).
Horn M, Collingro A, Schmitz-Esser S, Beier CL, Purkhold U, Fartmann B, Brandt P, Nyakatura GJ, Droege M, Frishman D, Rattei T, Mewes HW, Wagner M. Illuminating the evolutionary history of chlamydiae. Science 304: 728-730 (2004). *
Hornik L, Tenderich G, Wlost S, Zittermann A, Minami K, Koerfer R. Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients. Transplant. Proc. 36: 3133-3137 (2004).
Hornum L, Markholst H. New autoimmune genes and the pathogenesis of type 1 diabetes. Curr. Diab. Rep. 4: 135-142 (2004).
Horre R, Jovanic B, Herff S, Marklein G, Zhou H, Heinze I, De Hoog GS, Ruchel R, Schaal KP. Wound infection due to Absidia corymbifera and Candida albicans with fatal outcome. Med. Mycol. 42: 373-378 (2004).
Horrocks LA, Farooqui AA. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids 70: 361-372 (2004). *
Horslen S. Organ allocation for liver-intestine candidates. Liver Transpl. 10: S86-S89 (2004). *
Horsthuis K, Stoker J. MRI of perianal Crohn's disease. AJR Am. J. Roentgenol. 183: 1309-1315 (2004). *
Horswill AR, Savinov SN, Benkovic SJ. A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 101: 15591-15596 (2004). *
Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC, Wright MW, Wain HM, Trowsdale J, Ziegler A, Beck S. Gene map of the extended human MHC. Nat. Rev. Genet. 5: 889-899 (2004). *
Horvath A, Folhoffer A, Lakatos PL, Halosz J, Illyes G, Schaff Z, Hantos MB, Tekes K, Szalay F. Rising plasma nociceptin level during development of HCC: a case report. World J. Gastroenterol. 10: 152-154 (2004). *
Horvath G, David K. Iron storage disease. Orv. Hetil. 145: 1979-1984 (2004).
Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol. 26: 61-69 (2004).
Hoshida Y, Tomita Y, Zhiming D, Yamauchi A, Nakatsuka S, Kurasono Y, Arima Y, Tsudo M, Shintaku M, Aozasa K. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int. J. Cancer 108: 443-449 (2004). *
Hosoda H, Okawa-Takatsuji M, Tanaka A, Uwatoko S, Aotsuka S, Hasimoto N, Ozaki Y, Ikeda Y. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions. Clin. Chim. Acta 342: 71-81 (2004). *
Hosoe N, Miura S, Watanabe C, Tsuzuki Y, Hokari R, Oyama T, Fujiyama Y, Nagata H, Ishii H. Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa. Am. J. Physiol. Gastrointest Liver Physiol. 286: G458-G466 (2004). *
Hosoya K, Tomi M, Takayama M, Komokata Y, Nakai D, Tokui T, Nishimura K, Ueda M, Obinata M, Hori S, Ohtsuki S, Amidon GL, Terasaki T. Transporter mRNA expression in a conditionally immortalized rat small intestine epithelial cell line (TR-SIE). Drug Metab. Pharmacokinet. 19: 264-269 (2004). *
Hostutler RA, Luria BJ, Johnson SE, Weisbrode SE, Sherding RG, Jaeger JQ, Guilford WG. Antibiotic-responsive histiocytic ulcerative colitis in 9 dogs. J. Vet. Intern. Med. 18: 499-504 (2004).
Hou SK, Chern CH, How CK, Chen JD, Wang LM, Lee CH. Hepatic portal venous gas: clinical significance of computed tomography findings. Am. J. Emerg. Med. 22: 214-218 (2004).
Houman H, Hamzaoui A, Ben Ghorbal I, Khanfir M, Feki M, Hamzaoui K. Abnormal expression of chemokine receptors in Behcet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. J. Autoimmun. 23: 267-273 (2004).
Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH. Role of the CD40 locus in Graves' disease. Thyroid 14: 506-509 (2004).
Houten S, Auwerx J. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts. Ann. Med. 36: 482-491 (2004).
Hover AR, McDonnell SM, Burke W. Changing the clinical management of hereditary hemochromatosis: translating screening and early case detection strategies into clinical practice. Arch. Intern. Med. 164: 957-961 (2004). *
Howard JC, Reid G, Gan BS. Probiotics in surgical wound infections: current status. Clin. Invest. Med. 27: 274-281 (2004).
Howard LM, Miller SD. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity 37: 411-418 (2004).
Howdle PD, Holmes GK. Small bowel malignancy in coeliac disease. Gut 53: 470 (2004). *
Howe KL, Wang A, Hunter MM, Stanton BA, McKay DM. TGFbeta down-regulation of the CFTR: a means to limit epithelial chloride secretion. Exp. Cell Res. 298: 473-484 (2004). *
Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am. J. Gastroenterol. 99: 1572-1578 (2004). *
Howell SC, Eslick GD, Talley NJ. Cluster's last stand. Gut 53: 773-774 (2004). *
Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic trypsinogen mutations and pancreatitis. Gastroenterol. Clin. North Am. 33: 767-787 (2004).
Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC, Neoptolemos JP. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2: 252-261 (2004). *
Howroyd P, Swanson C, Dunn C, Cattley RC, Corton JC. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Toxicol. Pathol. 32: 591-599 (2004). *
Hoyas-Pablos E, Castro-Fernandez M, Rodriguez-Alonso C, Guerrero P, Escudero-Ordonez J. Ulcerative colitis and erythema multiforme. Gastroenterol. Hepatol. 27: 501-502 (2004).
Hozyasz K, Czerwinska B. Free and total carnitine levels in patients with celiac disease. Indian J. Gastroenterol. 23: 194 (2004). *
Hrbaty B, Skultety J, Labas P, Reis R, Ziak P. Conditions responsible for small bowel resection. Bratisl. Lek. Listy. 105: 86-88 (2004).
Hsieh JC, Dang HT, Galligan MA, Whitfield GK, Haussler CA, Jurutka PW, Haussler MR. Phosphorylation of human vitamin D receptor serine-182 by PKA suppresses 1,25(OH)(2)D(3)-dependent transactivation. Biochem. Biophys. Res. Commun. 324: 801-809 (2004). *
Hsu HC, Zhou T, Mountz JD. Nur77 family of nuclear hormone receptors. Curr. Drug Targets Inflamm. Allergy 3: 413-423 (2004).
Hsu JM, Wang PH, Liu BH, Ding ST. The effect of dietary docosahexaenoic acid on the expression of porcine lipid metabolism-related genes. J. Anim. Sci. 82: 683-689 (2004). *
Hsu YH, Hsieh MS, Liang YC, Li CY, Sheu MT, Chou DT, Chen TF, Chen CH. Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation. J. Cell. Biochem. 93: 929-939 (2004). *
Hu AB, Cai JY, Zheng QC, He XQ, Shan Y, Pan YL, Zeng GC, Hong A, Dai Y, Li LS. High-ratio differentiation of embryonic stem cells into hepatocytes in vitro. Liver Int. 24: 237-245 (2004). *
Hu DC, Cathro HP, Okusa MD. Polymorphoneutrophilic infiltration in acute interstitial nephritis of Sjogren syndrome. Am. J. Med. Sci. 327: 278-280 (2004).
Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am. J. Gastroenterol. 99: 860-865 (2004). *
Hu X, Plomp A, Gorgels T, Brink JT, Loves W, Mannens M, de Jong PT, Bergen AA. Efficient molecular diagnostic strategy for ABCC6 in pseudoxanthoma elasticum. Genet. Test. 8: 292-300 (2004).
Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W, Watanabe S, Terasawa K, Hamazaki T. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol. Psychiatry 56: 490-496 (2004). *
Huang CM, Hang LW, Chen CL, Wu JY, Tsai FJ. Polymorphisms of TAP1 transporter genes in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol. Int. 24: 130-132 (2004). *
Huang CM, Tsai CH, Chen CL, Chang CP, Lai CC, Tsai FJ. Epidermal growth factor receptor (EGFR) gene Bsr I polymorphism is associated with systemic lupus erythematosus. Lupus 13: 773-776 (2004).
Huang CM, Yang YH, Chiang BL. Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis. J. Microbiol. Immunol. Infect. 37: 88-94 (2004). *
Huang CS, O'Brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am. J. Gastroenterol. 99: 2242-2255 (2004). *
Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. Identification of a novel mutation (C321X) in HJV. Blood 104: 2176-2177 (2004). *
Huang JL, Gao PS, Mathias RA, Yao TC, Chen LC, Kuo ML, Hsu SC, Plunkett B, Togias A, Barnes KC, Stellato C, Beaty TH, Huang SK. Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum. Mol. Genet. 13: 2691-2697 (2004). *
Huang JL, Yeh CC, Shaw CK, Yao TC, Chen LC, Lee TD, Kuo ML. HLA-DRB1 genotyping in patients with juvenile idiopathic arthritis in Taiwan. Eur. J. Immunogenet. 31: 185-188 (2004).
Huang JS, Noack D, Rae J, Ellis BA, Newbury R, Pong AL, Lavine JE, Curnutte JT, Bastian J. Chronic granulomatous disease caused by a deficiency in p47 mimicking Crohn's disease. Clin. Gastroenterol. Hepatol. 2: 690-695 (2004). *
Huang JY, Liu H. Analysis on therapeutic effect of Western and Chinese drug in treating intrahepatic cholestasis pregnancy. Zhongguo Zhong Xi Yi Jie He Za Zhi 24: 309-311 (2004).
Huang P, Gilmore E, Kultgen P, Barnes P, Milgram S, Stutts MJ. Local regulation of cystic fibrosis transmembrane regulator and epithelial sodium channel in airway epithelium. Proc. Am. Thorac. Soc. 1: 33-37 (2004). *
Huang R, Schiano TD, Amolat MJ, Miller CM, Thung SN, Saxena R. Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl. 10: 1461-1467 (2004). *
Huang SH, Frydas S, Conti P, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Papadopoulou N, Donelan J, Madhappan B, Theoharides TC, De Lutiis MA, Riccioni G, Sabatino G. Interleukin-17: a revisited study. Int. J. Immunopathol. Pharmacol. 17: 1-4 (2004).
Huang SH, Frydas S, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Madhappan B, Papadopoulou N, Verna N, De Lutiis MA, Iezzi T, Riccioni G, Theoharides TC, Conti P. Interleukin-17 and the interleukin-17 family member network. Allergy Asthma Proc. 25: 17-21 (2004).
Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631 (2004). *
Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J. Clin. Invest. 113: 137-143 (2004). *
Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF, Li N. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J. Clin. Pathol. 57: 1273-1277 (2004). *
Huang Y, Li T, Sane DC, Li L. IRAK1 serves as a novel regulator essential for LPS-induced IL-10 gene expression. J. Biol. Chem. 279: 51697-51703 (2004). *
Huang YH, Chen CH, Chang TT, Chen SC, Wang SY, Lee PC, Lee HS, Lin PW, Huang GT, Sheu JC, Tsai HM, Chau GY, Chiang JH, Lui WY, Lee SD, Wu JC. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study. Liver Int. 24: 419-424 (2004). *
Hubacek JA, Berge KE, Stefkova J, Pitha J, Skodova Z, Lanska V, Poledne R. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol. Res. 53: 395-401 (2004). *
Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114: 569-581 (2004). *
Hubert D, Fajac I, Bienvenu T, Desmazes-Dufeu N, Ellaffi M, Dall'ava-Santucci J, Dusser D. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis. J. Cyst. Fibros. 3: 15-22 (2004).
Hubscher SG. Role of liver biopsy in the assessment of non-alcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 16: 1107-1115 (2004).
Hudson LL, Silver RM, Pandey JP. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J. Rheumatol. 31: 85-87 (2004).
Hudson VM. New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat. Respir. Med. 3: 353-363 (2004).
Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377 (2004). *
Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Br�uer R, Buer J, Scheffold A, Hamann A. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199: 303-313 (2004). *
Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martinez C, Blazquez M, Guisasola LM, Salvador C, Lahoz CH, Pena J. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease. Neurosci. Lett. 370: 151-154 (2004).
Huet E, Morand K, Blanchet B, Astier A, Hulin A. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients. Transplant. Proc. 36: 1317-1320 (2004). *
Huffman DM, Altena TS, Mawhinney TP, Thomas TR. Effect of n-3 fatty acids on free tryptophan and exercise fatigue. Eur. J. Appl. Physiol. 92: 584-591 (2004). *
Hug BA, Ahmed N, Robbins JA, Lazar MA. A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target gene. J. Biol. Chem. 279: 825-830 (2004). *
Huggett J, Dheda K, Zumla A, Rook G. Crohn's disease and MAP. Lancet 364: 2178 (2004). *
Huggins ML, Radford PM, McIntosh RS, Bainbridge SE, Dickinson P, Draper-Morgan KA, Tighe PJ, Powell RJ, Todd I. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum. 50: 2651-2659 (2004). *
Hughes AR, Mosteller M, Bansal AT, Davies K, Haneline SA, Lai EH, Nangle K, Scott T, Spreen WR, Warren LL, Roses AD; CNA30027 Study Team; CNA30032 Study Team. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5: 203-211 (2004).
Hughes BW, De Casillas ML, Kaminski HJ. Pathophysiology of myasthenia gravis. Semin. Neurol. 24: 21-30 (2004).
Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M. Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics 14: 335-342 (2004).
Hughes LB, Criswell LA, Beasley TM, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL. Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes Immun. 5: 641-647 (2004). *
Hugnet C, Bentjen SA, Mealey KL. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of collies from France. J. Vet. Pharmacol. Ther. 27: 227-229 (2004). *
Hugot JP. Genetic origin of IBD. Inflamm. Bowel Dis. 10 Suppl. 1: S11-S15 (2004). *
Hugot JP. Inflammatory bowel disease: a complex group of genetic disorders. Best Pract. Res. Clin. Gastroenterol. 18: 451-462 (2004).
Hugot JP. Inflammatory bowel disease: causes and consequences. Best Pract. Res. Clin. Gastroenterol. 18: 447-449 (2004).
Huguet S, Labas V, Duclos-Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E. Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics 4: 1341-1345 (2004). *
Huijsdens XW, Linskens RK, Koppes J, Tang YL, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol. Med. Microbiol. 41: 79-84 (2004). *
Huilgol RL, Wright CM, Solomon MJ. Laparoscopic versus open ileocolic resection for Crohn's disease. J. Laparoendosc. Adv. Surg. Tech. A. 14: 61-65 (2004).
Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, Pollanen P, Lehtimaki T. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) 43: 1476-1479 (2004). *
Hull J, Rowlands K, Lockhart E, Sharland M, Moore C, Hanchard N, Kwiatkowski DP. Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum. Genet. 114: 272-279 (2004). *
Hulsewe KW, van Acker BA, Hameeteman W, van der Hulst RR, Vainas T, Arends JW, van Kreel BK, von Meyenfeldt MF, Soeters PB. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability? Clin. Nutr. 23: 1217-1225 (2004).
Hulsewe KW, van der Hulst RW, van Acker BA, von Meyenfeldt MF, Soeters PB. Inflammation rather than nutritional depletion determines glutamine concentrations and intestinal permeability. Clin. Nutr. 23: 1209-1216 (2004).
Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, Uchanska-Ziegler B. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 199: 271-281 (2004). *
Hultgren OH, Ohman L, Hornquist EH. Decreased leptin production in mice after onset of ulcerative colitis-like disease. Scand. J. Gastroenterol. 39: 1166-1167 (2004). *
Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. U.S.A. 101: 12646-12651 (2004). *
Hulzebos CV, Bijleveld CM, Stellaard F, Kuipers F, Fidler V, Slooff MJ, Peeters PM, Sauer PJ, Verkade HJ. Cyclosporine A-induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transpl. 10: 872-880 (2004). *
Humar A. Maximizing the donor pool: marginal donors, splits, and living donor liver transplants. J. Gastroenterol. Hepatol. 19: S410-S413 (2004). *
Humar A. Living donor liver transplants: potential disadvantages. J. Gastroenterol. Hepatol. 19: S304-S306 (2004). *
Humar A, Khwaja K, Glessing B, Larson E, Asolati M, Durand B, Lake J, Payne WD. Regionwide sharing for status 1 liver patients - beneficial impact on waiting time and pre- and posttransplant survival. Liver Transpl. 10: 661-665 (2004). *
Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, et al. DNA sequence and analysis of human chromosome 9. Nature 429: 369-374 (2004). *
Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, Colditz GA, Rosner B, Spiegelman D, Willett WC. Fruit and vegetable intake and risk of major chronic disease. J. Natl. Cancer Inst. 96: 1577-1584 (2004). *
Hunt JR, Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am. J. Clin. Nutr. 80: 924-931 (2004). *
Hunt M, O'Byrne J, Solaas K, Frode Kase B, Alexson SEH. New insights into bile acid amidation. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 24. June 18-19 (2004). *
Hunter MM, McKay DM. Helminths as therapeutic agents for inflammatory bowel disease. Aliment. Pharmacol. Ther. 19: 167-177 (2004). *
Hunter PR, Hughes S, Woodhouse S, Raj N, Syed Q, Chalmers RM, Verlander NQ, Goodacre J. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin. Infect. Dis. 39: 504-510 (2004). *
Hunter RJ, Patel VB, Baker AJ, Preedy VR. Liver dysfunction induced by bile duct ligation and galactosamine injection alters cardiac protein synthesis. Metabolism 53: 964-968 (2004). *
Huo TI, Lee SD. Management of inoperable hepatocellular carcinoma. J. Gastroenterol. Hepatol. 19: S272-S278 (2004). *
Huo TI, Wu JC, Lee PC, Chang FY, Lee SD. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study. Liver Int. 24: 210-215 (2004). *
Huo TI, Wu JC, Lee SD. Contrast medium-associated renal dysfunction in patients with cirrhosis. Hepatology 40: 1474 (2004). *
Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transpl. 10: 1507-1513 (2004). *
Huo TI, Wu JC, Lui WY, Huang YH, Lee PC, Chiang JH, Chang FY, Lee SD. Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am. J. Gastroenterol. 99: 1479-1487 (2004). *
Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ; European EOB Study Group. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230: 266-275 (2004). *
Hur C, Gazelle GS, Zalis ME, Podolsky DK. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology 127: 1312-1321 (2004). *
Hurley BP, McCormick BA. Intestinal epithelial defense systems protect against bacterial threats. Curr. Gastroenterol. Rep. 6: 355-361 (2004).
Hurlimann D, Enseleit F, Ruschitzka F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz. 29: 760-768 (2004).
Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, Lobo AJ. Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis. Gut 53: 284-290 (2004). *
Hurlstone DP, Cross SS, Slater R, Sanders DS, Brown S. Detecting diminutive colorectal lesions at colonoscopy: a randomised controlled trial of pan-colonic versus targeted chromoscopy. Gut 53: 376-380 (2004). *
Hurlstone DP, Sanders DS, Cross SS, Adam I, Shorthouse AJ, Brown S, Drew K, Lobo AJ. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut 53: 1334-1339 (2004). *
Hurlstone DP, Shorthouse AJ, Cross SS, Brown S, Sanders DS, Lobo AJ. High-magnification chromoscopic pouchoscopy: a novel in vivo technique for surveillance of the anal transition zone and columnar cuff following ileal pouch-anal anastomosis. Tech. Coloproctol. 8: 173-178 (2004).
Hurst CH, Waxman DJ. Environmental phthalate monoesters activate pregnane X receptor-mediated transcription. Toxicol. Appl. Pharmacol. 199: 266-274 (2004). *
Hurst RD, Michelassi F. Ileal-pouch anal restorative proctocolectomy for ulcerative colitis. Adv. Surg. 38: 311-336 (2004).
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350: 2335-2342 (2004). *
Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr. Transplant. 8: 267-272 (2004).
Hurwitz M, Garcia MG, Poole RL, Kerner JA. Copper deficiency during parenteral nutrition: a report of four pediatric cases. Nutr. Clin. Pract. 19: 305-308 (2004).
Husain A, Triadafilopoulos G. Communicating with patients with inflammatory bowel disease. Inflamm. Bowel Dis. 10: 444-450 (2004). *
Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ. Res. 95: 568-578 (2004). *
Huss JM, Torra IP, Staels B, Giguere V, Kelly DP. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell Biol. 24: 9079-9091 (2004). *
Hussain I, Kline JN. DNA, the immune system, and atopic disease. J. Investig. Dermatol. Symp. Proc. 9: 23-28 (2004). *
Hussain S. Role of surfactant protein A in the innate host defense and autoimmunity. Autoimmunity 37: 125-130 (2004).
Hustad S, Nedrebo BG, Ueland PM, Schneede J, Vollset SE, Ulvik A, Lien EA. Phenotypic expression of the methylenetetrahydrofolate reductase 677C-->T polymorphism and flavin cofactor availability in thyroid dysfunction. Am. J. Clin. Nutr. 80: 1050-1057 (2004). *
Huszti Z, Bene L, Kovacs A, Fekete B, Fust G, Romics L, Singh M, Prohaszka Z. Low levels of antibodies against E. coli and mycobacterial 65kDa heat shock proteins in patients with inflammatory bowel disease. Inflamm. Res. 53: 551-555 (2004). *
Hutchins GF, Gollan JL. Recent developments in the pathophysiology of cholestasis. Clin. Liver Dis. 8: 1-26 (2004).
Hutton JJ, Jegga AG, Kong S, Gupta A, Ebert C, Williams S, Katz JD, Aronow BJ. Microarray and comparative genomics-based identification of genes and gene regulatory regions of the mouse immune system. BMC Genomics 5: 82 (2004). *
Hutyrova B, Lukac J, Bosak V, Buc M, du Bois R, Petrek M. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. J. Rheumatol. 31: 81-84 (2004).
Huuskonen J, Vishnu M, Pullinger CR, Fielding PE, Fielding CJ. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 43: 1626-1632 (2004). *
Huxley P, Sutton DH, Debnam P, Matthews IR, Brewer JE, Rose J, Trickett M, Williams DD, Andersen TB, Classon BJ. High-affinity small molecule inhibitors of T cell costimulation: compounds for immunotherapy. Chem. Biol. 11: 1651-1658 (2004). *
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Childhood vaccination and type 1 diabetes. N. Engl. J. Med. 350: 1398-1404 (2004). *
Hwang KW, Sweatt WB, Mashayekhi M, Palucki DA, Sattar H, Chuang E, Alegre ML. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J. Immunol. 173: 5415-5424 (2004). *
Hwang MT, Goldfarb DS. Uric acid stones following hepatic transplantation. Urol. Res. 32: 423-426 (2004).
Hwang S, Lee SG, Ha TY, Ahn CS, Park KM, Kim KH, Lee YJ, Moon DB, Kim KK, Kim YD. Simplified standardized technique for living donor liver transplantation using left liver graft plus caudate lobe. Liver Transpl. 10: 1398-1405 (2004). *
Hwang S, Lee SG, Lee YJ, Park KM, Kim KH, Ahn CS, Sung KB, Moon DB, Ha TY, Kim KK, Kim YD. Donor selection for procurement of right posterior segment graft in living donor liver transplantation. Liver Transpl. 10: 1150-1155 (2004). *
Hwang SR, Lim SJ, Park JS, Kim CK. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm. 276: 175-183 (2004). *
Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, Kim HY. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 6: R120-R128 (2004). *
Hydzik P, Drozdz M, Sulowicz W, Groszek B. Liver albumin dialysis - application in acetaminophen poisoning. Przegl. Lek. 61: 377-382 (2004).
Hylemon PB, Gupta S, Dent P. Regulation of bile acid biosynthesis by cell signaling pathways. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 29. June 18-19 (2004). *
Hynes SO, Ferris JA, Szponar B, Wadstrom T, Fox JG, O'Rourke J, Larsson L, Yaquian E, Ljungh A, Clyne M, Andersen LP, Moran AP. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic Helicobacters. Helicobacter 9: 313-323 (2004). *
Hyrich KL, Silman AJ, Watson KD, Symmons DP. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety. Ann. Rheum. Dis. 63: 1538-1543 (2004). *
Hytiroglou P. Morphological changes of early human hepatocarcinogenesis. Semin. Liver Dis. 24: 65-75 (2004).
Iannaccone R, Laghi A, Catalano C, Mangiapane F, Lamazza A, Schillaci A, Sinibaldi G, Murakami T, Sammartino P, Hori M, Piacentini F, Nofroni I, Stipa V, Passariello R. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology 127: 1300-1311 (2004). *
Iannaccone R, Laghi A, Catalano C, Mangiapane F, Marin D, Passariello R. Computed tomography colonography: colon examination or Pandora's box. Gut 53: 915 (2004). *
Ibarrola C, Castellano VM, Colina F. Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules. Histopathology 44: 172-179 (2004). *
Ichai P, Samuel D. Treatment of patients with hepatic failure: the difficult place of liver support systems. J. Hepatol. 41: 694-695 (2004). *
Ichiche M, Lacor P, Hoorens A, Vanden Brande J, Brussaard H, Vanstraelen D. Congenital spherocytosis with hereditary hemochromatosis without pathogenic mutations in the HFE gene. Eur. J. Intern. Med. 15: 460-462 (2004).
Ichikawa M, Asai T, Chiba S, Kurokawa M, Ogawa S. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle 3: 722-724 (2004). *
Ichiki Y, Leung PS, Ishibashi H, Coppel RL, Ansari AA, Gershwin ME. Mitochondria and autoimmunity in primary biliary cirrhosis. Mitochondrion 4: 743-753 (2004).
Ichiki Y, Shimoda S, Ishibashi H, Gershwin ME. Is primary biliary cirrhosis a model autoimmune disease? Autoimmun. Rev. 3: 331-336 (2004).
Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell. Mol. Biol. 30: 761-770 (2004). *
Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, Huang M, Tamai M, Origuchi T, Kawakami A, Migita K, Motomura M, Yoshimura T, Eguchi K. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology (Oxford) 43: 1292-1299 (2004). *
Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, Takahashi R, Kuwahara H, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 22: 73-78 (2004).
Ide T, Tsunoda M, Mochizuki T, Murakami K. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) a in obese mice. Med. Sci. Monit. 10: BR388-BR395 (2004). *
Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi S, Otsubo K, Sugiyama Y. Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol. Res. 30: 91-95 (2004).
Ieiri I, Takane H, Otsubo K. The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clin. Pharmacokinet. 43: 553-576 (2004).
Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL, Assaraf YG. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: a role for BCRP in cellular folate homeostasis. J. Biol. Chem. 279: 25527-25534 (2004). *
Iftikhar R, Kladney RD, Havlioglu N, Schmitt-Graff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ. Disease- and cell-specific expression of GP73 in human liver disease. Am. J. Gastroenterol. 99: 1087-1095 (2004). *
Iida A, Nakamura Y. Identification of 45 novel SNPs in the 83-kb region containing peptidylarginine deiminase types 1 and 3 loci on chromosomal band 1p36.13. J. Hum. Genet. 49: 387-390 (2004). *
Iijima H, Neurath MF, Nagaishi T, Glickman JN, Nieuwenhuis EE, Nakajima A, Chen D, Fuss IJ, Utku N, Lewicki DN, Becker C, Gallagher TM, Holmes KV, Blumberg RS. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J. Exp. Med. 199: 471-482 (2004). *
Iino S, Tomita E, Kumada H, Suzuki H, Toyota J, Kiyosawa K, Tanikawa K, Sata M, Hayashi N, Kakumu S, Matsushima T, Ohno T. Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy. Hepatol. Res. 30: 63-70 (2004).
Iinuma Y, Senda K, Fujihara N, Saito T, Takakura S, Kudo T, Kiuchi T, Tanaka K, Ichiyama S. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 78: 704-709 (2004).
IJpenberg A, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J, Metzger D, Canaple L, Chambon P, Wahli W, Desvergne B. In vivo activation of PPAR target genes by RXR homodimers. EMBO J. 23: 2083-2091 (2004). *
Ikai I, Itai Y, Okita K, Omata M, Kojiro M, Kobayashi K, Nakanuma Y, Futagawa S, Makuuchi M, Yamaoka Y. Report of the 15th follow-up survey of primary liver cancer. Hepatol. Res. 28: 21-29 (2004).
Ikeda H, Nishi S, Sakai M. Transcription factor Nrf2/MafK regulates rat glutathione S-transferase P gene during hepatocarcinogenesis. Biochem. J. 380: 515-521 (2004). *
Ikeda Y, Yoshida W, Noguchi T, Asaba K, Nishioka T, Takao T, Hashimoto K. Lack of association between IL-12B gene polymorphism and autoimmune thyroid disease in Japanese patients. Endocr. J. 51: 609-613 (2004). *
Ikeuchi H, Nakano H, Uchino M, Nakamura M, Yanagi H, Noda M, Yamamura T. Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. Dig. Surg. 21: 197-201 (2004).
Ikeuchi H, Yamamura T, Nakano H, Kosaka T, Shimoyama T, Fukuda Y. Efficacy of nutritional therapy for perforating and non-perforating Crohn's disease. Hepatogastroenterology 51: 1050-1052 (2004).
Ikewaki K, Cain W, Fairwell T, Schambureck R, Zech LA, Usher D, Brewer HB Jr, Rader DJ. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency. J. Lipid Res. 45: 1302-1311 (2004). *
Ilan Y. Oral immune regulation toward disease-associated antigens: results of phase I clinical trials in Crohn's disease and chronic hepatitis. Ann. N. Y. Acad. Sci. 1029: 286-298 (2004). *
Ile KE, Davis W, Boyd JT, Soulika AM, Tew KD. Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus. Biochim. Biophys. Acta 1678: 22-32 (2004). *
Ilkgul O, Icoz G, Dayangac M, Tokat Y, Ozutemiz O. A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal hemorrhage. Turk. J. Gastroenterol. 15: 115-116 (2004). *
Im E, Martinez JD. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic ccid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J. Nutr. 134: 483-486 (2004). *
Imahara SD, O'Keefe GE. Genetic determinants of the inflammatory response. Curr. Opin. Crit. Care 10: 318-324 (2004).
Imanishi Y, Maeda N, Otogawa K, Seki S, Matsui H, Kawada N, Arakawa T. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J. Hepatol. 41: 242-250 (2004). *
Imaoka T, Kusuhara H, Adachi-Akahane S, Hasegawa M, Morita N, Endou H, Sugiyama Y. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J. Am. Soc. Nephrol. 15: 2012-2022 (2004). *
Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4: 432-444 (2004). *
Imler JL, Ferrandon D, Royet J, Reichhart JM, Hetru C, Hoffmann JA. Toll-dependent and Toll-independent immune responses in Drosophila. J. Endotoxin Res. 10: 241-246 (2004). *
Imose M, Nagaki M, Kimura K, Takai S, Imao M, Naiki T, Osawa Y, Asano T, Hayashi H, Moriwaki H. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Hepatology 40: 1160-1169 (2004). *
Imperato AK, Smiles S, Abramson SB. Long-term risks associated with biologic response modifiers used in rheumatic diseases. Curr. Opin. Rheumatol. 16: 199-205 (2004).
Inagaki T, Kliewer S. Bile acid receptor, FXR, regulates host defense in intestine. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 59. June 18-19 (2004). *
Inagaki-Ohara K, Chinen T, Matsuzaki G, Sasaki A, Sakamoto Y, Hiromatsu K, Nakamura-Uchiyama F, Nawa Y, Yoshimura A. Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J. Immunol. 173: 1390-1398 (2004). *
Inano A, Sai Y, Kato Y, Tamai I, Ishiguro M, Tsuji A. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition. Drug Metab. Pharmacokinet. 19: 180-189 (2004). *
Inao M, Mochida S, Matsui A, Eguchi Y, Yulutuz Y, Wang Y, Naiki K, Kakinuma T, Fujimori K, Nagoshi S, Fujiwara K. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. J. Hepatol. 41: 584-591 (2004). *
Inarrairaegui Bastarrica M, Arin Letamendia A, Zozaya Urmeneta JM, Rodriguez Gutierrez C, Castan Martinez B, Amat Villegas I, Beloqui Perez R. Inflammatory bowel disease and amyloidosis. Gastroenterol. Hepatol. 27: 260-263 (2004).
Inatsuchi S, Nakajima T, Yoshio Y, Entani A, Okada K. A case of the ulcerative colitis that showed a similar side effect in acute aggravation of colitis by mesalazine. Nippon Shokakibyo Gakkai Zasshi 101: 989-992 (2004).
Ingram JR, Routledge P, Rhodes J, Marshall RW, Buss DC, Evans BK, Feyerabend C, Thomas GA. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. Aliment. Pharmacol. Ther. 20: 859-865 (2004). *
Innocencio RM, Romaldini JH, Ward LS. Thyroid autoantibodies in autoimmune diseases. Medicina (B. Aires) 64: 227-230 (2004).
Innocenti F, Hepp J, Humeres R, Rios H, Suarez L, Zapata R, Sanhueza E, Rius M. Transcystic cholangiogram access via rubber band with early withdrawal after liver transplantation: a safe technique. Transplant Proc. 36: 1681-1682 (2004). *
Innocenti F, Hepp J, Humeres R, Sanhueza E, Zapata R, Rios H, Suarez L, Sandoval R, Rius M, Zamboni M. Rapid steroid taper and neoral monotherapy in liver transplantation in Chile: a step in the right direction? Transplant Proc. 36: 1675-1676 (2004). *
Innocenti F, Hepp J, Zapata R, Sanhueza E, Humeres R, Rios H, Suarez L, Palacios JM, Quiroga M, Rodriguez G, Abarca J, Montalvan C, Zaror M, Valderrama R, Niedmann JP, Rius M. A decade of adult liver transplantation in a single center in Chile. Transplant Proc. 36: 1673-1674 (2004). *
Inobe M, Schwartz RH. CTLA-4 engagement acts as a brake on CD4+ T cell proliferation and cytokine production but is not required for tuning T cell reactivity in adaptive tolerance. J. Immunol. 173: 7239-7248 (2004). *
Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 10: 168-174 (2004). *
Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J. Biol. Chem. 279: 44740-44748 (2004). *
Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation. J. Biol. Chem. 279: 2480-2489 (2004). *
Inuzuka T. Limbic encephalitis: etiology, pathogenesis, diagnosis and therapy. Rinsho Shinkeigaku 44: 799-801 (2004).
Invernizzi P, Alvaro D, Crosignani A, Gaudio E, Podda M. Tamoxifen in treatment of primary biliary cirrhosis. Hepatology 39: 1175-1176 (2004). *
Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, Selmi C, Watnik M, Gershwin ME, Podda M. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363: 533-535 (2004). *
Invernizzi P, Wesierska-Gadek J, Battezzati PM, Oertelt S, Busatto PL, Benetti A, Penner E, Hitchman E, Podda M. Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCs) in early primary biliary cirrhosis (PBC). J. Hepatol. 40 Suppl. 1: 159-160 (2004).
Ioachim EE, Katsanos KH, Michael MC, Tsianos EV, Agnantis NJ. Immunohistochemical expression of Cyclin D1, Cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int. J. Colorectal Dis. 19: 325-333 (2004). *
Ioannidis JP, Ntzani EE, Trikalinos TA. 'Racial' differences in genetic effects for complex diseases. Nat. Genet. 36: 1312-1318 (2004). *
Ioannou GN, Kowdley KV. Hepcidin in HFE-associated hemochromatosis: another piece of the "iron" puzzle. Gastroenterology 126: 615-616 (2004). *
Iolascon A, Volinia S, Borriello A, Giordani L, Moretti A, Servedio V, Maiorano N, Cucciolla V, Criniti V, Gasparini P, Indaco S, Della Ragione F. Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity. Haematologica 89: 1046-1053 (2004). *
Iorio R, D'Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, Giacchino R, Vajro P, Marazzi MG, Francavilla R, Michielutti F, Resti M, Frediani T, Pastore M, Mazzarella G, Fusco G, Cirillo F, Vegnente A. Serum transaminases in children with Wilson's disease. J. Pediatr. Gastroenterol. Nutr. 39: 331-336 (2004). *
Iorio R, D'Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, Giacchino R, Vajro P, Marazzi MG, Francavilla R, Michielutti F, Resti M, Frediani T, Pastore M, Vegnente A. Persistence of elevated aminotransferases in Wilson's disease despite adequate therapy. Hepatology 39: 1173-1174 (2004). *
Iorio R, Sepe A, Giannattasio A, Spagnuolo MI, Vecchione R, Vegnente A. Lack of benefit of gluten-free diet on autoimmune hepatitis in a boy with celiac disease. J. Pediatr. Gastroenterol. Nutr. 39: 207-210 (2004). *
Ip E, Farrell G, Hall P, Robertson G, Leclercq I. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39: 1286-1296 (2004). *
Iredale JP. A cut above the rest? MMP-8 and liver fibrosis gene therapy. Gastroenterology 126: 1199-1201 (2004). *
Irie T, Maeda Y, Aida T, Sumitani K, Nagumo M, Tachikawa T. Multiple granulomatous inflammation in the minor salivary glands: a proposed new entity, allergic granulomatous sialadenitis. Pathol. Int. 54: 850-853 (2004). *
Irvine EJ. Patients' fears and unmet needs in inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 54-59 (2004). *
Irving PM, Macey MG, Shah U, Webb L, Langmead L, Rampton DS. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm. Bowel Dis. 10: 361-372 (2004).
Irving PM, Rampton DS. Leucocytapheresis for ulcerative colitis. Dig. Liver Dis. 36: 799-802 (2004).
Isaacs KL, Sartor RB. Treatment of inflammatory bowel disease with antibiotics. Gastroenterol. Clin. North Am. 33: 335-345 (2004).
Isaia GC, Casalis S, Grosso I, Molinatti PA, Tamone C, Sategna-Guidetti C. Hypoparathyroidism and co-existing celiac disease. J. Endocrinol. Invest. 27: 778-781 (2004).
Isam H, Al-Wahadneh A. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. Saudi J. Kidney Dis. Transpl. 15: 489-493 (2004). *
Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, Nakai Y, Yamamoto N, Tada M, Yoshida H, Shiratori Y, Kawabe T, Omata M. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 53: 729-734 (2004). *
Isenberg DA. Systemic lupus erythematosus and Sjogren's syndrome: historical perspective and ongoing concerns. Arthritis Rheum. 50: 681-683 (2004). *
Isermann B, Bierhaus A, Humpert PM, Rudofsky G, Chavakis T, Ritzel R, Wendt T, Morcos M, Kasperk C, Hamann A, Nawroth PP. AGE-RAGE: a hypothesis or a mechanism? Herz. 29: 504-509 (2004).
Ishaq S. Treatment of achalasia: the role of laparoscopic cardiomyotomy needs to be emphasized. Am. J. Gastroenterol. 99: 2278-2279 (2004). *
Ishida N, Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch. 447: 768-775 (2004). *
Ishiguro Y, Sakuraba H, Yamagata K, Munakata A. The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat. Ann. N. Y. Acad. Sci. 1029: 346-347 (2004). *
Ishiguro Y, Yamagata K, Sakuraba H, Munakata A, Nakane A, Morita T, Nishihira J. Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis. Ann. N. Y. Acad. Sci. 1029: 348-349 (2004). *
Ishii H. Foreword. Hepatol. Res. 30S: 1 (2004).
Ishii H. Common pathogenic mechanisms in ASH and NASH. Hepatol. Res. 28: 18-20 (2004).
Ishikawa H, Nakao K, Matsumoto K, Nishimura D, Ichikawa T, Hamasaki K, Eguchi K. Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma. Gut 53: 884-889 (2004). *
Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Miki H. Hepatic resection leads to predominance of the T helper-2 lymphocyte phenotype. Hepatol. Res. 30: 96-103 (2004).
Ishikawa T, Hirano H, Onishi Y, Sakurai A, Tarui S. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. Drug Metab. Pharmacokinet. 19: 1-14 (2004). *
Ishikawa T, Onishi Y, Hirano H, Oosumi K, Nagakura M, Tarui S. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1). Biol. Pharm. Bull. 27: 939-948 (2004). *
Ishikawa T, Tsuji A, Inui K, Sai Y, Anzai N, Wada M, Endou H, Sumino Y. The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 5: 67-99 (2004).
Ishimoto H, Isomoto H, Shikuwa S, Wen CY, Suematu T, Ito M, Murata I, Ishibashi H, Kohno S. Endoscopic identification of Peyer's patches of the terminal ileum in a patient with Crohn's disease. World J. Gastroenterol. 10: 2767-2768 (2004). *
Ishimura N, Bronk SF, Gores GJ. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G88-G95 (2004). *
Ishizakai M, Yoshida K, Nishimoto N, Saleh AM, Ishii C, Handa H, Ogawara H, Nagamine T, Murakami M, Murakami H. Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases. Rinsho Byori 52: 732-736 (2004).
Islam S, Dasika N, Hirschl RB, Coran AG. A novel approach to the management of late-onset liver failure in biliary atresia. J. Pediatr. Surg. 39: 371-374 (2004).
Isolauri E, Rautava S, Kalliomaki M. Food allergy in irritable bowel syndrome: new facts and old fallacies. Gut 53: 1391-1393 (2004). *
Isomoto H, Mukae H, Ishimoto H, Date Y, Nishi Y, Inoue K, Wada A, Hirayama T, Nakazato M, Kohno S. Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am. J. Gastroenterol. 99: 1916-1923 (2004). *
Isordia-Salas I, Pixley RA, Sainz IM, Martinez-Murillo C, Colman RW. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch. Med. Res. 35: 369-377 (2004).
Israelian-Konaraki Z, Reaven PD. Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiology 103: 1-9 (2004).
Itagaki S, Shimamoto S, Hirano T, Iseki K, Sugawara M, Nishimura S, Fujimoto M, Kobayashi M, Miyazaki K. Comparison of urinary excretion of phenolsulfonphthalein in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Wistar rats: involvement of primary active organic anion transporter. J. Pharm. Pharm. Sci. 7: 227-234 (2004). *
Itagaki S, Sugawara M, Kobayashi M, Miyazaki K, Hirano T, Iseki K. Comparison of the disposition behavior of organic anions in an animal model for Wilson's disease (Long-Evans Cinnamon rats) with that in normal Long-Evans Agouti rats. Drug Metab. Pharmacokinet. 19: 150-154 (2004). *
Itagaki S, Sugawara M, Kobayashi M, Miyazaki K, Iseki K. Mechanism of active secretion of phenolsulfonphthalein in the liver via Mrp2 (abcc2), an organic anion transporter. Drug Metab. Pharmacokinet. 18: 238-244 (2004). *
Itakura J, Izumi N, Nishimura Y, Inoue K, Ueda K, Nakanishi H, Tsuchiya K, Hamano K, Asahina Y, Kurosaki M, Uchihara M, Miyake S. Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis. Hepatol. Res. 29: 216-222 (2004).
Ito H. Novel therapy for Crohn's disease targeting IL-6 signalling. Expert Opin. Ther. Targets 8: 287-294 (2004).
Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126: 989-996 (2004). *
Ito I, Mitsuoka N, Sobajima J, Uesugi H, Ozaki S, Ohya K, Yoshida M. Conformational difference in HMGB1 proteins of human neutrophils and lymphocytes revealed by epitope mapping of a monoclonal antibody. J. Biochem. 136: 155-162 (2004). *
Ito K, Koresawa T, Nakano K, Horie T. Mrp2 is involved in benzylpenicillin-induced choleresis. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G42-G49 (2004). *
Ito M, Ogawa K, Takeuchi K, Nakada A, Heishi M, Suto H, Mitsuishi K, Sugita Y, Ogawa H, Ra C. Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J. Dermatol. Sci. 36: 157-164 (2004).
Ito S, Oyake T, Uchiyama T, Sugawara T, Murai K, Ishida Y. Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia. Int. J. Hematol. 80: 250-253 (2004).
Ito Y. Oncogenic potential of the RUNX gene family: 'overview'. Oncogene 23: 4198-4208 (2004). *
Itoda M, Saito Y, Maekawa K, Hichiya H, Komamura K, Kamakura S, Kitakaze M, Tomoike H, Ueno K, Ozawa S, Sawada J. Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1). Drug Metab. Pharmacokinet. 19: 308-312 (2004). *
Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T, Miyazawa K, Yamada G, Kitamura N, Koono M, Kataoka H. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127: 1423-1435 (2004). *
Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126: 1634-1648 (2004). *
Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G7-G17 (2004). *
Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 23: 8432-8438 (2004). *
Ivanov AI, Nusrat A, Parkos CA. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found. Symp. 263: 115-124 (2004).
Iwadate H, Ohira H, Suzuki T, Abe K, Yokokawa J, Takiguchi J, Rai T, Orikasa H, Irisawa A, Obara K, Kasukawa R, Sato Y. Hepatocellular carcinoma associated with Wilson's disease. Intern. Med. 43: 1042-1045 (2004). *
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995 (2004). *
Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin. Med. Res. 2: 243-252 (2004). *
Iwasaki Y, Asai M, Yoshida M, Nigawara T, Kambayashi M, Nakashima N. Dehydroepiandrosterone-sulfate inhibits nuclear factor-kappaB-dependent transcription in hepatocytes, possibly through antioxidant effect. J. Clin. Endocrinol. Metab. 89: 3449-3454 (2004). *
Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538 (2004). *
Izad M, Vodjgani M, Nicknam MH, Lotfi J, Fathi D, Amirzargar AA. Interferon-gamma gene polymorphism in Iranian patients with multiple sclerosis. Iran. J. Allergy Asthma Immunol. 3: 115-119 (2004).
Izakovicova Holla L, Jurajda M, Fassmann A, Dvorakova N, Znojil V, Vacha J. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population. J. Clin. Periodontol. 31: 685-690 (2004).
Izraeli S. Leukaemia - a developmental perspective. Br. J. Haematol. 126: 3-10 (2004). *
Izzo L, Caputo M, Galati G. Intrahepatic accessory spleen: imaging features. Liver Int. 24: 216-217 (2004). *
Jaakkola E, Crane AM, Laiho K, Herzberg I, Sims AM, Bradbury L, Calin A, Brophy S, Kauppi M, Kaarela K, Wordsworth BP, Tuomilehto J, Brown MA. The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) 43: 32-38 (2004). *
Jabbour N, Gagandeep S, Mateo R, Sher L, Henderson R, Selby R, Genyk Y. Live donor liver transplantation: staging hepatectomy in a Jehovah's Witness recipient. J. Hepatobiliary Pancreat. Surg. 11: 211-214 (2004). *
Jabs DA, Gerard HC, Wei Y, Campbell AL, Hudson AP, Akpek EK, Lee B, Prendergast RA, Whittum-Hudson JA. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Invest. Ophthalmol. Vis. Sci. 45: 2293-2298 (2004). *
Jacka EN, Pasco JA, Henry MJ, Kotowicz MA, Nicholson GC, Berk M. Dietary omega-3 fatty acids and depression in a community sample. Nutr. Neurosci. 7: 101-106 (2004).
Jackson Allen PL. Guidelines for the diagnosis and treatment of celiac disease in children. Pediatr. Nurs. 30: 473-476 (2004).
Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, Smith C, Zeng W, Brown LE. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. U.S.A. 101: 15440-15445 (2004). *
Jacob M, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, Van Der Meulen JH. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl. 10: 903-907 (2004). *
Jacobs ET, Giuliano AR, Mart�nez ME, Hollis BW, Reid ME, Marshall JR. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J. Steroid Biochem. Mol. Biol. 89-90: 533-537 (2004).
Jacobs MN. In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology 205: 43-53 (2004). *
Jacobsohn DA, Vogelsang GB. Anti-cytokine therapy for the treatment of graft-versus-host disease. Curr. Pharm. Des. 10: 1195-1205 (2004).
Jacobson-Brown P, Neuman MG. Colorectal polyposis and immune-based therapies. Can. J. Gastroenterol. 18: 239-249 (2004). *
Jacoby RF, Cole CE, Hawk Et E, Lubet Ra R. Ursodeoxycholate/sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Gastroenterology 127: 838-844 (2004). *
Jadaho SB, Yang RZ, Lin Q, Hu H, Anania FA, Shuldiner AR, Gong DW. Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver. Hepatology 39: 1297-1302 (2004). *
Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int. 24: 85-89 (2004). *
Jaffe R. Liver involvement in the histiocytic disorders of childhood. Pediatr. Dev. Pathol. 7: 214-225 (2004). *
Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats. Biopharm. Drug Dispos. 25: 323 (2004). *
Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum. Genet. 114: 468-477 (2004). *
Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J. Ethnopharmacol. 90: 195-204 (2004). *
Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig. Dis. Sci. 49: 1752-1757 (2004). *
Jahnke K, Korfel A, Thiel E. Effective treatment of anaemia with darbepoetin alfa in a patient with hereditary hemochromatosis. Dtsch. Med. Wochenschr. 129: 739-740 (2004).
Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand. J. Gastroenterol. 39: 145-153 (2004). *
Jain A, Ma CA, Lopez-Granados E, Means G, Brady W, Orange JS, Liu S, Holland S, Derry JM. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J. Clin. Invest. 114: 1593-1602 (2004). *
Jain R. Biliary sludge: when should it not be ignored? Curr. Treat. Options Gastroenterol. 7: 105-109 (2004).
Jaisson-Hot I, Flourie B, Descos L, Colin C. Management for severe Crohn's disease: a lifetime cost-utility analysis. Int. J. Technol. Assess. Health Care 20: 274-279 (2004).
Jakel H, Nowak M, Moitrot E, Dehondt H, Hum D, Penacchio LA, Fruchart-Najib J, Fruchart JC. The LXR ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J. Biol. Chem. 279: 45462-45469 (2004). *
Jakobsson J, Karypidis H, Johansson JE, Roh HK, Rane A, Ekstrom L. A functional C-G polymorphism in the CYP7B1 promoter region and its different distribution in Orientals and Caucasians. Pharmacogenomics J. 4: 245-250 (2004).
Jalalirad M, Houshmand M, Mirfakhraie R, Goharbari MH, Mirzajani F. First study of CF mutations in the CFTR gene of Iranian patients: detection of F508, G542X, W1282X, A120T, R117H, and R347H mutations. J. Trop. Pediatr. 50: 359-361 (2004). *
Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127: 1338-1346 (2004). *
Jalan R, Olde Damink SW, Hayes PC, Deutz NE, Lee A. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J. Hepatol. 41: 613-620 (2004). *
Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut 53: 890-898 (2004). *
James Mason A, Siarheyeva A, Haase W, Lorch M, Van Veen H, Glaubitz C. Amino acid type selective isotope labelling of the multidrug ABC transporter LmrA for solid-state NMR studies. FEBS Lett. 568: 117-121 (2004). *
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80: 1611-1517 (2004). *
James SP. This month at the NIH: Action Plan for Liver Disease Research: call for public comment. Gastroenterology 127: 701-702 (2004). *
Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM, Shaw MA, Burgner D, Xu W, Lins-Lainson Z, Shaw JJ, Ramos F, Silveira F, Blackwell JM. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun. 5: 46-57 (2004). *
Jamil M, Ahmed U, Sobia H. Role of somatostatin analogues in the management of enterocutaneous fistulae. J. Coll. Physicians Surg. Pak. 14: 237-240 (2004).
Jamroziak K, Mlynarski W, Balcerczak E, Mistygacz M, Trelinska J, Mirowski M, Bodalski J, Robak T. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur. J. Haematol. 72: 314-321 (2004). *
Jamroziak K, Robak T. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies. Hematology 9: 91-105 (2004).
Janciauskiene S, Eriksson S, Callea F, Mallya M, Zhou A, Seyama K, Hata S, Lomas DA. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin. Hepatology 40: 1203-1210 (2004). *
Janczewska I, Mejhert M, Hast R, Runarsson G, Sandstedt B. Primary AL-amyloidosis, ulcerative colitis and collagenous colitis in a 57-year-old woman: a case study. Scand. J. Gastroenterol. 39: 1306-1309 (2004). *
Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K, Sasakawa C, Suzuki T, Nochi T, Yokota Y, Rennert PD, Hiroi T, Tamagawa H, Iijima H, Kunisawa J, Yuki Y, Kiyono H. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. U.S.A. 101: 6110-6115 (2004). *
Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat. Cell Biol. 6: 532-539 (2004). *
Janke KH, Raible A, Bauer M, Clemens P, Meisner C, Hauser W, Steder-Neukamm U, Henrich G, Herschbach P, Gregor M, Klump B. Questions on life satisfaction (FLZ(M)) in inflammatory bowel disease. Int. J. Colorectal Dis. 19: 343-353 (2004). *
Jankovic M, Casellas R, Yannoutsos N, Wardemann H, Nussenzweig MC. RAGs and regulation of autoantibodies. Annu. Rev. Immunol. 22: 485-501 (2004). *
Jankowiak B, Krajewska-Kulak E, Van Damme-Ostapowicz K, Wronska I, Lukaszuk C, Niczyporuk W, Baranowska A. The need for health education among patients with psoriasis. Dermatol. Nurs. 16: 439-444 (2004).
Jankowska I, Oldakowska-Jedynak U, Jabiry-Zieniewicz Z, Cyganek A, Pawlowska J, Teisseyre M, Kalicinski P, Markiewicz M, Paczek L, Socha J. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient. Transplant. Proc. 36: 3232-3233 (2004). *
Jankowska I, Pawlowska J, Teisseyre M, Kalicinski P, Kaminski A, Czubkowski P, Cielecka-Kuszyk J, Kluge P, Wozniak M, Oldakowska-Jedynak U, Socha J. Autoimmune hepatitis in transplanted liver. Transplant. Proc. 36: 3077-3082 (2004). *
Jansen G, van der Heijden J, Oerlemans R, Lems WF, Ifergan I, Scheper RJ, Assaraf YG, Dijkmans BA. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum. 50: 2130-2139 (2004). *
Jansen H. Hepatic lipase: friend or foe and under what circumstances? Curr. Atheroscler. Rep. 6: 343-347 (2004).
Jansen PL. Non-alcoholic steatohepatitis. Eur. J. Gastroenterol. Hepatol. 16: 1079-1085 (2004).
Jansen PL. Nonalcoholic steatohepatitis. Neth. J. Med. 62: 217-224 (2004). *
Janssen H, Janssen PH, Broelsch CE. UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury. Liver Transpl. 10: 1514-1523 (2004). *
Janssen LJ. The pulmonary biology of isoprostanes. Chem. Phys. Lipids 128: 101-116 (2004). *
Janssen R, Van Wengen A, Hoeve MA, Ten Dam M, Van Der Burg M, Van Dongen J, Van De Vosse E, Van Tol M, Bredius R, Ottenhoff TH, Weemaes C, Van Dissel JT, Lankester A. The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. J. Exp. Med. 200: 559-568 (2004). *
Jansson EA. Pivotal role of the nuclear receptor PPARgamma in colon epithelial cells. Ph.D. Thesis, Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden (2004). *
Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J. Appl. Genet. 45: 237-248 (2004). *
Jappe U, Boit R, Farrar MD, Ingham E, Sandoe J, Holland KT. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory. J. Eur. Acad. Dermatol. Venereol. 18: 450-454 (2004). *
Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin. Liver Dis. 24: 189-199 (2004).
Jaruga B, Hong F, Kim WH, Sun R, Fan S, Gao B. Chronic alcohol consumption accelerates liver injury in T cell-mediated hepatitis: alcohol disregulation of NF-kappaB and STAT3 signaling pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G471-G479 (2004). *
Jaskiewicz E. Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients. Postepy. Hig. Med. Dosw. (Online) 58: 472-482 (2004).
Jasny BR, Roberts L. Solving gene expression. Science 306: 629 (2004). *
Jass JR. Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC). Gut 53: 1055 (2004). *
Jauhar S, Talwalkar JA, Schneekloth T, Jowsey S, Wiesner RH, Menon KV. Analysis of factors that predict alcohol relapse following liver transplantation. Liver Transpl. 10: 408-411 (2004). *
Jaume M, Jacquet S, Cavailles P, Mace G, Stephan L, Blanpied C, Demur C, Brousset P, Dietrich G. Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 40: 1136-1143 (2004). *
Javitt NB. Oxysteroids: a new class of steroids with autocrine and paracrine functions. Trends Endocrinol. Metab. 15: 393-397 (2004). *
Jawaheer D, Lum RF, Amos CI, Gregersen PK, Criswell LA. Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum. 50: 736-741 (2004). *
Jawan B, de Villa V, Luk HN, Wang CS, Huang CJ, Chen YS, Wang CC, Cheng YF, Huang TL, Eng HL, Liu PP, Chiu KW, Chen CL. Perioperative normovolemic anemia is safe in pediatric living-donor liver transplantation. Transplantation 77: 1394-1398 (2004).
Jayaprakash A, Creed T, Stewart L, Colton B, Mountford R, Standen G, Probert C. Should we monitor vitamin B(12) levels in patients who have had end-ileostomy for inflammatory bowel disease? Int. J. Colorectal Dis. 19: 316-318 (2004). *
Jayaprakash A, Gould S, Lim AG, Shehata HA. Use of cyclosporin in pregnancy. Gut 53: 1386-1387 (2004). *
Jayasuriya H, Herath KB, Ondeyka JG, Polishook JD, Bills GF, Dombrowski AW, Springer MS, Siciliano S, Malkowitz L, Sanchez M, Guan Z, Tiwari S, Stevenson DW, Borris RP, Singh SB. Isolation and structure of antagonists of chemokine receptor (CCR5). J. Nat. Prod. 67: 1036-1038 (2004). *
Jayne D. The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies. Jpn. J. Infect. Dis. 57: S16-S17 (2004). *
Jayne D. Stem cell transplantation in systemic lupus erythematosus. Best Pract. Res. Clin. Haematol. 17: 291-304 (2004).
Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, Hiepe F, Lisukov I, Musso M, Ou-Yang J, Marsh J, Wulffraat N, Besalduch J, Bingham SJ, Emery P, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13: 168-176 (2004).
Jayne D, Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13: 359-365 (2004).
Jaysekhar P, Rao SB, Santhakumari G. Effect of 5-substituted benzylideneaminosalicylic acid on carrageenan-induced ulcerative colitis. Boll. Chim. Farm. 143: 309-313 (2004).
Jedlitschky G, Tirschmann K, Lubenow LE, Nieuwenhuis HK, Akkerman JW, Greinacher A, Kroemer HK. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 104: 3603-3610 (2004). *
Jeejeebhoy KN. Enteral feeding. Curr. Opin. Gastroenterol. 20: 110-113 (2004).
Jeffery B, Choudhury AI, Horley N, Bruce M, Tomlinson SR, Roberts RA, Gray TJ, Barrett DA, Shaw PN, Kendall D, Bell DR. Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver. Arch. Biochem. Biophys. 429: 231-236 (2004). *
Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27: 2422-2428 (2004). *
Jelinkova L, Tuckova L, Cinova J, Flegelova Z, Tlaskalova-Hogenova H. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett. 571: 81-85 (2004). *
Jelleyman T, Ure A. Attitudes to immunisation: a survey of health professionals in the Rotorua District. N. Z. Med. J. 117: U769 (2004).
Jeng KS, Sheen IS, Tsai YC. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? Am. J. Gastroenterol. 99: 1503-1509 (2004). *
Jenkins MC. Present and future control of cryptosporidiosis in humans and animals. Expert Rev. Vaccines 3: 669-671 (2004).
Jensen DM. Cholestasis. Clin. Liver Dis. 8: xi-xii (2004).
Jensen LE, Wall AM, Cook M, Hoess K, Thorn CF, Whitehead AS, Mitchell LE. A common ABCC2 promoter polymorphism is not a determinant of the risk of spina bifida. Birth Defects Res. Part A. Clin. Mol. Teratol. 70: 396-399 (2004). *
Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, Elly C, Yang C, Arya S, Bachmaier K, Su L, Bouchard D, Jones R, Gronski M, Ohashi P, Wada T, Bloom D, Fathman CG, Liu YC, Penninger JM. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177 (2004). *
Jerala R, Porro M. Endotoxin neutralizing peptides. Curr. Top. Med. Chem. 4: 1173-1184 (2004).
Jergens AE. Clinical assessment of disease activity for canine inflammatory bowel disease. J. Am. Anim. Hosp. Assoc. 40: 437-445 (2004).
Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment. Pharmacol. Ther. 19: 287-293 (2004). *
Jessop DS, Richards LJ, Harbuz MS. Brief review. Stress 7: 261-266 (2004).
Jette C, Peterson PW, Sandoval IT, Manos EJ, Hadley E, Ireland CM, Jones DA. The tumor suppressor adenomatous polyposis coli and caudal related homeodomain protein regulate expression of retinol dehydrogenase L. J. Biol. Chem. 279: 34397-34405 (2004). *
Jetten AM. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr. Drug Targets Inflamm. Allergy 3: 395-412 (2004).
Jeurissen A, Wuyts G, Kasran A, Ramdien-Murli S, Blanckaert N, Boon L, Ceuppens JL, Bossuyt X. The human antibody response to pneumococcal capsular polysaccharides is dependent on the CD40-CD40 ligand interaction. Eur. J. Immunol. 34: 850-858 (2004). *
Jeyarajah DR. Recurrent pyogenic cholangitis. Curr. Treat. Options Gastroenterol. 7: 91-98 (2004).
Jha R, Al-Kawas FH. How good is IDUS in patients with isolated biliary strictures? Am. J. Gastroenterol. 99: 1690-1691 (2004). *
Jho DH, Cole SM, Lee EM, Espat NJ. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr. Cancer Ther. 3: 98-111 (2004). *
Ji B, Ito K, Sekine S, Tajima A, Horie T. Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver. Free Radic. Biol. Med. 37: 1718-1729 (2004).
Ji C, Deng Q, Kaplowitz N. Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40: 442-451 (2004). *
Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J. Gastroenterol. 10: 1699-1708 (2004). *
Ji SL, Du HY, Chi YQ, Cui HF, Cao JC, Geng MY, Guan HS. Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients. World J. Gastroenterol. 10: 3485-3489 (2004). *
Jia C, Zheng S, Zhu Y. Intrathymic inoculation of liver specific antigen alleviates liver transplant rejection. Chin. Med. Sci. J. 19: 38-43 (2004).
Jia L, Choong CS, Ricciardelli C, Kim J, Tilley WD, Coetzee GA. Androgen receptor signaling: mechanism of interleukin-6 inhibition. Cancer Res. 64: 2619-2626 (2004). *
Jia Q, Zhou HR, Bennink M, Pestka JJ. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J. Nutr. 134: 3343-3349 (2004). *
Jia Y, Qi C, Kashireddi P, Surapureddi S, Zhu YJ, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J. Biol. Chem. 279: 24427-24434 (2004). *
Jian YT, Wang JD, Mai GF, Zhang YL, Lai ZS. Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis. Di Yi Jun Yi Da Xue Xue Bao 24: 1353-1358 (2004).
Jiang HQ, Thurnheer MC, Zuercher AW, Boiko NV, Bos NA, Cebra JJ. Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. Vaccine 22: 805-811 (2004). *
Jiang JT, Wu CP, Deng HF, Lu MY, Wu J, Zhang HY, Sun WH, Ji M. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. World J. Gastroenterol. 10: 1675-1677 (2004). *
Jiang X, Norman M, Roth L, Li X. Protein/DNA array based Identification of transcription factor activities regulated by interaction with the glucocorticoid receptor. J. Biol. Chem. 279: 38480-38485 (2004). *
Jiang XH, Song YL, Long YQ. Facile synthesis of 4-substituted-4-aminopiperidine derivatives, the key building block of piperazine-based CCR5 antagonists. Bioorg. Med. Chem. Lett. 14: 3675-3678 (2004). *
Jiang XH, Zong RQ, Fang XY, An F, Hu Y, Kong XT. Relationship between alleles of HLA-DRB and HLA-DQB1 and Chinese patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 12: 436 (2004).
Jiang XL, Cui HF. Different therapy for different types of ulcerative colitis in China. World J. Gastroenterol. 10: 1513-1520 (2004). *
Jiang Y, Xia B. Association between the cytotoxic T lymphocyte antigen-4 gene microsatellite polymorphism and inflammatory bowel diseases in the Chinese. Zhonghua Nei Ke Za Zhi 43: 191-194 (2004).
Jiang YG, Wang YM. Study on the polymorphisme of human leucocyte antigen-DRB1, -DQA1 and -DQB1 alleles in patients with hepatitis B. Zhonghua Liu Xing Bing Xue Za Zhi 25: 337-340 (2004).
Jiao Z, Liang HQ, Ding JJ, Li ZD, Shi XJ, Zhong MK. Effect of MDR1 polymorphic expression on oral disposition of cyclosporine A. Yao Xue Xue Bao 39: 971-974 (2004).
Jie HB, Sarvetnick N. The role of NK cells and NK cell receptors in autoimmune disease. Autoimmunity 37: 147-153 (2004).
Jimenez JM. Infliximab in the treatment of severe ulcerative colitis. Rev. Esp. Enferm. Dig. 96: 89-93 (2004).
Jimenez-Lara AM, Clarke N, Altucci L, Gronemeyer H. Retinoic-acid-induced apoptosis in leukemia cells. Trends Mol. Med. 10: 508-515 (2004). *
Jimenez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr. Transplant. 8: 243-248 (2004).
Jin S, Mathis AS, Rosenblatt J, Minko T, Friedman GS, Gioia K, Serur DS, Knipp GT. Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: macrophage scavenger receptor regulation. Transplantation 77: 497-504 (2004).
Jin SY. Familial primary biliary cirrhosis in sisters. Korean J. Hepatol. 10: 73-77 (2004).
Jin SY. Primary sclerosing cholangitis. Korean J. Hepatol. 10: 154-157 (2004).
Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Hong SJ, Park HK, Chung JH, Lee MH. Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res. 17: 84-86 (2004). *
Jin YH, Jeon EJ, Li QL, Lee YH, Choi JK, Kim WJ, Lee KY, Bae SC. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279: 29409-29417 (2004). *
Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Serum matrix metalloproteinase-3 in systemic sclerosis. Arch. Dermatol. Res. 296: 25-29 (2004). *
Jirsa M, Cebecauerova D, Budisova L, Chuzhanova N, Hrebicek M, Dvorakova L, Vitek L, Brodanova M, Hulek P, Taimr P. Indel in the FIC1/ATP8B1 gene - a novel rare type of mutation associated with benign recurrent intrahepatic cholestasis. Hepatol. Res. 30: 1-3 (2004).
Jirtle RL. IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterology 126: 1190-1193 (2004). *
Joglekar S, Levin M. The promise of thalidomide: evolving indications. Drugs Today (Barc.) 40: 197-204 (2004).
Johal SS, Hammond J, Solomon K, James PD, Mahida YR. Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy. Gut 53: 673-677 (2004). *
Johal SS, Lambert CP, Hammond J, James PD, Borriello SP, Mahida YR. Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea. J. Clin. Pathol. 57: 973-979 (2004). *
Johansen FE, Brandtzaeg P. Transcriptional regulation of the mucosal IgA system. Trends Immunol. 25: 150-157 (2004). *
Johansson CM, Zunec R, Garcia MA, Scherbarth HR, Tate GA, Paira S, Navarro SM, Perandones CE, Gamron S, Alvarellos A, Graf CE, Manni J, Berbotto GA, Palatnik SA, Catoggio LJ, Battagliotti CG, Sebastiani GD, Migliaresi S, Galeazzi M, Pons-Estel BA, et al. Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus. Hum. Genet. 115: 230-238 (2004). *
Johansson-Lindbom B, Agace WW. Vitamin A helps gut T cells find their way in the dark. Nat. Med. 10: 1300-1301 (2004). *
John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W, Vasavda N, Mills T, Barton A, Hinks A, Eyre S, Jones KW, Ollier W, Silman A, Gibson N, Worthington J, Kennedy GC. Whole-genome scan, in a complex disease, using 11,245 single-nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75: 54-64 (2004). *
Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 53: 1340-1344 (2004). *
Johnson CD, Balagurunathan Y, Tadesse MG, Falahatpisheh MH, Brun M, Walker MK, Dougherty ER, Ramos KS. Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. Environ. Health Perspect. 112: 403-412 (2004). *
Johnson LB, Al-Kawas FH. The bile duct - the Achilles' heel of living donor liver transplantation. Am. J. Gastroenterol. 99: 1296-1297 (2004). *
Johnson MB, Enns CA. Regulation of transferrin receptor 2 by transferrin: diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104: 4287-4293 (2004). *
Johnson MW, Dewar DH, Ciclitira P, Forbes A, Nicholls RJ, Bjarnason I. Use of fecal lactoferrin to diagnose irritable pouch syndrome: a word of caution. Gastroenterology 127: 1647-1648 (2004). *
Johnson P, Richard C, Ravid A, Spencer L, Pinto E, Hanna M, Cohen Z, McLeod R. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis. Colon Rectum 47: 1119-1126 (2004). *
Johnson TC, Diamond B, Memeo L, Negulescu H, Hovhanissyan Z, Verkarre V, Rotterdam H, Fasano A, Caillat-Zucman S, Grosdidier E, Winchester R, Cellier C, Jabri B, Green PH. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin. Gastroenterol. Hepatol. 2: 888-894 (2004). *
Jolesz FA, Hynynen K, McDannold N, Freundlich D, Kopelman D. Noninvasive thermal ablation of hepatocellular carcinoma by using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 127 (5 Suppl. 2): S242-S247 (2004). *
Jolly CA. Dietary restriction and immune function. J. Nutr. 134: 1853-1856 (2004). *
Jonas E, Naslund E, Freedman J, Befrits R, Blomqvist L, Siosteen AK, Jacobsson H, Hultcrantz R. Parenchymal function and bile duct flow as measured by dynamic 99m Tc-HIDA SPECT as prognostic tool in primary sclerosing cholangitis. Gastroenterology 126: A714 (2004).
Jones DA, Yawalkar N, Suh KY, Sadat S, Rich B, Kupper TS. Identification of autoantigens in psoriatic plaques using expression cloning. J. Invest. Dermatol. 123: 93-100 (2004). *
Jones DE. Primary biliary cirrhosis. Autoimmunity 37: 325-328 (2004).
Jones DE. Experimental models for primary biliary cirrhosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 41-42 (2004). *
Jones EA. Fatigue complicating chronic liver disease. Metab. Brain Dis. 19: 421-429 (2004).
Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on recent research. Cell. Mol. Life Sci. 61: 682-699 (2004). *
Jones S, Shannon H, Srivastava E, Haboubi N. A novel approach to a patient with Crohn disease and a high stoma output: a missed opportunity? Scand. J. Gastroenterol. 39: 398-400 (2004). *
Jones SA, Butler RN, Sanderson IR, Wilson JW. The effect of specific caspase inhibitors on TNF-alpha and butyrate-induced apoptosis of intestinal epithelial cells. Exp. Cell Res. 292: 29-39 (2004). *
Jonnalagadda SS. Improving prognosis in pancreatic cancer-an uphill endeavor. Gastroenterology 127: 1636-1637 (2004). *
Jono H, Lim JH, Chen LF, Xu H, Trompouki E, Pan ZK, Mosialos G, Li JD. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279: 36171-36174 (2004). *
Jonsdottir T, Forslid J, Van Vollenhoven AM, Harju A, Brannemark SA, Klareskog L, Van Vollenhoven RF. Treatment with TNF-alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies (ACLA): ACLA predict worse clinical outcome with infliximab and more frequent treatment limiting infusion reactions. Ann. Rheum. Dis. 63: 1075-1078 (2004). *
Jonsen A, Bengtsson AA, Sturfelt G, Truedsson L. Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility. Arthritis Res. Ther. 6: R557-R562 (2004). *
Jonsson JR, Gu W, Vanags DM, Bishop GA, McCaughan GW, Fawcett J, Lynch SV, Balderson GA, Powell EE, Clouston AD. Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transpl. 10: 397-403 (2004). *
Joo SS, Won TJ, Lee do I. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res. 27: 954-960 (2004).
Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, Hahn EG, Schuppan D. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Digestion 69: 131-139 (2004).
Joossens S, Daperno M, Shums Z, Van Steen K, Goeken JA, Trapani C, Norman GL, Godefridis G, Claessens G, Pera A, Pierik M, Vermeire S, Rutgeerts P, Bossuyt X. Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis. Clin. Chem. 50: 1422-1425 (2004). *
Joossens S, Vermeire S, Van Steen K, Godefridis G, Claessens G, Pierik M, Vlietinck R, Aerts R, Rutgeerts P, Bossuyt X. Pancreatic autoantibodies in inflammatory bowel disease. Inflamm. Bowel Dis. 10: 771-777 (2004). *
Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr. Opin. Rheumatol. 16: 62-66 (2004).
Jorde LB, Wooding SP. Genetic variation, classification and 'race'. Nat. Genet. 36 (11 Suppl.): S28-S33 (2004). *
Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O'Connell RM, Cheng G, Saez E, Miller JF, Tontonoz P. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119: 299-309 (2004). *
Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology 24: 149-152 (2004).
Joshi R. Immunopathogenesis of psoriasis. Indian J. Dermatol. Venereol. Leprol. 70: 10-12 (2004).
Jou YS, Lee CS, Chang YH, Hsiao CF, Chen CF, Chao CC, Wu LS, Yeh SH, Chen DS, Chen PJ. Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res. 64: 3030-3036 (2004). *
Jouen F, Vittecoq O, Leguillou F, Tabti-Titon I, Menard JF, Mejjad O, Pouplin S, Boumier P, Fardellone P, Gayet A, Gilbert D, Tron F, Le Loet X. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin. Exp. Immunol. 137: 606-611 (2004). *
Jourdan M, Vaubourdolle M, Cynober L, Aussel C. Effect of aging on liver functions-an experimental study in a perfused rat liver model. Exp. Gerontol. 39: 1341-1346 (2004).
Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 53: 1479-1484 (2004). *
Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin. Nutr. 23: 161-170 (2004).
Jubeh TT, Barenholz Y, Rubinstein A. Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm. Res. 21: 447-453 (2004). *
Judge TA, Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterol. Clin. North Am. 33: 421-454 (2004).
Judkowski V, Rodriguez E, Pinilla C, Masteller E, Bluestone JA, Sarvetnick N, Wilson DB. Peptide specific amelioration of T cell mediated pathogenesis in murine type 1 diabetes. Clin. Immunol. 113: 29-37 (2004). *
Judkowski VA, Allicotti GM, Sarvetnick N, Pinilla C. Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells. Diabetes 53: 2301-2309 (2004). *
Juedes AE, Von Herrath MG. Regulatory T-cells in type 1 diabetes. Diabetes Metab. Res. Rev. 20: 446-451 (2004).
Julia A, Gallardo D, Vidal F, Tomas C, Barcelo P, Vilardell M, Marsal S. Lack of association between the corticotropin-releasing hormone locus and rheumatoid arthritis. Arthritis Rheum. 50: 2706-2708 (2004). *
Jump DB. Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci. 41: 41-78 (2004).
Jump RL, Levine AD. Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease. Inflamm. Bowel Dis. 10: 462-478 (2004). *
Jun TY, Lee KU, Pae CU, Kweon YS, Chae JH, Bahk WM, Kim KS, Lew TY, Han H. No evidence for an association of the CTLA4 gene with bipolar I disorder. Psychiatry Clin. Neurosci. 58: 21-24 (2004).
Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am. J. Med. Genet. 131A: 11-17 (2004). *
Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 126: 654-659 (2004). *
Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53: 78-84 (2004). *
Jung D, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick GA. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse and rat NTCP gene. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G752-G761 (2004). *
Jung JW, Park JS, Hwang JW, Kang KS, Lee YS, Song BS, Lee GJ, Yeo CD, Kang JS, Lee WS, Jeon KS, Um CH, Kim YS, Oh MJ, Youn JP, Li P, Park JE, Hwang SY. Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarray. J. Vet. Med. Sci. 66: 1329-1333 (2004). *
Jung S. Good, bad and beautiful - the role of dendritic cells in autoimmunity. Autoimmun. Rev. 3: 54-60 (2004). *
Jungles SL. Video wireless capsule endoscopy: a diagnostic tool for early Crohn's disease. Gastroenterol. Nurs. 27: 170-175 (2004).
Jungst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 39: 1663-1672 (2004). *
Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50: 81-92 (2004). *
K Brenner M. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential. Best Pract. Res. Clin. Haematol. 17: 359-374 (2004).
Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found. Symp. 262: 247-260 (2004).
Kaaroud H, Boubaker K, Beji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB. Renal amyloidosis followed more than 5 years: report of 12 cases. Transplant. Proc. 36: 1796-1798 (2004). *
Kabesch M, Hasemann K, Schickinger V, Tzotcheva I, Bohnert A, Carr D, Baldini M, Hackstein H, Leupold W, Weiland SK, Martinez FD, Mutius E, Bein G. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy 59: 520-535 (2004). *
Kadaja L, Kisand KE, Peet N, Braun U, Metskua K, Teesalu K, Vibo R, Kisand KV, Uibo R, Jockusch H, Seppet EK. IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units? Mol. Cell. Biochem. 256: 291-303 (2004). *
Kadivar K, Ruchelli ED, Markowitz JE, Defelice ML, Strogatz ML, Kanzaria MM, Reddy KP, Baldassano RN, von Allmen D, Brown KA. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. Inflamm. Bowel Dis. 10: 593-598 (2004). *
Kadry Z, Cintorino D, Foglieni CS, Fung J. The pitfall of the cystic duct biliary anastomosis in right lobe living donor liver transplantation. Liver Transpl. 10: 1549-1550 (2004). *
Kadry Z, Selzner N, Selzner M, Clavien PA. Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl. 10: 1078 (2004). *
Kageyama G, Kawano S, Kanagawa S, Kondo S, Sugita M, Nakanishi T, Shimizu A, Kumagai S. Effect of mutated transporters associated with antigen-processing 2 on characteristic major histocompatibility complex binding peptides: analysis using electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18: 995-1000 (2004). *
Kahaleh M, Shami VM, Brock A, Conaway MR, Yoshida C, Moskaluk CA, Adams RB, Tokar J, Yeaton P. Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia. Am. J. Gastroenterol. 99: 2335-2339 (2004). *
Kahan BD. Sirolimus-based immunosuppression: present state of the art. J. Nephrol. 17 Suppl. 8: S32-S39 (2004).
Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS, Lifton RP. WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc. Natl. Acad. Sci. U.S.A. 101: 2064-2069 (2004). *
Kahn E. Biliary atresia revisited. Pediatr. Dev. Pathol. 7: 109-124 (2004).
Kaila B, Grant D, Pettigrew N, Greenberg H, Bernstein CN. Crohn's disease recurrence in a small bowel transplant. Am. J. Gastroenterol. 99: 158-162 (2004). *
Kaiser HB. Risk factors in allergy/asthma. Allergy Asthma Proc. 25: 7-10 (2004).
Kaiser J. Scholarly publishing. NIH flooded with comments on public access proposal. Science 306: 1451 (2004). *
Kaiser J. Patient records. Privacy rule creates bottleneck for U.S. biomedical researchers. Science 305: 168-169 (2004). *
Kajinami K, Brousseau ME, Nartsupha C, Ordovas JM, Schaefer EJ. ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. J. Lipid Res. 45: 653-656 (2004). *
Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia. Am. J. Cardiol. 93: 104-107 (2004). *
Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner. Am. J. Cardiol. 93: 1046-1050 (2004). *
Kakar S, Aksoy S, Burgart LJ, Smyrk TC. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod. Pathol. 17: 696-700 (2004). *
Kakar S, Batts KP, Poterucha JJ, Burgart LJ. Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment. Mod. Pathol. 17: 874-878 (2004). *
Kakumu S. Is mortality from liver disease associated with normal serum aminotransferase concentrations? Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 2-3 (2004). *
Kalambokis G, Vassiliou V, Vergos T, Christou L, Tsatsoulis A, Tsianos EV. Isolated ACTH deficiency associated with Crohn's disease. J. Endocrinol. Invest. 27: 961-964 (2004).
Kalashnikova LA. Ischemic stroke at the young age: the role of antiphospholipid antibodies. Angiol. Sosud. Khir. 10: 8-12 (2004).
Kaler B, Karram T, Morgan WA, Bach PH, Yousef IM, Bomzon A. Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. Ren. Fail. 26: 507-516 (2004).
Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr. Gastroenterol. Rep. 6: 377-383 (2004).
Kalitsky-Szirtes J, Shayeganpour A, Brocks DR, Piquette-Miller M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab. Dispos. 32: 20-27 (2004). *
Kallianpur AR, Hall LD, Yadav M, Christman BW, Dittus RS, Haines JL, Parl FF, Summar ML. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol. Biomarkers Prev. 13: 205-212 (2004). *
Kallinich T, Briese S, Roesler J, Rudolph B, Sarioglu N, Blankenstein O, Keitzer R, Querfeld U, Haffner D. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. J. Rheumatol. 31: 2519-2522 (2004).
Kalra V, Mahajan S, Kesarwani PK. Rare presentation of Wilson's disease: a case report. Int. Urol. Nephrol. 36: 289-291 (2004).
Kaltenthaler E, Vergel YB, Chilcott J, Thomas S, Blakeborough T, Walters SJ, Bouchier H. A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. Health Technol. Assess. 8: iii, 1-89 (2004). *
Kam MH, Barben CP, Eu KW, Seow-Choen F. Small bowel malignancies: a review of 29 patients at a single centre. Colorectal Dis. 6: 195-197 (2004).
Kamada F, Suzuki Y, Shao C, Tamari M, Hasegawa K, Hirota T, Shimizu M, Takahashi N, Mao XQ, Doi S, Fujiwara H, Miyatake A, Fujita K, Chiba Y, Aoki Y, Kure S, Tamura G, Shirakawa T, Matsubara Y. Association of the hCLCA1 gene with childhood and adult asthma. Genes Immun. 5: 540-547 (2004). *
Kamal MA, Jusko WJ. Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays. J. Clin. Pharmacol. 44: 1034-1045 (2004). *
Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am. J. Surg. Pathol. 28: 365-373 (2004).
Kamboh MI, Sanghera DK, Mehdi H, Nestlerode CS, Chen Q, Khalifa O, Naqvi A, Manzi S, Bunker CH. Single nucleotide polymorphisms in the coding region of the apolipoprotein H (beta2-glycoprotein I) gene and their correlation with the protein polymorphism, anti-beta2glycoprotein I antibodies and cardiolipin binding. Ann. Hum. Genet. 68: 285-299 (2004). *
Kaminska B, Landowski P, Korzon M. Environmental factors in the etiopathology of the inflammatory bowels syndrome. Med. Wieku. Rozwoj. VIII: 97-105 (2004).
Kaminski M, Sippel M, Hirner A. Persistent perineal sinus closure after rectal extirpation-an alternative using bulbocavernosus fat flaps. Chirurg. 75: 627-630 (2004).
Kamisako T. What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia. J. Gastroenterol. Hepatol. 19: 955-957 (2004). *
Kamisako T, Ogawa H. Effects of pravastatin and bezafibrate on biliary lipid excretion and hepatic expression of Abcg5 and Abcg8 in the rat. J. Gastroenterol. Hepatol. 19: 879-883 (2004). *
Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand. J. Gastroenterol. 39: 1154-1158 (2004). *
Kamiya A, Gonzalez FJ. TNF-alpha regulates mouse fetal hepatic maturation induced by oncostatin M and extracellular matrices. Hepatology 40: 527-536 (2004). *
Kamiya A, Inoue Y, Kodama T, Gonzalez FJ. Hepatocyte nuclear factors 1alpha and 4alpha control expression of proline oxidase in adult liver. FEBS Lett. 578: 63-68 (2004). *
Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann. Surg. 239: 510-517 (2004). *
Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol. 173: 3871-3877 (2004). *
Kamm MA. Chronic active disease and maintaining remission in Crohn's disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 102-105 (2004). *
Kamm MA. Manipulation of enteric flora in clinical practice. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 36. May 7-8 (2004). *
Kamm MA. Early surgical intervention in ulcerative colitis. Gut 53: 308-309 (2004). *
Kammer GM, Laxminarayana D, Khan IU. Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes. Int. Rev. Immunol. 23: 225-244 (2004).
Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, Ebner F, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ulbrich C, Chrobok K, Forster G, Praetorius GM, Meyer P, Rehbock J, Cantor CR, Nelson MR, Braun A. Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res. 64: 8906-8910 (2004). *
Kamradt T, Volkmer-Engert R. Cross-reactivity of T lymphocytes in infection and autoimmunity. Mol. Divers. 8: 271-280 (2004).
Kanai T, Watanabe M. Regulatory T cells and inflammatory bowel diseases. Nihon Rinsho Meneki Gakkai Kaishi 27: 302-308 (2004).
Kanai Y, Hediger MA. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch. 447: 469-479 (2004). *
Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J. Pediatr. Surg. 39: 1686-1692 (2004).
Kanaoka S, Yoshida K, Miura N, Sugimura H, Kajimura M. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening. Gastroenterology 127: 422-427 (2004). *
Kanaya E, Shiraki T, Jingami H. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner. Biochem. J. 382: 913-921 (2004). *
Kanazawa A, Tsukada S, Sekine A, Tsunoda T, Takahashi A, Kashiwagi A, Tanaka Y, Babazono T, Matsuda M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakamura Y, Maeda S. Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. Am. J. Hum. Genet. 75: 832-843 (2004). *
Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y. Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J. Invest. Dermatol. 122: 851-852 (2004). *
Kanda T, Yokosuka O, Kojima H, Imazeki F, Nagao K, Tatsuno I, Saito Y, Saisho H. Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman. World J. Gastroenterol. 10: 2607-2608 (2004). *
Kane D, FitzGerald O. Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective. Curr. Rheumatol. Rep. 6: 292-298 (2004).
Kane D, Grassi W, Sturrock R, Balint PV. Musculoskeletal ultrasound - a state of the art review in rheumatology. Part 2: Clinical indications for musculoskeletal ultrasound in rheumatology. Rheumatology (Oxford) 43: 829-838 (2004). *
Kane D, Jensen LE, Grehan S, Whitehead AS, Bresnihan B, Fitzgerald O. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. J. Rheumatol. 31: 1274-1280 (2004). *
Kane S, Cohen SM, Hart J. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease. Inflamm. Bowel Dis. 10: 652-654 (2004). *
Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am. J. Gastroenterol. 99: 1523-1526 (2004). *
Kaneko J, Sugawara Y, Akamatsu N, Kokudo N, Makuuchi M. Spleen volume and platelet number changes after living donor liver transplantation in adults. Hepatogastroenterology 51: 262-263 (2004).
Kaneko J, Sugawara Y, Togashi J, Kishi Y, Akamatsu N, Makuuchi M. Simultaneous hepatic artery and portal vein thrombosis after living donor liver transplantation. Transplant. Proc. 36: 3087-3089 (2004).
Kaneko M, Ono T, Matsubara T, Yamamoto Y, Ikeda H, Yoshiki T, Furukawa S, Nakayama E. Serological identification of endothelial antigens predominantly recognized in Kawasaki disease patients by recombinant expression cloning. Microbiol. Immunol. 48: 703-711 (2004). *
Kanematsu M, Danet MI, Leonardou P, Mastropasqua M, Mosetti MA, Braga L, Woosley JT, Semelka RC. Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J. Magn. Reson. Imaging 20: 242-249 (2004). *
Kang A, Gray J, MacGuire T, Amar J, Owen D, Yoshida E, Salh B. Celiac sprue and ulcerative colitis in three South Asian women. Indian J. Gastroenterol. 23: 24-25 (2004). *
Kang H, Fisher MH, Xu D, Miyamoto YJ, Marchand A, Van Aerschot A, Herdewijn P, Juliano RL. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides. Nucleic Acids Res. 32: 4411-4419 (2004). *
Kang HY, Chung E, Lee M, Cho Y, Kang WH. Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br. J. Dermatol. 150: 462-468 (2004). *
Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172: 1287-1294 (2004). *
Kang Kim M, Petrovic L, Maltz C. Metastatic hepatocellular carcinoma. J. Hepatol. 41: 684 (2004). *
Kang MJ, Namgung KY, Kim MS, Ko BS, Han CS, Ahn HT, Shin HM. A case of Kaposi's sarcoma associated with ulcerative colitis. Korean J. Gastroenterol. 43: 316-319 (2004).
Kang TJ, Yeum CE, Kim BC, You EY, Chae GT. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 112: 674-680 (2004). *
Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum. Immunol. 65: 47-53 (2004).
Kanke K, Nakano M, Hiraishi H, Terano A. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig. Liver Dis. 36: 811-817 (2004).
Kankesan J, Vanama R, Yusuf A, Thiessen JJ, Ling V, Rao PM, Rajalakshmi S, Sarma DS. Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats. Carcinogenesis 25: 425-230 (2004). *
Kano M, Shoda J, Sumazaki R, Oda K, Nimura Y, Tanaka N. Mutations identified in the human multidrug resistance P-glycoprotein 3 (ABCB4) gene in patients with primary hepatolithiasis. Hepatol. Res. 29: 160-166 (2004).
Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, de Andrade M, McMurray CT, Weinshenker BG. CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS. J. Neuroimmunol. 146: 162-170 (2004).
Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am. J. Gastroenterol. 99: 1726-1732 (2004). *
Kanwar JR, Kanwar RK, Krissansen GW. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127: 1313-1331 (2004).
Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J. Immunol. 173: 3482-3491 (2004). *
Kao YL, Ffrench RA, Williams G. Polymorphism report: identification of two common single nucleotide polymorphisms in the human Toll-like receptor 5 (TLR5) gene. Mol. Cell. Probes 18: 205 (2004).
Kapel N, Barbot L, Gobert JG. New fecal markers: recent developments and perspectives. Ann. Pharm. Fr. 62: 371-375 (2004).
Kaplan G, Panaccione R. The race to block TNF-alpha: the caution flag is raised again. Inflamm. Bowel Dis. 10: 61-62 (2004). *
Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99: 2147-2149 (2004). *
Kaplan MM, Bianchi DW. Primary biliary cirrhosis: for want of an X chromosome? Lancet 363: 505-506 (2004). *
Kaplan MM, Cheng S, Price LL, Bonis PAL. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Hepatology 39: 915-923 (2004). *
Kaplowitz N. Statin-induced hepatotoxicity. Gastroenterology 127: 1278 (2004). *
Kaplowitz N. Hepatology highlights. Hepatology 40: 1031-1032 (2004).
Kaplowitz N. Hepatology highlights. Hepatology 39: 271-272 (2004). *
Kapp P, Bely M, Nemesanszky E. Ultrastructural findings in the liver due to long-term retinol (isotretinoin) treatment. Significance of the perisinusoidal (Ito) cells. Orv. Hetil. 145: 173-179 (2004).
Kapturczak MH, Wasserfall C, Brusko T, Campbell-Thompson M, Ellis TM, Atkinson MA, Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165: 1045-1053 (2004). *
Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16: 166-177 (2004). *
Kara E, Sungurtekin H, Sungurtekin U, Alkanat M, Ilkgul O. The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats: an experimental study. Inflamm. Bowel Dis. 10: 112-115 (2004). *
Karaca C, Pinarbasi B, Danalioglu A, Akyuz F, Kaymakoglu S, Ozdil S, Boztas G, Mungan Z. Liver abscess as a rare complication of Crohn's disease: a case report. Turk. J. Gastroenterol. 15: 45-48 (2004). *
Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun. 5: 261-266 (2004). *
Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel PY, Menz G, Akdis CA, Blaser K, Schmidt-Weber CB. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114: 1425-1433 (2004). *
Karagiannis ED, Popel AS. A theoretical model of type I collagen proteolysis by MMP2 and MT1-MMP in the presence of TIMP2. J. Biol. Chem. 279: 39105-39114 (2004). *
Karajeh MA, Hadjivassiliou M, Hurlstone P, Grundman MJ. Neurological sequelae of Crohn's disease: opportunity to study common etiological pathways. J. Gastroenterol. Hepatol. 19: 1093-1094 (2004). *
Karaoglu AO, Yukselen V. Obstructing Crohn's disease of the duodenum: is surgery always mandatory? Int. J. Clin. Pract. 58: 221-223 (2004).
Karaoglu AO, Yukselen V, Ertem GT, Erkus M. Salmonellosis and ulcerative colitis. A causal relationship or just a coincidence. Saudi Med. J. 25: 1486-1488 (2004).
Karassa FB, Trikalinos TA, Ioannidis JP. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed. Pharmacother. 58: 286-291 (2004).
Karasu Z, Mindikoglu AL, Van Thiel DH. Cardiovascular problems in cirrhotic patients. Turk. J. Gastroenterol. 15: 126-132 (2004). *
Karasu Z, Ulukaya S, Ayanoglu HO, Basturk B, Ulukaya E, Akyildiz M, Tokat Y. Cytokine gene polymorphism and early graft rejection in liver transplant recipients. Transplant. Proc. 36: 2791-2795 (2004).
Karban A, Eliakim R. Failure to replicate the association of the novel NOD2/CARD15 haplotype (S268P-JW1) to Crohn's disease in the Jewish Israeli population. Gastroenterology 126: 624-625 (2004). *
Karban A, Waterman M, Panhuysen CI, Pollak RD, Nesher S, Datta L, Weiss B, Suissa A, Shamir R, Brant SR, Eliakim R. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic jews with Crohn's disease. Am. J. Gastroenterol. 99: 1134-1140 (2004). *
Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 13: 35-45 (2004). *
Karhausen JO, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114: 1098-1106 (2004). *
Kariko K, Bhuyan P, Capodici J, Ni H, Lubinski J, Friedman H, Weissman D. Exogenous siRNA mediates sequence-independent gene suppression by signaling through Toll-like receptor 3. Cells Tissues Organs 177: 132-138 (2004).
Kariko K, Weissman D, Welsh FA. Inhibition of Toll-like receptor and cytokine signaling - a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24: 1288-1304 (2004).
Karimi M, Yavarian M, Delbini P, Harteveld CL, Farjadian S, Fiorelli G, Giordano PC. Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous. Hematol. J. 5: 524-527 (2004).
Karlis J, Penttila I, Tran TB, Jones B, Nobbs S, Zola H, Flesch IE. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm. Bowel Dis. 10: 834-847 (2004). *
Karlsson Faresjo MG, Ernerudh J, Ludvigsson J. Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes. Scand. J. Immunol. 59: 517-526 (2004). *
Karoui M, Cohen R, Nicholls J. Results of surgical removal of the pouch after failed restorative proctocolectomy. Dis. Colon Rectum 47: 869-875 (2004). *
Karoui S, Bouallegue L, Hamzaoui S, Filali A, Boubaker J. Fatal miliary tuberculosis following treatment with infliximab. Tunis. Med. 82: 393-396 (2004).
Karoui S, Boubaker J, Filali A. Indications and results of infliximab in Crohn's disease. Tunis. Med. 82: 1057-1063 (2004).
Karoui S, Boubaker J, Filali A. Inflammatory bowel diseases and lymphoma. Tunis. Med. 82: 185-189 (2004).
Kasahara M, Kozaki K, Yoshida T, Yamamoto H, Ogawa K, Ogura Y, Tanaka K. Subcapsular hematoma after right-lobe living-donor liver transplantation. J. Hepatobiliary Pancreat. Surg. 11: 330-332 (2004).
Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Murzl E, Grasl E, Jasarevic Z, Romani N, Offner FA, Tilg H. Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 24: 74-85 (2004). *
Kaser A, Nieuwenhuis EE, Strober W, Fuss I, Colgan S, Blumberg RS. CD1d-restricted T cell pathways at the epithelial-lymphocyte-luminal interface. J. Pediatr. Gastroenterol. Nutr. 39: S719-S722 (2004). *
Kaser A, Nieuwenhuis EE, Strober W, Mayer L, Fuss I, Colgan S, Blumberg RS. Natural killer T cells in mucosal homeostasis. Ann. N. Y. Acad. Sci. 1029: 154-168 (2004). *
Kashireddy PR, Rao MS. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp. Biol. Med. (Maywood) 229: 158-162 (2004). *
Kashireddy PV, Rao MS. Lack of peroxisome proliferator-activated receptor a in mice enhances methionine and choline deficient diet-induced steatohepatitis. Hepatol. Res. 30: 104-110 (2004).
Kasman NM, Badley EM. Beyond access: who reports that health care is not being received when needed in a publicly-funded health care system? Can. J. Public Health 95: 304-308 (2004).
Kaspers S, Kordonouri O, Schober E, Grabert M, Hauffa BP, Holl RW; German Working Group for Pediatric Diabetology. Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: a multicenter survey. J. Pediatr. 145: 790-795 (2004). *
Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch. Intern. Med. 164: 1275-1284 (2004). *
Kast RE, Altschuler EL. Bone density loss in Crohn's disease: role of TNF and potential for prevention by bupropion. Gut 53: 1056 (2004). *
Kastin DA, Buchman AL, Barrett T, Halverson A, Wallin A. Strictures from Crohn's disease diagnosed by video capsule endoscopy. J. Clin. Gastroenterol. 38: 346-349 (2004).
Kasumov T, Brunengraber LL, Comte B, Puchowicz MA, Jobbins K, Thomas K, David F, Kinman R, Wehrli S, Dahms W, Kerr D, Nissim I, Brunengraber H. New secondary metabolites of phenylbutyrate in humans and rats. Drug Metab. Dispos. 32: 10-19 (2004). *
Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, Murata T, Narumiya S, Kakita A, Majima M. Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology 39: 139-150 (2004). *
Kataria RK, Brent LH. Spondyloarthropathies. Am. Fam. Physician 69: 2853-2860 (2004). *
Katayama K. Ammonia metabolism and hepatic encephalopathy. Hepatol. Res. 30S: 73-80 (2004).
Katayama Y, Hidalgo A, Peired A, Frenette PS. Integrin alpha4beta7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation. Blood 104: 2020-2026 (2004). *
Kato A, Kato M, Ishii H, Ichimiya Y, Suzuki K, Kawasaki H, Yamamoto SI, Kumashiro R, Yamamoto K, Kawamura N, Hayashi N, Matsuzaki S, Terano A, Okita K, Watanabe A. Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol. Res. 30: 71-78 (2004).
Kato A, Suzuki K. How to select BCAA preparations. Hepatol. Res. 30S: 30-35 (2004).
Kato H, Ito A, Kawanokuchi J, Jin S, Mizuno T, Ojika K, Ueda R, Suzumura A. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult. Scler. 10: 651-659 (2004). *
Kato H, Nakamura M, Muramatsu M, Orito E, Ueda R, Mizokami M. Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. Hepatol. Res. 29: 180-190 (2004).
Kato J, Ido A, Hasuike S, Uto H, Hori T, Hayashi K, Murakami S, Terano A, Tsubouchi H. Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis. Hepatol. Res. 30: 34-41 (2004).
Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, Otsuka M, Hasunuma O, Kurihara R, Iwasaki A, Arakawa Y. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 20: 1133-1141 (2004). *
Kato M, Moriwaki H. Metabolic disorders in patients with liver cirrhosis. Hepatol. Res. 30S: 59-62 (2004).
Kato S, Ishii H. Lifestyle guidance for patients with chronic liver diseases; information provision via educational classes on liver diseases. Hepatol. Res. 30S: 81-85 (2004).
Kato T, Miyakawa H, Ishibashi M. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis. J. Autoimmun. 22: 211-216 (2004).
Kato T, Ubara Y, Sawa N, Tagami T, Katori H, Takemoto F, Tanimoto A, Takaichi K. A case of rheumatoid arthritis exhibiting accelerating rheumatoid pleurisy during low-dose weekly methotrexate therapy. Mod. Rheumatol. 14: 414-418 (2004).
Kato Y, Yoshida K, Watanabe C, Sai Y, Tsuji A. Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm. Res. 21: 1886-1894 (2004). *
Katoh M, Katoh M. Human FOX gene family (review). Int. J. Oncol. 25: 1495-1500 (2004).
Katyal M, Tiwari SC, Kumar A, Dinda AK, Arora V, Kumar R, Das N. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects. Mol. Immunol. 40: 1325-1332 (2004).
Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S, Mandelboim O. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J. Immunol. 173: 1819-1825 (2004). *
Katz J, Stavropoulos F, Bhattacharyya I, Stewart C, Perez FM, Caudle RM. Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren's syndrome: a preliminary study. Scand. J. Rheumatol. 33: 174-178 (2004).
Katz JA. Pregnancy and inflammatory bowel disease. Curr. Opin. Gastroenterol. 20: 328-332 (2004).
Katz JA. Treatment of inflammatory bowel disease with corticosteroids. Gastroenterol. Clin. North Am. 33: 171-189 (2004).
Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am. J. Gastroenterol. 99: 2385-2392 (2004). *
Katz PO, Rex DK. Highlights from the 68th Annual Scientific Meeting of the American College of Gastroenterology, October 13-15, 2003, Baltimore, MD. Rev. Gastroenterol. Disord. 4: 29-35 (2004). *
Kau CK, Hu JC, Lu LY, Tseng JC, Wang JS, Cheng HH. Primary Sjogren's syndrome complicated with cryoglobulinemic glomerulonephritis, myocarditis, and multi-organ involvement. J. Formos. Med. Assoc. 103: 707-710 (2004).
Kauffman CL, Aria N, Toichi E, McCormick TS, Cooper KD, Gottlieb AB, Everitt DE, Frederick B, Zhu Y, Graham MA, Pendley CE, Mascelli MA. A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J. Invest. Dermatol. 123: 1037-1044 (2004). *
Kaunitz JD, Akiba Y. Gastroduodenal mucosal defense: role of endogenous mediators. Curr. Opin. Gastroenterol. 20: 526-532 (2004).
Kaur N, Mahl TC. Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease. Dig. Dis. Sci. 49: 1458-1460 (2004). *
Kaur S, Norkina O, Ziemer D, Samuelson LC, De Lisle RC. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G480-G490 (2004). *
Kavanagh T, Lonergan PE, Lynch MA. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation. Prostaglandins Leukot. Essent. Fatty Acids 70: 391-397 (2004). *
Kavia S, Gilbert JM. Crohn's disease and discitis. J. R. Soc. Med. 97: 484-485 (2004). *
Kawabata H, Tong X, Kawanami T, Wano Y, Hirose Y, Sugai S, Phillip Koeffler H. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2. Br. J. Haematol. 127: 464-473 (2004). *
Kawabata Y, Kamada E, Furuta S, Takei M, Kurimoto T, Okudaira K, Nishigaki R. ATP-dependent transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) and its xenobiotic taurine conjugate (Z-335-Tau) by rat bile canalicular membrane vesicles. Pharm. Res. 21: 467-475 (2004). *
Kawaguchi H. Molecular mechanism of age-related osteoporosis. Nippon Ronen Igakkai Zasshi 41: 612-615 (2004).
Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Satomura Y, Arimura K, Osame M, Hattori T; The Study Group for Myasthenia Gravis in Japan. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J. Neurol. Sci. 224: 43-47 (2004).
Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum. 50: 216-226 (2004). *
Kawai K, Sasaki S, Morita H, Ito T, Suzuki S, Misawa H, Nakamura H. Unliganded thyroid hormone receptor beta1 represses liver X receptor alpha/oxysterol-dependent transactivation. Endocrinology 145: 5515-5524 (2004). *
Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, Terai K, Matsuda M, Inoue JI, Uematsu S, Takeuchi O, Akira S. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068 (2004). *
Kawamoto S, Siegelman SS, Hruban RH, Fishman EK. Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. AJR Am. J. Roentgenol. 183: 915-921 (2004). *
Kawamoto T, Noshiro M, Sato F, Maemura K, Takeda N, Nagai R, Iwata T, Fujimoto K, Furukawa M, Miyazaki K, Honma S, Honma K, Kato Y. A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation. Biochem. Biophys. Res. Commun. 313: 117-124 (2004). *
Kawamura N, Nakajima H, Takashi SI. Administration of granulated BCAA and quality of life. Hepatol. Res. 30S: 42-45 (2004).
Kawamura T, Bruce SE, Abraha A, Sugaya M, Hartley O, Offord RE, Arts EJ, Zimmerman PA, Blauvelt A. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J. Virol. 78: 7602-7609 (2004). *
Kawamura T, Kanai T, Dohi T, Uraushihara K, Totsuka T, Iiyama R, Taneda C, Yamazaki M, Nakamura T, Higuchi T, Aiba Y, Tsubata T, Watanabe M. Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J. Immunol. 172: 6388-6397 (2004). *
Kawasaki E, Ide A, Abiru N, Kobayashi M, Fukushima T, Kuwahara H, Kita A, Uotani S, Yamasaki H, Eguchi K. Stromal cell-derived factor-1 chemokine gene variant in patients with type 1 diabetes and autoimmune thyroid disease. Ann. N. Y. Acad. Sci. 1037: 79-83 (2004). *
Kawasaki M, Yagasaki K, Miura Y, Funabiki R. Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats. Biosci. Biotechnol. Biochem. 68: 72-78 (2004). *
Kawasaki Y, Kato Y, Sai Y, Tsuji A. Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. J. Pharm. Sci. 93: 2920-2926 (2004). *
Kawasaki Y, Suzuki J, Suzuki S, Suzuki H. Leukocytapheresis with leukocyte removal filter for severe ulcerative colitis in childhood. J. Pediatr. Gastroenterol. Nutr. 39: 422-425 (2004). *
Kawashima H, Ihara T, Ioi H, Oana S, Sato S, Kato N, Takami T, Kashiwagi Y, Takekuma K, Hoshika A, Mori T. Enterovirus-related type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan. J. Infect. 49: 147-151 (2004).
Kawashima H, Ryou S, Nishimata S, Ioi H, Kashiwagi Y, Iizumi M, Takami T, Sasamoto M, Takekuma K, Hoshika A, Mori T. Enteroviral hepatitis in children. Pediatr. Int. 46: 130-134 (2004). *
Kawashima K, Nomura A, Makino T, Saito K, Kano Y. Pharmacological properties of traditional medicine (XXIX): effect of Hange-shashin-to and the combinations of its herbal constituents on rat experimental colitis. Biol. Pharm. Bull. 27: 1599-1603 (2004). *
Kayacetin E, Koklu S, Temucin T. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure. Dig. Liver Dis. 36: 419-422 (2004).
Kaymakoglu S. Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? Turk. J. Gastroenterol. 15: 123-125 (2004). *
Kazkaz H, Isenberg D. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr. Opin. Pharmacol. 4: 398-402 (2004).
Keaveny AP, Gordon FD, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Khettry U. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome. Liver Transpl. 10: 115-122 (2004). *
Kedda MA, Shi J, Duffy D, Phelps S, Yang I, O'Hara K, Fong K, Thompson PJ. Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J. Allergy Clin. Immunol. 113: 889-895 (2004). *
Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, Kisiel N, Vujcic S, Mazurchuk RV, Porter CW. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J. Biol. Chem. 279: 40076-40083 (2004). *
Keech AC, The Field Study Investigators. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and